TW201740812A - Bacillus amyloliquefaciens RTI301 compositions and methods of use for benefiting plant growth and treating plant disease - Google Patents
Bacillus amyloliquefaciens RTI301 compositions and methods of use for benefiting plant growth and treating plant disease Download PDFInfo
- Publication number
- TW201740812A TW201740812A TW105115448A TW105115448A TW201740812A TW 201740812 A TW201740812 A TW 201740812A TW 105115448 A TW105115448 A TW 105115448A TW 105115448 A TW105115448 A TW 105115448A TW 201740812 A TW201740812 A TW 201740812A
- Authority
- TW
- Taiwan
- Prior art keywords
- plant
- genus
- phytophthora
- composition
- beans
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 194
- 241000193744 Bacillus amyloliquefaciens Species 0.000 title claims abstract description 104
- 230000008635 plant growth Effects 0.000 title claims abstract description 96
- 238000000034 method Methods 0.000 title claims abstract description 90
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims description 42
- 201000010099 disease Diseases 0.000 title claims description 40
- 230000001717 pathogenic effect Effects 0.000 claims abstract description 107
- 208000015181 infectious disease Diseases 0.000 claims abstract description 105
- 239000002689 soil Substances 0.000 claims abstract description 82
- 239000001963 growth medium Substances 0.000 claims abstract description 77
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 55
- 239000000417 fungicide Substances 0.000 claims abstract description 53
- 239000002917 insecticide Substances 0.000 claims abstract description 48
- 239000000126 substance Substances 0.000 claims abstract description 41
- 239000004009 herbicide Substances 0.000 claims abstract description 30
- 239000003337 fertilizer Substances 0.000 claims abstract description 29
- 239000005645 nematicide Substances 0.000 claims abstract description 25
- 244000000003 plant pathogen Species 0.000 claims abstract description 25
- 239000005648 plant growth regulator Substances 0.000 claims abstract description 23
- 230000000813 microbial effect Effects 0.000 claims abstract description 22
- 239000000419 plant extract Substances 0.000 claims abstract description 22
- 239000003899 bactericide agent Substances 0.000 claims abstract description 16
- 238000009331 sowing Methods 0.000 claims abstract 3
- 241000196324 Embryophyta Species 0.000 claims description 513
- -1 stalk Chemical compound 0.000 claims description 86
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 68
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 67
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 66
- 241000813090 Rhizoctonia solani Species 0.000 claims description 63
- 241000233614 Phytophthora Species 0.000 claims description 57
- 235000010469 Glycine max Nutrition 0.000 claims description 54
- 244000068988 Glycine max Species 0.000 claims description 54
- 241000209140 Triticum Species 0.000 claims description 54
- 235000021307 Triticum Nutrition 0.000 claims description 52
- 230000009286 beneficial effect Effects 0.000 claims description 52
- 240000008042 Zea mays Species 0.000 claims description 51
- 241000233639 Pythium Species 0.000 claims description 50
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 48
- 235000005822 corn Nutrition 0.000 claims description 48
- 150000001875 compounds Chemical class 0.000 claims description 47
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 47
- 239000000843 powder Substances 0.000 claims description 45
- 241000223221 Fusarium oxysporum Species 0.000 claims description 44
- 241000233866 Fungi Species 0.000 claims description 43
- 241000123650 Botrytis cinerea Species 0.000 claims description 41
- 238000013138 pruning Methods 0.000 claims description 41
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 40
- 240000003768 Solanum lycopersicum Species 0.000 claims description 40
- 235000013311 vegetables Nutrition 0.000 claims description 40
- 241000371644 Curvularia ravenelii Species 0.000 claims description 39
- 240000007594 Oryza sativa Species 0.000 claims description 38
- 235000007164 Oryza sativa Nutrition 0.000 claims description 38
- 235000009566 rice Nutrition 0.000 claims description 38
- 244000241257 Cucumis melo Species 0.000 claims description 37
- 240000007124 Brassica oleracea Species 0.000 claims description 36
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 36
- 235000010582 Pisum sativum Nutrition 0.000 claims description 36
- 240000004713 Pisum sativum Species 0.000 claims description 36
- 210000001519 tissue Anatomy 0.000 claims description 35
- 240000001980 Cucurbita pepo Species 0.000 claims description 34
- 235000014443 Pyrus communis Nutrition 0.000 claims description 30
- 244000025254 Cannabis sativa Species 0.000 claims description 29
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 29
- 230000012010 growth Effects 0.000 claims description 29
- 230000035876 healing Effects 0.000 claims description 28
- 239000005944 Chlorpyrifos Substances 0.000 claims description 27
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 claims description 27
- 230000000855 fungicidal effect Effects 0.000 claims description 27
- 241000220225 Malus Species 0.000 claims description 25
- 235000011430 Malus pumila Nutrition 0.000 claims description 25
- 235000015103 Malus silvestris Nutrition 0.000 claims description 25
- 240000005561 Musa balbisiana Species 0.000 claims description 25
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 25
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 25
- 240000006365 Vitis vinifera Species 0.000 claims description 25
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 25
- 241000223602 Alternaria alternata Species 0.000 claims description 24
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims description 24
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims description 24
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims description 24
- 241000894006 Bacteria Species 0.000 claims description 23
- 240000009088 Fragaria x ananassa Species 0.000 claims description 23
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 23
- 244000061456 Solanum tuberosum Species 0.000 claims description 23
- 240000001717 Vaccinium macrocarpon Species 0.000 claims description 23
- 230000008901 benefit Effects 0.000 claims description 23
- 241000223600 Alternaria Species 0.000 claims description 22
- 244000105624 Arachis hypogaea Species 0.000 claims description 22
- 241000221785 Erysiphales Species 0.000 claims description 22
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 22
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 22
- 241000221696 Sclerotinia sclerotiorum Species 0.000 claims description 22
- 244000078534 Vaccinium myrtillus Species 0.000 claims description 22
- 235000020232 peanut Nutrition 0.000 claims description 22
- 241000234282 Allium Species 0.000 claims description 21
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims description 21
- 235000002566 Capsicum Nutrition 0.000 claims description 21
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 21
- 235000021019 cranberries Nutrition 0.000 claims description 21
- 239000000284 extract Substances 0.000 claims description 21
- 235000014571 nuts Nutrition 0.000 claims description 21
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 claims description 20
- 241001361634 Rhizoctonia Species 0.000 claims description 20
- 239000008187 granular material Substances 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 20
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 19
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims description 19
- 235000009852 Cucurbita pepo Nutrition 0.000 claims description 19
- 239000006002 Pepper Substances 0.000 claims description 19
- 235000016761 Piper aduncum Nutrition 0.000 claims description 19
- 240000003889 Piper guineense Species 0.000 claims description 19
- 235000017804 Piper guineense Nutrition 0.000 claims description 19
- 235000008184 Piper nigrum Nutrition 0.000 claims description 19
- 241000335053 Beta vulgaris Species 0.000 claims description 18
- 240000002791 Brassica napus Species 0.000 claims description 18
- 240000008067 Cucumis sativus Species 0.000 claims description 18
- 241000482268 Zea mays subsp. mays Species 0.000 claims description 18
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims description 18
- 241000675108 Citrus tangerina Species 0.000 claims description 17
- 240000000560 Citrus x paradisi Species 0.000 claims description 17
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims description 17
- 241000223195 Fusarium graminearum Species 0.000 claims description 17
- 240000003183 Manihot esculenta Species 0.000 claims description 17
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 17
- 241000589516 Pseudomonas Species 0.000 claims description 17
- 240000007651 Rubus glaucus Species 0.000 claims description 17
- 230000001580 bacterial effect Effects 0.000 claims description 17
- 229940041514 candida albicans extract Drugs 0.000 claims description 17
- 239000012138 yeast extract Substances 0.000 claims description 17
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 16
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 16
- 235000018262 Arachis monticola Nutrition 0.000 claims description 16
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 16
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 16
- 235000014036 Castanea Nutrition 0.000 claims description 16
- 241001070941 Castanea Species 0.000 claims description 16
- 241000233616 Phytophthora capsici Species 0.000 claims description 16
- 241000221577 Uromyces appendiculatus Species 0.000 claims description 16
- 244000193174 agave Species 0.000 claims description 16
- 230000000844 anti-bacterial effect Effects 0.000 claims description 16
- 230000002363 herbicidal effect Effects 0.000 claims description 16
- 235000020234 walnut Nutrition 0.000 claims description 16
- 235000000832 Ayote Nutrition 0.000 claims description 15
- 229920000742 Cotton Polymers 0.000 claims description 15
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 15
- 241000233622 Phytophthora infestans Species 0.000 claims description 15
- 235000002597 Solanum melongena Nutrition 0.000 claims description 15
- 244000061458 Solanum melongena Species 0.000 claims description 15
- 235000021028 berry Nutrition 0.000 claims description 15
- 244000052769 pathogen Species 0.000 claims description 15
- 235000015136 pumpkin Nutrition 0.000 claims description 15
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 14
- 235000005979 Citrus limon Nutrition 0.000 claims description 14
- 244000131522 Citrus pyriformis Species 0.000 claims description 14
- 244000000626 Daucus carota Species 0.000 claims description 14
- 235000002767 Daucus carota Nutrition 0.000 claims description 14
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 14
- 241000589634 Xanthomonas Species 0.000 claims description 14
- 244000053095 fungal pathogen Species 0.000 claims description 14
- 235000021013 raspberries Nutrition 0.000 claims description 14
- 235000020354 squash Nutrition 0.000 claims description 14
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 13
- 240000005979 Hordeum vulgare Species 0.000 claims description 13
- 241001330975 Magnaporthe oryzae Species 0.000 claims description 13
- 240000000111 Saccharum officinarum Species 0.000 claims description 13
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 13
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 13
- 235000021014 blueberries Nutrition 0.000 claims description 13
- 239000002270 dispersing agent Substances 0.000 claims description 13
- 230000036541 health Effects 0.000 claims description 13
- 230000002829 reductive effect Effects 0.000 claims description 13
- 230000021749 root development Effects 0.000 claims description 13
- 241000222290 Cladosporium Species 0.000 claims description 12
- 235000009847 Cucumis melo var cantalupensis Nutrition 0.000 claims description 12
- 241000235527 Rhizopus Species 0.000 claims description 12
- 239000013543 active substance Substances 0.000 claims description 12
- 235000021374 legumes Nutrition 0.000 claims description 12
- 244000005700 microbiome Species 0.000 claims description 12
- 238000011282 treatment Methods 0.000 claims description 12
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 11
- 241001157813 Cercospora Species 0.000 claims description 11
- 244000020551 Helianthus annuus Species 0.000 claims description 11
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 11
- 235000002245 Penicillium camembertii Nutrition 0.000 claims description 11
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 11
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims description 10
- 240000002234 Allium sativum Species 0.000 claims description 10
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims description 10
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 10
- 240000000385 Brassica napus var. napus Species 0.000 claims description 10
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims description 10
- 241001486796 Calonectria pseudonaviculata Species 0.000 claims description 10
- 241000223218 Fusarium Species 0.000 claims description 10
- 241000948155 Phytophthora sojae Species 0.000 claims description 10
- 241000579741 Sphaerotheca <fungi> Species 0.000 claims description 10
- 235000009499 Vanilla fragrans Nutrition 0.000 claims description 10
- 244000263375 Vanilla tahitensis Species 0.000 claims description 10
- 235000012036 Vanilla tahitensis Nutrition 0.000 claims description 10
- 241000082085 Verticillium <Phyllachorales> Species 0.000 claims description 10
- 235000013339 cereals Nutrition 0.000 claims description 10
- 235000004611 garlic Nutrition 0.000 claims description 10
- 238000010899 nucleation Methods 0.000 claims description 10
- 240000007087 Apium graveolens Species 0.000 claims description 9
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims description 9
- 235000010591 Appio Nutrition 0.000 claims description 9
- 235000011330 Armoracia rusticana Nutrition 0.000 claims description 9
- 240000003291 Armoracia rusticana Species 0.000 claims description 9
- 241001465180 Botrytis Species 0.000 claims description 9
- 241000219198 Brassica Species 0.000 claims description 9
- 235000003351 Brassica cretica Nutrition 0.000 claims description 9
- 235000011293 Brassica napus Nutrition 0.000 claims description 9
- 235000004221 Brassica oleracea var gemmifera Nutrition 0.000 claims description 9
- 244000308368 Brassica oleracea var. gemmifera Species 0.000 claims description 9
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 claims description 9
- 235000003343 Brassica rupestris Nutrition 0.000 claims description 9
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 9
- 244000020518 Carthamus tinctorius Species 0.000 claims description 9
- 235000010523 Cicer arietinum Nutrition 0.000 claims description 9
- 244000045195 Cicer arietinum Species 0.000 claims description 9
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 claims description 9
- 244000193629 Cyphomandra crassifolia Species 0.000 claims description 9
- 235000000298 Cyphomandra crassifolia Nutrition 0.000 claims description 9
- 244000017020 Ipomoea batatas Species 0.000 claims description 9
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 9
- 235000003228 Lactuca sativa Nutrition 0.000 claims description 9
- 240000004322 Lens culinaris Species 0.000 claims description 9
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 claims description 9
- 241000209510 Liliopsida Species 0.000 claims description 9
- 235000004431 Linum usitatissimum Nutrition 0.000 claims description 9
- 240000004371 Panax ginseng Species 0.000 claims description 9
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 9
- 235000009230 Physalis pubescens Nutrition 0.000 claims description 9
- 240000001558 Physalis viscosa Species 0.000 claims description 9
- 235000002491 Physalis viscosa Nutrition 0.000 claims description 9
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims description 9
- 241000221662 Sclerotinia Species 0.000 claims description 9
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 9
- 244000040738 Sesamum orientale Species 0.000 claims description 9
- 240000003829 Sorghum propinquum Species 0.000 claims description 9
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 9
- 235000009337 Spinacia oleracea Nutrition 0.000 claims description 9
- 241000589636 Xanthomonas campestris Species 0.000 claims description 9
- 241000589652 Xanthomonas oryzae Species 0.000 claims description 9
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 9
- 244000052616 bacterial pathogen Species 0.000 claims description 9
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims description 9
- 210000004027 cell Anatomy 0.000 claims description 9
- 244000013123 dwarf bean Species 0.000 claims description 9
- 241001233957 eudicotyledons Species 0.000 claims description 9
- 238000009472 formulation Methods 0.000 claims description 9
- 235000008397 ginger Nutrition 0.000 claims description 9
- 235000008434 ginseng Nutrition 0.000 claims description 9
- 235000021331 green beans Nutrition 0.000 claims description 9
- 235000021384 green leafy vegetables Nutrition 0.000 claims description 9
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 claims description 9
- 235000010460 mustard Nutrition 0.000 claims description 9
- 235000011197 perejil Nutrition 0.000 claims description 9
- 239000004460 silage Substances 0.000 claims description 9
- 235000013599 spices Nutrition 0.000 claims description 9
- 241000208140 Acer Species 0.000 claims description 8
- 235000009434 Actinidia chinensis Nutrition 0.000 claims description 8
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 8
- 244000144725 Amygdalus communis Species 0.000 claims description 8
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 8
- 241000167854 Bourreria succulenta Species 0.000 claims description 8
- 244000045232 Canavalia ensiformis Species 0.000 claims description 8
- 235000009025 Carya illinoensis Nutrition 0.000 claims description 8
- 244000068645 Carya illinoensis Species 0.000 claims description 8
- 235000007542 Cichorium intybus Nutrition 0.000 claims description 8
- 244000298479 Cichorium intybus Species 0.000 claims description 8
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 8
- 244000060011 Cocos nucifera Species 0.000 claims description 8
- 235000007466 Corylus avellana Nutrition 0.000 claims description 8
- 235000001950 Elaeis guineensis Nutrition 0.000 claims description 8
- 244000127993 Elaeis melanococca Species 0.000 claims description 8
- 240000002395 Euphorbia pulcherrima Species 0.000 claims description 8
- 235000010099 Fagus sylvatica Nutrition 0.000 claims description 8
- 240000000731 Fagus sylvatica Species 0.000 claims description 8
- 235000010649 Lupinus albus Nutrition 0.000 claims description 8
- 240000000894 Lupinus albus Species 0.000 claims description 8
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims description 8
- 240000007817 Olea europaea Species 0.000 claims description 8
- 235000010617 Phaseolus lunatus Nutrition 0.000 claims description 8
- 240000006711 Pistacia vera Species 0.000 claims description 8
- 235000009827 Prunus armeniaca Nutrition 0.000 claims description 8
- 244000018633 Prunus armeniaca Species 0.000 claims description 8
- 235000006029 Prunus persica var nucipersica Nutrition 0.000 claims description 8
- 244000017714 Prunus persica var. nucipersica Species 0.000 claims description 8
- 241000221300 Puccinia Species 0.000 claims description 8
- 244000305267 Quercus macrolepis Species 0.000 claims description 8
- 235000002357 Ribes grossularia Nutrition 0.000 claims description 8
- 235000018735 Sambucus canadensis Nutrition 0.000 claims description 8
- 235000021536 Sugar beet Nutrition 0.000 claims description 8
- 235000020224 almond Nutrition 0.000 claims description 8
- 235000021029 blackberry Nutrition 0.000 claims description 8
- 235000007123 blue elder Nutrition 0.000 claims description 8
- 235000020226 cashew nut Nutrition 0.000 claims description 8
- 235000019693 cherries Nutrition 0.000 claims description 8
- 235000007124 elderberry Nutrition 0.000 claims description 8
- 235000008995 european elder Nutrition 0.000 claims description 8
- 235000015097 nutrients Nutrition 0.000 claims description 8
- 235000020233 pistachio Nutrition 0.000 claims description 8
- 239000004094 surface-active agent Substances 0.000 claims description 8
- 239000004563 wettable powder Substances 0.000 claims description 8
- 241000589158 Agrobacterium Species 0.000 claims description 7
- 241000228245 Aspergillus niger Species 0.000 claims description 7
- 241001091440 Grossulariaceae Species 0.000 claims description 7
- 241000208467 Macadamia Species 0.000 claims description 7
- 241000228143 Penicillium Species 0.000 claims description 7
- 241000589615 Pseudomonas syringae Species 0.000 claims description 7
- 235000001537 Ribes X gardonianum Nutrition 0.000 claims description 7
- 235000001535 Ribes X utile Nutrition 0.000 claims description 7
- 235000016919 Ribes petraeum Nutrition 0.000 claims description 7
- 244000281247 Ribes rubrum Species 0.000 claims description 7
- 235000002355 Ribes spicatum Nutrition 0.000 claims description 7
- 241000242583 Scyphozoa Species 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 7
- 241000219094 Vitaceae Species 0.000 claims description 7
- CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 claims description 7
- 239000006185 dispersion Substances 0.000 claims description 7
- 235000021021 grapes Nutrition 0.000 claims description 7
- 235000019198 oils Nutrition 0.000 claims description 7
- 235000012015 potatoes Nutrition 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 239000004575 stone Substances 0.000 claims description 7
- 241000589155 Agrobacterium tumefaciens Species 0.000 claims description 6
- 244000144730 Amygdalus persica Species 0.000 claims description 6
- 240000008564 Boehmeria nivea Species 0.000 claims description 6
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 6
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 6
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 6
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 6
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 6
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 6
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 6
- 240000000171 Crataegus monogyna Species 0.000 claims description 6
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 6
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 6
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 6
- 241000588698 Erwinia Species 0.000 claims description 6
- 244000004281 Eucalyptus maculata Species 0.000 claims description 6
- 241000758791 Juglandaceae Species 0.000 claims description 6
- JUUFBMODXQKSTD-UHFFFAOYSA-N N-[2-amino-6-[(4-fluorophenyl)methylamino]-3-pyridinyl]carbamic acid ethyl ester Chemical compound N1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CC=C(F)C=C1 JUUFBMODXQKSTD-UHFFFAOYSA-N 0.000 claims description 6
- 241001503951 Phoma Species 0.000 claims description 6
- 241000233645 Phytophthora nicotianae Species 0.000 claims description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 6
- 229960003667 flupirtine Drugs 0.000 claims description 6
- 239000012634 fragment Substances 0.000 claims description 6
- UIKROCXWUNQSPJ-VIFPVBQESA-N (-)-cotinine Chemical compound C1CC(=O)N(C)[C@@H]1C1=CC=CN=C1 UIKROCXWUNQSPJ-VIFPVBQESA-N 0.000 claims description 5
- 241000228212 Aspergillus Species 0.000 claims description 5
- UIKROCXWUNQSPJ-UHFFFAOYSA-N Cotinine Natural products C1CC(=O)N(C)C1C1=CC=CN=C1 UIKROCXWUNQSPJ-UHFFFAOYSA-N 0.000 claims description 5
- 241000131448 Mycosphaerella Species 0.000 claims description 5
- 241001480007 Phomopsis Species 0.000 claims description 5
- 240000005809 Prunus persica Species 0.000 claims description 5
- 241000722133 Tilletia Species 0.000 claims description 5
- 241000607479 Yersinia pestis Species 0.000 claims description 5
- 235000021015 bananas Nutrition 0.000 claims description 5
- 229950006073 cotinine Drugs 0.000 claims description 5
- 241000213004 Alternaria solani Species 0.000 claims description 4
- 241001290235 Ceratobasidium cereale Species 0.000 claims description 4
- 241000221760 Claviceps Species 0.000 claims description 4
- 241000222199 Colletotrichum Species 0.000 claims description 4
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 claims description 4
- 239000005750 Copper hydroxide Substances 0.000 claims description 4
- 241000221787 Erysiphe Species 0.000 claims description 4
- 241001518729 Monilinia Species 0.000 claims description 4
- 241000845082 Panama Species 0.000 claims description 4
- 241000233633 Phytophthora drechsleri Species 0.000 claims description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims description 4
- 206010039509 Scab Diseases 0.000 claims description 4
- 241001539383 Slafractonia leguminicola Species 0.000 claims description 4
- 238000009825 accumulation Methods 0.000 claims description 4
- 239000002363 auxin Substances 0.000 claims description 4
- 229910001956 copper hydroxide Inorganic materials 0.000 claims description 4
- PGOOBECODWQEAB-UHFFFAOYSA-N (E)-clothianidin Chemical compound [O-][N+](=O)\N=C(/NC)NCC1=CN=C(Cl)S1 PGOOBECODWQEAB-UHFFFAOYSA-N 0.000 claims description 3
- ZFHGXWPMULPQSE-SZGBIDFHSA-N (Z)-(1S)-cis-tefluthrin Chemical compound FC1=C(F)C(C)=C(F)C(F)=C1COC(=O)[C@@H]1C(C)(C)[C@@H]1\C=C(/Cl)C(F)(F)F ZFHGXWPMULPQSE-SZGBIDFHSA-N 0.000 claims description 3
- 229930192334 Auxin Natural products 0.000 claims description 3
- 241000223679 Beauveria Species 0.000 claims description 3
- 229920002101 Chitin Polymers 0.000 claims description 3
- 241001187100 Dickeya dadantii Species 0.000 claims description 3
- 241000862466 Monilinia laxa Species 0.000 claims description 3
- 241000440444 Phakopsora Species 0.000 claims description 3
- 241000233629 Phytophthora parasitica Species 0.000 claims description 3
- 241000896242 Podosphaera Species 0.000 claims description 3
- 241000271567 Struthioniformes Species 0.000 claims description 3
- 239000005939 Tefluthrin Substances 0.000 claims description 3
- XFDJMIHUAHSGKG-UHFFFAOYSA-N chlorethoxyfos Chemical compound CCOP(=S)(OCC)OC(Cl)C(Cl)(Cl)Cl XFDJMIHUAHSGKG-UHFFFAOYSA-N 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 230000000749 insecticidal effect Effects 0.000 claims description 3
- 230000002147 killing effect Effects 0.000 claims description 3
- 239000002609 medium Substances 0.000 claims description 3
- 239000002728 pyrethroid Substances 0.000 claims description 3
- 235000021012 strawberries Nutrition 0.000 claims description 3
- QGHREAKMXXNCOA-UHFFFAOYSA-N thiophanate-methyl Chemical compound COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC QGHREAKMXXNCOA-UHFFFAOYSA-N 0.000 claims description 3
- QNBTYORWCCMPQP-JXAWBTAJSA-N (Z)-dimethomorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(Cl)=CC=1)=C/C(=O)N1CCOCC1 QNBTYORWCCMPQP-JXAWBTAJSA-N 0.000 claims description 2
- MNHVNIJQQRJYDH-UHFFFAOYSA-N 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-1,2-dihydro-1,2,4-triazole-3-thione Chemical compound N1=CNC(=S)N1CC(C1(Cl)CC1)(O)CC1=CC=CC=C1Cl MNHVNIJQQRJYDH-UHFFFAOYSA-N 0.000 claims description 2
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 claims description 2
- 241000266349 Alternaria tenuissima Species 0.000 claims description 2
- 241000208223 Anacardiaceae Species 0.000 claims description 2
- 241000238421 Arthropoda Species 0.000 claims description 2
- 241000228197 Aspergillus flavus Species 0.000 claims description 2
- 241000194108 Bacillus licheniformis Species 0.000 claims description 2
- 239000005874 Bifenthrin Substances 0.000 claims description 2
- 241000228438 Bipolaris maydis Species 0.000 claims description 2
- 239000005738 Bixafen Substances 0.000 claims description 2
- 241001274890 Boeremia exigua Species 0.000 claims description 2
- 241000190146 Botryosphaeria Species 0.000 claims description 2
- 241000555706 Botryosphaeria dothidea Species 0.000 claims description 2
- 241000994678 Botryotinia squamosa Species 0.000 claims description 2
- 240000006432 Carica papaya Species 0.000 claims description 2
- 235000009467 Carica papaya Nutrition 0.000 claims description 2
- 241001085757 Ceratobasidium ramicola Species 0.000 claims description 2
- 241000437818 Cercospora vignicola Species 0.000 claims description 2
- 241001065113 Cercosporidium Species 0.000 claims description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 2
- 241001149956 Cladosporium herbarum Species 0.000 claims description 2
- 239000005888 Clothianidin Substances 0.000 claims description 2
- 241001123536 Colletotrichum acutatum Species 0.000 claims description 2
- 241001529387 Colletotrichum gloeosporioides Species 0.000 claims description 2
- 241000782774 Coniothyrium glycines Species 0.000 claims description 2
- 241000723382 Corylus Species 0.000 claims description 2
- 241000609458 Corynespora Species 0.000 claims description 2
- 241001508802 Diaporthe Species 0.000 claims description 2
- 241001306390 Diaporthe ampelina Species 0.000 claims description 2
- 241001645342 Diaporthe citri Species 0.000 claims description 2
- 241001187099 Dickeya Species 0.000 claims description 2
- 241001160201 Dickeya solani Species 0.000 claims description 2
- 239000005761 Dimethomorph Substances 0.000 claims description 2
- 241000588694 Erwinia amylovora Species 0.000 claims description 2
- 241000510928 Erysiphe necator Species 0.000 claims description 2
- 239000005899 Fipronil Substances 0.000 claims description 2
- 241001556359 Fusarium solani f. sp. glycines Species 0.000 claims description 2
- 241000221557 Gymnosporangium Species 0.000 claims description 2
- 241001516047 Gymnosporangium juniperi-virginianae Species 0.000 claims description 2
- 241000223642 Helicobasidium purpureum Species 0.000 claims description 2
- 241000721662 Juniperus Species 0.000 claims description 2
- 241000228457 Leptosphaeria maculans Species 0.000 claims description 2
- 241001478324 Liberibacter Species 0.000 claims description 2
- 241001495426 Macrophomina phaseolina Species 0.000 claims description 2
- 241001344133 Magnaporthe Species 0.000 claims description 2
- 241001344131 Magnaporthe grisea Species 0.000 claims description 2
- 241000879364 Monilinia vaccinii-corymbosi Species 0.000 claims description 2
- 241000633856 Mycosphaerella pomi Species 0.000 claims description 2
- 241001279846 Neofabraea Species 0.000 claims description 2
- 241000588701 Pectobacterium carotovorum Species 0.000 claims description 2
- 241000440445 Phakopsora meibomiae Species 0.000 claims description 2
- 241000682645 Phakopsora pachyrhizi Species 0.000 claims description 2
- 244000309557 Phyllachora pomigena Species 0.000 claims description 2
- 241000522452 Phytophthora fragariae Species 0.000 claims description 2
- 241000370518 Phytophthora ramorum Species 0.000 claims description 2
- 241001337928 Podosphaera leucotricha Species 0.000 claims description 2
- 241001294742 Podosphaera macularis Species 0.000 claims description 2
- 241000896203 Podosphaera pannosa Species 0.000 claims description 2
- 239000005825 Prothioconazole Substances 0.000 claims description 2
- 241000087479 Pseudocercospora fijiensis Species 0.000 claims description 2
- 241000371676 Pyrenophora japonica Species 0.000 claims description 2
- 241000190117 Pyrenophora tritici-repentis Species 0.000 claims description 2
- 241000918585 Pythium aphanidermatum Species 0.000 claims description 2
- 241000918584 Pythium ultimum Species 0.000 claims description 2
- 241000873910 Rhizoctonia fragariae Species 0.000 claims description 2
- 240000005384 Rhizopus oryzae Species 0.000 claims description 2
- 235000013752 Rhizopus oryzae Nutrition 0.000 claims description 2
- 241000825109 Schizothyrium Species 0.000 claims description 2
- 241000825108 Schizothyrium pomi Species 0.000 claims description 2
- 241001518640 Sclerotinia homoeocarpa Species 0.000 claims description 2
- 241001518705 Sclerotinia minor Species 0.000 claims description 2
- 241000226724 Sporisorium scitamineum Species 0.000 claims description 2
- 241000533281 Stagonospora Species 0.000 claims description 2
- 241000187747 Streptomyces Species 0.000 claims description 2
- 241000722093 Tilletia caries Species 0.000 claims description 2
- 241000722096 Tilletia controversa Species 0.000 claims description 2
- 241000031845 Tilletia laevis Species 0.000 claims description 2
- 241000223259 Trichoderma Species 0.000 claims description 2
- 241000510929 Uncinula Species 0.000 claims description 2
- 241000221576 Uromyces Species 0.000 claims description 2
- 241000221566 Ustilago Species 0.000 claims description 2
- 235000015919 Ustilago maydis Nutrition 0.000 claims description 2
- 244000301083 Ustilago maydis Species 0.000 claims description 2
- 241000007070 Ustilago nuda Species 0.000 claims description 2
- 239000005860 Valifenalate Substances 0.000 claims description 2
- 241000317942 Venturia <ichneumonid wasp> Species 0.000 claims description 2
- 241000228452 Venturia inaequalis Species 0.000 claims description 2
- 241001266781 Wilsonomyces Species 0.000 claims description 2
- 241000282188 Wilsonomyces carpophilus Species 0.000 claims description 2
- 241000567083 Xanthomonas arboricola Species 0.000 claims description 2
- 241000985670 Xanthomonas arboricola pv. pruni Species 0.000 claims description 2
- 241000520892 Xanthomonas axonopodis Species 0.000 claims description 2
- 241000321047 Xanthomonas campestris pv. carotae Species 0.000 claims description 2
- 241000204366 Xylella Species 0.000 claims description 2
- 241000204362 Xylella fastidiosa Species 0.000 claims description 2
- 241000587986 Zasmidium citri-griseum Species 0.000 claims description 2
- 241000845449 [Rhizoctonia] oryzae Species 0.000 claims description 2
- 241000845448 [Rhizoctonia] zeae Species 0.000 claims description 2
- 229940009868 aluminum magnesium silicate Drugs 0.000 claims description 2
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 claims description 2
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 claims description 2
- 150000004056 anthraquinones Chemical class 0.000 claims description 2
- OMFRMAHOUUJSGP-IRHGGOMRSA-N bifenthrin Chemical compound C1=CC=C(C=2C=CC=CC=2)C(C)=C1COC(=O)[C@@H]1[C@H](\C=C(/Cl)C(F)(F)F)C1(C)C OMFRMAHOUUJSGP-IRHGGOMRSA-N 0.000 claims description 2
- LDLMOOXUCMHBMZ-UHFFFAOYSA-N bixafen Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=C(F)C=C1C1=CC=C(Cl)C(Cl)=C1 LDLMOOXUCMHBMZ-UHFFFAOYSA-N 0.000 claims description 2
- 235000017803 cinnamon Nutrition 0.000 claims description 2
- 229960001591 cyfluthrin Drugs 0.000 claims description 2
- QQODLKZGRKWIFG-QSFXBCCZSA-N cyfluthrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-QSFXBCCZSA-N 0.000 claims description 2
- 229940013764 fipronil Drugs 0.000 claims description 2
- 235000013305 food Nutrition 0.000 claims description 2
- 235000012055 fruits and vegetables Nutrition 0.000 claims description 2
- WJZHMLNIAZSFDO-UHFFFAOYSA-N manganese zinc Chemical compound [Mn].[Zn] WJZHMLNIAZSFDO-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims description 2
- 238000004382 potting Methods 0.000 claims description 2
- 239000000758 substrate Substances 0.000 claims description 2
- AWYOMXWDGWUJHS-UHFFFAOYSA-N tebupirimfos Chemical compound CCOP(=S)(OC(C)C)OC1=CN=C(C(C)(C)C)N=C1 AWYOMXWDGWUJHS-UHFFFAOYSA-N 0.000 claims description 2
- DBXFMOWZRXXBRN-LWKPJOBUSA-N valifenalate Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)NC(CC(=O)OC)C1=CC=C(Cl)C=C1 DBXFMOWZRXXBRN-LWKPJOBUSA-N 0.000 claims description 2
- 240000001987 Pyrus communis Species 0.000 claims 26
- 241000193738 Bacillus anthracis Species 0.000 claims 14
- 241000219146 Gossypium Species 0.000 claims 13
- 240000007049 Juglans regia Species 0.000 claims 10
- 235000009496 Juglans regia Nutrition 0.000 claims 10
- 241001075517 Abelmoschus Species 0.000 claims 8
- 241000219109 Citrullus Species 0.000 claims 8
- 241000235503 Glomus Species 0.000 claims 8
- 241000208822 Lactuca Species 0.000 claims 8
- 241000208202 Linaceae Species 0.000 claims 8
- 241000208317 Petroselinum Species 0.000 claims 8
- 241000220259 Raphanus Species 0.000 claims 8
- 241000219315 Spinacia Species 0.000 claims 8
- 241000234314 Zingiber Species 0.000 claims 8
- 241000219823 Medicago Species 0.000 claims 7
- 241000208829 Sambucus Species 0.000 claims 7
- 239000011121 hardwood Substances 0.000 claims 7
- 235000011437 Amygdalus communis Nutrition 0.000 claims 6
- 244000226021 Anacardium occidentale Species 0.000 claims 6
- 241000207199 Citrus Species 0.000 claims 6
- 240000009226 Corylus americana Species 0.000 claims 6
- 235000001543 Corylus americana Nutrition 0.000 claims 6
- 235000009844 Cucumis melo var conomon Nutrition 0.000 claims 6
- 235000003447 Pistacia vera Nutrition 0.000 claims 6
- 241001558929 Sclerotium <basidiomycota> Species 0.000 claims 6
- 235000020971 citrus fruits Nutrition 0.000 claims 6
- 244000298697 Actinidia deliciosa Species 0.000 claims 5
- 241000223203 Coccidioides Species 0.000 claims 5
- 241000235070 Saccharomyces Species 0.000 claims 5
- 241000245665 Taraxacum Species 0.000 claims 5
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims 5
- 239000004459 forage Substances 0.000 claims 5
- 241001061264 Astragalus Species 0.000 claims 4
- 241000221751 Claviceps purpurea Species 0.000 claims 4
- 241000218218 Ficus <angiosperm> Species 0.000 claims 4
- 241000427940 Fusarium solani Species 0.000 claims 4
- 235000011034 Rubus glaucus Nutrition 0.000 claims 4
- 235000009122 Rubus idaeus Nutrition 0.000 claims 4
- 235000006533 astragalus Nutrition 0.000 claims 4
- 210000004233 talus Anatomy 0.000 claims 4
- 241000224489 Amoeba Species 0.000 claims 3
- 241000228456 Leptosphaeria Species 0.000 claims 3
- 241001466487 Phaeocystis Species 0.000 claims 3
- 241000418669 Phialocephala sphaeroides Species 0.000 claims 3
- 241000224016 Plasmodium Species 0.000 claims 3
- 241000317981 Podosphaera fuliginea Species 0.000 claims 3
- 241000005091 Pygathrix cinerea Species 0.000 claims 3
- 235000004443 Ricinus communis Nutrition 0.000 claims 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims 2
- 241001133760 Acoelorraphe Species 0.000 claims 2
- 235000016425 Arthrospira platensis Nutrition 0.000 claims 2
- 240000002900 Arthrospira platensis Species 0.000 claims 2
- 240000008574 Capsicum frutescens Species 0.000 claims 2
- 229920002307 Dextran Polymers 0.000 claims 2
- 241000588722 Escherichia Species 0.000 claims 2
- 244000307700 Fragaria vesca Species 0.000 claims 2
- 244000081841 Malus domestica Species 0.000 claims 2
- 206010027146 Melanoderma Diseases 0.000 claims 2
- 206010035148 Plague Diseases 0.000 claims 2
- 101100505672 Podospora anserina grisea gene Proteins 0.000 claims 2
- 241000222640 Polyporus Species 0.000 claims 2
- 244000234609 Portulaca oleracea Species 0.000 claims 2
- 241000589626 Pseudomonas syringae pv. tomato Species 0.000 claims 2
- 241000220317 Rosa Species 0.000 claims 2
- 241000222480 Schizophyllum Species 0.000 claims 2
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims 2
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims 2
- 239000001390 capsicum minimum Substances 0.000 claims 2
- 235000004634 cranberry Nutrition 0.000 claims 2
- 235000009973 maize Nutrition 0.000 claims 2
- 235000016709 nutrition Nutrition 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- 235000021018 plums Nutrition 0.000 claims 2
- 241000894007 species Species 0.000 claims 2
- JWUCHKBSVLQQCO-UHFFFAOYSA-N 1-(2-fluorophenyl)-1-(4-fluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanol Chemical compound C=1C=C(F)C=CC=1C(C=1C(=CC=CC=1)F)(O)CN1C=NC=N1 JWUCHKBSVLQQCO-UHFFFAOYSA-N 0.000 claims 1
- 241000588986 Alcaligenes Species 0.000 claims 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 claims 1
- 240000001592 Amaranthus caudatus Species 0.000 claims 1
- 229920000945 Amylopectin Polymers 0.000 claims 1
- 241001600407 Aphis <genus> Species 0.000 claims 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 claims 1
- 241000237519 Bivalvia Species 0.000 claims 1
- 240000004355 Borago officinalis Species 0.000 claims 1
- 235000007689 Borago officinalis Nutrition 0.000 claims 1
- 241000589562 Brucella Species 0.000 claims 1
- 241000218645 Cedrus Species 0.000 claims 1
- 235000007516 Chrysanthemum Nutrition 0.000 claims 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims 1
- 241000723346 Cinnamomum camphora Species 0.000 claims 1
- 241000193403 Clostridium Species 0.000 claims 1
- 241000218176 Corydalis Species 0.000 claims 1
- 241000186216 Corynebacterium Species 0.000 claims 1
- 235000009849 Cucumis sativus Nutrition 0.000 claims 1
- 101710088194 Dehydrogenase Proteins 0.000 claims 1
- 108010022355 Fibroins Proteins 0.000 claims 1
- 239000005787 Flutriafol Substances 0.000 claims 1
- 241000879841 Fusarium oxysporum f. cubense Species 0.000 claims 1
- 241000589989 Helicobacter Species 0.000 claims 1
- 239000005867 Iprodione Substances 0.000 claims 1
- 239000005802 Mancozeb Substances 0.000 claims 1
- 241000187708 Micromonospora Species 0.000 claims 1
- 235000016357 Mirtillo rosso Nutrition 0.000 claims 1
- 241000234295 Musa Species 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims 1
- 244000061176 Nicotiana tabacum Species 0.000 claims 1
- 241000736122 Parastagonospora nodorum Species 0.000 claims 1
- 241001072653 Parodia mammulosa Species 0.000 claims 1
- 241000589774 Pseudomonas sp. Species 0.000 claims 1
- 241001038563 Pseudostellaria Species 0.000 claims 1
- 240000008199 Rhododendron molle Species 0.000 claims 1
- 244000171263 Ribes grossularia Species 0.000 claims 1
- 240000001890 Ribes hudsonianum Species 0.000 claims 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 claims 1
- 235000001466 Ribes nigrum Nutrition 0.000 claims 1
- 244000160370 Rothmannia globosa Species 0.000 claims 1
- 235000017848 Rubus fruticosus Nutrition 0.000 claims 1
- 244000235659 Rubus idaeus Species 0.000 claims 1
- 240000009056 Saccharum arundinaceum Species 0.000 claims 1
- 241000223238 Trichophyton Species 0.000 claims 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 claims 1
- 244000077923 Vaccinium vitis idaea Species 0.000 claims 1
- 235000007244 Zea mays Nutrition 0.000 claims 1
- 241001360088 Zymoseptoria tritici Species 0.000 claims 1
- 235000012735 amaranth Nutrition 0.000 claims 1
- 239000004178 amaranth Substances 0.000 claims 1
- 229960000846 camphor Drugs 0.000 claims 1
- 229930008380 camphor Natural products 0.000 claims 1
- 239000010238 camphora Substances 0.000 claims 1
- 229940025250 camphora Drugs 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000000711 cancerogenic effect Effects 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 231100000315 carcinogenic Toxicity 0.000 claims 1
- 235000020639 clam Nutrition 0.000 claims 1
- RCJVRSBWZCNNQT-UHFFFAOYSA-N dichloridooxygen Chemical compound ClOCl RCJVRSBWZCNNQT-UHFFFAOYSA-N 0.000 claims 1
- 235000021038 drupes Nutrition 0.000 claims 1
- 239000000428 dust Substances 0.000 claims 1
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 239000003630 growth substance Substances 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- ONUFESLQCSAYKA-UHFFFAOYSA-N iprodione Chemical compound O=C1N(C(=O)NC(C)C)CC(=O)N1C1=CC(Cl)=CC(Cl)=C1 ONUFESLQCSAYKA-UHFFFAOYSA-N 0.000 claims 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 claims 1
- 239000010977 jade Substances 0.000 claims 1
- 235000015110 jellies Nutrition 0.000 claims 1
- 239000008274 jelly Substances 0.000 claims 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims 1
- 229960005375 lutein Drugs 0.000 claims 1
- 210000002706 plastid Anatomy 0.000 claims 1
- 150000003180 prostaglandins Chemical class 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 201000004409 schistosomiasis Diseases 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 230000001568 sexual effect Effects 0.000 claims 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims 1
- 150000003852 triazoles Chemical class 0.000 claims 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims 1
- 235000008210 xanthophylls Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 101000993347 Gallus gallus Ciliary neurotrophic factor Proteins 0.000 abstract description 2
- 206010020649 Hyperkeratosis Diseases 0.000 abstract 2
- 238000005520 cutting process Methods 0.000 abstract 2
- 229920001817 Agar Polymers 0.000 description 15
- 239000008272 agar Substances 0.000 description 15
- 239000003112 inhibitor Substances 0.000 description 13
- TWFZGCMQGLPBSX-UHFFFAOYSA-N carbendazim Chemical compound C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- 229960003260 chlorhexidine Drugs 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- 235000014469 Bacillus subtilis Nutrition 0.000 description 8
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 8
- 108010028921 Lipopeptides Proteins 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000000575 pesticide Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 7
- 238000000855 fermentation Methods 0.000 description 7
- 230000004151 fermentation Effects 0.000 description 7
- 239000002207 metabolite Substances 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 244000063299 Bacillus subtilis Species 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 6
- 241000220324 Pyrus Species 0.000 description 6
- 239000006013 carbendazim Substances 0.000 description 6
- 238000012656 cationic ring opening polymerization Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 150000002576 ketones Chemical class 0.000 description 6
- 239000010452 phosphate Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000003042 antagnostic effect Effects 0.000 description 5
- CWFOCCVIPCEQCK-UHFFFAOYSA-N chlorfenapyr Chemical compound BrC1=C(C(F)(F)F)N(COCC)C(C=2C=CC(Cl)=CC=2)=C1C#N CWFOCCVIPCEQCK-UHFFFAOYSA-N 0.000 description 5
- 230000002538 fungal effect Effects 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- VTNQPKFIQCLBDU-UHFFFAOYSA-N Acetochlor Chemical compound CCOCN(C(=O)CCl)C1=C(C)C=CC=C1CC VTNQPKFIQCLBDU-UHFFFAOYSA-N 0.000 description 4
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000193388 Bacillus thuringiensis Species 0.000 description 4
- 108010062877 Bacteriocins Proteins 0.000 description 4
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 4
- 241000238631 Hexapoda Species 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 4
- 241000219745 Lupinus Species 0.000 description 4
- 241000244206 Nematoda Species 0.000 description 4
- 238000003916 acid precipitation Methods 0.000 description 4
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 4
- 230000008485 antagonism Effects 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 4
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 4
- 229960003883 furosemide Drugs 0.000 description 4
- 229960001019 oxacillin Drugs 0.000 description 4
- WCXDHFDTOYPNIE-RIYZIHGNSA-N (E)-acetamiprid Chemical compound N#C/N=C(\C)N(C)CC1=CC=C(Cl)N=C1 WCXDHFDTOYPNIE-RIYZIHGNSA-N 0.000 description 3
- 108020004465 16S ribosomal RNA Proteins 0.000 description 3
- BMTZEAOGFDXDAD-UHFFFAOYSA-M 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholin-4-ium;chloride Chemical compound [Cl-].COC1=NC(OC)=NC([N+]2(C)CCOCC2)=N1 BMTZEAOGFDXDAD-UHFFFAOYSA-M 0.000 description 3
- 239000005875 Acetamiprid Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241001674044 Blattodea Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
- 239000004100 Oxytetracycline Substances 0.000 description 3
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 241000239226 Scorpiones Species 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 3
- 229960005164 acesulfame Drugs 0.000 description 3
- 229940121373 acetyl-coa carboxylase inhibitor Drugs 0.000 description 3
- LEWCAQWVBYTPMP-UHFFFAOYSA-K aluminum;magnesium;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Mg+2].[Al+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O LEWCAQWVBYTPMP-UHFFFAOYSA-K 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 229940097012 bacillus thuringiensis Drugs 0.000 description 3
- 239000003139 biocide Substances 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 239000013043 chemical agent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KIEDNEWSYUYDSN-UHFFFAOYSA-N clomazone Chemical compound O=C1C(C)(C)CON1CC1=CC=CC=C1Cl KIEDNEWSYUYDSN-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000003617 indole-3-acetic acid Substances 0.000 description 3
- 230000020868 induced systemic resistance Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- WLPCAERCXQSYLQ-UHFFFAOYSA-N isotianil Chemical compound ClC1=NSC(C(=O)NC=2C(=CC=CC=2)C#N)=C1Cl WLPCAERCXQSYLQ-UHFFFAOYSA-N 0.000 description 3
- 239000012669 liquid formulation Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 229960002715 nicotine Drugs 0.000 description 3
- UWYHMGVUTGAWSP-JKIFEVAISA-N oxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 UWYHMGVUTGAWSP-JKIFEVAISA-N 0.000 description 3
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 3
- 229960000625 oxytetracycline Drugs 0.000 description 3
- 235000019366 oxytetracycline Nutrition 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 230000003032 phytopathogenic effect Effects 0.000 description 3
- 101150090202 rpoB gene Proteins 0.000 description 3
- FZMKKCQHDROFNI-UHFFFAOYSA-N sulfometuron Chemical compound CC1=CC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)C(O)=O)=N1 FZMKKCQHDROFNI-UHFFFAOYSA-N 0.000 description 3
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 3
- DBGIVFWFUFKIQN-UHFFFAOYSA-N (+-)-Fenfluramine Chemical compound CCNC(C)CC1=CC=CC(C(F)(F)F)=C1 DBGIVFWFUFKIQN-UHFFFAOYSA-N 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 2
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 2
- ZAIDIVBQUMFXEC-UHFFFAOYSA-N 1,1-dichloroprop-1-ene Chemical compound CC=C(Cl)Cl ZAIDIVBQUMFXEC-UHFFFAOYSA-N 0.000 description 2
- PIFBMJMXJMZZRG-UHFFFAOYSA-N 2,2,4,6,6-pentamethyl-1,5-dihydropyrimidine Chemical compound CC1=NC(C)(C)NC(C)(C)C1 PIFBMJMXJMZZRG-UHFFFAOYSA-N 0.000 description 2
- HBEDSQVIWPRPAY-UHFFFAOYSA-N 2,3-dihydrobenzofuran Chemical compound C1=CC=C2OCCC2=C1 HBEDSQVIWPRPAY-UHFFFAOYSA-N 0.000 description 2
- ZXAIYDYMRWTSSV-UHFFFAOYSA-N 2-butylpyrimidine Chemical compound CCCCC1=NC=CC=N1 ZXAIYDYMRWTSSV-UHFFFAOYSA-N 0.000 description 2
- FBXGQDUVJBKEAJ-UHFFFAOYSA-N 4h-oxazin-3-one Chemical compound O=C1CC=CON1 FBXGQDUVJBKEAJ-UHFFFAOYSA-N 0.000 description 2
- GOFJDXZZHFNFLV-UHFFFAOYSA-N 5-fluoro-1,3-dimethyl-N-[2-(4-methylpentan-2-yl)phenyl]pyrazole-4-carboxamide Chemical compound CC(C)CC(C)C1=CC=CC=C1NC(=O)C1=C(F)N(C)N=C1C GOFJDXZZHFNFLV-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 239000005730 Azoxystrobin Substances 0.000 description 2
- 241000003114 Bacillus velezensis FZB42 Species 0.000 description 2
- 229940123208 Biguanide Drugs 0.000 description 2
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 2
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical compound CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 description 2
- JFLRKDZMHNBDQS-UCQUSYKYSA-N CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C Chemical compound CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C JFLRKDZMHNBDQS-UCQUSYKYSA-N 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 2
- 239000005499 Clomazone Substances 0.000 description 2
- 108010069514 Cyclic Peptides Proteins 0.000 description 2
- 102000001189 Cyclic Peptides Human genes 0.000 description 2
- 102100028717 Cytosolic 5'-nucleotidase 3A Human genes 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- MHZGKXUYDGKKIU-UHFFFAOYSA-N Decylamine Chemical compound CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- VZWGRQBCURJOMT-UHFFFAOYSA-N Dodecyl acetate Chemical compound CCCCCCCCCCCCOC(C)=O VZWGRQBCURJOMT-UHFFFAOYSA-N 0.000 description 2
- 239000005531 Flufenacet Substances 0.000 description 2
- 239000005558 Fluroxypyr Substances 0.000 description 2
- 244000299507 Gossypium hirsutum Species 0.000 description 2
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000005906 Imidacloprid Substances 0.000 description 2
- 108010041872 Islet Amyloid Polypeptide Proteins 0.000 description 2
- 102000036770 Islet Amyloid Polypeptide Human genes 0.000 description 2
- 239000005798 Isofetamid Substances 0.000 description 2
- 229930182844 L-isoleucine Natural products 0.000 description 2
- 229920001732 Lignosulfonate Polymers 0.000 description 2
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 2
- XQJQCBDIXRIYRP-UHFFFAOYSA-N N-{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1C(C2CC2)C1 XQJQCBDIXRIYRP-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N Phosphinothricin Natural products CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 102000007327 Protamines Human genes 0.000 description 2
- 108010007568 Protamines Proteins 0.000 description 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 2
- 239000005927 Pyriproxyfen Substances 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 108010016634 Seed Storage Proteins Proteins 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 239000005930 Spinosad Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- QHTQREMOGMZHJV-UHFFFAOYSA-N Thiobencarb Chemical compound CCN(CC)C(=O)SCC1=CC=C(Cl)C=C1 QHTQREMOGMZHJV-UHFFFAOYSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 235000013832 Valeriana officinalis Nutrition 0.000 description 2
- 244000126014 Valeriana officinalis Species 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 235000016720 allyl isothiocyanate Nutrition 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 229940025084 amphetamine Drugs 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 235000021016 apples Nutrition 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 2
- 230000001851 biosynthetic effect Effects 0.000 description 2
- HKPHPIREJKHECO-UHFFFAOYSA-N butachlor Chemical compound CCCCOCN(C(=O)CCl)C1=C(CC)C=CC=C1CC HKPHPIREJKHECO-UHFFFAOYSA-N 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- QZXCCPZJCKEPSA-UHFFFAOYSA-N chlorfenac Chemical compound OC(=O)CC1=C(Cl)C=CC(Cl)=C1Cl QZXCCPZJCKEPSA-UHFFFAOYSA-N 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- MZZBPDKVEFVLFF-UHFFFAOYSA-N cyanazine Chemical compound CCNC1=NC(Cl)=NC(NC(C)(C)C#N)=N1 MZZBPDKVEFVLFF-UHFFFAOYSA-N 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- WEBQKRLKWNIYKK-UHFFFAOYSA-N demeton-S-methyl Chemical compound CCSCCSP(=O)(OC)OC WEBQKRLKWNIYKK-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- OEBRKCOSUFCWJD-UHFFFAOYSA-N dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 244000079386 endoparasite Species 0.000 description 2
- 230000006353 environmental stress Effects 0.000 description 2
- CEIPQQODRKXDSB-UHFFFAOYSA-N ethyl 3-(6-hydroxynaphthalen-2-yl)-1H-indazole-5-carboximidate dihydrochloride Chemical compound Cl.Cl.C1=C(O)C=CC2=CC(C3=NNC4=CC=C(C=C43)C(=N)OCC)=CC=C21 CEIPQQODRKXDSB-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229960001582 fenfluramine Drugs 0.000 description 2
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 2
- 229960002428 fentanyl Drugs 0.000 description 2
- BFWMWWXRWVJXSE-UHFFFAOYSA-M fentin hydroxide Chemical compound C=1C=CC=CC=1[Sn](C=1C=CC=CC=1)(O)C1=CC=CC=C1 BFWMWWXRWVJXSE-UHFFFAOYSA-M 0.000 description 2
- IANUJLZYFUDJIH-UHFFFAOYSA-N flufenacet Chemical compound C=1C=C(F)C=CC=1N(C(C)C)C(=O)COC1=NN=C(C(F)(F)F)S1 IANUJLZYFUDJIH-UHFFFAOYSA-N 0.000 description 2
- SAADBVWGJQAEFS-UHFFFAOYSA-N flurazepam Chemical compound N=1CC(=O)N(CCN(CC)CC)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1F SAADBVWGJQAEFS-UHFFFAOYSA-N 0.000 description 2
- 229960003528 flurazepam Drugs 0.000 description 2
- SXSGXWCSHSVPGB-UHFFFAOYSA-N fluxapyroxad Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1=CC(F)=C(F)C(F)=C1 SXSGXWCSHSVPGB-UHFFFAOYSA-N 0.000 description 2
- 244000000004 fungal plant pathogen Species 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- BPMFZUMJYQTVII-UHFFFAOYSA-N guanidinoacetic acid Chemical compound NC(=N)NCC(O)=O BPMFZUMJYQTVII-UHFFFAOYSA-N 0.000 description 2
- 150000002391 heterocyclic compounds Chemical class 0.000 description 2
- GFAZHVHNLUBROE-UHFFFAOYSA-N hydroxymethyl propionaldehyde Natural products CCC(=O)CO GFAZHVHNLUBROE-UHFFFAOYSA-N 0.000 description 2
- 229940056881 imidacloprid Drugs 0.000 description 2
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- JTEDVYBZBROSJT-UHFFFAOYSA-N indole-3-butyric acid Chemical compound C1=CC=C2C(CCCC(=O)O)=CNC2=C1 JTEDVYBZBROSJT-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- WMKZDPFZIZQROT-UHFFFAOYSA-N isofetamid Chemical compound CC1=CC(OC(C)C)=CC=C1C(=O)C(C)(C)NC(=O)C1=C(C)C=CS1 WMKZDPFZIZQROT-UHFFFAOYSA-N 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- BCTQJXQXJVLSIG-UHFFFAOYSA-N mepronil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C)=C1 BCTQJXQXJVLSIG-UHFFFAOYSA-N 0.000 description 2
- 229960004452 methionine Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000019508 mustard seed Nutrition 0.000 description 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- RYDICHIKLKVOEJ-UHFFFAOYSA-N oxadiazepine Chemical compound O1C=CC=CN=N1 RYDICHIKLKVOEJ-UHFFFAOYSA-N 0.000 description 2
- 235000021017 pears Nutrition 0.000 description 2
- IZUPBVBPLAPZRR-UHFFFAOYSA-N pentachlorophenol Chemical compound OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl IZUPBVBPLAPZRR-UHFFFAOYSA-N 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 2
- 230000008121 plant development Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 229940048914 protamine Drugs 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 229940044601 receptor agonist Drugs 0.000 description 2
- 239000000018 receptor agonist Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229940014213 spinosad Drugs 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 150000003445 sucroses Chemical class 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium Chemical compound [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000021918 systemic acquired resistance Effects 0.000 description 2
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 150000003673 urethanes Chemical class 0.000 description 2
- 229940070710 valerate Drugs 0.000 description 2
- 235000016788 valerian Nutrition 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- YNWVFADWVLCOPU-MDWZMJQESA-N (1E)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1 YNWVFADWVLCOPU-MDWZMJQESA-N 0.000 description 1
- NHOWDZOIZKMVAI-UHFFFAOYSA-N (2-chlorophenyl)(4-chlorophenyl)pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(Cl)C=C1 NHOWDZOIZKMVAI-UHFFFAOYSA-N 0.000 description 1
- SAPGTCDSBGMXCD-UHFFFAOYSA-N (2-chlorophenyl)-(4-fluorophenyl)-pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(F)C=C1 SAPGTCDSBGMXCD-UHFFFAOYSA-N 0.000 description 1
- UUIPAJHTKDSSOK-UHFFFAOYSA-N (2-nonylphenyl) dihydrogen phosphate Chemical compound CCCCCCCCCC1=CC=CC=C1OP(O)(O)=O UUIPAJHTKDSSOK-UHFFFAOYSA-N 0.000 description 1
- ROBSGBGTWRRYSK-SNVBAGLBSA-N (2r)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propanoic acid Chemical compound C1=CC(O[C@H](C)C(O)=O)=CC=C1OC1=CC=C(C#N)C=C1F ROBSGBGTWRRYSK-SNVBAGLBSA-N 0.000 description 1
- CXNPLSGKWMLZPZ-GIFSMMMISA-N (2r,3r,6s)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid Chemical compound O1[C@@H](C(O)=O)[C@H](NC(=O)C[C@@H](N)CCN(C)C(N)=N)C=C[C@H]1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-GIFSMMMISA-N 0.000 description 1
- VZQHRKZCAZCACO-PYJNHQTQSA-N (2s)-2-[[(2s)-2-[2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]prop-2-enoylamino]-3-methylbutanoyl]amino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)C(=C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VZQHRKZCAZCACO-PYJNHQTQSA-N 0.000 description 1
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 1
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3ar,7as)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 description 1
- XUNYDVLIZWUPAW-UHFFFAOYSA-N (4-chlorophenyl) n-(4-methylphenyl)sulfonylcarbamate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)OC1=CC=C(Cl)C=C1 XUNYDVLIZWUPAW-UHFFFAOYSA-N 0.000 description 1
- SJHPCNCNNSSLPL-CSKARUKUSA-N (4e)-4-(ethoxymethylidene)-2-phenyl-1,3-oxazol-5-one Chemical compound O1C(=O)C(=C/OCC)\N=C1C1=CC=CC=C1 SJHPCNCNNSSLPL-CSKARUKUSA-N 0.000 description 1
- UOORRWUZONOOLO-OWOJBTEDSA-N (E)-1,3-dichloropropene Chemical compound ClC\C=C\Cl UOORRWUZONOOLO-OWOJBTEDSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BKBSMMUEEAWFRX-NBVRZTHBSA-N (E)-flumorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(F)=CC=1)=C\C(=O)N1CCOCC1 BKBSMMUEEAWFRX-NBVRZTHBSA-N 0.000 description 1
- CFRPSFYHXJZSBI-DHZHZOJOSA-N (E)-nitenpyram Chemical compound [O-][N+](=O)/C=C(\NC)N(CC)CC1=CC=C(Cl)N=C1 CFRPSFYHXJZSBI-DHZHZOJOSA-N 0.000 description 1
- WVQBLGZPHOPPFO-LBPRGKRZSA-N (S)-metolachlor Chemical compound CCC1=CC=CC(C)=C1N([C@@H](C)COC)C(=O)CCl WVQBLGZPHOPPFO-LBPRGKRZSA-N 0.000 description 1
- HOKKPVIRMVDYPB-UVTDQMKNSA-N (Z)-thiacloprid Chemical compound C1=NC(Cl)=CC=C1CN1C(=N/C#N)/SCC1 HOKKPVIRMVDYPB-UVTDQMKNSA-N 0.000 description 1
- CKPCAYZTYMHQEX-NBVRZTHBSA-N (e)-1-(2,4-dichlorophenyl)-n-methoxy-2-pyridin-3-ylethanimine Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(=N/OC)/CC1=CC=CN=C1 CKPCAYZTYMHQEX-NBVRZTHBSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- UWTUEMKLYAGTNQ-UHFFFAOYSA-N 1,2-dibromoethene Chemical group BrC=CBr UWTUEMKLYAGTNQ-UHFFFAOYSA-N 0.000 description 1
- VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- PPFLVVPJZRDDKD-UHFFFAOYSA-N 1,3-dimethyl-n-[2-(2,4,5-trifluorophenyl)phenyl]pyrazole-4-carboxamide Chemical compound CC1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1=CC(F)=C(F)C=C1F PPFLVVPJZRDDKD-UHFFFAOYSA-N 0.000 description 1
- UJLRDONJQRUUHU-UHFFFAOYSA-N 1,3-dimethyl-n-[2-(3,4,5-trifluorophenyl)phenyl]pyrazole-4-carboxamide Chemical compound CC1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1=CC(F)=C(F)C(F)=C1 UJLRDONJQRUUHU-UHFFFAOYSA-N 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- GVROBYMTUJVBJZ-UHFFFAOYSA-N 1-(3-methylphenyl)-5-phenyl-1,2,4-triazole-3-carboxamide Chemical compound CC1=CC=CC(N2C(=NC(=N2)C(N)=O)C=2C=CC=CC=2)=C1 GVROBYMTUJVBJZ-UHFFFAOYSA-N 0.000 description 1
- IHGSAQHSAGRWNI-UHFFFAOYSA-N 1-(4-bromophenyl)-2,2,2-trifluoroethanone Chemical compound FC(F)(F)C(=O)C1=CC=C(Br)C=C1 IHGSAQHSAGRWNI-UHFFFAOYSA-N 0.000 description 1
- WRGKWWRFSUGDPX-UHFFFAOYSA-N 1-(4-chlorophenyl)-2-(1,2,4-triazol-1-yl)cycloheptan-1-ol Chemical compound C=1C=C(Cl)C=CC=1C1(O)CCCCCC1N1C=NC=N1 WRGKWWRFSUGDPX-UHFFFAOYSA-N 0.000 description 1
- PXMNMQRDXWABCY-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol Chemical compound C1=NC=NN1CC(O)(C(C)(C)C)CCC1=CC=C(Cl)C=C1 PXMNMQRDXWABCY-UHFFFAOYSA-N 0.000 description 1
- YWZNTXOVJBWUQL-UHFFFAOYSA-N 1-[1-(4-cyanophenyl)ethylsulfonyl]butan-2-yl-(4-fluorophenyl)carbamic acid Chemical compound C=1C=C(F)C=CC=1N(C(O)=O)C(CC)CS(=O)(=O)C(C)C1=CC=C(C#N)C=C1 YWZNTXOVJBWUQL-UHFFFAOYSA-N 0.000 description 1
- MGNFYQILYYYUBS-UHFFFAOYSA-N 1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1CCCCC1 MGNFYQILYYYUBS-UHFFFAOYSA-N 0.000 description 1
- PAJPWUMXBYXFCZ-UHFFFAOYSA-N 1-aminocyclopropanecarboxylic acid Chemical compound OC(=O)C1(N)CC1 PAJPWUMXBYXFCZ-UHFFFAOYSA-N 0.000 description 1
- SAEWEAKBGDVOPX-UHFFFAOYSA-N 1-methyl-3-(trifluoromethyl)-n-[2-(2,4,5-trifluorophenyl)phenyl]pyrazole-4-carboxamide Chemical compound FC(F)(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1=CC(F)=C(F)C=C1F SAEWEAKBGDVOPX-UHFFFAOYSA-N 0.000 description 1
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 1
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 1
- BNYCHCAYYYRJSH-UHFFFAOYSA-N 1h-pyrazole-5-carboxamide Chemical compound NC(=O)C1=CC=NN1 BNYCHCAYYYRJSH-UHFFFAOYSA-N 0.000 description 1
- QMNWYGTWTXOQTP-UHFFFAOYSA-N 1h-triazin-6-one Chemical compound O=C1C=CN=NN1 QMNWYGTWTXOQTP-UHFFFAOYSA-N 0.000 description 1
- KNGWEAQJZJKFLI-UHFFFAOYSA-N 2,2-dimethyl-4h-1,3-benzodioxine-6-carbaldehyde Chemical compound O=CC1=CC=C2OC(C)(C)OCC2=C1 KNGWEAQJZJKFLI-UHFFFAOYSA-N 0.000 description 1
- HKROQOWBHZLRCU-UHFFFAOYSA-N 2,2-diphenoxypropanoic acid Chemical compound C=1C=CC=CC=1OC(C(O)=O)(C)OC1=CC=CC=C1 HKROQOWBHZLRCU-UHFFFAOYSA-N 0.000 description 1
- UMPSXRYVXUPCOS-UHFFFAOYSA-N 2,3-dichlorophenol Chemical compound OC1=CC=CC(Cl)=C1Cl UMPSXRYVXUPCOS-UHFFFAOYSA-N 0.000 description 1
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
- NIOPZPCMRQGZCE-WEVVVXLNSA-N 2,4-dinitro-6-(octan-2-yl)phenyl (E)-but-2-enoate Chemical compound CCCCCCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)\C=C\C NIOPZPCMRQGZCE-WEVVVXLNSA-N 0.000 description 1
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
- CCBICDLNWJRFPO-UHFFFAOYSA-N 2,6-dichloroindophenol Chemical compound C1=CC(O)=CC=C1N=C1C=C(Cl)C(=O)C(Cl)=C1 CCBICDLNWJRFPO-UHFFFAOYSA-N 0.000 description 1
- NUPJIGQFXCQJBK-UHFFFAOYSA-N 2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)-5-(methoxymethyl)nicotinic acid Chemical compound OC(=O)C1=CC(COC)=CN=C1C1=NC(C)(C(C)C)C(=O)N1 NUPJIGQFXCQJBK-UHFFFAOYSA-N 0.000 description 1
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- UWHURBUBIHUHSU-UHFFFAOYSA-N 2-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoylsulfamoyl]benzoic acid Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)C(O)=O)=N1 UWHURBUBIHUHSU-UHFFFAOYSA-N 0.000 description 1
- VPWGKZJMAGHQMR-UHFFFAOYSA-N 2-[2-[6-(3-chloro-2-methylphenoxy)-5-fluoropyrimidin-4-yl]oxyphenyl]-2-methoxyimino-n-methylacetamide Chemical compound CNC(=O)C(=NOC)C1=CC=CC=C1OC1=NC=NC(OC=2C(=C(Cl)C=CC=2)C)=C1F VPWGKZJMAGHQMR-UHFFFAOYSA-N 0.000 description 1
- CABMTIJINOIHOD-UHFFFAOYSA-N 2-[4-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl]quinoline-3-carboxylic acid Chemical compound N1C(=O)C(C(C)C)(C)N=C1C1=NC2=CC=CC=C2C=C1C(O)=O CABMTIJINOIHOD-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- PVTHJAPFENJVNC-UHFFFAOYSA-N 2-amino-2-[5-amino-2-methyl-6-(2,3,4,5,6-pentahydroxycyclohexyl)oxyoxan-3-yl]iminoacetic acid Chemical compound NC1CC(N=C(N)C(O)=O)C(C)OC1OC1C(O)C(O)C(O)C(O)C1O PVTHJAPFENJVNC-UHFFFAOYSA-N 0.000 description 1
- MWNKQGDEDAEHSQ-UHFFFAOYSA-N 2-chloro-3-phenylthiophene Chemical compound S1C=CC(C=2C=CC=CC=2)=C1Cl MWNKQGDEDAEHSQ-UHFFFAOYSA-N 0.000 description 1
- WVQBLGZPHOPPFO-UHFFFAOYSA-N 2-chloro-N-(2-ethyl-6-methylphenyl)-N-(1-methoxypropan-2-yl)acetamide Chemical compound CCC1=CC=CC(C)=C1N(C(C)COC)C(=O)CCl WVQBLGZPHOPPFO-UHFFFAOYSA-N 0.000 description 1
- YPSCQJTUAKNUNF-UHFFFAOYSA-N 2-chloro-n-[(4-chlorophenyl)carbamoyl]benzamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC(=O)C1=CC=CC=C1Cl YPSCQJTUAKNUNF-UHFFFAOYSA-N 0.000 description 1
- VONWPEXRCLHKRJ-UHFFFAOYSA-N 2-chloro-n-phenylacetamide Chemical compound ClCC(=O)NC1=CC=CC=C1 VONWPEXRCLHKRJ-UHFFFAOYSA-N 0.000 description 1
- JDDAFHUEOVUDFJ-UHFFFAOYSA-N 2-iodobenzonitrile Chemical compound IC1=CC=CC=C1C#N JDDAFHUEOVUDFJ-UHFFFAOYSA-N 0.000 description 1
- NNWTYSZJLCDUDC-UHFFFAOYSA-N 2-propoxyquinoline Chemical compound C1=CC=CC2=NC(OCCC)=CC=C21 NNWTYSZJLCDUDC-UHFFFAOYSA-N 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- FQWBGZVXVRORRM-UHFFFAOYSA-N 2-pyrimidin-2-yloxypyrimidine Chemical compound N=1C=CC=NC=1OC1=NC=CC=N1 FQWBGZVXVRORRM-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- REEXLQXWNOSJKO-UHFFFAOYSA-N 2h-1$l^{4},2,3-benzothiadiazine 1-oxide Chemical compound C1=CC=C2S(=O)NN=CC2=C1 REEXLQXWNOSJKO-UHFFFAOYSA-N 0.000 description 1
- ADRRIUGXSOGPPW-UHFFFAOYSA-N 2h-oxazine-3-carboxamide Chemical compound NC(=O)C1=CC=CON1 ADRRIUGXSOGPPW-UHFFFAOYSA-N 0.000 description 1
- 108020005065 3' Flanking Region Proteins 0.000 description 1
- ZVOWUYIDRJPVTD-UHFFFAOYSA-N 3,4,5-trichloropyridine-2,6-dicarbonitrile Chemical compound ClC1=C(Cl)C(C#N)=NC(C#N)=C1Cl ZVOWUYIDRJPVTD-UHFFFAOYSA-N 0.000 description 1
- UPMXNNIRAGDFEH-UHFFFAOYSA-N 3,5-dibromo-4-hydroxybenzonitrile Chemical compound OC1=C(Br)C=C(C#N)C=C1Br UPMXNNIRAGDFEH-UHFFFAOYSA-N 0.000 description 1
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical compound O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 1
- XMTQQYYKAHVGBJ-UHFFFAOYSA-N 3-(3,4-DICHLOROPHENYL)-1,1-DIMETHYLUREA Chemical compound CN(C)C(=O)NC1=CC=C(Cl)C(Cl)=C1 XMTQQYYKAHVGBJ-UHFFFAOYSA-N 0.000 description 1
- HXKPOEOLTWELSY-UHFFFAOYSA-N 3-(difluoromethyl)-1-methyl-n-[2-[4-(trifluoromethylsulfanyl)phenyl]phenyl]pyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1=CC=C(SC(F)(F)F)C=C1 HXKPOEOLTWELSY-UHFFFAOYSA-N 0.000 description 1
- XNXCINUKGNQCEZ-UHFFFAOYSA-N 3-(difluoromethyl)-1-methylpyrazole-4-carboxamide Chemical compound CN1C=C(C(N)=O)C(C(F)F)=N1 XNXCINUKGNQCEZ-UHFFFAOYSA-N 0.000 description 1
- CYGFDJPWDOAVRM-UHFFFAOYSA-N 3-(difluoromethyl)-5-fluoro-1-methyl-n-[2-(3,4,5-trifluorophenyl)phenyl]pyrazole-4-carboxamide Chemical compound CN1N=C(C(F)F)C(C(=O)NC=2C(=CC=CC=2)C=2C=C(F)C(F)=C(F)C=2)=C1F CYGFDJPWDOAVRM-UHFFFAOYSA-N 0.000 description 1
- LSQYQBKLVIQVGL-UHFFFAOYSA-N 3-(difluoromethyl)-n-[2-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]-1-methylpyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1OC(F)(F)C(F)C(F)(F)F LSQYQBKLVIQVGL-UHFFFAOYSA-N 0.000 description 1
- IDMOROJFXNJQLT-UHFFFAOYSA-N 3-(difluoromethyl)-n-[2-(3,4-difluorophenyl)-4-fluorophenyl]-1-methylpyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=C(F)C=C1C1=CC=C(F)C(F)=C1 IDMOROJFXNJQLT-UHFFFAOYSA-N 0.000 description 1
- NWDMGJNJPADRBN-UHFFFAOYSA-N 3-(difluoromethyl)-n-[2-(3,4-difluorophenyl)-5-fluorophenyl]-1-methylpyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC(F)=CC=C1C1=CC=C(F)C(F)=C1 NWDMGJNJPADRBN-UHFFFAOYSA-N 0.000 description 1
- KNGPIXBYTDFKAR-UHFFFAOYSA-N 3-(difluoromethyl)-n-[4-fluoro-2-(3-fluoro-4-methylphenyl)phenyl]-1-methylpyrazole-4-carboxamide Chemical compound C1=C(F)C(C)=CC=C1C1=CC(F)=CC=C1NC(=O)C1=CN(C)N=C1C(F)F KNGPIXBYTDFKAR-UHFFFAOYSA-N 0.000 description 1
- JKGGFKZHTXQAPJ-UHFFFAOYSA-N 3-(fluoromethyl)-1-methyl-n-[2-(2,4,5-trifluorophenyl)phenyl]pyrazole-4-carboxamide Chemical compound FCC1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1=CC(F)=C(F)C=C1F JKGGFKZHTXQAPJ-UHFFFAOYSA-N 0.000 description 1
- IUHDOVCDCVDKKK-UHFFFAOYSA-N 3-[chloro(difluoro)methyl]-1-methyl-n-[2-(3,4,5-trifluorophenyl)phenyl]pyrazole-4-carboxamide Chemical compound FC(Cl)(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1=CC(F)=C(F)C(F)=C1 IUHDOVCDCVDKKK-UHFFFAOYSA-N 0.000 description 1
- REBFNYWFPYTPSZ-UHFFFAOYSA-N 3-[chloro(fluoro)methyl]-1-methyl-n-[2-(2,4,5-trifluorophenyl)phenyl]pyrazole-4-carboxamide Chemical compound FC(Cl)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1=CC(F)=C(F)C=C1F REBFNYWFPYTPSZ-UHFFFAOYSA-N 0.000 description 1
- KHGLJFGSFNGDCE-UHFFFAOYSA-N 3-amino-2-hydroxybenzamide Chemical compound NC(=O)C1=CC=CC(N)=C1O KHGLJFGSFNGDCE-UHFFFAOYSA-N 0.000 description 1
- XUPYLBDRWQBBOC-UHFFFAOYSA-N 3-chloropropoxycyclohexane Chemical compound ClCCCOC1CCCCC1 XUPYLBDRWQBBOC-UHFFFAOYSA-N 0.000 description 1
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 1
- NMWKWBPNKPGATC-UHFFFAOYSA-N 4,5,6,7-tetrachloro-2-benzofuran-1(3H)-one Chemical compound ClC1=C(Cl)C(Cl)=C2COC(=O)C2=C1Cl NMWKWBPNKPGATC-UHFFFAOYSA-N 0.000 description 1
- ZXVONLUNISGICL-UHFFFAOYSA-N 4,6-dinitro-o-cresol Chemical compound CC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O ZXVONLUNISGICL-UHFFFAOYSA-N 0.000 description 1
- WQMVTGCKCKMBSJ-UHFFFAOYSA-N 4-(difluoromethyl)-2-methyl-n-[2-[4-(trifluoromethyl)phenyl]phenyl]-1,3-thiazole-5-carboxamide Chemical compound S1C(C)=NC(C(F)F)=C1C(=O)NC1=CC=CC=C1C1=CC=C(C(F)(F)F)C=C1 WQMVTGCKCKMBSJ-UHFFFAOYSA-N 0.000 description 1
- SBUKOHLFHYSZNG-UHFFFAOYSA-N 4-dodecyl-2,6-dimethylmorpholine Chemical compound CCCCCCCCCCCCN1CC(C)OC(C)C1 SBUKOHLFHYSZNG-UHFFFAOYSA-N 0.000 description 1
- MBFHUWCOCCICOK-UHFFFAOYSA-N 4-iodo-2-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoylsulfamoyl]benzoic acid Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=C(I)C=2)C(O)=O)=N1 MBFHUWCOCCICOK-UHFFFAOYSA-N 0.000 description 1
- 108020005029 5' Flanking Region Proteins 0.000 description 1
- XJFIKRXIJXAJGH-UHFFFAOYSA-N 5-chloro-1,3-dihydroimidazo[4,5-b]pyridin-2-one Chemical group ClC1=CC=C2NC(=O)NC2=N1 XJFIKRXIJXAJGH-UHFFFAOYSA-N 0.000 description 1
- NRTLIYOWLVMQBO-UHFFFAOYSA-N 5-chloro-1,3-dimethyl-N-(1,1,3-trimethyl-1,3-dihydro-2-benzofuran-4-yl)pyrazole-4-carboxamide Chemical compound C=12C(C)OC(C)(C)C2=CC=CC=1NC(=O)C=1C(C)=NN(C)C=1Cl NRTLIYOWLVMQBO-UHFFFAOYSA-N 0.000 description 1
- ZHMMUAFLEODRRU-UHFFFAOYSA-N 5-chloro-1,3-dimethyl-n-[2-(2,4,5-trifluorophenyl)phenyl]pyrazole-4-carboxamide Chemical compound CC1=NN(C)C(Cl)=C1C(=O)NC1=CC=CC=C1C1=CC(F)=C(F)C=C1F ZHMMUAFLEODRRU-UHFFFAOYSA-N 0.000 description 1
- UOQQVODLCIREHZ-UHFFFAOYSA-N 5-chloro-1,3-dimethyl-n-[2-(3,4,5-trifluorophenyl)phenyl]pyrazole-4-carboxamide Chemical compound CC1=NN(C)C(Cl)=C1C(=O)NC1=CC=CC=C1C1=CC(F)=C(F)C(F)=C1 UOQQVODLCIREHZ-UHFFFAOYSA-N 0.000 description 1
- PYSWIWUUIADPSA-UHFFFAOYSA-N 5-chloro-1-methyl-3-(trifluoromethyl)-n-[2-(2,4,5-trifluorophenyl)phenyl]pyrazole-4-carboxamide Chemical compound CN1N=C(C(F)(F)F)C(C(=O)NC=2C(=CC=CC=2)C=2C(=CC(F)=C(F)C=2)F)=C1Cl PYSWIWUUIADPSA-UHFFFAOYSA-N 0.000 description 1
- VSLFTDSKEIIUKB-UHFFFAOYSA-N 5-chloro-1-methyl-3-(trifluoromethyl)-n-[2-(3,4,5-trifluorophenyl)phenyl]pyrazole-4-carboxamide Chemical compound CN1N=C(C(F)(F)F)C(C(=O)NC=2C(=CC=CC=2)C=2C=C(F)C(F)=C(F)C=2)=C1Cl VSLFTDSKEIIUKB-UHFFFAOYSA-N 0.000 description 1
- ASMNSUBMNZQTTG-UHFFFAOYSA-N 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine Chemical compound C1CC(C)CCN1C1=C(C=2C(=CC(F)=CC=2F)F)C(Cl)=NC2=NC=NN12 ASMNSUBMNZQTTG-UHFFFAOYSA-N 0.000 description 1
- RSPQEYYKCFEVLC-UHFFFAOYSA-N 5-ethyl-6-octyl-[1,2,4]triazolo[1,5-a]pyrimidine-2,7-diamine Chemical compound NC1=C(CCCCCCCC)C(CC)=NC2=NC(N)=NN21 RSPQEYYKCFEVLC-UHFFFAOYSA-N 0.000 description 1
- NVPGNIOAWSFTCM-UHFFFAOYSA-N 5-fluoro-1,3-dimethyl-n-[2-(2,4,5-trifluorophenyl)phenyl]pyrazole-4-carboxamide Chemical compound CC1=NN(C)C(F)=C1C(=O)NC1=CC=CC=C1C1=CC(F)=C(F)C=C1F NVPGNIOAWSFTCM-UHFFFAOYSA-N 0.000 description 1
- UHISDBYFQHCPMV-UHFFFAOYSA-N 5-fluoro-1-methyl-3-(trifluoromethyl)-n-[2-(2,4,5-trifluorophenyl)phenyl]pyrazole-4-carboxamide Chemical compound CN1N=C(C(F)(F)F)C(C(=O)NC=2C(=CC=CC=2)C=2C(=CC(F)=C(F)C=2)F)=C1F UHISDBYFQHCPMV-UHFFFAOYSA-N 0.000 description 1
- ZPAJAVGZZKPCTN-UHFFFAOYSA-N 5-methyl-1h-pyrazole-4-carboxamide Chemical compound CC1=NNC=C1C(N)=O ZPAJAVGZZKPCTN-UHFFFAOYSA-N 0.000 description 1
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 description 1
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000005660 Abamectin Substances 0.000 description 1
- 240000004507 Abelmoschus esculentus Species 0.000 description 1
- 241001290610 Abildgaardia Species 0.000 description 1
- 108010059616 Activins Proteins 0.000 description 1
- 102000005606 Activins Human genes 0.000 description 1
- MDBGGTQNNUOQRC-UHFFFAOYSA-N Allidochlor Chemical compound ClCC(=O)N(CC=C)CC=C MDBGGTQNNUOQRC-UHFFFAOYSA-N 0.000 description 1
- 241000212254 Alternaria porri Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241001124076 Aphididae Species 0.000 description 1
- 239000005878 Azadirachtin Substances 0.000 description 1
- 241000711784 Bacillus amyloliquefaciens CC178 Species 0.000 description 1
- 241000193747 Bacillus firmus Species 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- 235000005744 Bacillus subtilis subsp subtilis Nutrition 0.000 description 1
- 241000948854 Bacillus subtilis subsp. subtilis Species 0.000 description 1
- 241000751139 Beauveria bassiana Species 0.000 description 1
- 239000005734 Benalaxyl Substances 0.000 description 1
- 239000005472 Bensulfuron methyl Substances 0.000 description 1
- 239000005476 Bentazone Substances 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 239000005884 Beta-Cyfluthrin Substances 0.000 description 1
- 239000005653 Bifenazate Substances 0.000 description 1
- 239000005484 Bifenox Substances 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 239000005740 Boscalid Substances 0.000 description 1
- RTONBWTZPZBIAC-UHFFFAOYSA-N Br[P]Br Chemical compound Br[P]Br RTONBWTZPZBIAC-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 239000005489 Bromoxynil Substances 0.000 description 1
- 241000579185 Bucerotidae Species 0.000 description 1
- 239000005742 Bupirimate Substances 0.000 description 1
- GYEBEOQAUPEZCZ-UHFFFAOYSA-N C(C)(=N)N.C(C(O)C)(=O)O Chemical compound C(C)(=N)N.C(C(O)C)(=O)O GYEBEOQAUPEZCZ-UHFFFAOYSA-N 0.000 description 1
- AGYKGLGUMGTNHK-UHFFFAOYSA-N C.[Br] Chemical compound C.[Br] AGYKGLGUMGTNHK-UHFFFAOYSA-N 0.000 description 1
- KJAYNUDGSDKZCL-UHFFFAOYSA-N C1=CC=CC=C1.[N+](=O)([O-])Cl.[N+](=O)([O-])Cl.[N+](=O)([O-])Cl.[N+](=O)([O-])Cl Chemical compound C1=CC=CC=C1.[N+](=O)([O-])Cl.[N+](=O)([O-])Cl.[N+](=O)([O-])Cl.[N+](=O)([O-])Cl KJAYNUDGSDKZCL-UHFFFAOYSA-N 0.000 description 1
- GQKXQBOZMJNIOQ-UHFFFAOYSA-N CC1=NN(C=C1C(=NC2=C(C=C(C=C2)F)C3=CC=C(C=C3)Cl)N)C Chemical compound CC1=NN(C=C1C(=NC2=C(C=C(C=C2)F)C3=CC=C(C=C3)Cl)N)C GQKXQBOZMJNIOQ-UHFFFAOYSA-N 0.000 description 1
- WPKCMOKLDGIBPB-UHFFFAOYSA-N CN1C(=C(C(=N1)C(F)F)C2=C(NC3=CC=CC=C32)NC4=CC=CC=C4C5=CC(=C(C=C5F)F)F)F Chemical compound CN1C(=C(C(=N1)C(F)F)C2=C(NC3=CC=CC=C32)NC4=CC=CC=C4C5=CC(=C(C=C5F)F)F)F WPKCMOKLDGIBPB-UHFFFAOYSA-N 0.000 description 1
- APAFGZUOUHXQBS-UHFFFAOYSA-N CN1C(=C(C(=N1)CF)C(=O)NC2=CC=CC=C2C3=CC(=C(C(=C3)F)F)F)Cl Chemical compound CN1C(=C(C(=N1)CF)C(=O)NC2=CC=CC=C2C3=CC(=C(C(=C3)F)F)F)Cl APAFGZUOUHXQBS-UHFFFAOYSA-N 0.000 description 1
- FZDMXPMGDDBEAY-UHFFFAOYSA-N CN1C=C(C(=N1)C(F)F)C(=NC2=C(C=CC(=C2)F)C3=CC(=C(C=C3)Cl)Cl)N Chemical compound CN1C=C(C(=N1)C(F)F)C(=NC2=C(C=CC(=C2)F)C3=CC(=C(C=C3)Cl)Cl)N FZDMXPMGDDBEAY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000316922 Caldicoprobacter faecalis Species 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 239000005745 Captan Substances 0.000 description 1
- 229940123982 Cell wall synthesis inhibitor Drugs 0.000 description 1
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
- 239000005886 Chlorantraniliprole Substances 0.000 description 1
- 239000005945 Chlorpyrifos-methyl Substances 0.000 description 1
- 239000005496 Chlorsulfuron Substances 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 239000005498 Clodinafop Substances 0.000 description 1
- 241000255749 Coccinellidae Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 239000005752 Copper oxychloride Substances 0.000 description 1
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 1
- 239000005889 Cyantraniliprole Substances 0.000 description 1
- 239000005758 Cyprodinil Substances 0.000 description 1
- 235000018783 Dacrycarpus dacrydioides Nutrition 0.000 description 1
- NPOJQCVWMSKXDN-UHFFFAOYSA-N Dacthal Chemical compound COC(=O)C1=C(Cl)C(Cl)=C(C(=O)OC)C(Cl)=C1Cl NPOJQCVWMSKXDN-UHFFFAOYSA-N 0.000 description 1
- NDUPDOJHUQKPAG-UHFFFAOYSA-N Dalapon Chemical compound CC(Cl)(Cl)C(O)=O NDUPDOJHUQKPAG-UHFFFAOYSA-N 0.000 description 1
- 102100034289 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Human genes 0.000 description 1
- 239000005893 Diflubenzuron Substances 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 239000005947 Dimethoate Substances 0.000 description 1
- 239000005630 Diquat Substances 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 235000005422 Distichlis palmeri Nutrition 0.000 description 1
- 244000077283 Distichlis palmeri Species 0.000 description 1
- 239000005510 Diuron Substances 0.000 description 1
- 239000005698 Dodecyl acetate Substances 0.000 description 1
- GUVLYNGULCJVDO-UHFFFAOYSA-N EPTC Chemical compound CCCN(CCC)C(=O)SCC GUVLYNGULCJVDO-UHFFFAOYSA-N 0.000 description 1
- 239000005894 Emamectin Substances 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
- FNELVJVBIYMIMC-UHFFFAOYSA-N Ethiprole Chemical compound N1=C(C#N)C(S(=O)CC)=C(N)N1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl FNELVJVBIYMIMC-UHFFFAOYSA-N 0.000 description 1
- UWVKRNOCDUPIDM-UHFFFAOYSA-N Ethoxysulfuron Chemical compound CCOC1=CC=CC=C1OS(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 UWVKRNOCDUPIDM-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- ICWUMLXQKFTJMH-UHFFFAOYSA-N Etobenzanid Chemical compound C1=CC(OCOCC)=CC=C1C(=O)NC1=CC=CC(Cl)=C1Cl ICWUMLXQKFTJMH-UHFFFAOYSA-N 0.000 description 1
- 239000005769 Etridiazole Substances 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 239000005898 Fenoxycarb Substances 0.000 description 1
- 239000005777 Fenpropidin Substances 0.000 description 1
- 239000005779 Fenpyrazamine Substances 0.000 description 1
- PNVJTZOFSHSLTO-UHFFFAOYSA-N Fenthion Chemical compound COP(=S)(OC)OC1=CC=C(SC)C(C)=C1 PNVJTZOFSHSLTO-UHFFFAOYSA-N 0.000 description 1
- 239000005900 Flonicamid Substances 0.000 description 1
- 239000005901 Flubendiamide Substances 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 239000005784 Fluoxastrobin Substances 0.000 description 1
- 239000005788 Fluxapyroxad Substances 0.000 description 1
- 239000005790 Fosetyl Substances 0.000 description 1
- 241000611205 Fusarium oxysporum f. sp. lycopersici Species 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 239000005561 Glufosinate Substances 0.000 description 1
- 239000005562 Glyphosate Substances 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- 241000255967 Helicoverpa zea Species 0.000 description 1
- WJYIASZWHGOTOU-UHFFFAOYSA-N Heptylamine Chemical compound CCCCCCCN WJYIASZWHGOTOU-UHFFFAOYSA-N 0.000 description 1
- CAWXEEYDBZRFPE-UHFFFAOYSA-N Hexazinone Chemical compound O=C1N(C)C(N(C)C)=NC(=O)N1C1CCCCC1 CAWXEEYDBZRFPE-UHFFFAOYSA-N 0.000 description 1
- 102000007625 Hirudins Human genes 0.000 description 1
- 108010007267 Hirudins Proteins 0.000 description 1
- 101000641031 Homo sapiens Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Proteins 0.000 description 1
- 244000267823 Hydrangea macrophylla Species 0.000 description 1
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 1
- 235000002294 Ilex volkensiana Nutrition 0.000 description 1
- 239000005566 Imazamox Substances 0.000 description 1
- 239000005981 Imazaquin Substances 0.000 description 1
- XVOKUMIPKHGGTN-UHFFFAOYSA-N Imazethapyr Chemical compound OC(=O)C1=CC(CC)=CN=C1C1=NC(C)(C(C)C)C(=O)N1 XVOKUMIPKHGGTN-UHFFFAOYSA-N 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
- 239000005907 Indoxacarb Substances 0.000 description 1
- 239000005568 Iodosulfuron Substances 0.000 description 1
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 1
- 239000005571 Isoxaflutole Substances 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- 239000005800 Kresoxim-methyl Substances 0.000 description 1
- FFFHZYDWPBMWHY-UHFFFAOYSA-N L-Homocysteine Natural products OC(=O)C(N)CCS FFFHZYDWPBMWHY-UHFFFAOYSA-N 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 125000002061 L-isoleucyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])[C@](C([H])([H])[H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 239000005717 Laminarin Substances 0.000 description 1
- 229920001543 Laminarin Polymers 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- SUSRORUBZHMPCO-UHFFFAOYSA-N MC-4379 Chemical compound C1=C([N+]([O-])=O)C(C(=O)OC)=CC(OC=2C(=CC(Cl)=CC=2)Cl)=C1 SUSRORUBZHMPCO-UHFFFAOYSA-N 0.000 description 1
- 239000005949 Malathion Substances 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 241000366182 Melaleuca alternifolia Species 0.000 description 1
- 239000005806 Meptyldinocap Substances 0.000 description 1
- 239000005578 Mesotrione Substances 0.000 description 1
- 239000005807 Metalaxyl Substances 0.000 description 1
- 241000223201 Metarhizium Species 0.000 description 1
- 239000005580 Metazachlor Substances 0.000 description 1
- 101100038261 Methanococcus vannielii (strain ATCC 35089 / DSM 1224 / JCM 13029 / OCM 148 / SB) rpo2C gene Proteins 0.000 description 1
- LGDSHSYDSCRFAB-UHFFFAOYSA-N Methyl isothiocyanate Chemical compound CN=C=S LGDSHSYDSCRFAB-UHFFFAOYSA-N 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- 102000013379 Mitochondrial Proton-Translocating ATPases Human genes 0.000 description 1
- 108010026155 Mitochondrial Proton-Translocating ATPases Proteins 0.000 description 1
- WVZQGXVKJJBGKN-UHFFFAOYSA-N N'-[4-(13,13-dimethyltetradecoxy)-2-methyl-5-(trifluoromethyl)phenyl]-N-ethyl-N-methylmethanimidamide Chemical compound C(C)N(C=NC1=C(C=C(C(=C1)C(F)(F)F)OCCCCCCCCCCCCC(C)(C)C)C)C WVZQGXVKJJBGKN-UHFFFAOYSA-N 0.000 description 1
- NGFSZTBYWRYIIA-UHFFFAOYSA-N N'-[5-(difluoromethyl)-4-(13,13-dimethyltetradecoxy)-2-methylphenyl]-N-ethyl-N-methylmethanimidamide Chemical compound FC(C=1C(=CC(=C(C1)N=CN(C)CC)C)OCCCCCCCCCCCCC(C)(C)C)F NGFSZTBYWRYIIA-UHFFFAOYSA-N 0.000 description 1
- MCHGLSWPSXWRKO-UHFFFAOYSA-N N-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-N-[2-(3,4,5-trifluorophenyl)phenyl]formamide Chemical compound FC(F)(F)C1=NN(C)C=C1N(C=O)C1=CC=CC=C1C1=CC(F)=C(F)C(F)=C1 MCHGLSWPSXWRKO-UHFFFAOYSA-N 0.000 description 1
- OOLXUVGVANEOLY-UHFFFAOYSA-N N-[3-(fluoromethyl)-1-methylpyrazol-4-yl]-N-[2-(3,4,5-trifluorophenyl)phenyl]formamide Chemical compound CN1C=C(C(=N1)CF)N(C=O)C2=CC=CC=C2C3=CC(=C(C(=C3)F)F)F OOLXUVGVANEOLY-UHFFFAOYSA-N 0.000 description 1
- WGZRLCSNSDVVTH-UHFFFAOYSA-N N-[3-[chloro(fluoro)methyl]-1-methylpyrazol-4-yl]-N-[2-(3,4,5-trifluorophenyl)phenyl]formamide Chemical compound CN1C=C(C(=N1)C(F)Cl)N(C=O)C2=CC=CC=C2C3=CC(=C(C(=C3)F)F)F WGZRLCSNSDVVTH-UHFFFAOYSA-N 0.000 description 1
- NQRFDNJEBWAUBL-UHFFFAOYSA-N N-[cyano(2-thienyl)methyl]-4-ethyl-2-(ethylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NCC)=NC(CC)=C1C(=O)NC(C#N)C1=CC=CS1 NQRFDNJEBWAUBL-UHFFFAOYSA-N 0.000 description 1
- 241000000718 Naytia glabrata Species 0.000 description 1
- 239000005586 Nicosulfuron Substances 0.000 description 1
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 description 1
- 241000495841 Oenanthe oenanthe Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- HPUXDMUGCAWDFW-UHFFFAOYSA-N Osthole Natural products COc1ccc2CCC(=O)Oc2c1C=CC(=O)C HPUXDMUGCAWDFW-UHFFFAOYSA-N 0.000 description 1
- 239000005588 Oxadiazon Substances 0.000 description 1
- CHNUNORXWHYHNE-UHFFFAOYSA-N Oxadiazon Chemical compound C1=C(Cl)C(OC(C)C)=CC(N2C(OC(=N2)C(C)(C)C)=O)=C1Cl CHNUNORXWHYHNE-UHFFFAOYSA-N 0.000 description 1
- 239000005950 Oxamyl Substances 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 1
- 229940087098 Oxidase inhibitor Drugs 0.000 description 1
- KYGZCKSPAKDVKC-UHFFFAOYSA-N Oxolinic acid Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC2=C1OCO2 KYGZCKSPAKDVKC-UHFFFAOYSA-N 0.000 description 1
- 241001236817 Paecilomyces <Clavicipitaceae> Species 0.000 description 1
- 241000520272 Pantoea Species 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 239000005591 Pendimethalin Substances 0.000 description 1
- 239000005815 Penflufen Substances 0.000 description 1
- 241000233679 Peronosporaceae Species 0.000 description 1
- 240000009164 Petroselinum crispum Species 0.000 description 1
- XPFRXWCVYUEORT-UHFFFAOYSA-N Phenacemide Chemical compound NC(=O)NC(=O)CC1=CC=CC=C1 XPFRXWCVYUEORT-UHFFFAOYSA-N 0.000 description 1
- QZVCTJOXCFMACW-UHFFFAOYSA-N Phenoxybenzamine Chemical compound C=1C=CC=CC=1CN(CCCl)C(C)COC1=CC=CC=C1 QZVCTJOXCFMACW-UHFFFAOYSA-N 0.000 description 1
- 239000005921 Phosmet Substances 0.000 description 1
- 241001224149 Pimelea cinerea Species 0.000 description 1
- 240000007320 Pinus strobus Species 0.000 description 1
- 235000008578 Pinus strobus Nutrition 0.000 description 1
- 239000005923 Pirimicarb Substances 0.000 description 1
- 239000005924 Pirimiphos-methyl Substances 0.000 description 1
- 241000500437 Plutella xylostella Species 0.000 description 1
- 229930182556 Polyacetal Natural products 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000157935 Promicromonospora citrea Species 0.000 description 1
- 239000005821 Propamocarb Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 108020001991 Protoporphyrinogen Oxidase Proteins 0.000 description 1
- 102000005135 Protoporphyrinogen oxidase Human genes 0.000 description 1
- 241001646398 Pseudomonas chlororaphis Species 0.000 description 1
- 241001123569 Puccinia recondita Species 0.000 description 1
- 239000005925 Pymetrozine Substances 0.000 description 1
- VXMNDQDDWDDKOQ-UHFFFAOYSA-N Pyrazosulfuron Chemical compound COC1=CC(OC)=NC(NC(=O)NS(=O)(=O)C=2N(N=CC=2C(O)=O)C)=N1 VXMNDQDDWDDKOQ-UHFFFAOYSA-N 0.000 description 1
- VQXSOUPNOZTNAI-UHFFFAOYSA-N Pyrethrin I Natural products CC(=CC1CC1C(=O)OC2CC(=O)C(=C2C)CC=C/C=C)C VQXSOUPNOZTNAI-UHFFFAOYSA-N 0.000 description 1
- 239000005828 Pyrimethanil Substances 0.000 description 1
- MWMQNVGAHVXSPE-UHFFFAOYSA-N Pyriprole Chemical compound ClC=1C=C(C(F)(F)F)C=C(Cl)C=1N1N=C(C#N)C(SC(F)F)=C1NCC1=CC=CC=N1 MWMQNVGAHVXSPE-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 235000009001 Quillaja saponaria Nutrition 0.000 description 1
- 239000005831 Quinoxyfen Substances 0.000 description 1
- 239000005614 Quizalofop-P-ethyl Substances 0.000 description 1
- 241000232299 Ralstonia Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- ISRUGXGCCGIOQO-UHFFFAOYSA-N Rhoden Chemical compound CNC(=O)OC1=CC=CC=C1OC(C)C ISRUGXGCCGIOQO-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 239000005617 S-Metolachlor Substances 0.000 description 1
- 229910052772 Samarium Inorganic materials 0.000 description 1
- 244000151637 Sambucus canadensis Species 0.000 description 1
- 241000694414 Sapindus saponaria Species 0.000 description 1
- 241000341387 Scutellaria serrata Species 0.000 description 1
- 239000005834 Sedaxane Substances 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 108010052164 Sodium Channels Proteins 0.000 description 1
- 102000018674 Sodium Channels Human genes 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 239000005929 Spinetoram Substances 0.000 description 1
- GOENIMGKWNZVDA-OAMCMWGQSA-N Spinetoram Chemical compound CO[C@@H]1[C@H](OCC)[C@@H](OC)[C@H](C)O[C@H]1OC1C[C@H]2[C@@H]3C=C4C(=O)[C@H](C)[C@@H](O[C@@H]5O[C@H](C)[C@H](CC5)N(C)C)CCC[C@H](CC)OC(=O)CC4[C@@H]3CC[C@@H]2C1 GOENIMGKWNZVDA-OAMCMWGQSA-N 0.000 description 1
- 239000005931 Spirotetramat Substances 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 239000005618 Sulcotrione Substances 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 1
- 239000005839 Tebuconazole Substances 0.000 description 1
- 239000005658 Tebufenpyrad Substances 0.000 description 1
- 239000005940 Thiacloprid Substances 0.000 description 1
- 239000005941 Thiamethoxam Substances 0.000 description 1
- 101000844260 Thrixopelma pruriens Beta/omega-theraphotoxin-Tp1a Proteins 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical class [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 239000005847 Triazoxide Substances 0.000 description 1
- 241000256618 Trichogramma Species 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 229930195482 Validamycin Natural products 0.000 description 1
- FVECELJHCSPHKY-WTFKENEKSA-N Veratrine (amorphous) Chemical compound C1=C(OC)C(OC)=CC=C1C(=O)O[C@@H]1[C@]2(O)O[C@@]34C[C@@]5(O)[C@H](CN6[C@@H](CC[C@H](C)C6)[C@@]6(C)O)[C@]6(O)[C@@H](O)C[C@@]5(O)[C@@H]4CC[C@H]2[C@]3(C)CC1 FVECELJHCSPHKY-WTFKENEKSA-N 0.000 description 1
- 241000907138 Xanthomonas oryzae pv. oryzae Species 0.000 description 1
- BUHNCQOJJZAOMJ-UHFFFAOYSA-N ZXI 8901 Chemical compound C=1C=C(OC(F)F)C=CC=1C(C(C)C)C(=O)OC(C#N)C(C=1)=CC=CC=1OC1=CC=C(Br)C=C1 BUHNCQOJJZAOMJ-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- QQODLKZGRKWIFG-RUTXASTPSA-N [(R)-cyano-(4-fluoro-3-phenoxyphenyl)methyl] (1S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)C(C=C(Cl)Cl)[C@@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-RUTXASTPSA-N 0.000 description 1
- FSAVDKDHPDSCTO-WQLSENKSSA-N [(z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] diethyl phosphate Chemical compound CCOP(=O)(OCC)O\C(=C/Cl)C1=CC=C(Cl)C=C1Cl FSAVDKDHPDSCTO-WQLSENKSSA-N 0.000 description 1
- NUSORQHHEXCNQC-UHFFFAOYSA-N [Cu].N1C(C=C2N=C(C=C3NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 Chemical compound [Cu].N1C(C=C2N=C(C=C3NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 NUSORQHHEXCNQC-UHFFFAOYSA-N 0.000 description 1
- 229950008167 abamectin Drugs 0.000 description 1
- 230000036579 abiotic stress Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- YASYVMFAVPKPKE-UHFFFAOYSA-N acephate Chemical compound COP(=O)(SC)NC(C)=O YASYVMFAVPKPKE-UHFFFAOYSA-N 0.000 description 1
- NUFNQYOELLVIPL-UHFFFAOYSA-N acifluorfen Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(OC=2C(=CC(=CC=2)C(F)(F)F)Cl)=C1 NUFNQYOELLVIPL-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000488 activin Substances 0.000 description 1
- 108010023079 activin B Proteins 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- XCSGPAVHZFQHGE-UHFFFAOYSA-N alachlor Chemical compound CCC1=CC=CC(CC)=C1N(COC)C(=O)CCl XCSGPAVHZFQHGE-UHFFFAOYSA-N 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- GMAUQNJOSOMMHI-JXAWBTAJSA-N alanycarb Chemical compound CSC(\C)=N/OC(=O)N(C)SN(CCC(=O)OCC)CC1=CC=CC=C1 GMAUQNJOSOMMHI-JXAWBTAJSA-N 0.000 description 1
- HXHWSAZORRCQMX-UHFFFAOYSA-N albendazole Chemical compound CCCSC1=CC=C2NC(NC(=O)OC)=NC2=C1 HXHWSAZORRCQMX-UHFFFAOYSA-N 0.000 description 1
- 229960002669 albendazole Drugs 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- QGLZXHRNAYXIBU-WEVVVXLNSA-N aldicarb Chemical compound CNC(=O)O\N=C\C(C)(C)SC QGLZXHRNAYXIBU-WEVVVXLNSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- BREATYVWRHIPIY-UHFFFAOYSA-N amisulbrom Chemical compound CN(C)S(=O)(=O)N1C=NC(S(=O)(=O)N2C3=CC(F)=CC=C3C(Br)=C2C)=N1 BREATYVWRHIPIY-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002528 anti-freeze Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 description 1
- 229960004191 artemisinin Drugs 0.000 description 1
- 229930101531 artemisinin Natural products 0.000 description 1
- MXWJVTOOROXGIU-UHFFFAOYSA-N atrazine Chemical compound CCNC1=NC(Cl)=NC(NC(C)C)=N1 MXWJVTOOROXGIU-UHFFFAOYSA-N 0.000 description 1
- 229960000892 attapulgite Drugs 0.000 description 1
- VEHPJKVTJQSSKL-UHFFFAOYSA-N azadirachtin Natural products O1C2(C)C(C3(C=COC3O3)O)CC3C21C1(C)C(O)C(OCC2(OC(C)=O)C(CC3OC(=O)C(C)=CC)OC(C)=O)C2C32COC(C(=O)OC)(O)C12 VEHPJKVTJQSSKL-UHFFFAOYSA-N 0.000 description 1
- FTNJWQUOZFUQQJ-NDAWSKJSSA-N azadirachtin A Chemical compound C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C\C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-NDAWSKJSSA-N 0.000 description 1
- FTNJWQUOZFUQQJ-IRYYUVNJSA-N azadirachtin A Natural products C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C/C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-IRYYUVNJSA-N 0.000 description 1
- RQVGAIADHNPSME-UHFFFAOYSA-N azinphos-ethyl Chemical group C1=CC=C2C(=O)N(CSP(=S)(OCC)OCC)N=NC2=C1 RQVGAIADHNPSME-UHFFFAOYSA-N 0.000 description 1
- ONHBDDJJTDTLIR-UHFFFAOYSA-N azocyclotin Chemical compound C1CCCCC1[Sn](N1N=CN=C1)(C1CCCCC1)C1CCCCC1 ONHBDDJJTDTLIR-UHFFFAOYSA-N 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- WFDXOXNFNRHQEC-GHRIWEEISA-N azoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=CC(OC=2C(=CC=CC=2)C#N)=NC=N1 WFDXOXNFNRHQEC-GHRIWEEISA-N 0.000 description 1
- 229940005348 bacillus firmus Drugs 0.000 description 1
- PARMADWNFXEEFC-UHFFFAOYSA-N bamethan sulfate Chemical compound [O-]S([O-])(=O)=O.CCCC[NH2+]CC(O)C1=CC=C(O)C=C1.CCCC[NH2+]CC(O)C1=CC=C(O)C=C1 PARMADWNFXEEFC-UHFFFAOYSA-N 0.000 description 1
- FYZBOYWSHKHDMT-UHFFFAOYSA-N benfuracarb Chemical compound CCOC(=O)CCN(C(C)C)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 FYZBOYWSHKHDMT-UHFFFAOYSA-N 0.000 description 1
- LJOZMWRYMKECFF-UHFFFAOYSA-N benodanil Chemical compound IC1=CC=CC=C1C(=O)NC1=CC=CC=C1 LJOZMWRYMKECFF-UHFFFAOYSA-N 0.000 description 1
- PPWBRCCBKOWDNB-UHFFFAOYSA-N bensulfuron Chemical compound COC1=CC(OC)=NC(NC(=O)NS(=O)(=O)CC=2C(=CC=CC=2)C(O)=O)=N1 PPWBRCCBKOWDNB-UHFFFAOYSA-N 0.000 description 1
- XMQFTWRPUQYINF-UHFFFAOYSA-N bensulfuron-methyl Chemical group COC(=O)C1=CC=CC=C1CS(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 XMQFTWRPUQYINF-UHFFFAOYSA-N 0.000 description 1
- ZOMSMJKLGFBRBS-UHFFFAOYSA-N bentazone Chemical compound C1=CC=C2NS(=O)(=O)N(C(C)C)C(=O)C2=C1 ZOMSMJKLGFBRBS-UHFFFAOYSA-N 0.000 description 1
- PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical compound NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 description 1
- CNBGNNVCVSKAQZ-UHFFFAOYSA-N benzidamine Natural products C12=CC=CC=C2C(OCCCN(C)C)=NN1CC1=CC=CC=C1 CNBGNNVCVSKAQZ-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- NDTSRXAMMQDVSW-UHFFFAOYSA-N benzthiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(S(N2)(=O)=O)=C1N=C2CSCC1=CC=CC=C1 NDTSRXAMMQDVSW-UHFFFAOYSA-N 0.000 description 1
- 229960001541 benzthiazide Drugs 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- VHLKTXFWDRXILV-UHFFFAOYSA-N bifenazate Chemical compound C1=C(NNC(=O)OC(C)C)C(OC)=CC=C1C1=CC=CC=C1 VHLKTXFWDRXILV-UHFFFAOYSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 1
- 230000001764 biostimulatory effect Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 230000004790 biotic stress Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- CXNPLSGKWMLZPZ-UHFFFAOYSA-N blasticidin-S Natural products O1C(C(O)=O)C(NC(=O)CC(N)CCN(C)C(N)=N)C=CC1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-UHFFFAOYSA-N 0.000 description 1
- 229940118790 boscalid Drugs 0.000 description 1
- WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 description 1
- CODNYICXDISAEA-UHFFFAOYSA-N bromine monochloride Chemical compound BrCl CODNYICXDISAEA-UHFFFAOYSA-N 0.000 description 1
- FOANIXZHAMJWOI-UHFFFAOYSA-N bromopropylate Chemical compound C=1C=C(Br)C=CC=1C(O)(C(=O)OC(C)C)C1=CC=C(Br)C=C1 FOANIXZHAMJWOI-UHFFFAOYSA-N 0.000 description 1
- DSKJPMWIHSOYEA-UHFFFAOYSA-N bupirimate Chemical compound CCCCC1=C(C)N=C(NCC)N=C1OS(=O)(=O)N(C)C DSKJPMWIHSOYEA-UHFFFAOYSA-N 0.000 description 1
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 1
- KXRPCFINVWWFHQ-UHFFFAOYSA-N cadusafos Chemical compound CCC(C)SP(=O)(OCC)SC(C)CC KXRPCFINVWWFHQ-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000828 canola oil Substances 0.000 description 1
- 235000019519 canola oil Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229940117949 captan Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229960005286 carbaryl Drugs 0.000 description 1
- CVXBEEMKQHEXEN-UHFFFAOYSA-N carbaryl Chemical compound C1=CC=C2C(OC(=O)NC)=CC=CC2=C1 CVXBEEMKQHEXEN-UHFFFAOYSA-N 0.000 description 1
- DUEPRVBVGDRKAG-UHFFFAOYSA-N carbofuran Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2 DUEPRVBVGDRKAG-UHFFFAOYSA-N 0.000 description 1
- 229950005499 carbon tetrachloride Drugs 0.000 description 1
- JLQUFIHWVLZVTJ-UHFFFAOYSA-N carbosulfan Chemical compound CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 JLQUFIHWVLZVTJ-UHFFFAOYSA-N 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- IRUJZVNXZWPBMU-UHFFFAOYSA-N cartap Chemical compound NC(=O)SCC(N(C)C)CSC(N)=O IRUJZVNXZWPBMU-UHFFFAOYSA-N 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- UWGBIKPRXRSRNM-UHFFFAOYSA-N cevadine Natural products CC=C(C)/C(=O)OC1CCC2(C)C3CCC4C5(O)CC(O)C6(O)C(CN7CC(C)CCC7C6(C)O)C5(O)CC24OCC13O UWGBIKPRXRSRNM-UHFFFAOYSA-N 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- PSOVNZZNOMJUBI-UHFFFAOYSA-N chlorantraniliprole Chemical compound CNC(=O)C1=CC(Cl)=CC(C)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl PSOVNZZNOMJUBI-UHFFFAOYSA-N 0.000 description 1
- UISUNVFOGSJSKD-UHFFFAOYSA-N chlorfluazuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC(C=C1Cl)=CC(Cl)=C1OC1=NC=C(C(F)(F)F)C=C1Cl UISUNVFOGSJSKD-UHFFFAOYSA-N 0.000 description 1
- 239000003467 chloride channel stimulating agent Substances 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- HKMOPYJWSFRURD-UHFFFAOYSA-N chloro hypochlorite;copper Chemical compound [Cu].ClOCl HKMOPYJWSFRURD-UHFFFAOYSA-N 0.000 description 1
- ITVPBBDAZKBMRP-UHFFFAOYSA-N chloro-dioxido-oxo-$l^{5}-phosphane;hydron Chemical compound OP(O)(Cl)=O ITVPBBDAZKBMRP-UHFFFAOYSA-N 0.000 description 1
- PFIADAMVCJPXSF-UHFFFAOYSA-N chloroneb Chemical compound COC1=CC(Cl)=C(OC)C=C1Cl PFIADAMVCJPXSF-UHFFFAOYSA-N 0.000 description 1
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- YUIKUTLBPMDDNQ-MRVPVSSYSA-N clodinafop Chemical compound C1=CC(O[C@H](C)C(O)=O)=CC=C1OC1=NC=C(Cl)C=C1F YUIKUTLBPMDDNQ-MRVPVSSYSA-N 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- CWVRPJSBNHNJSI-XQNSMLJCSA-N coumoxystrobin Chemical compound C1=C2OC(=O)C(CCCC)=C(C)C2=CC=C1OCC1=CC=CC=C1\C(=C/OC)C(=O)OC CWVRPJSBNHNJSI-XQNSMLJCSA-N 0.000 description 1
- 229910001610 cryolite Inorganic materials 0.000 description 1
- SCKHCCSZFPSHGR-UHFFFAOYSA-N cyanophos Chemical compound COP(=S)(OC)OC1=CC=C(C#N)C=C1 SCKHCCSZFPSHGR-UHFFFAOYSA-N 0.000 description 1
- DVBUIBGJRQBEDP-UHFFFAOYSA-N cyantraniliprole Chemical compound CNC(=O)C1=CC(C#N)=CC(C)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl DVBUIBGJRQBEDP-UHFFFAOYSA-N 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- RXQDTMKIWOTJSQ-UHFFFAOYSA-N cycloheptyloxycycloheptane Chemical compound C1CCCCCC1OC1CCCCCC1 RXQDTMKIWOTJSQ-UHFFFAOYSA-N 0.000 description 1
- ZXQYGBMAQZUVMI-UNOMPAQXSA-N cyhalothrin Chemical compound CC1(C)C(\C=C(/Cl)C(F)(F)F)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-UNOMPAQXSA-N 0.000 description 1
- WCMMILVIRZAPLE-UHFFFAOYSA-M cyhexatin Chemical compound C1CCCCC1[Sn](C1CCCCC1)(O)C1CCCCC1 WCMMILVIRZAPLE-UHFFFAOYSA-M 0.000 description 1
- HAORKNGNJCEJBX-UHFFFAOYSA-N cyprodinil Chemical compound N=1C(C)=CC(C2CC2)=NC=1NC1=CC=CC=C1 HAORKNGNJCEJBX-UHFFFAOYSA-N 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 description 1
- 229950001327 dichlorvos Drugs 0.000 description 1
- BYNQFCJOHGOKSS-UHFFFAOYSA-N diclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1 BYNQFCJOHGOKSS-UHFFFAOYSA-N 0.000 description 1
- UOAMTSKGCBMZTC-UHFFFAOYSA-N dicofol Chemical compound C=1C=C(Cl)C=CC=1C(C(Cl)(Cl)Cl)(O)C1=CC=C(Cl)C=C1 UOAMTSKGCBMZTC-UHFFFAOYSA-N 0.000 description 1
- VEENJGZXVHKXNB-VOTSOKGWSA-N dicrotophos Chemical compound COP(=O)(OC)O\C(C)=C\C(=O)N(C)C VEENJGZXVHKXNB-VOTSOKGWSA-N 0.000 description 1
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 description 1
- 229940019503 diflubenzuron Drugs 0.000 description 1
- 238000005906 dihydroxylation reaction Methods 0.000 description 1
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- AXAZMDOAUQTMOW-UHFFFAOYSA-N dimethylzinc Chemical compound C[Zn]C AXAZMDOAUQTMOW-UHFFFAOYSA-N 0.000 description 1
- YKBZOVFACRVRJN-UHFFFAOYSA-N dinotefuran Chemical compound [O-][N+](=O)\N=C(/NC)NCC1CCOC1 YKBZOVFACRVRJN-UHFFFAOYSA-N 0.000 description 1
- SYJFEGQWDCRVNX-UHFFFAOYSA-N diquat Chemical compound C1=CC=[N+]2CC[N+]3=CC=CC=C3C2=C1 SYJFEGQWDCRVNX-UHFFFAOYSA-N 0.000 description 1
- DOFZAZXDOSGAJZ-UHFFFAOYSA-N disulfoton Chemical compound CCOP(=S)(OCC)SCCSCC DOFZAZXDOSGAJZ-UHFFFAOYSA-N 0.000 description 1
- 230000008641 drought stress Effects 0.000 description 1
- CXEGAUYXQAKHKJ-NSBHKLITSA-N emamectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](NC)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 CXEGAUYXQAKHKJ-NSBHKLITSA-N 0.000 description 1
- ZSWFCLXCOIISFI-UHFFFAOYSA-N endo-cyclopentadiene Natural products C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 1
- RDYMFSUJUZBWLH-SVWSLYAFSA-N endosulfan Chemical compound C([C@@H]12)OS(=O)OC[C@@H]1[C@]1(Cl)C(Cl)=C(Cl)[C@@]2(Cl)C1(Cl)Cl RDYMFSUJUZBWLH-SVWSLYAFSA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- VMNULHCTRPXWFJ-UJSVPXBISA-N enoxastrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)\C=C\C1=CC=C(Cl)C=C1 VMNULHCTRPXWFJ-UJSVPXBISA-N 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- DWRKFAJEBUWTQM-UHFFFAOYSA-N etaconazole Chemical compound O1C(CC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 DWRKFAJEBUWTQM-UHFFFAOYSA-N 0.000 description 1
- IRLGCAJYYKDTCG-UHFFFAOYSA-N ethametsulfuron Chemical compound CCOC1=NC(NC)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)C(O)=O)=N1 IRLGCAJYYKDTCG-UHFFFAOYSA-N 0.000 description 1
- RIZMRRKBZQXFOY-UHFFFAOYSA-N ethion Chemical compound CCOP(=S)(OCC)SCSP(=S)(OCC)OCC RIZMRRKBZQXFOY-UHFFFAOYSA-N 0.000 description 1
- IGUYEXXAGBDLLX-UHFFFAOYSA-N ethyl 3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1C(C(=O)OCC)(C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 IGUYEXXAGBDLLX-UHFFFAOYSA-N 0.000 description 1
- KQTVWCSONPJJPE-UHFFFAOYSA-N etridiazole Chemical compound CCOC1=NC(C(Cl)(Cl)Cl)=NS1 KQTVWCSONPJJPE-UHFFFAOYSA-N 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- RBWGTZRSEOIHFD-UHUFKFKFSA-N fenaminstrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1CO\N=C(/C)\C=C\C1=C(Cl)C=CC=C1Cl RBWGTZRSEOIHFD-UHUFKFKFSA-N 0.000 description 1
- JFSPBVWPKOEZCB-UHFFFAOYSA-N fenfuram Chemical compound O1C=CC(C(=O)NC=2C=CC=CC=2)=C1C JFSPBVWPKOEZCB-UHFFFAOYSA-N 0.000 description 1
- CUOJDWBMJMRDHN-VIHUIGFUSA-N fengycin Chemical compound C([C@@H]1C(=O)N[C@H](C(=O)OC2=CC=C(C=C2)C[C@@H](C(N[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(N)=O)C(=O)N1)[C@@H](C)O)=O)NC(=O)[C@@H](CCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)C[C@H](O)CCCCCCCCCCCCC)[C@@H](C)CC)C1=CC=C(O)C=C1 CUOJDWBMJMRDHN-VIHUIGFUSA-N 0.000 description 1
- 108010002015 fengycin Proteins 0.000 description 1
- ZNOLGFHPUIJIMJ-UHFFFAOYSA-N fenitrothion Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C(C)=C1 ZNOLGFHPUIJIMJ-UHFFFAOYSA-N 0.000 description 1
- DIRFUJHNVNOBMY-UHFFFAOYSA-N fenobucarb Chemical compound CCC(C)C1=CC=CC=C1OC(=O)NC DIRFUJHNVNOBMY-UHFFFAOYSA-N 0.000 description 1
- HJUFTIJOISQSKQ-UHFFFAOYSA-N fenoxycarb Chemical compound C1=CC(OCCNC(=O)OCC)=CC=C1OC1=CC=CC=C1 HJUFTIJOISQSKQ-UHFFFAOYSA-N 0.000 description 1
- UTOHZQYBSYOOGC-UHFFFAOYSA-N fenpyrazamine Chemical compound O=C1N(C(C)C)N(C(=O)SCC=C)C(N)=C1C1=CC=CC=C1C UTOHZQYBSYOOGC-UHFFFAOYSA-N 0.000 description 1
- WDQNIWFZKXZFAY-UHFFFAOYSA-M fentin acetate Chemical compound CC([O-])=O.C1=CC=CC=C1[Sn+](C=1C=CC=CC=1)C1=CC=CC=C1 WDQNIWFZKXZFAY-UHFFFAOYSA-M 0.000 description 1
- NJVOZLGKTAPUTQ-UHFFFAOYSA-M fentin chloride Chemical compound C=1C=CC=CC=1[Sn](C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 NJVOZLGKTAPUTQ-UHFFFAOYSA-M 0.000 description 1
- GOWLARCWZRESHU-AQTBWJFISA-N ferimzone Chemical compound C=1C=CC=C(C)C=1C(/C)=N\NC1=NC(C)=CC(C)=N1 GOWLARCWZRESHU-AQTBWJFISA-N 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- RLQJEEJISHYWON-UHFFFAOYSA-N flonicamid Chemical compound FC(F)(F)C1=CC=NC=C1C(=O)NCC#N RLQJEEJISHYWON-UHFFFAOYSA-N 0.000 description 1
- ZGNITFSDLCMLGI-UHFFFAOYSA-N flubendiamide Chemical compound CC1=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C1NC(=O)C1=CC=CC(I)=C1C(=O)NC(C)(C)CS(C)(=O)=O ZGNITFSDLCMLGI-UHFFFAOYSA-N 0.000 description 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
- 229960004884 fluconazole Drugs 0.000 description 1
- MBHXIQDIVCJZTD-RVDMUPIBSA-N flufenoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=C(C(F)(F)F)C=C1Cl MBHXIQDIVCJZTD-RVDMUPIBSA-N 0.000 description 1
- IPENDKRRWFURRE-UHFFFAOYSA-N fluoroimide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(Cl)=C(Cl)C1=O IPENDKRRWFURRE-UHFFFAOYSA-N 0.000 description 1
- UQSQSQZYBQSBJZ-UHFFFAOYSA-M fluorosulfonate Chemical compound [O-]S(F)(=O)=O UQSQSQZYBQSBJZ-UHFFFAOYSA-M 0.000 description 1
- UFEODZBUAFNAEU-NLRVBDNBSA-N fluoxastrobin Chemical compound C=1C=CC=C(OC=2C(=C(OC=3C(=CC=CC=3)Cl)N=CN=2)F)C=1C(=N/OC)\C1=NOCCO1 UFEODZBUAFNAEU-NLRVBDNBSA-N 0.000 description 1
- MEFQWPUMEMWTJP-UHFFFAOYSA-N fluroxypyr Chemical compound NC1=C(Cl)C(F)=NC(OCC(O)=O)=C1Cl MEFQWPUMEMWTJP-UHFFFAOYSA-N 0.000 description 1
- KGXUEPOHGFWQKF-ZCXUNETKSA-N flutianil Chemical compound COC1=CC=CC=C1N(CCS\1)C/1=C(C#N)/SC1=CC(C(F)(F)F)=CC=C1F KGXUEPOHGFWQKF-ZCXUNETKSA-N 0.000 description 1
- 229950010709 fluzinamide Drugs 0.000 description 1
- NVVZQXQBYZPMLJ-UHFFFAOYSA-N formaldehyde;naphthalene-1-sulfonic acid Chemical compound O=C.C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 NVVZQXQBYZPMLJ-UHFFFAOYSA-N 0.000 description 1
- VUERQRKTYBIULR-UHFFFAOYSA-N fosetyl Chemical compound CCOP(O)=O VUERQRKTYBIULR-UHFFFAOYSA-N 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940097068 glyphosate Drugs 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-M glyphosate(1-) Chemical compound OP(O)(=O)CNCC([O-])=O XDDAORKBJWWYJS-UHFFFAOYSA-M 0.000 description 1
- OCDGBSUVYYVKQZ-UHFFFAOYSA-N gramine Chemical compound C1=CC=C2C(CN(C)C)=CNC2=C1 OCDGBSUVYYVKQZ-UHFFFAOYSA-N 0.000 description 1
- 102000017941 granulin Human genes 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- WTJKUFMLQFLJOT-UHFFFAOYSA-N heptadecan-9-one Chemical compound CCCCCCCCC(=O)CCCCCCCC WTJKUFMLQFLJOT-UHFFFAOYSA-N 0.000 description 1
- CKAPSXZOOQJIBF-UHFFFAOYSA-N hexachlorobenzene Chemical compound ClC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl CKAPSXZOOQJIBF-UHFFFAOYSA-N 0.000 description 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
- 229940006607 hirudin Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- VBCVPMMZEGZULK-NRFANRHFSA-N indoxacarb Chemical compound C([C@@]1(OC2)C(=O)OC)C3=CC(Cl)=CC=C3C1=NN2C(=O)N(C(=O)OC)C1=CC=C(OC(F)(F)F)C=C1 VBCVPMMZEGZULK-NRFANRHFSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- QBSJMKIUCUGGNG-UHFFFAOYSA-N isoprocarb Chemical compound CNC(=O)OC1=CC=CC=C1C(C)C QBSJMKIUCUGGNG-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- PUIYMUZLKQOUOZ-UHFFFAOYSA-N isoproturon Chemical compound CC(C)C1=CC=C(NC(=O)N(C)C)C=C1 PUIYMUZLKQOUOZ-UHFFFAOYSA-N 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- OYIKARCXOQLFHF-UHFFFAOYSA-N isoxaflutole Chemical compound CS(=O)(=O)C1=CC(C(F)(F)F)=CC=C1C(=O)C1=C(C2CC2)ON=C1 OYIKARCXOQLFHF-UHFFFAOYSA-N 0.000 description 1
- 229940088649 isoxaflutole Drugs 0.000 description 1
- SDMSCIWHRZJSRN-UHFFFAOYSA-N isoxathion Chemical compound O1N=C(OP(=S)(OCC)OCC)C=C1C1=CC=CC=C1 SDMSCIWHRZJSRN-UHFFFAOYSA-N 0.000 description 1
- 229930014550 juvenile hormone Natural products 0.000 description 1
- 239000002949 juvenile hormone Substances 0.000 description 1
- 150000003633 juvenile hormone derivatives Chemical class 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- PVTHJAPFENJVNC-MHRBZPPQSA-N kasugamycin Chemical compound N[C@H]1C[C@H](NC(=N)C(O)=O)[C@@H](C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O PVTHJAPFENJVNC-MHRBZPPQSA-N 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- ZOTBXTZVPHCKPN-HTXNQAPBSA-N kresoxim-methyl Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC=C1C ZOTBXTZVPHCKPN-HTXNQAPBSA-N 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960000453 malathion Drugs 0.000 description 1
- XEWDGUOIXXJVTA-UHFFFAOYSA-N manganese niobium Chemical compound [Mn].[Mn].[Nb] XEWDGUOIXXJVTA-UHFFFAOYSA-N 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- XIGAUIHYSDTJHW-UHFFFAOYSA-N mefenacet Chemical compound N=1C2=CC=CC=C2SC=1OCC(=O)N(C)C1=CC=CC=C1 XIGAUIHYSDTJHW-UHFFFAOYSA-N 0.000 description 1
- KPUREKXXPHOJQT-UHFFFAOYSA-N mesotrione Chemical compound [O-][N+](=O)C1=CC(S(=O)(=O)C)=CC=C1C(=O)C1C(=O)CCCC1=O KPUREKXXPHOJQT-UHFFFAOYSA-N 0.000 description 1
- ZQEIXNIJLIKNTD-GFCCVEGCSA-N metalaxyl-M Chemical compound COCC(=O)N([C@H](C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-GFCCVEGCSA-N 0.000 description 1
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 description 1
- STEPQTYSZVCJPV-UHFFFAOYSA-N metazachlor Chemical compound CC1=CC=CC(C)=C1N(C(=O)CCl)CN1N=CC=C1 STEPQTYSZVCJPV-UHFFFAOYSA-N 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- MEBQXILRKZHVCX-UHFFFAOYSA-N methidathion Chemical compound COC1=NN(CSP(=S)(OC)OC)C(=O)S1 MEBQXILRKZHVCX-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229930002897 methoprene Natural products 0.000 description 1
- 229950003442 methoprene Drugs 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- GEPDYQSQVLXLEU-AATRIKPKSA-N methyl (e)-3-dimethoxyphosphoryloxybut-2-enoate Chemical compound COC(=O)\C=C(/C)OP(=O)(OC)OC GEPDYQSQVLXLEU-AATRIKPKSA-N 0.000 description 1
- USSIUIGPBLPCDF-JMIUGGIZSA-N methyl 2-(4,6-dimethoxypyrimidin-2-yl)oxy-6-[(z)-n-methoxy-c-methylcarbonimidoyl]benzoate Chemical compound CO\N=C(\C)C1=CC=CC(OC=2N=C(OC)C=C(OC)N=2)=C1C(=O)OC USSIUIGPBLPCDF-JMIUGGIZSA-N 0.000 description 1
- WPRYUWYMOZQHIY-UHFFFAOYSA-N methyl 2-propylpentanoate Chemical compound CCCC(CCC)C(=O)OC WPRYUWYMOZQHIY-UHFFFAOYSA-N 0.000 description 1
- KBHDSWIXRODKSZ-UHFFFAOYSA-N methyl 5-chloro-2-(trifluoromethylsulfonylamino)benzoate Chemical compound COC(=O)C1=CC(Cl)=CC=C1NS(=O)(=O)C(F)(F)F KBHDSWIXRODKSZ-UHFFFAOYSA-N 0.000 description 1
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate Chemical compound COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 description 1
- CJPQIRJHIZUAQP-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)alaninate Chemical compound CC=1C=CC=C(C)C=1N(C(C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-UHFFFAOYSA-N 0.000 description 1
- CIEXPHRYOLIQQD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-2-furoylalaninate Chemical compound CC=1C=CC=C(C)C=1N(C(C)C(=O)OC)C(=O)C1=CC=CO1 CIEXPHRYOLIQQD-UHFFFAOYSA-N 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- VOEYXMAFNDNNED-UHFFFAOYSA-N metolcarb Chemical compound CNC(=O)OC1=CC=CC(C)=C1 VOEYXMAFNDNNED-UHFFFAOYSA-N 0.000 description 1
- HIIRDDUVRXCDBN-OBGWFSINSA-N metominostrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1OC1=CC=CC=C1 HIIRDDUVRXCDBN-OBGWFSINSA-N 0.000 description 1
- 229960001952 metrifonate Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- GVYLCNUFSHDAAW-UHFFFAOYSA-N mirex Chemical compound ClC12C(Cl)(Cl)C3(Cl)C4(Cl)C1(Cl)C1(Cl)C2(Cl)C3(Cl)C4(Cl)C1(Cl)Cl GVYLCNUFSHDAAW-UHFFFAOYSA-N 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- RXFQELGMJUSBGP-UHFFFAOYSA-N n'-[4-[4-chloro-3-(trifluoromethyl)phenoxy]-2,5-dimethylphenyl]-n-ethyl-n-methylmethanimidamide Chemical compound C1=C(C)C(N=CN(C)CC)=CC(C)=C1OC1=CC=C(Cl)C(C(F)(F)F)=C1 RXFQELGMJUSBGP-UHFFFAOYSA-N 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- APDZUEJJUCDJTL-UHFFFAOYSA-N n-(4-chloro-2-nitrophenyl)-n-ethyl-4-methylbenzenesulfonamide Chemical compound C=1C=C(C)C=CC=1S(=O)(=O)N(CC)C1=CC=C(Cl)C=C1[N+]([O-])=O APDZUEJJUCDJTL-UHFFFAOYSA-N 0.000 description 1
- JPLCQHHISLYGRA-UHFFFAOYSA-N n-(6-methoxypyridin-3-yl)cyclopropanecarboxamide Chemical compound C1=NC(OC)=CC=C1NC(=O)C1CC1 JPLCQHHISLYGRA-UHFFFAOYSA-N 0.000 description 1
- AIKGDMPRMHKYLV-UHFFFAOYSA-N n-[(2-iodophenyl)methyl]aniline Chemical compound IC1=CC=CC=C1CNC1=CC=CC=C1 AIKGDMPRMHKYLV-UHFFFAOYSA-N 0.000 description 1
- HUIIJWKWSHEQRI-UHFFFAOYSA-N n-[2-(3,4-dichlorophenyl)-4-fluorophenyl]-1,3-dimethylpyrazole-4-carboxamide Chemical compound CC1=NN(C)C=C1C(=O)NC1=CC=C(F)C=C1C1=CC=C(Cl)C(Cl)=C1 HUIIJWKWSHEQRI-UHFFFAOYSA-N 0.000 description 1
- YJJQCALWJNPBRF-UHFFFAOYSA-N n-[2-(3,4-dichlorophenyl)-4-fluorophenyl]-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound FC(F)(F)C1=NN(C)C=C1C(=O)NC1=CC=C(F)C=C1C1=CC=C(Cl)C(Cl)=C1 YJJQCALWJNPBRF-UHFFFAOYSA-N 0.000 description 1
- RVBLTRBVPPIIOS-UHFFFAOYSA-N n-[2-(3,4-dichlorophenyl)-5-fluorophenyl]-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound FC(F)(F)C1=NN(C)C=C1C(=O)NC1=CC(F)=CC=C1C1=CC=C(Cl)C(Cl)=C1 RVBLTRBVPPIIOS-UHFFFAOYSA-N 0.000 description 1
- NEYMPMHIZYOJPC-UHFFFAOYSA-N n-[2-(3,4-dichlorophenyl)-6-fluorophenyl]-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound FC(F)(F)C1=NN(C)C=C1C(=O)NC1=C(F)C=CC=C1C1=CC=C(Cl)C(Cl)=C1 NEYMPMHIZYOJPC-UHFFFAOYSA-N 0.000 description 1
- FFNPUKGMEGFGPJ-UHFFFAOYSA-N n-[2-(3,4-dichlorophenyl)-6-fluorophenyl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=C(F)C=CC=C1C1=CC=C(Cl)C(Cl)=C1 FFNPUKGMEGFGPJ-UHFFFAOYSA-N 0.000 description 1
- BVBZTWGDQSACIR-UHFFFAOYSA-N n-[2-(3,4-difluorophenyl)-4-fluorophenyl]-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound FC(F)(F)C1=NN(C)C=C1C(=O)NC1=CC=C(F)C=C1C1=CC=C(F)C(F)=C1 BVBZTWGDQSACIR-UHFFFAOYSA-N 0.000 description 1
- KORCYMOFEJJGQX-UHFFFAOYSA-N n-[2-(3,4-difluorophenyl)-6-fluorophenyl]-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound FC(F)(F)C1=NN(C)C=C1C(=O)NC1=C(F)C=CC=C1C1=CC=C(F)C(F)=C1 KORCYMOFEJJGQX-UHFFFAOYSA-N 0.000 description 1
- UUHIQFPPUFPRCJ-UHFFFAOYSA-N n-[2-(3-chloro-4-fluorophenyl)-4-fluorophenyl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=C(F)C=C1C1=CC=C(F)C(Cl)=C1 UUHIQFPPUFPRCJ-UHFFFAOYSA-N 0.000 description 1
- VBCBHYFMCNULKC-UHFFFAOYSA-N n-[2-(4-chloro-3-fluorophenyl)-4-fluorophenyl]-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound FC(F)(F)C1=NN(C)C=C1C(=O)NC1=CC=C(F)C=C1C1=CC=C(Cl)C(F)=C1 VBCBHYFMCNULKC-UHFFFAOYSA-N 0.000 description 1
- YENQGBSTIXBYQJ-UHFFFAOYSA-N n-[2-(4-chloro-3-fluorophenyl)-4-fluorophenyl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=C(F)C=C1C1=CC=C(Cl)C(F)=C1 YENQGBSTIXBYQJ-UHFFFAOYSA-N 0.000 description 1
- AYVPXJFRSYHRJX-UHFFFAOYSA-N n-[2-(4-chloro-3-fluorophenyl)phenyl]-4-(difluoromethyl)-2-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C)=NC(C(F)F)=C1C(=O)NC1=CC=CC=C1C1=CC=C(Cl)C(F)=C1 AYVPXJFRSYHRJX-UHFFFAOYSA-N 0.000 description 1
- YWKDVEUQAMVUBH-UHFFFAOYSA-N n-[2-(4-chlorophenyl)-3-fluorophenyl]-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound FC(F)(F)C1=NN(C)C=C1C(=O)NC1=CC=CC(F)=C1C1=CC=C(Cl)C=C1 YWKDVEUQAMVUBH-UHFFFAOYSA-N 0.000 description 1
- MPEFUIHLDHAAFP-UHFFFAOYSA-N n-[2-(4-chlorophenyl)-4-fluorophenyl]-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound FC(F)(F)C1=NN(C)C=C1C(=O)NC1=CC=C(F)C=C1C1=CC=C(Cl)C=C1 MPEFUIHLDHAAFP-UHFFFAOYSA-N 0.000 description 1
- MIXUGDPCHOOYCN-UHFFFAOYSA-N n-[3-fluoro-2-(4-fluorophenyl)phenyl]-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound FC(F)(F)C1=NN(C)C=C1C(=O)NC1=CC=CC(F)=C1C1=CC=C(F)C=C1 MIXUGDPCHOOYCN-UHFFFAOYSA-N 0.000 description 1
- ODLAIUZHJAYXDZ-UHFFFAOYSA-N n-[4-fluoro-2-(3-fluoro-4-methylphenyl)phenyl]-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound C1=C(F)C(C)=CC=C1C1=CC(F)=CC=C1NC(=O)C1=CN(C)N=C1C(F)(F)F ODLAIUZHJAYXDZ-UHFFFAOYSA-N 0.000 description 1
- QIHJXOZXMUTZBW-UHFFFAOYSA-N n-[4-fluoro-2-(4-fluorophenyl)phenyl]-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound FC(F)(F)C1=NN(C)C=C1C(=O)NC1=CC=C(F)C=C1C1=CC=C(F)C=C1 QIHJXOZXMUTZBW-UHFFFAOYSA-N 0.000 description 1
- DQJOSFQSNAGUCG-UHFFFAOYSA-N n-[4-fluoro-2-(4-methylphenyl)phenyl]-1,3-dimethylpyrazole-4-carboxamide Chemical compound CC1=NN(C)C=C1C(=O)NC1=CC=C(F)C=C1C1=CC=C(C)C=C1 DQJOSFQSNAGUCG-UHFFFAOYSA-N 0.000 description 1
- MMDHNAZZYDMCQP-UHFFFAOYSA-N n-[4-fluoro-2-(4-methylphenyl)phenyl]-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound C1=CC(C)=CC=C1C1=CC(F)=CC=C1NC(=O)C1=CN(C)N=C1C(F)(F)F MMDHNAZZYDMCQP-UHFFFAOYSA-N 0.000 description 1
- YIEDSISPYKQADU-UHFFFAOYSA-N n-acetyl-n-[2-methyl-4-[(2-methylphenyl)diazenyl]phenyl]acetamide Chemical compound C1=C(C)C(N(C(C)=O)C(=O)C)=CC=C1N=NC1=CC=CC=C1C YIEDSISPYKQADU-UHFFFAOYSA-N 0.000 description 1
- NMBXMBCZBXUXAM-UHFFFAOYSA-N n-butyl-1-dibutoxyphosphorylcyclohexan-1-amine Chemical compound CCCCOP(=O)(OCCCC)C1(NCCCC)CCCCC1 NMBXMBCZBXUXAM-UHFFFAOYSA-N 0.000 description 1
- WNPVAXLJVUXYFU-UHFFFAOYSA-N n-cyclohex-2-en-1-ylidenehydroxylamine Chemical compound ON=C1CCCC=C1 WNPVAXLJVUXYFU-UHFFFAOYSA-N 0.000 description 1
- OKQXFDSPKIACRT-UHFFFAOYSA-N n-ethyl-n'-[4-[4-fluoro-3-(trifluoromethyl)phenoxy]-2,5-dimethylphenyl]-n-methylmethanimidamide Chemical compound C1=C(C)C(N=CN(C)CC)=CC(C)=C1OC1=CC=C(F)C(C(F)(F)F)=C1 OKQXFDSPKIACRT-UHFFFAOYSA-N 0.000 description 1
- YULWJRNIKFFGNU-UHFFFAOYSA-N n-methyl-3-[3-(trifluoromethyl)phenoxy]azetidine-1-carboxamide Chemical compound C1N(C(=O)NC)CC1OC1=CC=CC(C(F)(F)F)=C1 YULWJRNIKFFGNU-UHFFFAOYSA-N 0.000 description 1
- LZGUHMNOBNWABZ-UHFFFAOYSA-N n-nitro-n-phenylnitramide Chemical compound [O-][N+](=O)N([N+]([O-])=O)C1=CC=CC=C1 LZGUHMNOBNWABZ-UHFFFAOYSA-N 0.000 description 1
- GOJDSMIXPMMHPO-UHFFFAOYSA-N n-propanoylpropanamide Chemical compound CCC(=O)NC(=O)CC GOJDSMIXPMMHPO-UHFFFAOYSA-N 0.000 description 1
- OZGNYLLQHRPOBR-DHZHZOJOSA-N naftifine Chemical compound C=1C=CC2=CC=CC=C2C=1CN(C)C\C=C\C1=CC=CC=C1 OZGNYLLQHRPOBR-DHZHZOJOSA-N 0.000 description 1
- 229960004313 naftifine Drugs 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- RTCOGUMHFFWOJV-UHFFFAOYSA-N nicosulfuron Chemical compound COC1=CC(OC)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CN=2)C(=O)N(C)C)=N1 RTCOGUMHFFWOJV-UHFFFAOYSA-N 0.000 description 1
- 229940079888 nitenpyram Drugs 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 229960001907 nitrofurazone Drugs 0.000 description 1
- 125000006501 nitrophenyl group Chemical group 0.000 description 1
- WSGCRAOTEDLMFQ-UHFFFAOYSA-N nonan-5-one Chemical compound CCCCC(=O)CCCC WSGCRAOTEDLMFQ-UHFFFAOYSA-N 0.000 description 1
- 108010003516 norsynephrine receptor Proteins 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- PZXOQEXFMJCDPG-UHFFFAOYSA-N omethoate Chemical compound CNC(=O)CSP(=O)(OC)OC PZXOQEXFMJCDPG-UHFFFAOYSA-N 0.000 description 1
- 229940127240 opiate Drugs 0.000 description 1
- 150000004045 organic chlorine compounds Chemical class 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 150000002903 organophosphorus compounds Chemical class 0.000 description 1
- MBRLOUHOWLUMFF-UHFFFAOYSA-N osthole Chemical compound C1=CC(=O)OC2=C(CC=C(C)C)C(OC)=CC=C21 MBRLOUHOWLUMFF-UHFFFAOYSA-N 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- UWVQIROCRJWDKL-UHFFFAOYSA-N oxadixyl Chemical compound CC=1C=CC=C(C)C=1N(C(=O)COC)N1CCOC1=O UWVQIROCRJWDKL-UHFFFAOYSA-N 0.000 description 1
- KZAUOCCYDRDERY-UHFFFAOYSA-N oxamyl Chemical compound CNC(=O)ON=C(SC)C(=O)N(C)C KZAUOCCYDRDERY-UHFFFAOYSA-N 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 229960000321 oxolinic acid Drugs 0.000 description 1
- AMEKQAFGQBKLKX-UHFFFAOYSA-N oxycarboxin Chemical compound O=S1(=O)CCOC(C)=C1C(=O)NC1=CC=CC=C1 AMEKQAFGQBKLKX-UHFFFAOYSA-N 0.000 description 1
- PMCVMORKVPSKHZ-UHFFFAOYSA-N oxydemeton-methyl Chemical group CCS(=O)CCSP(=O)(OC)OC PMCVMORKVPSKHZ-UHFFFAOYSA-N 0.000 description 1
- 229930015582 oxymatrine Natural products 0.000 description 1
- 229910052625 palygorskite Inorganic materials 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- RLBIQVVOMOPOHC-UHFFFAOYSA-N parathion-methyl Chemical group COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C=C1 RLBIQVVOMOPOHC-UHFFFAOYSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- CHIFOSRWCNZCFN-UHFFFAOYSA-N pendimethalin Chemical compound CCC(CC)NC1=C([N+]([O-])=O)C=C(C)C(C)=C1[N+]([O-])=O CHIFOSRWCNZCFN-UHFFFAOYSA-N 0.000 description 1
- LKPLKUMXSAEKID-UHFFFAOYSA-N pentachloronitrobenzene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl LKPLKUMXSAEKID-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229960003418 phenoxybenzamine Drugs 0.000 description 1
- XAMUDJHXFNRLCY-UHFFFAOYSA-N phenthoate Chemical compound CCOC(=O)C(SP(=S)(OC)OC)C1=CC=CC=C1 XAMUDJHXFNRLCY-UHFFFAOYSA-N 0.000 description 1
- 229960003424 phenylacetic acid Drugs 0.000 description 1
- 239000003016 pheromone Substances 0.000 description 1
- BULVZWIRKLYCBC-UHFFFAOYSA-N phorate Chemical compound CCOP(=S)(OCC)SCSCC BULVZWIRKLYCBC-UHFFFAOYSA-N 0.000 description 1
- IOUNQDKNJZEDEP-UHFFFAOYSA-N phosalone Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=S)(OCC)OCC)C2=C1 IOUNQDKNJZEDEP-UHFFFAOYSA-N 0.000 description 1
- LMNZTLDVJIUSHT-UHFFFAOYSA-N phosmet Chemical compound C1=CC=C2C(=O)N(CSP(=S)(OC)OC)C(=O)C2=C1 LMNZTLDVJIUSHT-UHFFFAOYSA-N 0.000 description 1
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- ATROHALUCMTWTB-OWBHPGMISA-N phoxim Chemical compound CCOP(=S)(OCC)O\N=C(\C#N)C1=CC=CC=C1 ATROHALUCMTWTB-OWBHPGMISA-N 0.000 description 1
- 229950001664 phoxim Drugs 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
- 229930195732 phytohormone Natural products 0.000 description 1
- 230000008659 phytopathology Effects 0.000 description 1
- 229940081066 picolinic acid Drugs 0.000 description 1
- YFGYUFNIOHWBOB-UHFFFAOYSA-N pirimicarb Chemical compound CN(C)C(=O)OC1=NC(N(C)C)=NC(C)=C1C YFGYUFNIOHWBOB-UHFFFAOYSA-N 0.000 description 1
- QHOQHJPRIBSPCY-UHFFFAOYSA-N pirimiphos-methyl Chemical group CCN(CC)C1=NC(C)=CC(OP(=S)(OC)OC)=N1 QHOQHJPRIBSPCY-UHFFFAOYSA-N 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 235000010958 polyglycerol polyricinoleate Nutrition 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940096992 potassium oleate Drugs 0.000 description 1
- MLICVSDCCDDWMD-KVVVOXFISA-M potassium;(z)-octadec-9-enoate Chemical compound [K+].CCCCCCCC\C=C/CCCCCCCC([O-])=O MLICVSDCCDDWMD-KVVVOXFISA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- WHHIPMZEDGBUCC-UHFFFAOYSA-N probenazole Chemical compound C1=CC=C2C(OCC=C)=NS(=O)(=O)C2=C1 WHHIPMZEDGBUCC-UHFFFAOYSA-N 0.000 description 1
- QYMMJNLHFKGANY-UHFFFAOYSA-N profenofos Chemical compound CCCSP(=O)(OCC)OC1=CC=C(Br)C=C1Cl QYMMJNLHFKGANY-UHFFFAOYSA-N 0.000 description 1
- WZZLDXDUQPOXNW-UHFFFAOYSA-N propamocarb Chemical compound CCCOC(=O)NCCCN(C)C WZZLDXDUQPOXNW-UHFFFAOYSA-N 0.000 description 1
- OYJMHAFVOZPIOY-UHFFFAOYSA-N propan-2-yl 2-chloro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]benzoate Chemical compound C1=C(Cl)C(C(=O)OC(C)C)=CC(N2C(N(C)C(=CC2=O)C(F)(F)F)=O)=C1 OYJMHAFVOZPIOY-UHFFFAOYSA-N 0.000 description 1
- LFULEKSKNZEWOE-UHFFFAOYSA-N propanil Chemical compound CCC(=O)NC1=CC=C(Cl)C(Cl)=C1 LFULEKSKNZEWOE-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- MWWATHDPGQKSAR-UHFFFAOYSA-N propyne Chemical compound CC#C MWWATHDPGQKSAR-UHFFFAOYSA-N 0.000 description 1
- PHNUZKMIPFFYSO-UHFFFAOYSA-N propyzamide Chemical compound C#CC(C)(C)NC(=O)C1=CC(Cl)=CC(Cl)=C1 PHNUZKMIPFFYSO-UHFFFAOYSA-N 0.000 description 1
- YRRBXJLFCBCKNW-UHFFFAOYSA-N prothiocarb Chemical compound CCSC(=O)NCCCN(C)C YRRBXJLFCBCKNW-UHFFFAOYSA-N 0.000 description 1
- FITIWKDOCAUBQD-UHFFFAOYSA-N prothiofos Chemical compound CCCSP(=S)(OCC)OC1=CC=C(Cl)C=C1Cl FITIWKDOCAUBQD-UHFFFAOYSA-N 0.000 description 1
- UFZNZKGKBWOSJG-UHFFFAOYSA-N purin-2-one Chemical compound O=C1N=CC2=NC=NC2=N1 UFZNZKGKBWOSJG-UHFFFAOYSA-N 0.000 description 1
- QHMTXANCGGJZRX-WUXMJOGZSA-N pymetrozine Chemical compound C1C(C)=NNC(=O)N1\N=C\C1=CC=CN=C1 QHMTXANCGGJZRX-WUXMJOGZSA-N 0.000 description 1
- DDIQWGKUSJOETH-UHFFFAOYSA-N pyrafluprole Chemical compound ClC=1C=C(C(F)(F)F)C=C(Cl)C=1N1N=C(C#N)C(SCF)=C1NCC1=CN=CC=N1 DDIQWGKUSJOETH-UHFFFAOYSA-N 0.000 description 1
- URXNNPCNKVAQRA-XMHGGMMESA-N pyraoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC(C=2C=CC(Cl)=CC=2)=NN1C URXNNPCNKVAQRA-XMHGGMMESA-N 0.000 description 1
- JOOMJVFZQRQWKR-UHFFFAOYSA-N pyrazophos Chemical compound N1=C(C)C(C(=O)OCC)=CN2N=C(OP(=S)(OCC)OCC)C=C21 JOOMJVFZQRQWKR-UHFFFAOYSA-N 0.000 description 1
- HYJYGLGUBUDSLJ-UHFFFAOYSA-N pyrethrin Natural products CCC(=O)OC1CC(=C)C2CC3OC3(C)C2C2OC(=O)C(=C)C12 HYJYGLGUBUDSLJ-UHFFFAOYSA-N 0.000 description 1
- VJFUPGQZSXIULQ-XIGJTORUSA-N pyrethrin II Chemical compound CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VJFUPGQZSXIULQ-XIGJTORUSA-N 0.000 description 1
- CRFYLQMIDWBKRT-LPYMAVHISA-N pyribencarb Chemical compound C1=C(Cl)C(CNC(=O)OC)=CC(C(\C)=N\OCC=2N=C(C)C=CC=2)=C1 CRFYLQMIDWBKRT-LPYMAVHISA-N 0.000 description 1
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- MIOBBYRMXGNORL-UHFFFAOYSA-N pyrifluquinazon Chemical compound C1C2=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C2N(C(=O)C)C(=O)N1NCC1=CC=CN=C1 MIOBBYRMXGNORL-UHFFFAOYSA-N 0.000 description 1
- WKSAUQYGYAYLPV-UHFFFAOYSA-N pyrimethamine Chemical compound CCC1=NC(N)=NC(N)=C1C1=CC=C(Cl)C=C1 WKSAUQYGYAYLPV-UHFFFAOYSA-N 0.000 description 1
- 229960000611 pyrimethamine Drugs 0.000 description 1
- ZLIBICFPKPWGIZ-UHFFFAOYSA-N pyrimethanil Chemical compound CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 ZLIBICFPKPWGIZ-UHFFFAOYSA-N 0.000 description 1
- BAUQXSYUDSNRHL-UHFFFAOYSA-N pyrimorph Chemical compound C1=CC(C(C)(C)C)=CC=C1C(C=1C=NC(Cl)=CC=1)=CC(=O)N1CCOCC1 BAUQXSYUDSNRHL-UHFFFAOYSA-N 0.000 description 1
- DHTJFQWHCVTNRY-OEMAIJDKSA-N pyrisoxazole Chemical compound C1([C@@]2(C)CC(ON2C)C=2C=CC(Cl)=CC=2)=CC=CN=C1 DHTJFQWHCVTNRY-OEMAIJDKSA-N 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- JYQUHIFYBATCCY-UHFFFAOYSA-N quinalphos Chemical compound C1=CC=CC2=NC(OP(=S)(OCC)OCC)=CN=C21 JYQUHIFYBATCCY-UHFFFAOYSA-N 0.000 description 1
- WRPIRSINYZBGPK-UHFFFAOYSA-N quinoxyfen Chemical compound C1=CC(F)=CC=C1OC1=CC=NC2=CC(Cl)=CC(Cl)=C12 WRPIRSINYZBGPK-UHFFFAOYSA-N 0.000 description 1
- OSUHJPCHFDQAIT-GFCCVEGCSA-N quizalofop-P-ethyl Chemical group C1=CC(O[C@H](C)C(=O)OCC)=CC=C1OC1=CN=C(C=C(Cl)C=C2)C2=N1 OSUHJPCHFDQAIT-GFCCVEGCSA-N 0.000 description 1
- 229940075993 receptor modulator Drugs 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 230000002786 root growth Effects 0.000 description 1
- 229940080817 rotenone Drugs 0.000 description 1
- JUVIOZPCNVVQFO-UHFFFAOYSA-N rotenone Natural products O1C2=C3CC(C(C)=C)OC3=CC=C2C(=O)C2C1COC1=C2C=C(OC)C(OC)=C1 JUVIOZPCNVVQFO-UHFFFAOYSA-N 0.000 description 1
- 101150085857 rpo2 gene Proteins 0.000 description 1
- KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium atom Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- ODCWYMIRDDJXKW-UHFFFAOYSA-N simazine Chemical compound CCNC1=NC(Cl)=NC(NCC)=N1 ODCWYMIRDDJXKW-UHFFFAOYSA-N 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 239000003195 sodium channel blocking agent Substances 0.000 description 1
- 150000003388 sodium compounds Chemical class 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000004016 soil organic matter Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940061368 sonata Drugs 0.000 description 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
- 229960002256 spironolactone Drugs 0.000 description 1
- CLSVJBIHYWPGQY-GGYDESQDSA-N spirotetramat Chemical compound CCOC(=O)OC1=C(C=2C(=CC=C(C)C=2)C)C(=O)N[C@@]11CC[C@H](OC)CC1 CLSVJBIHYWPGQY-GGYDESQDSA-N 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- FKENQMMABCRJMK-RITPCOANSA-N sulbactam Chemical compound O=S1(=O)C(C)(C)[C@H](C(O)=O)N2C(=O)C[C@H]21 FKENQMMABCRJMK-RITPCOANSA-N 0.000 description 1
- 229960005256 sulbactam Drugs 0.000 description 1
- PQTBTIFWAXVEPB-UHFFFAOYSA-N sulcotrione Chemical compound ClC1=CC(S(=O)(=O)C)=CC=C1C(=O)C1C(=O)CCCC1=O PQTBTIFWAXVEPB-UHFFFAOYSA-N 0.000 description 1
- CCEKAJIANROZEO-UHFFFAOYSA-N sulfluramid Chemical compound CCNS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F CCEKAJIANROZEO-UHFFFAOYSA-N 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- ZZYSLNWGKKDOML-UHFFFAOYSA-N tebufenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(=CC=2)C(C)(C)C)=C1Cl ZZYSLNWGKKDOML-UHFFFAOYSA-N 0.000 description 1
- XQTLDIFVVHJORV-UHFFFAOYSA-N tecnazene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl XQTLDIFVVHJORV-UHFFFAOYSA-N 0.000 description 1
- UOORRWUZONOOLO-UHFFFAOYSA-N telone II Natural products ClCC=CCl UOORRWUZONOOLO-UHFFFAOYSA-N 0.000 description 1
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 1
- 229960002722 terbinafine Drugs 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
- UBCKGWBNUIFUST-YHYXMXQVSA-N tetrachlorvinphos Chemical compound COP(=O)(OC)O\C(=C/Cl)C1=CC(Cl)=C(Cl)C=C1Cl UBCKGWBNUIFUST-YHYXMXQVSA-N 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 239000004577 thatch Substances 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 1
- NWWZPOKUUAIXIW-FLIBITNWSA-N thiamethoxam Chemical compound [O-][N+](=O)\N=C/1N(C)COCN\1CC1=CN=C(Cl)S1 NWWZPOKUUAIXIW-FLIBITNWSA-N 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- LOQQVLXUKHKNIA-UHFFFAOYSA-N thifensulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C2=C(SC=C2)C(O)=O)=N1 LOQQVLXUKHKNIA-UHFFFAOYSA-N 0.000 description 1
- WOSNCVAPUOFXEH-UHFFFAOYSA-N thifluzamide Chemical compound S1C(C)=NC(C(F)(F)F)=C1C(=O)NC1=C(Br)C=C(OC(F)(F)F)C=C1Br WOSNCVAPUOFXEH-UHFFFAOYSA-N 0.000 description 1
- DNVLJEWNNDHELH-UHFFFAOYSA-N thiocyclam Chemical compound CN(C)C1CSSSC1 DNVLJEWNNDHELH-UHFFFAOYSA-N 0.000 description 1
- BAKXBZPQTXCKRR-UHFFFAOYSA-N thiodicarb Chemical compound CSC(C)=NOC(=O)NSNC(=O)ON=C(C)SC BAKXBZPQTXCKRR-UHFFFAOYSA-N 0.000 description 1
- YFNCATAIYKQPOO-UHFFFAOYSA-N thiophanate Chemical compound CCOC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OCC YFNCATAIYKQPOO-UHFFFAOYSA-N 0.000 description 1
- QSOHVSNIQHGFJU-UHFFFAOYSA-L thiosultap disodium Chemical compound [Na+].[Na+].[O-]S(=O)(=O)SCC(N(C)C)CSS([O-])(=O)=O QSOHVSNIQHGFJU-UHFFFAOYSA-L 0.000 description 1
- VJQYLJSMBWXGDV-UHFFFAOYSA-N tiadinil Chemical compound N1=NSC(C(=O)NC=2C=C(Cl)C(C)=CC=2)=C1C VJQYLJSMBWXGDV-UHFFFAOYSA-N 0.000 description 1
- WPALTCMYPARVNV-UHFFFAOYSA-N tolfenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(OC=3C=CC(C)=CC=3)=CC=2)=C1Cl WPALTCMYPARVNV-UHFFFAOYSA-N 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- AMFGTOFWMRQMEM-UHFFFAOYSA-N triazophos Chemical compound N1=C(OP(=S)(OCC)OCC)N=CN1C1=CC=CC=C1 AMFGTOFWMRQMEM-UHFFFAOYSA-N 0.000 description 1
- IQGKIPDJXCAMSM-UHFFFAOYSA-N triazoxide Chemical compound N=1C2=CC=C(Cl)C=C2[N+]([O-])=NC=1N1C=CN=C1 IQGKIPDJXCAMSM-UHFFFAOYSA-N 0.000 description 1
- NFACJZMKEDPNKN-UHFFFAOYSA-N trichlorfon Chemical compound COP(=O)(OC)C(O)C(Cl)(Cl)Cl NFACJZMKEDPNKN-UHFFFAOYSA-N 0.000 description 1
- QFNFRZHOXWNWAQ-UHFFFAOYSA-N triclopyricarb Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=NC(Cl)=C(Cl)C=C1Cl QFNFRZHOXWNWAQ-UHFFFAOYSA-N 0.000 description 1
- 229940087291 tridecyl alcohol Drugs 0.000 description 1
- ZSDSQXJSNMTJDA-UHFFFAOYSA-N trifluralin Chemical compound CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O ZSDSQXJSNMTJDA-UHFFFAOYSA-N 0.000 description 1
- RROQIUMZODEXOR-UHFFFAOYSA-N triforine Chemical compound O=CNC(C(Cl)(Cl)Cl)N1CCN(C(NC=O)C(Cl)(Cl)Cl)CC1 RROQIUMZODEXOR-UHFFFAOYSA-N 0.000 description 1
- IFOIAHYDBXLNJX-UHFFFAOYSA-N trioxazole Chemical compound O1OC=NO1 IFOIAHYDBXLNJX-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 241000701451 unidentified granulovirus Species 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- JARYYMUOCXVXNK-IMTORBKUSA-N validamycin Chemical compound N([C@H]1C[C@@H]([C@H]([C@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)CO)[C@H]1C=C(CO)[C@H](O)[C@H](O)[C@H]1O JARYYMUOCXVXNK-IMTORBKUSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003739 xylenols Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- FJBGIXKIXPUXBY-UHFFFAOYSA-N {2-[3-(4-chlorophenyl)propyl]-2,4,4-trimethyl-1,3-oxazolidin-3-yl}(imidazol-1-yl)methanone Chemical compound C1=CN=CN1C(=O)N1C(C)(C)COC1(C)CCCC1=CC=C(Cl)C=C1 FJBGIXKIXPUXBY-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pretreatment Of Seeds And Plants (AREA)
Abstract
Description
本申請案主張2014年12月29日申請之美國臨時申請案第62/097,203號之權益,該案之揭示內容以全文引用的方式併入本文中。 The present application claims the benefit of U.S. Provisional Application No. 62/097,203, filed on Dec. 29, 2014, the disclosure of which is hereby incorporated by reference.
本發明揭示之標的物係關於包含解澱粉芽孢桿菌RTI301之分離株之組合物,其用於施用於植物葉、植物果實及花、植物種子及根部以及植物周圍土壤,以有益於植物生長及治療植物疾病。 The subject matter disclosed in the present invention relates to a composition comprising an isolate of Bacillus amyloliquefaciens RTI301 for application to plant leaves, plant fruits and flowers, plant seeds and roots, and soil around plants to benefit plant growth and treatment. Plant diseases.
已知對植物生長及健康具有有益作用之多種微生物存在於土壤中,特別與植物聯合存活於根區中(植物根圍促生長細菌「PGPR」),或以內寄生菌形式存在於植物內。其有益促進植物生長特性包括固氮;鐵螯合;磷酸鹽溶解;抑制非有益微生物;抗蟲害;誘導系統抗性(ISR);系統獲得抗性(SAR);植物物質分解於土壤中以增加有用土壤有機物;及合成植物激素,諸如吲哚-乙酸(IAA)、乙偶姻及2,3-丁二醇,其刺激植物生長、發育及對環境壓力(諸如乾旱)作出反應。另外,此等微生物可藉由使前驅分子1-胺基環丙烷-1-甲酸酯 (ACC)分解來干擾植物之乙烯壓力反應,藉此刺激植物生長且減緩果實熟化。此等有益微生物可改善土壤品質、植物生長、產量及作物品質。各種微生物展現生物活性以便適用於控制植物疾病。此類生物殺蟲劑(活生物體及由此等生物體天然產生之化合物)可比合成肥料及殺蟲劑更安全且更生物可降解。 A variety of microorganisms known to have beneficial effects on plant growth and health are present in the soil, particularly in combination with plants in the root zone (plant root growth promoting bacteria "PGPR"), or in the form of endoparasites in plants. It is beneficial to promote plant growth characteristics including nitrogen fixation; iron chelation; phosphate dissolution; inhibition of non-beneficial microorganisms; insect resistance; induced systemic resistance (ISR); systemic acquired resistance (SAR); decomposition of plant matter into the soil to increase usefulness Soil organic matter; and synthetic plant hormones such as guanidine-acetic acid (IAA), acetoin and 2,3-butanediol, which stimulate plant growth, development, and respond to environmental stresses such as drought. In addition, these microorganisms can be made by the precursor molecule 1-aminocyclopropane-1-carboxylate. (ACC) decomposes to interfere with the ethylene stress response of the plant, thereby stimulating plant growth and slowing fruit ripening. These beneficial microorganisms can improve soil quality, plant growth, yield and crop quality. Various microorganisms exhibit biological activity for use in controlling plant diseases. Such biocides (live organisms and naturally occurring compounds of such organisms) are safer and more biodegradable than synthetic fertilizers and insecticides.
真菌植物病原體,包括(但不限於)葡萄孢屬(Botrytis spp.)(例如灰葡萄孢菌(Botrytis cinerea))、鐮刀菌屬(Fusarium spp.)(例如尖孢鐮刀菌(F.oxysporum)及禾穀鐮刀菌(F.graminearum))、絲核菌屬(Rhizoctonia spp.)(例如紋枯病菌(R.solani))、稻瘟菌屬(Magnaporthe spp.)、球腔菌屬(Mycosphaerella spp.)、柄鏽菌屬(Puccinia spp.)(例如小麥葉鏽菌(P.recondita))、疫菌屬(Phytopthora spp.)及層鏽菌屬(Phakopsora spp.)(例如豆薯層鏽菌(P.pachyrhizi))為一種類型之植物蟲害,其可在農業及園藝行業中造成嚴重經濟損失。化學試劑可用於控制真菌植物病原體,但使用化學試劑具有如下缺點,包括成本高、缺乏功效、出現真菌抗性菌株及不希望之環境影響。另外,除靶向處理之植物病原體之外,此類化學處理往往不加選擇而可能會對有益細菌、真菌及節肢動物有不利影響。第二種類型之植物蟲害為細菌病原體,包括(但不限於)歐文氏菌屬(Erwinia spp.)(諸如菊歐文氏菌(Erwinia chrysanthemi))、泛菌屬(Pantoea spp.)(諸如綠檸檬泛菌(P.citrea))、黃單孢菌屬(Xanthomonas)(例如野油菜黃單孢菌(Xanthomonas campestris))、假單孢菌屬(Pseudomonas spp.)(諸如丁香假單孢菌(P.syringae))及青枯病菌屬(Ralstonia spp.)(諸如番茄青枯病菌(R.soleacearum)),其在農業及園藝行業中造成嚴重經濟損失。類似於病原性真菌,使用化學試劑處理此等細菌病原體具有缺點。病毒及病毒樣生物體包含第三種類型之植物致病劑,其難以控制,但細菌微生物可經由誘導系統抗性(ISR)對其提供植物抗性。因此,可用作 生物肥料及/或生物殺蟲劑來控制病原性真菌、病毒及細菌之微生物為合乎需要的且高度需要其用以提高農業可持續性。最後一種類型之植物病原體包括植物病原性線蟲及昆蟲,其可造成植物嚴重損害及損失。 Fungal plant pathogens, including but not limited to, Botrytis spp. (eg Botrytis cinerea ), Fusarium spp. (eg F. oxysporum ) F. graminearum , Rhizoctonia spp. (eg R. solani), Magnaporthe spp ., Mycosphaerella spp .), Puccinia spp . (eg P. recondita ), Phytopthora spp . and Phakopsora spp. (eg Phaeocysteen rust) ( P. pachyrhizi )) is a type of plant pest that can cause serious economic losses in the agricultural and horticultural industries. Chemical agents can be used to control fungal plant pathogens, but the use of chemical agents has the following disadvantages, including high cost, lack of efficacy, emergence of fungal resistant strains, and undesirable environmental effects. In addition, in addition to targeted plant pathogens, such chemical treatments are often indiscriminate and may have adverse effects on beneficial bacteria, fungi, and arthropods. The second type of plant pest is a bacterial pathogen including, but not limited to, Erwinia spp. (such as Erwinia chrysanthemi ), Pantoea spp. (such as green lemon) P. citrea , Xanthomonas (eg Xanthomonas campestris ), Pseudomonas spp. (such as Pseudomonas syringae ( P) .syringae )) and Ralstonia spp. (such as R. soleacearum ), causing severe economic losses in the agricultural and horticultural industries. Similar to pathogenic fungi, the use of chemical agents to treat such bacterial pathogens has disadvantages. Viruses and virus-like organisms comprise a third type of phytopathogenic agent that is difficult to control, but bacterial microorganisms can provide plant resistance thereto via induction systemic resistance (ISR). Therefore, microorganisms that can be used as biological fertilizers and/or biocides to control pathogenic fungi, viruses and bacteria are desirable and highly desirable for improving agricultural sustainability. The last type of plant pathogen includes phytopathogenic nematodes and insects that can cause serious damage and loss to plants.
已報導芽抱桿菌屬之一些成員為生物控制菌株,且一些已應用於商業產品中(Joseph W.Kloepper等人,2004,Phytopathology第94卷,第11期,1259-1266)。舉例而言,當前用於商業生物控制產品中之菌株包括:地衣芽孢桿菌(Bacillus pumilus)菌株QST2808,用作SONATA及BALLAD-PLUS中之活性成分,由BAYER CROP SCIENCE生產;地衣芽孢桿菌菌株GB34,用作YIELDSHIELD中之活性成分,由BAYER CROP SCIENCE生產;枯草芽孢桿菌(Bacillus subtilis)菌株QST713,用作SERENADE之活性成分,由BAYER CROP SCIENCE生產;枯草芽孢桿菌菌株GBO3,用作KODIAK及SYSTEM3中之活性成分,由HELENA CHEMICAL COMPANY生產。蘇雲金芽孢桿菌(Bacillus thuringiensis)及強固芽孢桿菌(Bacillus firmus)之各種菌株已用作對抗線蟲及病媒昆蟲之生物控制劑,且此等菌株充當許多市售生物控制產品之基礎,該等產品包括NORTICA及PONCHO-VOTIVO,由BAYER CROP SCIENCE生產。另外,當前用於商業生物刺激產品中之芽孢桿菌菌株包括:解澱粉芽孢桿菌(Bacillus amyloliquefaciens)菌株FZB42,用作RHIZOVITAL 42中之活性成分,由ABiTEP GmbH生產;以及各種其他枯草芽孢桿菌屬,包括其作為全細胞,包括其在生物刺激產品中之醱酵提取物,諸如由JHBiotech Inc.生產之FULZYME。 Some members of the genus Bacillus have been reported to be biologically controlled strains, and some have been used in commercial products (Joseph W. Kloepper et al., 2004, Phytopathology Vol. 94, No. 11, 1259-1266). For example, strains currently used in commercial biological control products include: Bacillus pumilus strain QST2808, which is used as an active ingredient in SONATA and BALLAD-PLUS, produced by BAYER CROP SCIENCE; Bacillus licheniformis strain GB34, Used as an active ingredient in YIELDSHIELD, produced by BAYER CROP SCIENCE; Bacillus subtilis strain QST713, used as an active ingredient of SERENADE, produced by BAYER CROP SCIENCE; Bacillus subtilis strain GBO3, used as KODIAK and SYSTEM3 The active ingredient is produced by HELENA CHEMICAL COMPANY. Various strains of Bacillus thuringiensis and Bacillus firmus have been used as biological control agents against nematodes and vector insects, and these strains serve as the basis for many commercially available biological control products, including NORTICA and PONCHO-VOTIVO, produced by BAYER CROP SCIENCE. In addition, the current Bacillus strains used in commercial biostimulation products include: Bacillus amyloliquefaciens strain FZB42, which is used as an active ingredient in RHIZOVITAL 42, produced by ABiTEP GmbH; and various other Bacillus subtilis, including It acts as a whole cell, including its fermentation extract in biostimulating products, such as FULZYME manufactured by JH Biotech Inc.
本發明揭示之標的物提供有益於植物生長及預防及控制疾病之微生物組合物及其使用方法。 The subject matter disclosed herein provides a microbial composition useful for plant growth and prevention and control of disease and methods of use thereof.
在一個實施例中,提供一種包含以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301或其具有其所有鑑別特徵之突變體的生物純培養物的組合物,該組合物用於施用於植物以達成有益於植物生長或對易感病植物賦予保護以避免病原性感染中的一或兩者。 In one embodiment, there is provided a composition comprising a biologically pure culture of Bacillus amyloliquefaci RTI301 deposited with ATCC PTA-121165 or a mutant having all of its identifying characteristics, the composition being for application to a plant To achieve one or both of beneficial to plant growth or to confer protection to susceptible plants to avoid pathogenic infections.
在一個實施例中,提供一種用包含以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301或其具有其所有鑑別特徵之突變體的生物純培養物的孢子的組合物塗佈之植物種子,該組合物以適合於有益於植物生長及/或對易感病植物賦予保護以避免病原性感染之量存在。 In one embodiment, a plant seed coated with a composition comprising a spore of a biologically pure culture of a Bacillus amyloliquefaci RTI301 deposited with ATCC No. PTA-121165 or a mutant having all of its identifying characteristics is provided, The composition is present in an amount suitable to be beneficial for plant growth and/or to confer protection to susceptible plants to avoid pathogenic infections.
在一個實施例中,提供一種用於達成有益於植物生長及/或對易感病植物賦予保護以避免病原性感染中之一或兩者的組合物,該組合物包含以下各物:以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301或其具有其所有鑑別特徵之突變體的生物純培養物,呈適合於有益於植物生長及/或對易感病植物賦予保護以避免病原性感染之量;以及微生物、生物或化學殺蟲劑、殺真菌劑、殺線蟲劑、殺菌劑、除草劑、植物提取物、植物生長調節劑或肥料之一或組合,呈適合於有益於植物生長及/或對易感病植物賦予保護以避免病原性感染之量。 In one embodiment, a composition for achieving one or both of beneficial plant growth and/or protection of a susceptible plant to avoid a pathogenic infection is provided, the composition comprising: ATCC A biologically pure culture of Bacillus amyloliquefaciens RTI301 or a mutant having all of its identifying characteristics deposited under No. PTA-121165, which is suitable for plant growth and/or protection of susceptible plants to avoid pathogenic infections And one or a combination of microbial, biological or chemical insecticides, fungicides, nematicides, fungicides, herbicides, plant extracts, plant growth regulators or fertilizers, which are suitable for plant growth and / or protect the susceptible plants to avoid the amount of pathogenic infections.
在一個實施例中,提供一種用於達成有益於植物生長或對易感病植物賦予保護以避免病原性感染中之一或兩者的方法,該方法包含:將一種組合物輸送至植物葉、植物莖皮、植物果實、植物花、植物種子、植物根部、植物剪枝、植物移植物、植物癒合組織;植物周圍土壤或生長介質;在土壤或生長介質中播種植物種子之前的土壤或生長介質;或在土壤或生長介質中種植植物、植物剪枝、植物移植物或植物癒合組織之前的土壤或生長介質,該組合物包含以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301或其具有其所有鑑別特徵之突變體的生物純培養物,呈適合於有益於植物生長及/或對易感 病植物賦予保護以避免病原性感染之量。 In one embodiment, a method for achieving one or both of beneficial to plant growth or protection of a susceptible plant from pathogenic infection is provided, the method comprising: delivering a composition to a plant leaf, Plant bark, plant fruit, plant flower, plant seed, plant root, plant pruning, plant graft, plant healing tissue; soil or growth medium surrounding the plant; soil or growth medium prior to seeding the plant seed in soil or growth medium Or a soil or growth medium prior to planting a plant, plant pruning, plant graft or plant healing tissue in soil or growth medium, the composition comprising Bacillus amyloliquefaciens RTI301 deposited under ATCC PTA-121165 or having A biologically pure culture of all of its identified features, which are suitable for plant growth and/or susceptibility Diseased plants confer protection to avoid pathogenic infections.
在一個實施例中,提供一種用於達成有益於植物生長或對易感病植物賦予保護以避免病原性感染中之一或兩者的方法,該方法包含:將一種組合物輸送至植物葉、植物莖皮、植物果實、植物花、植物種子、植物根部、植物剪枝、植物移植物、植物癒合組織;植物周圍土壤或生長介質;在土壤或生長介質中播種植物種子之前的土壤或生長介質;或在土壤或生長介質中種植植物、植物剪枝、植物移植物或植物癒合組織之前的土壤或生長介質,該組合物包含以下各物:以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301或其具有其所有鑑別特徵之突變體的生物純培養物,呈適合於有益於植物生長及/或賦予保護以避免病原性感染之量;以及微生物、生物或化學殺蟲劑、殺真菌劑、殺線蟲劑、殺菌劑、除草劑、植物提取物、植物生長調節劑或肥料之一或組合,呈適合於有益於植物生長及/或賦予保護以避免病原性感染之量。 In one embodiment, a method for achieving one or both of beneficial to plant growth or protection of a susceptible plant from pathogenic infection is provided, the method comprising: delivering a composition to a plant leaf, Plant bark, plant fruit, plant flower, plant seed, plant root, plant pruning, plant graft, plant healing tissue; soil or growth medium surrounding the plant; soil or growth medium prior to seeding the plant seed in soil or growth medium Or soil or growth medium prior to planting plants, plant pruning, plant transplants or plant healing tissues in soil or growth medium, the composition comprising the following: Bacillus amyloliquefaciens deposited under ATCC PTA-121165 RTI301 or a biologically pure culture of a mutant having all of its identifying characteristics, in an amount suitable for beneficial to plant growth and/or conferring protection against pathogenic infection; and microbial, biological or chemical insecticides, fungicides , one or a combination of nematicides, fungicides, herbicides, plant extracts, plant growth regulators or fertilizers Conducive to plant growth and / or confer protection against the amount of pathogenic infection.
在一個實施例中,提供一種用於達成有益於植物生長或對易感病植物賦予保護以避免病原性感染中之一或兩者的方法,該方法包含:將第一組合物與第二組合物之組合輸送至植物葉、植物莖皮、植物果實、植物花、植物種子、植物根部、植物剪枝、植物移植物、植物癒合組織;植物周圍土壤或生長介質;在土壤或生長介質中播種植物種子之前的土壤或生長介質;或在土壤或生長介質中種植植物、植物剪枝、植物移植物或植物癒合組織之前的土壤或生長介質,該第一組合物包含以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301或其具有其所有鑑別特徵之突變體的生物純培養物,呈適合於有益於植物生長及/或對易感病植物賦予保護以避免病原性感染之量;且該第二組合物包含微生物、生物或化學殺蟲劑、殺真菌劑、殺線蟲劑、殺菌劑、除草劑、植物提取物、植物生長調節劑或肥料之一或組合,呈 適合於有益於植物生長及/或對易感病植物賦予保護以避免病原性感染之量。 In one embodiment, a method for achieving one or both of beneficial to plant growth or protection of a susceptible plant from pathogenic infection is provided, the method comprising: combining the first composition with the second The combination of substances is delivered to plant leaves, plant stems, plant fruits, plant flowers, plant seeds, plant roots, plant pruning, plant transplants, plant healing tissues; soil or growth medium around the plant; seeded in soil or growth medium Soil or growth medium prior to plant seeds; or soil or growth medium prior to planting plants, plant pruning, plant transplants or plant healing tissues in soil or growth medium, the first composition comprising ATCC PTA-121165 A biologically pure culture of the deposited Bacillus amyloliquefaciens RTI301 or a mutant thereof having all of its identifying characteristics, in an amount suitable for beneficial to plant growth and/or protection of susceptible plants to avoid pathogenic infection; The second composition comprises a microbial, biological or chemical insecticide, fungicide, nematicide, bactericide, herbicide, plant extract Plant growth regulators or fertilizers or a combination of one, was It is suitable for the benefit of plant growth and/or protection of susceptible plants to avoid pathogenic infections.
在一個實施例中,提供一種用於達成有益於植物生長或對易感病植物賦予保護以避免病原性感染中之一或兩者的方法,該方法包含:將植物種子種植在適合生長介質中或使植物之營養剪枝/組織在適合生長介質中再生,其中種子已用一種組合物塗佈或營養剪枝/組織已經該組合物接種,該組合物包含以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301或其具有其所有鑑別特徵之突變體的生物純培養物,其中有益於植物自種子或營養剪枝/組織之生長及/或賦予保護以避免病原性感染。 In one embodiment, a method for achieving one or both of beneficial to plant growth or protection of a susceptible plant to avoid pathogenic infection is provided, the method comprising: planting the plant seed in a suitable growth medium Or the nutrient pruning/tissue of the plant is regenerated in a suitable growth medium, wherein the seed has been coated with a composition or the nutrient pruning/tissue has been inoculated with the composition, the composition comprising the deposit of ATCC PTA-121165 A biologically pure culture of B. amyloliquesii RTI301 or a mutant thereof having all of its identifying characteristics, wherein the growth of the plant from the seed or nutrient pruning/tissue is beneficial and/or protection is provided to avoid pathogenic infection.
在一個實施例中,提供一種藉由對易感病植物賦予保護以避免病原性感染或減少病原性感染有益於植物生長,同時使針對處理之抗性積聚減至最少的方法,該方法包含:將第一組合物與第二組合物以分開施用及改變之時間間隔輸送至易感病植物,其中該第一組合物及該第二組合物各者以適合於對植物賦予保護以避免或減少病原性感染之量輸送,其中該第一組合物包含以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301或其具有其所有鑑別特徵之突變體的生物純培養物,且其中該第二組合物包含一或多種具有殺真菌或殺菌特性之化學活性劑,且其中該第一組合物及該第二組合物以改變之時間間隔輸送至以下之一或組合:植物葉、植物莖皮、植物果實、植物花、植物種子、植物根部、植物剪枝、植物移植物、植物癒合組織或植物周圍土壤或生長介質,其中賦予保護以避免及/或減少病原性感染所需之化學活性劑之總量減少且針對處理之抗性積聚減至最少。 In one embodiment, there is provided a method of providing plant protection by protecting a susceptible plant from pathogenic infection or reducing pathogenic infection while minimizing the accumulation of resistance to treatment, the method comprising: The first composition and the second composition are delivered to the susceptible plant at separate intervals of application and alteration, wherein the first composition and the second composition are each adapted to impart protection to the plant to avoid or reduce Delivery of a pathogenic infection, wherein the first composition comprises a B. amyloliquefaci RTI301 deposited with ATCC No. PTA-121165 or a biologically pure culture thereof having all of its identifying characteristics, and wherein the second combination The composition comprises one or more chemical active agents having fungicidal or bactericidal properties, and wherein the first composition and the second composition are delivered to one or a combination of the following at varying time intervals: plant leaves, plant bark, plants Fruit, plant flower, plant seed, plant root, plant pruning, plant graft, plant healing tissue or soil or growth medium around the plant, Protection against and / or decrease the amount of chemical needed to pathogenic infections and to reduce the accumulation of active agents for the treatment of resistance to be minimized.
在一個實施例中,提供一種組合物,該組合物包括以下中之至少一者:分離之豐原素MA化合物、分離之豐原素MB化合物、分離之豐原素MC化合物、分離之去羥基豐原素MA化合物、分離之去羥基豐
原素MB化合物、分離之去羥基豐原素MC化合物、分離之豐原素H化合物、分離之去羥基豐原素H化合物、分離之豐原素I化合物及分離之去羥基豐原素I化合物,呈適合於達成有益於植物生長或對易感病植物賦予保護以避免病原性感染中之一或兩者的量,該等豐原素及去羥基豐原素化合物具有下式:
其中R為OH,n在8至20範圍內,FA為直鏈、異或反異,且:對於豐原素MA,X1為Ala,X2為Thr,且X3為Met;對於豐原素MB,X1為Val,X2為Thr,且X3為Met;對於豐原素MC,X1為Aba,X2為Thr,且X3為Met;對於豐原素H,X1為Val,X2為Thr,且X3為Hcy;且對於豐原素I,X1為Ile,X2為Thr,且X3為Ile;或其中R為H,n在8至20範圍內,FA為直鏈、異或反異,且:對於去羥基豐原素MA,X1為Ala,X2為Thr,且X3為Met;對於去羥基豐原素MB,X1為Val,X2為Thr,且X3為Met;對於去羥基豐原素MC,X1為Aba,X2為Thr,且X3為Met;對於去羥基豐原素H,X1為Val,X2為Thr,且X3為Hcy;且對於去羥基豐原素I,X1為Ile,X2為Thr,且X3為Ile。 Wherein R is OH, n is in the range of 8 to 20, FA is linear, XOR or di-isomeric, and: for abundance MA, X 1 is Ala, X 2 is Thr, and X 3 is Met; for abundance MB X 1 is Val, X 2 is Thr, and X 3 is Met; for abundance MC, X 1 is Aba, X 2 is Thr, and X 3 is Met; for abundance H, X 1 is Val, X 2 Is Thr and X 3 is Hcy; and for abundance I, X 1 is Ile, X 2 is Thr, and X 3 is Ile; or wherein R is H, n is in the range of 8 to 20, and FA is linear, XOR or singular, and: for dehydroxylectin MA, X 1 is Ala, X 2 is Thr, and X 3 is Met; for dehydroxyl-rich MB, X 1 is Val, X 2 is Thr, and X 3 Is Met; for dehydroxylectin MC, X 1 is Aba, X 2 is Thr, and X 3 is Met; for dehydroxylectin H, X 1 is Val, X 2 is Thr, and X 3 is Hcy; For dehydroxylectin I, X 1 is Ile, X 2 is Thr, and X 3 is Ile.
在一個實施例中,提供解澱粉芽孢桿菌菌株之生物純培養物的提取物,該提取物包括豐原素-MA、豐原素-MB、豐原素-MC、豐原素-H及豐原素-I化合物以及去羥基豐原素-MA、去羥基豐原素-MB、去羥基豐原素-MC、去羥基豐原素-H及去羥基豐原素-I化合物以及表XIII中列出之其他豐原素樣及去羥基豐原素樣化合物之一或組合。 In one embodiment, there is provided an extract of a biologically pure culture of a B. amyloliquefaciens strain, the extract comprising amylin-MA, amylin-MB, a protosan-MC, a protosan-H, and a protoxin-I compound And dehydroxy-hydroxytoxin-MA, hydroxy-hydroxytoxin-MB, hydroxy-hydroxytoxin-MC, hydroxy-hydroxytoxin-H and hydroxy-hydroxy-proto-I compounds, and other abundances and dehydroxylations listed in Table XIII One or a combination of a protoplast-like compounds.
在一個實施例中,提供以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301之生物純培養物的提取物,該提取物包括豐原素-MA、豐原素-MB、豐原素-MC、豐原素-H及豐原素-I化合物以及去羥基豐原素-MA、去羥基豐原素-MB、去羥基豐原素-MC、去羥基豐原素-H及去羥基豐原素-I化合物以及表XIII中列出之其他豐原素樣及去羥基豐原素樣化合物之一或組合。 In one embodiment, an extract of a biologically pure culture of Bacillus amyloliquefaciens RTI301 deposited under ATCC PTA-121165 is provided, the extract comprising amylin-MA, amylin-MB, abundance-MC, Fengyuan素-H and adiponectin-I compounds as well as hydroxy-hydroxytoxin-MA, hydroxy-hydroxytoxin-MB, hydroxy-hydroxytoxin-MC, hydroxy-hydroxytoxin-H and dehydroxy-hydroxy-proto-I compounds and Table XIII One or a combination of other abundances and dehydroxy-flavone-like compounds.
在一個實施例中,提供一種有益於植物生長之組合物,該組合物包含:以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301或其具有所有其鑑別特徵之突變體的生物純培養物;以及畢芬寧(bifenthrin)殺蟲劑。 In one embodiment, a plant-promoting composition is provided, the composition comprising: Bacillus amyloliquefaciens RTI301 deposited with ATCC PTA-121165 or a biologically pure culture thereof having mutants of all of its identifying characteristics ; and bifenthrin insecticide.
在一個實施例中,提供一種有益於植物生長之組合物,該組合物包含:以ATCC第PTA-121165號寄存之解澱粉芽抱桿菌RTI301或其具有所有其鑑別特徵之突變體的生物純培養物;以及包含來自白羽扇豆(Lupinus albus)之提取物、BLAD多肽或BLAD多肽片段之一或組合的殺真菌劑。 In one embodiment, a plant-promoting composition is provided, the composition comprising: Bacillus amyloliquefaciens RTI301 deposited under ATCC PTA-121165 or a biologically pure culture thereof having all of its identifying characteristics And a fungicide comprising one or a combination of an extract from a white lupinus ( Lupinus albus ), a BLAD polypeptide or a BLAD polypeptide fragment.
在一個實施例中,提供一種產品,其包含:包含以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301或其具有其所有鑑別特徵之突變體的生物純培養物的第一組合物;包含微生物、生物或化學殺蟲劑、殺真菌劑、殺線蟲劑、殺菌劑、除草劑、植物提取物、植物生長調節劑或肥料之一或組合的第二組合物,其中該第一組合物及該第二組合物分開包裝且其中各組分為適合於達成有益於植物生長及/或對易感病植物賦予保護以避免病原性感染中之一或兩者之量;以及視情況存在之說明書,該說明書係針對用於將適合於有益於植物生長之量的第一與第二組合物之組合輸送至:植物葉、植物莖皮、植物果實、植物花、植物種子、植物根部、植物剪枝、植物移植物、植物癒合組織;植物周圍土壤或生長介質;在土壤或生長介質中播種植物種子之 前的土壤或生長介質;或在土壤或生長介質中種植植物、植物剪枝、植物移植物或植物癒合組織之前的土壤或生長介質。 In one embodiment, a product is provided comprising: a first composition comprising a biologically pure culture of Bacillus amyloliquefaci RTI301 deposited with ATCC PTA-121165 or a mutant having all of its identifying characteristics; a second composition of one or a combination of a microbial, biological or chemical insecticide, fungicide, nematicide, bactericide, herbicide, plant extract, plant growth regulator or fertilizer, wherein the first composition and The second composition is packaged separately and wherein the components are suitable for achieving an amount that is beneficial to plant growth and/or conferring protection to susceptible plants to avoid one or both of the pathogenic infections; and instructions as appropriate This specification is directed to the delivery of a combination of first and second compositions suitable for beneficial plant growth to: plant leaves, plant bark, plant fruits, plant flowers, plant seeds, plant roots, plant shears Branches, plant grafts, plant healing tissues; soil or growth medium around plants; seeding of plant seeds in soil or growth medium Pre-soil or growth medium; or soil or growth medium prior to planting plants, plant pruning, plant transplants, or plant healing tissue in soil or growth media.
圖1展示根據本發明之一或多個實施例,與兩種解澱粉芽孢桿菌參考菌株解澱粉芽孢桿菌FZB42及解澱粉芽孢桿菌TrigoCor1448之對應區域相比,包圍且包括在解澱粉芽孢桿菌菌株RTI301中發現之獨特羊毛硫抗生素生物合成操縱子的基因組結構之示意圖。 1 shows, in accordance with one or more embodiments of the present invention, surrounded and included in B. amyloliquefaciens strain RTI301, as compared to the corresponding regions of two B. amyloliquefaciens reference strains B. amyloliquefaciens FZB42 and B. amyloliquefaciens TrigoCor1448 Schematic representation of the genomic structure of the unique lantibiotic biosynthesis operon found in the medium.
圖2A為展示用RTI301菌株接種之植物的照片。圖2B為展示對照植物之照片。此等照片展示根據本發明之一或多個實施例,解澱粉芽孢桿菌菌株RTI301對小麥中早期植物生長之積極作用。生長13天後所提取之植物展示於圖中。 Figure 2A is a photograph showing a plant inoculated with the RTI301 strain. Figure 2B is a photograph showing a control plant. These photographs show the positive effects of B. amyloliquefaciens strain RTI301 on early plant growth in wheat according to one or more embodiments of the invention. The plants extracted after 13 days of growth are shown in the figure.
圖3A為展示用RTI301接種之植物的照片。圖3B為展示對照植物之照片。此等照片展示根據本發明之一或多個實施例,在28天之後解澱粉芽孢桿菌菌株RTI301對小麥中生長之積極作用。 Figure 3A is a photograph showing a plant inoculated with RTI301. Figure 3B is a photograph showing a control plant. These photographs show the positive effect of B. amyloliquefaciens strain RTI301 on growth in wheat after 28 days according to one or more embodiments of the invention.
圖4為展示根據本發明之一或多個實施例,在用以下各者處理後,感染豆銹病(菜豆銹病菌(Uromyces appendiculatus))10天後y軸上疾病控制%(平均值)的柱狀圖:廢醱酵液(SFB)中RTI301抱子(以1×108cfu/mL施用)、SERENADE OPTIMUM(以1×108cfu/ml施用)、TACTIC(以0.1875%施用於所有調配物且亦用作空白對照)、SERENADE OPTIMUM(以4×108cfu/ml施用)、得克利(Tebuconazole)(以50g a.i/ha施用)及四氯異苯腈(以500g a.i./ha施用)。未經處理之對照產生23%疾病。後面為相同字母之值不顯著不同(p=0.10)。 Figure 4 is a graph showing the % of disease control (average value) on the y-axis after 10 days of infection with soybean rust ( Uromyces appendiculatus ) after treatment with each of the following in accordance with one or more embodiments of the present invention. Plot: RTI301 stalk in waste broth (SFB) (administered at 1×10 8 cfu/mL), SERENADE OPTIMUM (administered at 1×10 8 cfu/ml), TACTIC (administered to all formulations at 0.1875%) Also used as a blank control), SERENADE OPTIMUM (administered at 4 x 10 8 cfu/ml), Tebuconazole (administered at 50 g ai/ha) and tetrachloroisophthalonitrile (administered at 500 g ai/ha). Untreated controls produced 23% of the disease. The values followed by the same letter are not significantly different (p=0.10).
圖5為展示根據本發明之一或多個實施例,在用以下各者處理後,感染增加量之豆銹病(菜豆銹病菌)(50k至300k分生孢子/毫升)10天後y軸上疾病控制%(平均值)的柱狀圖:與TACTIC(以0.1875%施用於所有調配物且亦用作空白對照)及得克利(HORIZON;以50g a.i/ha 施用)相比,廢醱酵液(SFB)中RTI301孢子(以1.0×108cfu/ml施用)及SERENADE OPTIMUM(以1×108cfu/ml及4×108cfu/ml施用)。檢查對照中疾病%分別為50k=6%,100k=6%,150k=15%,200k=15%,且300k=7%。後面為相同字母之值不顯著不同(p=0.10)。 Figure 5 is a graph showing the increase in the amount of infection of soybean rust (Nicky rust) (50k to 300k conidia/ml) on the y-axis after 10 days of treatment according to one or more embodiments of the present invention. Histogram of % of disease control (average): decoction broth compared to TACTIC (administered to all formulations at 0.1875% and also used as a blank) and Kelly (HORIZON; applied at 50 g ai/ha) (SFB) RTI301 spores (administered at 1.0 x 10 8 cfu/ml) and SERENADE OPTIMUM (administered at 1 x 10 8 cfu/ml and 4 x 10 8 cfu/ml). The % of diseases in the examination control were 50k=6%, 100k=6%, 150k=15%, 200k=15%, and 300k=7%, respectively. The values followed by the same letter are not significantly different (p=0.10).
圖6展示根據本發明之一或多個實施例,在確定RTI301菌株對抗灰葡萄孢菌病原體之拮抗作用的兩個獨立番茄田間試驗各者中未經處理之對照(「UT」)中感染此病原體之果實%隨時間發展的圖。 Figure 6 shows an infection in an untreated control ("UT") in each of two independent tomato field trials determining the antagonism of the RTI301 strain against Botrytis cinerea pathogens in accordance with one or more embodiments of the present invention. A graph of the growth of the fruit of the pathogen over time.
圖7展示根據本發明之一或多個實施例,在確定RTI301菌株對抗灰葡萄孢菌病原體之拮抗作用的四個獨立草莓田間試驗各者中未經處理之對照(「UT」)中感染此病原體之果實%隨時間發展的圖。 Figure 7 shows infection in an untreated control ("UT") in each of four independent strawberry field trials determining antagonism of RTI301 strain against Botrytis cinerea pathogens in accordance with one or more embodiments of the present invention. A graph of the growth of the fruit of the pathogen over time.
圖8A展示869瓊脂盤上禾穀鐮刀菌之生長。圖8B展示在20μl分別含有1×108CFU/ml(左)或1×109CFU/ml(右)之RTI301孢子溶液存在下869瓊脂盤上禾穀鐮刀菌之生長。圖8C展示在869瓊脂盤上20μl分別含有1×108CFU/ml(左)或1×109CFU/ml(右)之解澱粉芽孢桿菌RTI301孢子溶液的生長。圖8D展示869+1% FRACTURE瓊脂盤上禾穀鐮刀菌之生長。圖8E展示在20μl分別含有1×108CFU/ml(左)或1×109CFU/ml(右)之RTI301孢子溶液存在下869+1% FRACTURE瓊脂盤上禾穀鐮刀菌之生長。圖8F展示869+1% FRACTURE瓊脂盤上20μl分別含有1×108CFU/ml(左)或1×109CFU/ml(右)之解澱粉芽孢桿菌RTI301孢子溶液之生長。此等圖展示盤分析之影像,其展示根據本發明之一或多個實施例在FRACTURE存在及不存在下解澱粉芽孢桿菌RTI301對禾穀鐮刀菌之控制。 Figure 8A shows the growth of Fusarium graminearum on a 869 agar plate. Figure 8B shows the growth of Fusarium graminearum on a 869 agar plate in the presence of 20 μl of RTI301 spore solution containing 1 x 10 8 CFU/ml (left) or 1 x 10 9 CFU/ml (right), respectively. Figure 8C shows the growth of 20 μl of a solution of Bacillus amyloliquefaciens RTI301 spores containing 1 x 10 8 CFU/ml (left) or 1 x 10 9 CFU/ml (right) on a 869 agar plate. Figure 8D shows the growth of Fusarium graminearum on a 869+1% FRACTURE agar plate. Figure 8E shows the growth of Fusarium graminearum on a 869+1% FRACTURE agar plate in the presence of 20 μl of RTI301 spore solution containing 1 x 10 8 CFU/ml (left) or 1 x 10 9 CFU/ml (right), respectively. Figure 8F shows the growth of 20 μl of a spore solution of Bacillus amyloliquefaciens RTI301 containing 1 x 10 8 CFU/ml (left) or 1 x 10 9 CFU/ml (right) on a 869 + 1% FRACTURE agar plate. These figures show images of disc analysis showing the control of Fusarium graminearum RTI301 in the presence and absence of FRACTURE in accordance with one or more embodiments of the invention.
圖9A展示869瓊脂盤上古巴尖孢鐮刀菌之生長。圖9B展示在20μl分別含有1×108CFU/ml(左)或1×109CFU/ml(右)之RTI301孢子溶液存在下869瓊脂盤上古巴尖孢鐮刀菌之生長。圖9C展示在869瓊脂盤上20μl分別含有1×108CFU/ml(左)或1×109CFU/ml(右)之解澱粉芽孢 桿菌RTI301孢子溶液的生長。圖9D展示869+1% FRACTURE瓊脂盤上古巴尖孢鐮刀菌之生長。圖9E展示在20μl分別含有1×108CFU/ml(左)或1×109CFU/ml(右)之RTI301孢子溶液存在下869+1% FRACTURE瓊脂盤上古巴尖孢鐮刀菌之生長。圖9F展示869+1% FRACTURE瓊脂盤上20μl分別含有1×108CFU/ml(左)或1×109CFU/ml(右)之解澱粉芽孢桿菌RTI301抱子溶液之生長。此等圖展示盤分析之影像,其展示根據本發明之一或多個實施例在FRACTURE存在及不存在下解澱粉芽孢桿菌RTI301對古巴尖孢鐮刀菌之控制。 Figure 9A shows the growth of Fusarium oxysporum on the 869 agar plate. Figure 9B shows the growth of Fusarium oxysporum on the 869 agar plate in the presence of 20 μl of RTI301 spore solution containing 1 x 10 8 CFU/ml (left) or 1 x 10 9 CFU/ml (right), respectively. Figure 9C shows the growth of 20 μl of a solution of spores of Bacillus amyloliquefaciens RTI301 containing 1 x 10 8 CFU/ml (left) or 1 x 10 9 CFU/ml (right) on a 869 agar plate. Figure 9D shows the growth of Fusarium oxysporum on a 869+1% FRACTURE agar plate. Figure 9E shows the growth of Fusarium oxysporum on a 869+1% FRACTURE agar plate in the presence of 20 μl of RTI301 spore solution containing 1 x 10 8 CFU/ml (left) or 1 x 109 CFU/ml (right), respectively. Figure 9F shows the growth of 20 μl of B. amyloliquefaciens RTI 301 solution containing 1 x 10 8 CFU/ml (left) or 1 x 10 9 CFU/ml (right) on a 869 + 1% FRACTURE agar plate. These figures show images of disc analysis showing the control of B. oxysporum RTI301 against Fusarium oxysporum in the presence and absence of FRACTURE in accordance with one or more embodiments of the present invention.
圖10為展示由包括解澱粉芽孢桿菌之微生物物種產生的先前報導之豐原素型及去羥基豐原素型環狀脂肽,及由根據本發明之一或多個實施例,解澱粉芽孢桿菌RTI301分離株產生之新鑑別(以粗體展示)之豐原素型及去羥基豐原素型分子的示意圖。 Figure 10 is a diagram showing a previously reported abundance of protosanoids and dehydroxyhydroxytoxin-type cyclic lipopeptides produced by a microbial species including Bacillus amyloliquefaciens, and by Bacillus amyloliquefaciens RTI301 according to one or more embodiments of the present invention Schematic representation of the new identification (shown in bold) of the isolates and the dehydroxyl-rich molecules.
圖11為展示根據本發明之一或多個實施例,在酸沈澱之後自RTI301廢醱酵液(SFB)回收之脂肽百分比的圖。術語「301-AP-球粒」及「301-AP-上清液」分別指在SFB進行酸沈澱加上離心之後獲得的再懸浮球粒及上清液。計算百分比且基於來自RTI301廢醱酵液(301-SFB)之各脂肽之積分離子豐度比較。 Figure 11 is a graph showing the percentage of lipopeptides recovered from RTI301 spent broth (SFB) after acid precipitation, in accordance with one or more embodiments of the present invention. The terms "301-AP-spherulites" and "301-AP-supernatants" refer to resuspended pellets and supernatants obtained after acid precipitation and centrifugation of SFB, respectively. The percentage was calculated and based on the integrated ion abundance comparison of each lipopeptide from RTI301 waste broth (301-SFB).
術語「一(a/an)」及「該」在用於本申請案(包括申請專利範圍)時係指「一或多個」。因此,除非上下文明確相反,否則例如提及「植物」包括複數種植物。 The terms "a/an" and "the" are used in the context of the application (including the scope of the patent application) to mean "one or more." Thus, for example, reference to "a plant" includes a plurality of plants unless the context clearly dictates otherwise.
在本說明書及申請專利範圍通篇中,除上下文另外要求之外,術語「包含(comprise/comprises/comprising)」以非排斥含義使用。同樣,術語「包括」及其語法變化形式意欲為非限制性的,使得清單中項目之列舉不排除可取代或添加至所列項目中之其他類似項目。 Throughout the specification and claims, the term "comprise/comprises/comprising" is used in a non-exclusive sense, unless the context requires otherwise. Similarly, the term "comprise" and its grammatical variations are intended to be non-limiting, such that the listing of items in the list does not exclude other similar items that can be substituted or added to the listed items.
出於本說明書及申請專利範圍之目的,術語「約」在與一或多 個數字或數值範圍結合使用時應理解為指所有此類數字,包括範圍內之所有數字,且藉由擴展邊界高於及低於所闡述數值來修改彼範圍。由端點列舉之數值範圍包括包含在彼範圍內及彼範圍內任何範圍之所有數字,例如全部整數,包括其分數(例如,列舉1至5包括1、2、3、4及5,以及其分數,例如1.5、2.25、3.75、4.1及其類似者)。 For the purposes of this specification and the scope of the patent application, the term "about" is used with one or more The use of a range of numbers or ranges of values is understood to mean all such numbers, including all numbers in the range, and the extents are modified by extending the boundaries above and below the stated values. The recitation of numerical ranges by endpoints includes all numbers, including all integers, including the integers thereof, including the range of 1 to 5 including 1, 2, 3, 4, and 5, and Scores, such as 1.5, 2.25, 3.75, 4.1, and the like).
出於本說明書及申請專利範圍之目的,術語「代謝物」及「化合物」當與由RTI301菌株或其他解澱粉芽孢桿菌菌株產生之具有抗微生物活性之化合物結合使用時可互換使用。 For the purposes of this specification and the scope of the patent application, the terms "metabolite" and "compound" are used interchangeably when used in combination with a compound having antimicrobial activity produced by a strain of RTI301 or other strains of Bacillus amyloliquefaciens.
出於本說明書及申請專利範圍之目的,片語「細菌菌株之生物純培養物」係指以下各者之一或組合:細菌菌株之生物純醱酵培養物之孢子;細菌菌株之生物純醱酵培養物之營養細胞;細菌菌株之生物純醱酵培養物之一或多種產物;細菌菌株之生物純醱酵培養物之培養物固體;細菌菌株之生物純醱酵培養物之培養物上清液;細菌菌株之生物純醱酵培養物之提取物;及細菌菌株之生物純醱酵培養物之一或多種代謝物。 For the purposes of this specification and the scope of the patent application, the phrase "biologically pure culture of bacterial strain" means one or a combination of the following: a spore of a biologically pure fermentation culture of a bacterial strain; a vegetative cell of a yeast culture; one or more products of a biologically pure fermentation culture of a bacterial strain; a culture solid of a biologically pure fermentation culture of a bacterial strain; a culture supernatant of a biologically pure fermentation culture of a bacterial strain a liquid; an extract of a biologically pure fermentation culture of a bacterial strain; and one or more metabolites of a biologically pure fermentation culture of the bacterial strain.
在本發明之某些實施例中,提供包括新鑑別之解澱粉芽孢桿菌菌株之生物純培養物的組合物及方法,其用於施用於植物以達成有益於植物生長或對易感病植物賦予保護以避免病原性感染中的一或兩者。在本發明之組合物及方法中,植物生長益處藉由幼苗活力提高、根發育改善、植物生長改善、植物健康改善、產量增加、外觀改善、對植物病原體之抗性提高、病原性感染減少或其組合展現。 In certain embodiments of the invention, compositions and methods are provided comprising a biologically pure culture of a newly identified strain of Bacillus amyloliquefaciens for application to a plant to achieve a plant growth or to confer a susceptibility to a susceptible plant Protect from one or both of the pathogenic infections. In the compositions and methods of the present invention, plant growth benefits are enhanced by increased seedling vigor, improved root development, improved plant growth, improved plant health, increased yield, improved appearance, increased resistance to plant pathogens, reduced pathogenic infection, or Its combination is displayed.
鑑別為屬於物種解澱粉芽孢桿菌之植物相關細菌自生長在紐約長島(Long Island,NY)之溫亞德(vineyard)的葡萄藤根圍土壤分離且隨後測試植物病原體拮抗特性。更特定言之,經由高度保守之16S rRNA及rpoB基因之序列分析將分離之細菌菌株鑑別為解澱粉芽孢桿菌菌株之新菌株(參見實例1)。測得新細菌分離株(稱為「解澱粉芽孢 桿菌RTI301」)之16S RNA序列與解澱粉芽孢桿菌之三種其他已知菌株、解澱粉芽孢桿菌菌株NS6(KF177175)、解澱粉芽孢桿菌菌株FZB42(NR_075005)及枯草芽孢桿菌亞種(Bacillus subtilis subsp.)枯草菌株DSM 10(NR_027552)的16S rRNA基因序列一致。亦確定RTI301之rpoB基因序列與解澱粉芽孢桿菌植物亞種TrigoCor1448(CP007244)(99%序列一致性;3個鹼基對差異)、解澱粉芽孢桿菌植物亞種AS43.3(CP003838)(99%序列一致性;7個鹼基對差異)、解澱粉芽孢桿菌CC178(CP006845)(99%序列一致性;8個鹼基對差異)及解澱粉芽孢桿菌FZB42(CP000560)(99%序列一致性;8個鹼基對差異)中相同基因具有序列相似性。RTI301菌株鑑別為解澱粉芽孢桿菌,然而,在DNA層面下rpoB基因之序列差異指示RTI301為解澱粉芽孢桿菌之新菌株。解澱粉芽孢桿菌RTI301之該菌株於2014年4月17日依據國際承認用於專利程序的微生物寄存布達佩斯條約之條款寄存於美國菌種保藏中心(American Type Culture Collection,ATCC)(Manassas,Virginia,USA)且具有專利寄存編號PTA-121165。 Plant-associated bacteria identified as belonging to the species B. amyloliquefaciens were isolated from the vine roots of the vineyard in Long Island, NY, and the phytopathogenic antagonistic properties were subsequently tested. More specifically, the isolated bacterial strain was identified as a new strain of B. amyloliquefaciens strain by sequence analysis of the highly conserved 16S rRNA and rpoB genes (see Example 1). The 16S RNA sequence of the new bacterial isolate (referred to as "Bacillus amyloliquefaciens RTI301") and three other known strains of B. amyloliquefaciens, Bacillus amyloliquefaciens strain NS6 (KF177175), Bacillus amyloliquefaciens strain FZB42 ( NR_075005) and the 16S rRNA gene sequence of Bacillus subtilis subsp. subtilis strain DSM 10 (NR_027552) were identical. The rpoB gene sequence of RTI301 was also determined with the B. amyloliques plant subspecies TrigoCor1448 (CP007244) (99% sequence identity; 3 base pair differences), B. amyloliquefaciens plant subspecies AS43.3 (CP003838) (99% Sequence identity; 7 base pair differences), B. amyloliquefaciens CC178 (CP006845) (99% sequence identity; 8 base pair differences) and B. amyloliquefaciens FZB42 (CP000560) (99% sequence identity; The same genes in the 8 base pair differences have sequence similarity. The RTI301 strain was identified as B. amyloliquefaciens, however, the sequence difference of the rpoB gene at the DNA level indicated that RTI301 was a new strain of B. amyloliquefaciens. The strain of Bacillus amyloliquefaciens RTI301 was deposited with the American Type Culture Collection (ATCC) on April 17, 2014 in accordance with the terms of the Budapest Treaty on the International Recognition of Microorganisms for Patent Procedures (Manassas, Virginia, USA). And has the patent registration number PTA-121165.
解澱粉芽孢桿菌RTI301菌株之基因組的進一步序列分析揭露該菌株具有同源物在其他緊密相關解澱粉芽孢桿菌菌株中缺乏的與羊毛硫抗生素生物合成相關之基因(參見實例2)。此在圖1中說明,其展示在解澱粉芽孢桿菌RTI301中發現之羊毛硫抗生素生物合成簇及兩種已知解澱粉芽孢桿菌參考菌株FZB42(中間)及TrigoCor1448(底部)(展示在RTI301菌株下面)之對應區域之基因組結構的示意圖。自圖1可觀測到FZB42及TrigoCor1448菌株缺乏許多存在於此簇中之基因,且存在之許多基因內序列一致性程度低。針對NCBI之非冗餘(nr)核苷酸資料庫對此簇之BLASTn分析展示與解澱粉芽孢桿菌菌株之5'及3'側接區域具有高度同源性(類似於圖1中高度相似性%)。然而,羊毛硫肽生物合成簇為RTI301獨特的,且未觀測到與NCBI nr資料庫中任何先前測序 之DNA具有顯著同源性。該等資料表明新鑑別之RTI301具有獨特之羊毛硫抗生素生物合成路徑。 Further sequence analysis of the genome of Bacillus amyloliquefaciens RTI301 strain revealed that the strain has a gene associated with lantibiotic biosynthesis that is homologous to other closely related B. amyloliquefaciens strains (see Example 2). This is illustrated in Figure 1, which shows the lantibiotic biosynthetic cluster found in B. amyloliquesii RTI301 and two known B. amyloliquefaciens reference strains FZB42 (middle) and TrigoCor1448 (bottom) (shown under RTI301 strain) Schematic diagram of the genomic structure of the corresponding region. It can be observed from Figure 1 that the FZB42 and TrigoCor1448 strains lack many of the genes present in this cluster, and many of the genes present have a low degree of sequence identity. The BLASTn analysis of this cluster for NCBI's non-redundant (nr) nucleotide library demonstrates high homology to the 5' and 3' flanking regions of B. amyloliquefaciens strains (similar to the high similarity in Figure 1). %). However, the lanthiopeptide biosynthetic cluster is unique to RTI301 and no previous sequencing with the NCBI nr library was observed. The DNA has significant homology. This data indicates that the newly identified RTI301 has a unique lantibiotic biosynthetic pathway.
進行實驗以確定解澱粉芽孢桿菌RTI301菌株在各種植物中及在變化條件下之促生長及拮抗活性。實驗結果提供於圖2至11及本文實例3至16中,展示與含有枯草芽孢桿菌菌株QST713作為活性成分之市售SERENADE(BAYER CROP SCIENCE,INC)相比,解澱粉芽孢桿菌RTI301能夠有益於植物生長且賦予保護以避免或控制植物病原性感染。實驗結果亦提供新RTI301菌株與市售化學殺真菌劑/殺菌劑之益處比較。在一些情況下,單獨解澱粉芽孢桿菌RTI301菌株之施用的效能與化學殺真菌劑/殺菌劑之施用同等佳。實驗結果亦提供新RTI301菌株增強FRACTURE(CONSUMO EM VERDE(CEV),BIOTECNOLOGIA DAS PLANTAS S.A.,PORTUGAL)之拮抗特性之益處的實例,FRACTURE為含有BLAD多肽作為活性成分之植物提取物。 Experiments were carried out to determine the growth-promoting and antagonistic activity of the B. amyloliquefaciens RTI301 strain in various plants and under varying conditions. The results of the experiments are provided in Figures 2 to 11 and Examples 3 to 16 herein, showing that Bacillus amyloliquefaciens RTI301 can be beneficial to plants compared to the commercially available SERENADE (BAYER CROP SCIENCE, INC) containing Bacillus subtilis strain QST713 as an active ingredient. Grow and protect to avoid or control plant pathogenic infections. The experimental results also provide a comparison of the benefits of the new RTI 301 strain with commercially available chemical fungicides/bactericides. In some cases, the efficacy of the application of the B. amyloliquefaciens RTI 301 strain alone is as good as the application of a chemical fungicide/bactericide. The experimental results also provide an example of the benefits of the new RTI301 strain enhancing the antagonistic properties of FRACTURE (CONSUMO EM VERDE (CEV), BIOTECNOLOGIA DAS PLANTAS S.A., PORTUGAL), a plant extract containing the BLAD polypeptide as an active ingredient.
在本發明之一個實施例中,提供一種包括以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301或其具有其所有鑑別特徵之突變體的生物純培養物的組合物,該組合物用於施用於植物以達成有益於植物生長或對易感病植物賦予保護以避免病原性感染中的一或兩者。 In one embodiment of the present invention, there is provided a composition comprising a biologically pure culture of Bacillus amyloliquefaci RTI301 deposited with ATCC PTA-121165 or a mutant having all of its identifying characteristics, the composition being used for Application to plants to achieve one or both of beneficial to plant growth or to confer protection to susceptible plants to avoid pathogenic infections.
在另一個實施例中,提供一種用於達成有益於植物生長或對易感病植物賦予保護以避免病原性感染中之一或兩者的方法,該方法包括將包含以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301或其具有其所有鑑別特徵之突變體的生物純培養物的組合物輸送至:植物葉、植物莖皮、植物果實、植物花、植物種子、植物根部、植物剪枝、植物移植物、植物癒合組織;植物周圍土壤或生長介質;在土壤或生長介質中播種植物種子之前的土壤或生長介質;或在土壤或生長介質中種植植物、植物剪枝、植物移植物或植物癒合組織之前的土壤 或生長介質,該組合物之呈適合於有益於植物生長及/或對易感病植物賦予保護以避免病原性感染之量。 In another embodiment, a method for achieving one or both of beneficial to plant growth or protection of a susceptible plant from pathogenic infection is provided, the method comprising including ATCC No. PTA-121165 A composition of a deposited biologically pure culture of Bacillus amyloliquefaciens RTI301 or a mutant having all of its identifying characteristics is delivered to: plant leaves, plant bark, plant fruits, plant flowers, plant seeds, plant roots, plant pruning , plant grafts, plant healing tissue; soil or growth medium surrounding the plant; soil or growth medium prior to seeding the plant seed in soil or growth medium; or planting plants, plant pruning, plant transplants or in soil or growth medium The soil before the plant heals the tissue Or a growth medium, the composition being in an amount suitable to be beneficial for plant growth and/or to confer protection to susceptible plants to avoid pathogenic infections.
小麥中RTI301分離株之促生長活性描述於實例3中。將發芽小麥種子在約2×107CFU/ml RTI301菌株之懸浮液中接種2天,且隨後在盆中種植。生長13天後所提取之植物之照片展示於圖2中。圖2A展示用RTI301接種之植物且圖2B展示對照植物。測定小麥幼苗之乾重,結果RTI301處理植物之乾重比未接種對照增加8.1%。另外,解澱粉芽孢桿菌RTI301菌株對小麥中早期生長之有益作用展示在圖3中之影像中。圖3A展示用RTI301接種之28日齡小麥植物且圖3B展示對照植物。 The growth promoting activity of the RTI301 isolate in wheat is described in Example 3. Germinated wheat seeds were inoculated in a suspension of about 2 x 10 7 CFU/ml RTI 301 strain for 2 days and then planted in pots. A photograph of the plants extracted after 13 days of growth is shown in Figure 2. Figure 2A shows plants inoculated with RTI301 and Figure 2B shows control plants. The dry weight of wheat seedlings was determined. As a result, the dry weight of RTI301 treated plants increased by 8.1% compared with the uninoculated controls. In addition, the beneficial effects of B. amyloliquefaciens RTI301 strain on early growth in wheat are shown in the image in Figure 3. Figure 3A shows 28 day old wheat plants inoculated with RTI301 and Figure 3B shows control plants.
盤分析中解澱粉芽孢桿菌RTI301針對若干主要植物病原體之拮抗特性描述於實例4中且諸如菌株之植物激素產生、乙偶姻及吲哚乙酸(IAA)及養分循環的表現性狀描述在實例5中。 The antagonistic properties of B. amyloliquefaciens RTI301 against several major plant pathogens in the disc assay are described in Example 4 and the performance traits such as phytohormone production, acetoin and indole acetic acid (IAA) and nutrient cycling of the strain are described in Example 5. .
已知有益的植物相關細菌(根圍及內寄生)對宿主植物提供範圍為抗疾病及昆蟲蟲害及耐受環境壓力(包括冷、鹽度及乾旱壓力)之多種益處。由於接種植物促生長細菌之植物自土壤獲取更多水及養分,例如歸因於較佳發育之根系統,所以植物更健康生長且較不易受生物及非生物壓力影響。因此,本發明之微生物組合物可單獨或與當前作物管理輸入(諸如化學肥料、除草劑及殺蟲劑)組合施用以使作物產率最大化。促進植物生長影響轉變為植物生長較快及地上生物質量增加,該特性可應用於提高早期活力。提高早期活力之一個益處為植物更具競爭性且勝過雜草,藉由使勞動力及除草劑施用最小化直接降低雜草管理成本。促進植物生長影響亦轉變為改善之根發育,包括更深及更寬之根,有更多細根參與水及養分之吸收。此特性允許更佳地使用農業資源,且減少用於灌溉需求及/或施肥之水。根發育及根結構之變化影響植物與其他土壤媒介微生物之相互作用,該等微生物包括有助 於植物吸收養分(包括固氮及磷酸鹽溶解)之有益真菌及細菌。此等有益微生物亦與植物病原體競爭,提高總體植物健康且減少對化學殺真菌劑及殺蟲劑的需求。 Beneficial plant-associated bacteria (root and endoparasite) are known to provide host plants with a variety of benefits ranging from disease and insect pests to environmental stresses including cold, salinity and drought stress. Since plants inoculated with plant growth-promoting bacteria obtain more water and nutrients from the soil, for example due to better developed root systems, plants grow healthier and less susceptible to biotic and abiotic stresses. Thus, the microbial compositions of the present invention can be applied alone or in combination with current crop management inputs, such as chemical fertilizers, herbicides, and insecticides, to maximize crop yield. Promoting the effects of plant growth translates into faster plant growth and increased above-ground biomass quality, which can be applied to improve early vigor. One benefit of improving early vigor is that plants are more competitive and outweigh weeds, directly reducing weed management costs by minimizing labor and herbicide application. The promotion of plant growth effects is also transformed into improved root development, including deeper and wider roots, with more fine roots involved in the absorption of water and nutrients. This feature allows for better use of agricultural resources and reduces water for irrigation needs and/or fertilization. Changes in root development and root structure affect the interaction of plants with other soil-borne micro-organisms, including Useful fungi and bacteria that absorb nutrients (including nitrogen fixation and phosphate dissolution) in plants. These beneficial microorganisms also compete with plant pathogens, improving overall plant health and reducing the need for chemical fungicides and pesticides.
另外,在溫室中及田間試驗中對各種作物進行研究以確定解澱粉芽孢桿菌RTI301菌株預防及/或減輕許多常見植物病原體對植物之天然或人工感染作用的能力。結果描述於實例6至13及圖4至7中。其他研究描述RTI301與含有抗真菌多肽之產品組合對抗真菌病原體之拮抗作用(實例14;圖8-9),且鑑別藉由RTI301菌株產生之抗微生物代謝物且分別在實例15及16及圖10及11中分離。 In addition, various crops were studied in greenhouse and in field trials to determine the ability of B. amyloliquefaciens RTI301 to prevent and/or alleviate the natural or artificial infection effects of many common plant pathogens on plants. The results are described in Examples 6 to 13 and Figures 4 to 7. Other studies describe the antagonism of RTI301 in combination with a product containing an antifungal polypeptide against fungal pathogens (Example 14; Figures 8-9) and identify antimicrobial metabolites produced by the RTI 301 strain and in Examples 15 and 16 and Figure 10, respectively. And 11 in the separation.
實例6描述解澱粉芽孢桿菌RTI301菌株減輕植物病原體豆銹病(菜豆銹病菌)及植物病原體胡椒葡萄孢枯萎病(灰葡萄孢菌)之作用的能力。在第一組實驗中,針對RTI301菌株施用於葉面控制菜豆銹病菌及灰葡萄孢菌,測試解澱粉芽孢桿菌RTI301菌株之不同調配物。實驗設計經設定,以在感染病原體九天後,評估以下各者之疾病控制%:單獨用水稀釋之廢醱酵液中RTI301孢子(「RTI301+1% SFB」)、用水稀釋之廢醱酵液中RTI301孢子加上酵母提取物(「RTI301+1% SFB+酵母提取物」)、BRAVO WEATHER STIK(500g a.i./ha四氯異苯腈)、HORIZON(50g a.i./ha得克利)及與RTI301菌株相同孢子濃度之SERENADE OPTIMUM。未經處理之對照(僅水)產生28%疾病。豆銹病及胡椒葡萄孢枯萎病實驗之結果類似。豆銹病實驗之結果展示在表III中且指示與未添加酵母提取物而施用之RTI301菌株相比,添加酵母提取物以幫助植物葉上RTI301菌株之生長使得疾病控制約增加40%。當以相同施用率(亦即1×108cfu/ml)施用時,RTI301+1% SFB+酵母提取物展現之疾病控制量類似於針對SERENADE OPTIMUM所觀測之結果,即使RTI301調配物中SFB之量相對較低,為1%,且SFB可預期含有具有抗真菌活性之分泌代謝物。關於RTI301菌株對豆銹病之疾病控 制的類似實驗描述於實例6中,且結果展示在表IV-V及圖4-5中。結果展示與用SERENADE OPTIMUM處理相比,當以相同施用率施用時,用RTI301孢子處理豆類植物葉後豆銹病(菜豆銹病菌)之控制相當。 Example 6 describes the ability of the B. amyloliquefaciens RTI 301 strain to alleviate the effects of plant pathogen bean rust (String rust) and the plant pathogen Botrytis blight (B. cinerea). In the first set of experiments, different formulations of B. amyloliquefaciens RTI301 strain were tested for the application of the RTI301 strain to the leaf surface control of R. solani and Botrytis cinerea. The experimental design was set up to assess the disease control % of the following individuals after nine days of infection with the pathogen: RTI301 spores ("RTI301+1% SFB") in the waste broth diluted with water alone, in the waste broth diluted with water RTI301 spore plus yeast extract ("RTI301+1% SFB+ yeast extract"), BRAVO WEATHER STIK (500g ai/ha tetrachloroisophthalonitrile), HORIZON (50g ai/ha derkeley) and the same spores as RTI301 strain Concentration of SERENADE OPTIMUM. An untreated control (water only) produced 28% of the disease. The results of the bean rust and Botrytis cinerea wilt disease experiments were similar. The results of the bean rust test are shown in Table III and indicate that the yeast extract was added to help the growth of the RTI301 strain on the plant leaf to increase disease control by about 40% compared to the RTI301 strain administered without the addition of the yeast extract. When administered at the same application rate (i.e., 1 x 10 8 cfu/ml), the RTI301 + 1% SFB + yeast extract exhibited a disease control amount similar to that observed for SERENADE OPTIMUM, even though the amount of SFB in the RTI301 formulation Relatively low, it is 1%, and SFB is expected to contain secreted metabolites with antifungal activity. A similar experiment on disease control of RTI 301 strain against bean rust is described in Example 6, and the results are shown in Tables IV-V and Figures 4-5. The results show that the control of bean rust (leaf bean rust) with RTI301 spores is comparable to that treated with SERENADE OPTIMUM when treated at the same application rate.
在田間試驗中對各種作物進行研究以確定解澱粉芽孢桿菌RTI301菌株預防及/或減輕許多常見植物病原體對植物之天然或人工感染作用的能力。結果描述於實例7至9。實例7及8分別描述黃瓜上植物病原體白粉病及番茄中黃單孢菌屬之控制。在試驗中,RTI301以與SERENADE OPTIMUM相同之施用率施用於作物。施用1至6次,其中施用之間的時間間隔為5至7天,視作物而定。第一次施用之時間安排視特定作物而定且在種植時、作物萌芽後幾週、開始開花時、出現疾病時或在預期疾病出現前的範圍內。實例7及表VI中之結果展示當以相同施用率施用時,作為單獨生物殺真菌劑,與SERENADE OPTIMUM相比,RTI301對黃瓜中白粉病之控制類似。 Various crops were studied in field trials to determine the ability of B. amyloliquefaciens RTI301 to prevent and/or alleviate the natural or artificial infection effects of many common plant pathogens on plants. The results are described in Examples 7 to 9. Examples 7 and 8 describe the control of plant pathogen powdery mildew on cucumber and Xanthomonas in tomato, respectively. In the test, RTI 301 was applied to the crop at the same application rate as SERENADE OPTIMUM. The application is 1 to 6 times, wherein the time interval between administrations is 5 to 7 days, depending on the crop. The timing of the first application depends on the particular crop and is within the range of the crop, the weeks after the crop germination, the onset of flowering, the onset of the disease, or before the onset of the expected disease. The results in Examples 7 and VI show that RTI 301 has similar control for powdery mildew in cucumber as a single biofungicide when compared to SERENADE OPTIMUM when applied at the same application rate.
實例8及表VII中之結果展示與SERENADE OPTIMUM相比,當以相同施用率施用時,作為單獨生物殺真菌劑,RTI301對番茄中細菌性斑病(黃單孢菌屬)之控制類似。作為單獨生物殺真菌劑之RTI301展示與使用氫氧化銅與四氯異苯腈組合之方案類似的效能。 The results in Example 8 and Table VII show that RTI301 has similar control for bacterial spot disease (Homomonospora) in tomato as a single biofungicide when applied at the same application rate as compared to SERENADE OPTIMUM. RTI301, which is a separate biofungicide, demonstrates similar efficacy to the combination of copper hydroxide and tetrachloroisophthalonitrile.
實例9中所述及表VIII中所示之結果展示與SERENADE OPTIMUM相比,當以相同施用率施用時,作為單獨生物殺真菌劑,RTI301對小麥赤黴病、大豆銹病、玉米銹病、黃瓜白粉病及番茄細菌性斑病之控制改善或類似。 The results shown in Example 9 and in Table VIII show that RTI301 acts as a single biofungicide, wheat gibberellosis, soybean rust, corn rust, cucumber white powder when applied at the same application rate compared to SERENADE OPTIMUM. The control of disease and tomato bacterial spot disease is improved or similar.
實例10中所述之實驗及表IX中所示之結果展示與僅僅化學活性劑CRUISERMAXX(SYNGENTA CROP PROTECTION,INC)加甲基托布津殺真菌劑(該組合在本文中被稱作「化學對照」)處理之種子相比,RTI301與化學活性劑組合對大豆中猝死症候群之控制改善。 The experiments described in Example 10 and the results shown in Table IX are shown with only the chemical active agent CRUISERMAXX (SYNGENTA CROP PROTECTION, INC) plus methyl thiophanate fungicide (this combination is referred to herein as "chemical control") Compared with the treated seeds, the combination of RTI301 and chemical active agent improved the control of sudden death syndrome in soybean.
實例11描述在番茄田間試驗中進行之研究以確定解澱粉芽孢桿菌RTI301菌株預防及/或減輕植物病原體褐灰黴(灰葡萄孢菌)作用的能力。RTI301菌株與施用稱為「FARMER方案」之化學活性劑組合及施用枯草芽孢桿菌菌株QST713之濃度比RTI301菌株高10倍的SERENADE MAX比較。各番茄試驗中未經處理之對照(「UT」)中感染灰葡萄孢菌病原體之果實%隨時間之發展展示在圖6中之圖中。表X中之結果展示觀測到解澱粉芽孢桿菌RTI301及FARMER方案對蕃茄上褐灰黴之控制最佳,且勝過使用SERENADE MAX之處理。 Example 11 describes a study conducted in a tomato field trial to determine the ability of the B. amyloliquefaciens RTI301 strain to prevent and/or alleviate the effects of the plant pathogen, Botrytis cinerea (B. cinerea). The RTI301 strain was compared with the application of a chemical active agent called "FARMER protocol" and the application of B. subtilis strain QST713 at a concentration 10 times higher than the REN301 strain of SERENADE MAX. The % of the fruit of the infected Botrytis cinerea pathogen in the untreated control ("UT") in each tomato test over time is shown in the graph of Figure 6. The results in Table X show that the B. amyloliquefaciens RTI301 and FARMER protocols have the best control of the brown mold on tomato and outperform the treatment with SERENADE MAX.
實例12描述在草莓田間試驗中進行之研究以確定解澱粉芽抱桿菌RTI301菌株預防及/或減輕植物病原體褐灰黴(灰葡萄孢菌)作用的能力。RTI301菌株與施用稱為「FARMER方案」之化學活性劑組合及施用枯草芽孢桿菌菌株QST713之濃度比RTI301菌株高10倍的SERENADE MAX比較。各草莓試驗中未經處理之對照(「UT」)中感染灰葡萄孢菌病原體之果實%隨時間之發展展示在圖7中之圖中。表XI中之結果展示觀測到與未經處理之對照相比,所有三個處理解澱粉芽孢桿菌RTI301、SERENADE MAX及FARMER方案均改善對草莓上褐灰黴之控制,其中用RTI301處理之產量增加數值略高。 Example 12 describes a study conducted in a strawberry field trial to determine the ability of B. amyloliquefaciens RTI 301 strain to prevent and/or alleviate the effects of the plant pathogen, Botrytis cinerea (B. cinerea). The RTI301 strain was compared with the application of a chemical active agent called "FARMER protocol" and the application of B. subtilis strain QST713 at a concentration 10 times higher than the REN301 strain of SERENADE MAX. The % of the fruit of the infected Botrytis cinerea pathogen in the untreated control ("UT") in each strawberry test over time is shown in the graph of Figure 7. The results in Table XI show that all three treatments of B. amyloliquefaciens RTI301, SERENADE MAX and FARMER have improved control of B. cinerea on strawberries compared to untreated controls, with increased yields treated with RTI301 The value is slightly higher.
實例13描述玉米中之田間試驗以研究在用解澱粉芽孢桿菌RTI301菌株處理植物種子後對植物生長及發育之作用。實驗設定如下:1)種子未經處理;2)種子經MAXIM、APRON XL及PONCHO之組合(稱為「化學對照」)處理;以及3)種子經化學對照處理加上接種每顆種子5.0×10+5cfu菌株RTI301。進行三個田間試驗,其中一個具有天然疾病壓力,一個具有人工接種禾穀鐮刀菌之土壤,且一個具有人工接種絲核菌之土壤。值得注意地,在絲核菌試驗中,觀測到與單獨化學對照相比,RTI301加上化學對照獲得每英畝40.1蒲式耳之極大產量益處。概言之,用化學對照加上RTI301處理使得所有3個試驗之產 量均增加且接種絲核菌之試驗的產量極大增加(參見表XII)。 Example 13 describes a field trial in corn to investigate the effects on plant growth and development after treatment of plant seeds with B. amyloliquefaciens RTI301 strain. The experimental settings were as follows: 1) the seeds were untreated; 2) the seeds were treated with a combination of MAXIM, APRON XL and PONCHO (referred to as "chemical control"); and 3) the seeds were chemically treated plus plus 5.0 x 10 seeds per seed. +5 cfu strain RTI301. Three field trials were conducted, one with natural disease stress, one with artificially inoculated Fusarium graminearum, and one with artificially inoculated Rhizoctonia. Notably, in the Rhizoctonia test, RTI301 plus chemical controls were observed to yield a significant yield benefit of 40.1 bushels per acre compared to the chemical control alone. In summary, treatment with the chemical control plus RTI 301 resulted in an increase in the yield of all three trials and a significant increase in the yield of the test for inoculation of Rhizoctonia (see Table XII).
實例14描述一種活體外盤分析,其展示解澱粉芽孢桿菌RTI301菌株增強作為FRACTURE出售之產品控制植物病原體之效能的能力。FRACTURE產品為一種植物提取物,含有多肽(BLAD多肽)作為活性成分,其藉由對真菌細胞壁造成損害且破壞內細胞膜而作用於易感真菌病原體。對於該分析,在1% FRACTURE存在及不存在下RTI301細菌分離株與病原性真菌並排生長在瓊脂盤上。植物病原體禾穀鐮刀菌及古巴尖孢鐮刀菌之分析結果分別展示在圖8A-8F及圖9A-9F中。雖然添加1% FRACTURE至瓊脂使兩種病原體之生長減少,但未實現真菌生長全部抑制。瓊脂培養基中1% FRACTURE之存在未抑制解澱粉芽孢桿菌RTI301之生長。然而,解澱粉芽孢桿菌RTI301與FRACTURE之組合的存在引起禾穀鐮刀菌與古巴尖孢鐮刀菌之真菌生長額外抑制。因此,解澱粉芽孢桿菌RTI301可用於增強FRACTURE效能。 Example 14 describes an in vitro disc assay demonstrating the ability of B. amyloliquefaciens RTI 301 strain to enhance the efficacy of a product sold by FRACTURE to control plant pathogens. The FRACTURE product is a plant extract containing a polypeptide (BLAD polypeptide) as an active ingredient which acts on susceptible fungal pathogens by causing damage to the fungal cell wall and destroying the inner cell membrane. For this analysis, RTI301 bacterial isolates and pathogenic fungi were grown side by side on agar plates in the presence and absence of 1% FRACTURE. The results of the analysis of the plant pathogens Fusarium graminearum and Fusarium oxysporum were shown in Figures 8A-8F and Figures 9A-9F, respectively. Although the addition of 1% FRACTURE to agar reduced the growth of both pathogens, no complete inhibition of fungal growth was achieved. The presence of 1% FRACTURE in the agar medium did not inhibit the growth of B. amyloliquefaciens RTI301. However, the presence of a combination of B. amyloliquefaciens RTI301 and FRACTURE caused additional inhibition of fungal growth of Fusarium graminearum and Fusarium oxysporum. Therefore, B. amyloliquefaciens RTI301 can be used to enhance FRACTURE potency.
實例15描述由解澱粉芽孢桿菌RTI301菌株產生之環狀脂肽豐原素及去羥基豐原素之研究,且意料地,先前未報導之幾類此等分子的鑑別。確定解澱粉芽孢桿菌RTI301產生先前報導之豐原素A、豐原素B及豐原素C化合物以及去羥基豐原素A、去羥基豐原素B及去羥基豐原素C化合物。意外地,除此等已知之化合物之外,確定RTI301菌株亦產生先前未鑑別之此等化合物之衍生物,其中環狀肽鏈之位置8的L-異白胺酸(圖10中稱為X3)經L-甲硫胺酸置換。新類別豐原素及去羥基豐原素在本文中稱為MA、MB及MC,係指A類、B類及C類衍生物,其中圖10中X3處之L-異白胺酸經L-甲硫胺酸置換。新鑑別之分子粗體展示在圖10中及表XIII中。進一步確定RTI301菌株產生先前尚未鑑別之其他類別豐原素及去羥基豐原素。在此類別中,豐原素B及去羥基豐原素B之L-異白胺酸(圖10中之位置X3)經L-高半胱胺酸(Hcy)置 換。此等先前未鑑別之豐原素及去羥基豐原素代謝物在本文中稱作豐原素H及去羥基豐原素H且展示在圖10及表XIII中。進一步確定RTI301菌株產生先前未鑑別之其他類別豐原素及去羥基豐原素代謝物。在此類別中,環狀肽主鏈結構之位置4(圖10中之位置X1)的胺基酸經L-異白胺酸置換。此等先前未鑑別之代謝物在本文中稱為豐原素I及去羥基豐原素I且展示在圖10及表XIII中。 Example 15 describes the study of the cyclic lipopeptides auretolide and dehydroxylectin produced by the B. amyloliquefaciens RTI 301 strain, and unexpectedly, the identification of several classes of molecules not previously reported. It was determined that B. amyloliquefaciens RTI301 produced previously reported protosulin A, abundance B and abundance C compounds as well as dehydroxylectin A, dehydroxylectin B and dehydroxylectin C compounds. Surprisingly, in addition to these known compounds, it was determined that the RTI 301 strain also produced derivatives of such compounds that were not previously identified, wherein L-isoleucine at position 8 of the cyclic peptide chain (referred to as X in Figure 10) 3 ) Replacement with L-methionine. The new classes of protosan and dehydroxylectin are referred to herein as MA, MB and MC, and refer to class A, B and C derivatives, wherein L-isoleucine at X 3 in Figure 10 is L- Methionine replacement. The newly identified molecular bold is shown in Figure 10 and in Table XIII. It was further determined that the RTI301 strain produced other classes of amylin and dehydroxylectin which have not been previously identified. In this category, fengycin B and activin B to the hydroxyl BBCA L- isoleucine (position of FIG. 10 X 3) via L- homocysteine (of Hcy) replacement. These previously unidentified abundane and dehydroxylectin metabolites are referred to herein as protamine H and dehydroxylectin H and are shown in Figure 10 and Table XIII. It was further determined that the RTI 301 strain produced other classes of protosan and dehydroxylectin metabolites that were not previously identified. In this category, the position of the main chain structure of the cyclic peptide 4 (FIG. 10 in the position X 1) is replaced by the amino acid L- isoleucine. These previously unidentified metabolites are referred to herein as protamine I and dehydroxylectin I and are shown in Figure 10 and Table XIII.
實例16描述拮抗脂肽自解澱粉芽孢桿菌菌株RTI301廢醱酵液之分離及活體外盤分析,展示分離之脂肽保留其對抗兩種常見植物病原體之活性。培養RTI301且藉由LCMS分析培養物上清液之酸沈澱以比較伊枯草菌素、表面活性素及豐原素之相對豐度。圖11為展示在酸沈澱之後自RTI301廢醱酵液回收之脂肽的百分比之圖。結果展示脂肽總量之80%藉由酸沈澱回收。隨後,針對灰葡萄孢菌及禾穀鐮刀菌,用藉由LCMS分析之相同樣品進行盤生物分析。展示酸沈澱之樣品與起始廢醱酵液具有類似程度之對抗灰葡萄孢菌與禾穀鐮刀菌之拮抗活性的結果。 Example 16 describes the isolation of an antagonistic lipopeptide from B. amyloliquefaciens strain RTI301, and an in vitro disk assay showing that the isolated lipopeptide retains its activity against two common plant pathogens. RTI301 was cultured and the acid precipitate of the culture supernatant was analyzed by LCMS to compare the relative abundances of itallin, activin and amylin. Figure 11 is a graph showing the percentage of lipopeptide recovered from the RTI301 spent broth after acid precipitation. As a result, 80% of the total amount of lipopeptide was recovered by acid precipitation. Subsequently, for the Botrytis cinerea and Fusarium graminearum, disc bioassay was performed using the same sample analyzed by LCMS. The results showing that the acid precipitated sample had similar levels of resistance to the antagonism of Fusarium oxysporum and Fusarium graminearum to the starting waste mash.
在一個實施例中,提供一種包括以ATCC第PTA-121166號寄存之解澱粉芽孢桿菌RTI472或其具有其所有鑑別特徵之突變體的生物純培養物的組合物,該組合物用於施用於植物以達成有益於植物生長或對易感病植物賦予保護以避免病原性感染中的一或兩者。植物生長益處及/或所賦予之保護可藉由幼苗活力提高、根發育改善、植物生長改善、植物健康提高、產量增加、外觀改善、對植物病原體之抗性提高、病原性感染減少或其組合展現。 In one embodiment, there is provided a composition comprising a biologically pure culture of B. amyloliquefaci RTI472 or a mutant having all of its identifying characteristics deposited under ATCC PTA-121166, for use in application to a plant To achieve one or both of beneficial to plant growth or to confer protection to susceptible plants to avoid pathogenic infections. Plant growth benefits and/or protection afforded by increased seedling vigor, improved root development, improved plant growth, improved plant health, increased yield, improved appearance, increased resistance to plant pathogens, reduced pathogenic infection, or combinations thereof Show.
在一個實施例中,提供一種組合物,該組合物包括以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301或其具有其所有鑑別特徵之突變體的生物純培養物,用於施用於植物以達成有益於植物生長或對易感病植物賦予保護以避免病原性感染中的一或兩者。植物生長 益處及/或所賦予之保護可藉由幼苗活力提高、根發育改善、植物生長改善、植物健康提高、產量增加、外觀改善、對植物病原體之抗性提高或病原性感染減少或其組合展現。 In one embodiment, a composition is provided comprising a Bacillus amyloliquefaciens RTI301 deposited with ATCC No. PTA-121165 or a biologically pure culture thereof having mutants of all of its identifying characteristics for application to a plant To achieve one or both of beneficial to plant growth or to confer protection to susceptible plants to avoid pathogenic infections. plant growth Benefits and/or protection afforded may be manifested by increased seedling vigor, improved root development, improved plant growth, increased plant health, increased yield, improved appearance, increased resistance to plant pathogens, or reduced pathogenic infection or a combination thereof.
本發明之組合物及方法有益於各種植物,包括(但不限於)單子葉植物、雙子葉植物、穀物、玉米、甜玉米、爆玉米、玉米種、青貯玉米、飼料玉米、稻穀、小麥、大麥、高粱、蘆筍、漿果、藍莓、黑莓、樹莓、羅甘莓、越橘、蔓越橘、醋栗、接骨木、黑醋栗、蔓越莓、越莓、甘藍型蔬菜、椰菜、甘藍菜、花椰菜、芽甘藍、散葉甘蘭、羽衣甘藍、芥菜、球莖甘藍、瓜類蔬菜、黃瓜、哈密瓜、甜瓜、香甘瓜、番南瓜、西瓜、南瓜、茄子、鱗莖類蔬菜、洋蔥、大蒜、蔥、陳皮、橘子、葡萄柚、檸檬、紅橘、橘柚、柚、果蔬菜、胡椒、番茄、地面櫻桃、樹蕃茄、秋葵、葡萄、香草/香料、綠葉蔬菜、生菜、芹菜、菠菜、香芹、菊苣、豆科植物/蔬菜(多汁且乾燥之豆子及豌豆)、豆子、四季豆、食莢菜豆、殼豆、大豆、乾豆、回回豆、利馬豆、豌豆、鷹嘴豆、豌豆瓣、扁豆、油料種子作物、芥花、蓖麻、椰子、棉花、亞麻、油棕櫚、橄欖、花生、油菜籽、紅花、芝麻、向日葵、大豆、梨果、蘋果、海棠果、梨、木瓜、夏花山楂、根/塊莖及球莖蔬菜、胡蘿蔔、馬鈴薯、甘薯、木薯、甜菜、薑、辣根、蘿蔔、人參、蕪菁、核果、杏、櫻桃、油桃、桃子、李子、梅子、草莓、堅果、杏仁、開心果、山核桃、核桃、榛子、板栗、腰果、山毛櫸堅果、胡桃、夏威夷果、獼猴桃、香蕉、(藍)龍舌蘭、草、草皮草、觀賞植物、一品紅、繡球花、硬枝扡插、栗子、橡木、楓木、甘蔗及甜菜。 The compositions and methods of the present invention are beneficial to a variety of plants including, but not limited to, monocots, dicots, grains, corn, sweet corn, popcorn, corn, silage corn, feed corn, rice, wheat, barley , sorghum, asparagus, berries, blueberries, blackberries, raspberries, raspberries, cranberries, cranberries, gooseberries, elderberries, currants, cranberries, berry, cabbage, broccoli, kale Dish, broccoli, Brussels sprouts, broccoli, kale, mustard, broccoli, melon, cucumber, cantaloupe, melon, cantaloupe, squash, watermelon, pumpkin, eggplant, bulbous vegetables, onions, garlic, onions , tangerine peel, orange, grapefruit, lemon, red tangerine, tangerine, pomelo, fruit and vegetable, pepper, tomato, ground cherry, tree tomato, okra, grape, vanilla/spice, green leafy vegetables, lettuce, celery, spinach, fragrant Parsley, chicory, legumes/vegetables (succulent and dry beans and peas), beans, green beans, food pods, shell beans, soybeans, dried beans, peas, lima beans, peas, chickpeas, peas Petals, lentils, oilseed crops, canola, ramie, coconut, cotton, flax, oil palm, olive, peanut, rapeseed, safflower, sesame, sunflower, soybean, pear, apple, jellyfish, pear, papaya, Summer flower hawthorn, roots/tubers and bulbous vegetables, carrots, potatoes, sweet potatoes, cassava, beets, ginger, horseradish, radish, ginseng, turnip, stone fruit, apricot, cherry, nectarine, peach, plum, plum, strawberry, nut , almonds, pistachios, pecans, walnuts, hazelnuts, chestnuts, cashews, beech nuts, walnuts, macadamia nuts, kiwis, bananas, (blue) agave, grass, turfgrass, ornamental plants, poinsettia, hydrangea, hard Branches, chestnuts, oak, maple, sugar cane and beets.
在一或多個實施例中,植物可包括大豆、豆子、食莢菜豆、小麥、棉花、玉米、胡椒、番茄、馬鈴薯、木薯、葡萄、草莓、香蕉、花生、番南瓜、南瓜、茄子及黃瓜。 In one or more embodiments, the plant may include soybean, bean, pod bean, wheat, cotton, corn, pepper, tomato, potato, tapioca, grape, strawberry, banana, peanut, squash, pumpkin, eggplant, and cucumber. .
在本發明之組合物及方法中,病原性感染可由各種植物病原體引起,該等植物病原體包括例如(但不限於)植物真菌病原體、植物細菌病原體、鏽菌、葡萄孢屬、灰葡萄孢菌、蔥鱗葡萄孢菌(Botrytis squamosa)、歐文菌屬、胡蘿蔔軟腐歐文菌(Erwinia carotovora)、解澱粉歐文菌(Erwinia amylovora)、狄克氏菌屬(Dickeya spp.)、達旦狄克氏菌(Dickeya dadantii)、黑脛病菌(Dickeya solani)、土壤桿菌屬(Agrobacterium spp.)、根癌土壤桿菌(Agrobacterium tumefaciens)、黃單孢菌屬、地毯草黃單孢菌(Xanthomonas axonopodis)、油菜黃單孢菌胡蘿蔔致病變種(Xanthomonas campestris pv.carotae)、桃李黃單孢菌(Xanthomonas pruni)、核桃黃單孢菌(Xanthomonas arboricola)、水稻黃單孢菌水稻變種(Xanthomonas oryzae pv.oryzae)、焦枯菌屬(Xylella spp.)、葉緣焦枯菌(Xylella fastidiosa)、卡地菌屬(Candidatus spp.)、韌皮部桿菌(Candidatus liberibacter)、鐮刀菌屬、大刀鐮刀菌(Fusarium colmorum)、禾穀鐮刀菌、尖孢鐮刀菌、古巴尖抱鐮刀菌(Fusarium oxysporum f.sp.Cubense)、番茄尖孢鐮刀菌(Fusarium oxysporum f.sp.Lycopersici)、棒形鐮刀菌(Fusarium virguliforme)、核盤菌屬(Sclerotinia spp.)、向日葵核盤菌(Sclerotinia sclerotiorum)、小核盤菌(Sclerotinia minor)、同果核盤菌(Sclerotinia homeocarpa)、尾孢菌屬(Cercospora/Cercosporidium spp.)、鉤絲殼屬(Uncinula spp.)、葡萄白粉病菌(Uncinula necator)(白粉病(Powdery Mildew))、叉絲單囊殼屬(Podosphaera spp.)(白粉病)、白叉絲單囊殼(Podosphaera leucotricha)、克蘭德叉絲單囊殼(Poaosphaera clandestine)、擬莖點菌屬(Phomopsis spp.)、葡萄擬莖點黴病菌(Phomopsis viticola)、交鏈孢菌屬(Alternaria spp.)、細極鏈格孢菌(Alternaria tenuissima)、蔥鏈格孢菌(Alternaria porri)、交鏈格孢菌(Alternaria alternate)、立枯交鏈孢菌、鏈格孢菌(Alternaria tenuis)、假單胞菌屬、丁香假單胞菌番茄 變種(Pseudomonas syringae pv.Tomato)、疫黴菌屬(Phytophthora spp.)、致病疫黴菌(Phytophthora infestans)、寄生疫黴菌(Phytophthora parasitica)、大豆疫黴菌(Phytophthora sojae)、辣椒疫黴菌(Phytophthora capsici)、樟疫黴菌(Phytophthora cinnamon)、草莓疫黴菌(Phytophthora fragariae)、疫黴菌屬、櫟樹猝死病菌(Phytophthora ramorum)、棕櫚疫黴菌(Phytophthora palmivara)、菸草疫黴菌(Phytophthora nicotianae)、層鏽菌屬、豆薯層鏽菌、層鏽層假尾孢菌(Phakopsora meibomiae)、曲黴菌屬(Aspergillus spp.)、黃麴黴(Aspergillus flavus)、黑麯黴(Aspergillus niger)、單孢鏽菌屬(Uromyces spp.)、菜豆銹病菌、枝孢菌屬(Cladosporium spp.)、多主枝孢黴(Cladosporium herbarum)、根黴菌屬(Rhizopus spp.)、少根根黴菌(Rhizopus arrhizus)、青黴菌屬(Penicillium spp.)、絲核菌屬、立枯絲核菌(Rhizoctonia solani)、玉蜀黍絲核菌(Rhizoctonia zeae)、稻枯斑絲核菌(Rhizoctonia oryzae)、褐色絲核菌(Rhizoctonia caritae)、禾穀絲核菌(Rhizoctonia cerealis)、紫紋羽絲核菌(Rhizoctonia crocorum)、草莓絲核菌(Rhizoctonia fragariae)、枝生絲核菌(Rhizoctonia ramicola)、覆盆子絲核菌(Rhizoctonia rubi)、豆狀絲核菌(Rhizoctonia leguminicola)、菜豆殼球孢菌(Macrophomina phaseolina)、稻瘟菌(Magnaorthe oryzae)、球腔菌屬、禾生球腔菌(Mycosphaerella graminocola)、斐濟球腔菌(Mycosphaerella fijiensis)(黑色香蕉葉斑病(Black sigatoga))、蘋果斑點球腔菌(Mycosphaerella pomi)、檸檬球腔菌(Mycosphaerella citri)、稻瘟菌屬、稻瘟病菌(Magnaporthe grisea)、鏈核盤菌屬(Monilinia spp.)、桃褐腐病菌(Monilinia fruticola)、藍莓僵果病病原菌(Monilinia vacciniicorymbosi)、核果鏈核盤菌(Monilinia laxa)、炭疽菌屬(Colletotrichum spp.)、膠孢炭疽菌(Colletotrichum gloeosporiodes)、辣椒炭疽菌(Colletotrichum acutatum)、石斛炭疽菌(Colletotrichum Candidum)、間座殼屬(Diaporthe spp.)、柑桔間座殼菌(Diaporthe citri)、棒孢菌屬(Corynespora spp.)、多主棒孢菌(Corynespora Cassiicola)、膠鏽菌屬(Gymnosporangium spp.)、植物受檜膠鏽菌(Gymnosporangium juniperi-virginianae)、裂盾菌屬(Schizothyrium spp.)、仁果裂盾菌(Schizothyrium pomi)、黏殼孢菌屬(Gloeodes spp.)、梨果黏殼孢菌(Gloeodes pomigena)、葡萄座腔菌屬(Botryosphaeria spp.)、葡萄潰瘍病病菌(Botryosphaeria dothidea)、明孢盤菌屬(Neofabraea spp.)、威爾遜孢殼菌屬(Wilsonomyces spp.)、嗜果威爾遜孢殼菌(Wilsonomyces carpophilus)、單囊殼菌屬(Sphaerotheca spp.)、斑點單囊殼菌(Sphaerotheca macularis)、薔薇單囊殼菌(Sphaerotheca pannosa)、白粉菌屬(Erysiphe spp.)、殼多孢菌屬(Stagonospora spp.)、穎枯殼針孢(Stagonospora nodorum)、腐黴屬(Pythium spp.)、終極腐黴菌(Pythium ultimum)、瓜果腐黴菌(Pythium aphanidermatum)、畸雌腐黴菌(Pythium irregularum)、簇囊腐黴菌(Pythium ulosum)、水生腐黴菌(Pythium lutriarium)、森林腐黴菌(Pythium sylvatium)、黑星菌屬(Venturia spp)、蘋果黑星病菌(Venturia inaequalis)、輪枝孢菌屬(Verticillium spp.)、黑粉菌屬(Ustilago spp.)、裸黑粉菌(Ustilago nuda)、玉蜀黍黑粉菌(Ustilago maydis)、甘蔗鞭黑粉菌(Ustilago scitaminea)、麥角菌屬(Claviceps spp.)、麥角菌(Claviceps puprrea)、腥黑粉菌屬(Tilletia spp.)、小麥腥黑粉菌(Tilletia tritici)、光滑腥黑粉菌(Tilletia laevis)、稻粒黑粉菌(Tilletia horrid)、小麥矮腥黑粉菌(Tilletia controversa)、莖點黴屬(Phoma spp.)、大豆生莖點黴(Phoma glycinicola)、多變莖點黴(Phoma exigua)、甘藍莖點黴(Phoma lingam)、禾旋孢腔菌(Cocliobolus sativus)、禾頂囊殼(Gaeumanomyces gaminis)、炭疽菌屬(Colleototricum spp.)、雲紋病菌屬(Rhychosporium spp.)、大麥雲紋病菌(Rhychosporium secalis)、離蠕孢屬(Biopolaris spp.)、長蠕孢屬(Helminthosporium spp.)、大麥長蠕孢(Helminthosporium secalis)、玉蜀黍長蠕孢(Helminthosporium maydis)、索萊長蠕孢(Helminthosporium solai)及小麥褐斑長蠕孢(Helminthosporium tritici-repentis)或其組合。 In the compositions and methods of the present invention, pathogenic infections can be caused by a variety of plant pathogens including, for example, but not limited to, plant fungal pathogens, plant bacterial pathogens, rust, Botrytis, Botrytis cinerea, Botrytis squamosa , Erwinia, Erwinia carotovora , Erwinia amylovora , Dickeya spp ., Dickeya Dadantii ), Dickeya solani , Agrobacterium spp ., Agrobacterium tumefaciens , Xanthomonas, Xanthomonas axonopodis , Xanthomonas campestris Xanthomonas campestris pv. carotae , Xanthomonas pruni , Xanthomonas arboricola , Xanthomonas oryzae pv. oryzae , Saccharomyces cerevisiae Genus ( Xylella spp .), Xylella fastidiosa , Candidatus spp., phloem ( Can Didatus liberibacter ), Fusarium colmorum , Fusarium oxysporum , Fusarium oxysporum , Fusarium oxysporum f.sp. Cubense , Fusarium oxysporum f .sp.Lycopersici ), Fusarium virguliforme , Sclerotinia spp ., Sclerotinia sclerotiorum , Sclerotinia minor , Sclerotinia Homeocarpa ), Cercospora/Cercosporidium spp., Uncinula spp., Uncinula necator (Powdery Mildew), Podosphaera spp () Powdery mildew), Podosphaera leucotricha , Poaosphaera clandestine , Phomopsis spp., Phomopsis Viticola ), Alternaria spp ., Alternaria tenuissima , Alternaria porri , Alternaria alternate , Alzheimer's Alternaria tenuis , Pseudomonas, Pseudomonas syringae pv. Tomato , Phytophthora spp., Phytophthora infestans ), Phytophthora parasitica , Phytophthora sojae , Phytophthora capsici , Phytophthora cinnamon , Phytophthora fragariae , Phytophthora, eucalyptus ( Phytophthora ramorum ), Phytophthora palmivara , Phytophthora nicotianae , Puccinia, Phakopsora pylori, Phakopsora meibomiae , Aspergillus spp .), Aspergillus flavus , Aspergillus niger , Uromyces spp ., Bean rust, Cladosporium spp ., Cladosporium Herbarum ), Rhizopus spp., Rhizopus arrhizus , Penicillium spp., Rhizoctonia Genus, Rhizoctonia solani , Rhizoctonia zeae, Rhizoctonia oryzae , Rhizoctonia caritae , Rhizoctonia cerealis Rhizoctonia crocorum , Rhizoctonia fragariae , Rhizoctonia ramicola , Rhizoctonia rubi , Rhizoctonia leguminicola , Rhizoctonia leguminicola , Rhizoctonia leguminicola Macrophomina phaseolina , Magnaorthe oryzae , Cochlear , Mycosphaerella graminocola , Mycosphaerella fijiensis (Black sigatoga) ), Mycosphaerella pomi , Mycosphaerella citri , Magnaporthe oryzae, Magnaporthe grisea , Monilinia spp., Peach brown rot Monilinia fruticola ), Monilinia vacciniicorymbosi , Monilinia laxa , Anthracnose ( Colletotrichum) Spp.), Colletotrichum gloeosporiodes , Colletotrichum acutatum , Colletotrichum Candidum , Diaporthe spp., Diaporthe citri , oxysporum genus rod (Corynespora spp.), multi-master rod cinerea (Corynespora Cassiicola), the genus gum rust (Gymnosporangium spp.), gum juniper plants by rust (Gymnosporangium juniperi-virginianae), Scarshield genus (Schizothyrium spp .), Schizothyrium pomi , Gloeodes spp., Gloeodes pomigena , Botryosphaeria spp., grape canker ( Botryosphaeria dothidea ), Neofabraea spp., Wilsonomyces spp., Wilsonomyces carpophilus , Sphaerotheca spp., spots Sphaerotheca macularis , Sphaerotheca pannosa , Erysiphe spp., Stagonospora spp ., S. serrata ( S) Tagonospora nodorum ), Pythium spp ., Pythium ultimum , Pythium aphanidermatum , Pythium irregularum , Pythium ulosum , aquatic rot Pythium lutriarium , Pythium sylvatium , Venturia spp , Venturia inaequalis , Verticillium spp., Ustilago spp .), Ustilago nuda , Ustilago maydis , Ustilago scitaminea , Claviceps spp ., Claviceps puprrea , alfalfa Tilletia spp ., Tilletia tritici , Tilletia laevis , Tilletia horrid , Tilletia controversa , Phoma spp ., Phoma glycinicola , Phoma exigua , Phoma lingam , Cocliobolus sativus , Wo Gaeumanomyces gaminis , Colleototricum spp., Rhychosporium spp ., Rhychosporium secalis , Biopolaris spp ., Helminthosporium ( Helminthosporium spp .), Helminthosporium secalis , Helminthosporium maydis , Helminthosporium solai , and Helminthosporium tritici-repentis or combinations thereof.
在一些實施例中,病原性感染可由以下一者或組合引起:大豆鏽菌(豆薯層鏽菌、層鏽層假尾孢菌)且植物包含大豆;灰葡萄孢菌(葡萄孢疫病)且植物包含葡萄;灰葡萄孢菌(葡萄孢疫病)且植物包含草莓;灰葡萄孢菌(葡萄孢疫病)且該植物包含番茄;交鏈孢菌屬(例如立枯交鏈孢菌)且植物包含番茄;交鏈孢菌屬(例如立枯交鏈孢菌)且植物包含馬鈴薯;豆銹病(菜豆銹病菌)且植物包含常見豆子;白粉病菌(大豆白粉病)且植物包含大豆;斐濟球腔菌(黑色香蕉葉斑病)或古巴尖孢鐮刀菌(巴拿馬疾病)且植物包含香蕉;黃單孢菌屬或水稻黃單孢菌水稻變種且植物包含稻穀;地毯草黃單孢菌且植物包含木薯;野油菜黃單孢菌且植物包含番茄;灰葡萄孢菌(胡椒葡萄孢疫病)且植物包含胡椒;白粉病且植物包含葫蘆;向日葵核盤菌(白黴)且植物包含食莢菜豆;向日葵核盤菌(白黴)且植物包含馬鈴薯;同果核盤菌(幣斑病)且植物包含草皮草;南方白黴且植物包含花生;葉斑病(尾孢菌/尾孢菌)且植物包含花生;禾穀鐮刀菌(小麥赤黴病)且植物包含小麥;禾生球腔菌(小麥殼針孢斑)且植物包含小麥;穎枯殼針孢(穎枯病及殼針孢葉枯病)且植物包含小麥;解澱粉歐文菌且植物包含蘋果、梨及其他梨果果實;蘋果黑星病菌且植物包含蘋果、梨及其他梨果果實;或立枯絲核菌且植物包含小麥、稻穀、草皮草、大豆、玉米、豆科植物及蔬菜作物。 In some embodiments, the pathogenic infection can be caused by one or a combination of: soybean rust (Phaeophyllum serrata, Pseudomonas aeruginosa) and the plant comprises soybean; Botrytis cinerea (B. blight) and The plant comprises grapes; Botrytis cinerea (B. blight) and the plant comprises strawberries; Botrytis cinerea (B. blight) and the plant comprises tomato; Alternaria (such as Alternaria solani) and the plant comprises Tomato; Alternaria (such as Alternaria alternata) and the plant contains potato; bean rust (leaf bean rust) and the plant contains common beans; powdery mildew (soybean powdery mildew) and the plant contains soybean; (black banana leaf spot) or Fusarium oxysporum (Panama disease) and the plant contains bananas; Xanthomonas or Xanthomonas oryzae rice varieties and plants contain rice; Trichophyton rubrum and plants contain cassava Xanthomonas campestris and plant containing tomato; Botrytis cinerea (P. cinerea) and plant containing pepper; powdery mildew and plant containing gourd; S. cerevisiae (white mold) and plant containing pod bean; sunflower Sclerotinia White mold) and the plant contains potato; Sclerotinia sclerotiorum (coin spot disease) and the plant contains turfgrass; southern white mold and plants contain peanuts; leaf spot disease (C. cerevisiae / Cercospora) and plants contain peanuts; Fusarium oxysporum (French scab) and plants containing wheat; Phytophthora sinensis (S. cerevisiae) and plants containing wheat; Phytophthora capsici (Bacterial blight and Phytophthora capsici) and plants Wheat; starch-degrading Owen bacteria and plants containing apples, pears and other pear fruit; apple black scab and plants containing apples, pears and other pear fruit; or Rhizoctonia solani and plants containing wheat, rice, turf, Soybeans, corn, legumes and vegetable crops.
包括RTI301菌株之組合物可呈液體、油性分散液、粉劑、乾燥可潤濕粉末、可撒佈顆粒或乾燥可潤濕顆粒之形式。 Compositions comprising the RTI 301 strain may be in the form of a liquid, an oily dispersion, a powder, a dry wettable powder, a spreadable granule or a dry wettable granule.
當組合物施用於植物葉、植物莖皮、植物果實、植物花、植物種子、植物根部、植物剪枝、植物移植物、植物癒合組織;植物周圍土壤或生長介質;在土壤或生長介質中播種植物種子之前的土壤或生長介質;或在土壤或生長介質中種植植物、植物剪枝、植物移植物或植物癒合組織之前的土壤或生長介質時,當以適合於有益於植物生長及/或對易感病植物賦予保護以避免病原性感染之量施用時,該組合物有益於植物生長。 When the composition is applied to plant leaves, plant bark, plant fruits, plant flowers, plant seeds, plant roots, plant pruning, plant transplants, plant healing tissues; soil or growth medium surrounding the plant; seeding in soil or growth medium Soil or growth medium before plant seeds; or soil or growth medium prior to planting plants, plant pruning, plant transplants, or plant healing tissues in soil or growth medium, when suitable for plant growth and/or The composition is beneficial for plant growth when the susceptible plant is administered in an amount that provides protection against pathogenic infection.
包括RTI301菌株之組合物可進一步包括載劑、界面活性劑、分散劑或酵母提取物之一或組合。出於本說明書及申請專利範圍之目的,術語「界面活性劑」及「佐劑」可互換使用。酵母提取物可以在約0.01%至0.2% w/w範圍內的有益於植物生長之施用率輸送。 The composition comprising the RTI 301 strain may further comprise one or a combination of a carrier, a surfactant, a dispersant or a yeast extract. For the purposes of this specification and the scope of the patent application, the terms "interacting agent" and "adjuvant" are used interchangeably. The yeast extract can be delivered at a rate suitable for plant growth in the range of about 0.01% to 0.2% w/w.
組合物可呈種植基質形式。種植基質可呈盆栽土形式。 The composition can be in the form of a planting matrix. The planting substrate can be in the form of potting soil.
在一個實施例中,提供用於達成有益於植物生長或對易感病植物賦予保護以避免病原性感染中之一或兩者的組合物,該組合物包括:以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301或其具有其所有鑑別特徵之突變體的生物純培養物,呈適合於有益於植物生長及/或對易感病植物賦予保護以避免病原性感染之量;以及微生物、生物或化學殺蟲劑、殺真菌劑、殺線蟲劑、殺菌劑、除草劑、植物提取物、植物生長調節劑或肥料之一或組合,呈適合於有益於植物生長及/或對易感病植物賦予保護以避免病原性感染之量。在此實施例中,解澱粉芽孢桿菌RTI301之生物純培養物及微生物或化學殺蟲劑、殺真菌劑、殺線蟲劑、殺菌劑、除草劑、植物提取物、植物生長調節劑或肥料之一或組合調配在一起。 In one embodiment, a composition for achieving one or both of beneficial to plant growth or protection of a susceptible plant from pathogenic infection is provided, the composition comprising: being deposited under ATCC PTA-121165 A biologically pure culture of Bacillus amyloliquefaciens RTI301 or a mutant having all of its identifying characteristics, in an amount suitable for beneficial to plant growth and/or to confer protection to susceptible plants to avoid pathogenic infection; One or a combination of biological or chemical insecticides, fungicides, nematicides, bactericides, herbicides, plant extracts, plant growth regulators or fertilizers, suitable for plant growth and/or susceptible diseases Plants provide protection from the amount of pathogenic infections. In this embodiment, the biologically pure culture of Bacillus amyloliquefaciens RTI301 and one of microbial or chemical insecticides, fungicides, nematicides, bactericides, herbicides, plant extracts, plant growth regulators or fertilizers Or a combination of blends.
在一個實施例中,殺真菌劑可包括來自白羽扇豆之提取物。在一個實施例中,殺真菌劑可包括BLAD多肽。BLAD多肽可為來自甜羽扇豆(白羽扇豆)之天然存在之種子儲存蛋白的片段,其藉由對真菌 細胞壁造成損害且破壞內細胞膜而作用於易感真菌病原體。組合物可包括約20% BLAD多肽。 In one embodiment, the fungicide may comprise an extract from white lupin. In one embodiment, the fungicide may comprise a BLAD polypeptide. The BLAD polypeptide may be a fragment of a naturally occurring seed storage protein from sweet lupin (white lupin) by means of a fungus The cell wall causes damage and destroys the inner cell membrane and acts on susceptible fungal pathogens. The composition can include about 20% BLAD polypeptide.
在包括解澱粉芽孢桿菌RTI301之組合物中,組合物可呈液體形式且解澱粉芽孢桿菌RTI301可以約1.0×108CFU/ml至約1.0×1012CFU/ml之濃度存在。組合物可呈粉劑、乾燥可潤濕粉末、可撒佈顆粒或乾燥可潤濕顆粒之形式且解澱粉芽孢桿菌RTI301可以約1.0×108CFU/ml至約1.0×1012CFU/ml之量存在。組合物可呈油性分散液形式,且解澱粉芽孢桿菌RTI301可以約1.0×108CFU/ml至約1.0×1012CFU/ml之濃度存在。解澱粉芽孢桿菌RTI301可呈孢子或營養細胞形式。 In a composition comprising B. amyloliquesii RTI 301, the composition may be in liquid form and B. amyloliquefaciens RTI 301 may be present at a concentration of from about 1.0 x 10 8 CFU/ml to about 1.0 x 10 12 CFU/ml. The composition may be in the form of a powder, a dry wettable powder, a spreadable granule or a dry wettable granule and the B. amyloliquefaciens RTI 301 may be in an amount from about 1.0 x 10 8 CFU/ml to about 1.0 x 10 12 CFU/ml. presence. The composition may be in the form of an oily dispersion, and the B. amyloliquefaciens RTI301 may be present at a concentration of from about 1.0 x 10 8 CFU/ml to about 1.0 x 10 12 CFU/ml. Bacillus amyloliquefaciens RTI301 can be in the form of spores or vegetative cells.
在一個實施例中,提供一種用於達成有益於植物生長或對易感病植物賦予保護以避免病原性感染中之一或兩者的方法,該方法包括:將包含以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301或其具有其所有鑑別特徵之突變體的生物純培養物的組合物輸送至:植物葉、植物莖皮、植物果實、植物花、植物種子、植物根部、植物剪枝、植物移植物、植物癒合組織;植物周圍土壤或生長介質;在土壤或生長介質中播種植物種子之前的土壤或生長介質;或在土壤或生長介質中種植植物、植物剪枝、植物移植物或植物癒合組織之前的土壤或生長介質,該組合物之呈適合於有益於植物生長及/或對易感病植物賦予保護以避免病原性感染之量。組合物可輸送至植物葉。 In one embodiment, a method for achieving one or both of beneficial to plant growth or protection of a susceptible plant to avoid pathogenic infection is provided, the method comprising: comprising ATCC No. PTA-121165 A composition of a deposited biologically pure culture of Bacillus amyloliquefaciens RTI301 or a mutant having all of its identifying characteristics is delivered to: plant leaves, plant bark, plant fruits, plant flowers, plant seeds, plant roots, plant pruning , plant grafts, plant healing tissue; soil or growth medium surrounding the plant; soil or growth medium prior to seeding the plant seed in soil or growth medium; or planting plants, plant pruning, plant transplants or in soil or growth medium The soil or growth medium prior to the healing of the tissue, the composition being present in an amount suitable to benefit the growth of the plant and/or to confer protection to the susceptible plant to avoid pathogenic infection. The composition can be delivered to plant leaves.
在該方法中,包括解澱粉芽孢桿菌RTI301之組合物可進一步包括載劑、界面活性劑、分散劑或酵母提取物之一或組合。酵母提取物可以在約0.01%至0.2% w/w範圍內的有益於植物生長之施用率輸送。 In this method, the composition comprising B. amyloliquefaciens RTI 301 may further comprise one or a combination of a carrier, a surfactant, a dispersing agent or a yeast extract. The yeast extract can be delivered at a rate suitable for plant growth in the range of about 0.01% to 0.2% w/w.
在本發明之另一實施例中,提供一種用於達成有益於植物生長或對易感病植物賦予保護以避免病原性感染中之一或兩者的方法,該方法包括將一種組合物輸送至植物葉、植物莖皮、植物果實、植物 花、植物種子、植物根部、植物剪枝、植物移植物、植物癒合組織;植物周圍土壤或生長介質;在土壤或生長介質中播種植物種子之前的土壤或生長介質;或在土壤或生長介質中種植植物、植物剪枝、植物移植物或植物癒合組織之前的土壤或生長介質,該組合物包含以下各物:以ATCC第PTA-121165號寄存之解澱粉芽抱桿菌RTI301或其具有其所有鑑別特徵之突變體的生物純培養物,呈適合於有益於植物生長及/或對易感病植物賦予保護以避免病原性感染之量;以及微生物、生物或化學殺蟲劑、殺真菌劑、殺線蟲劑、殺菌劑、除草劑、植物提取物、植物生長調節劑或肥料之一或組合,呈適合於有益於植物生長及/或賦予保護以避免病原性感染之量。 In another embodiment of the invention, a method for achieving one or both of beneficial to plant growth or protection of a susceptible plant to avoid pathogenic infection is provided, the method comprising delivering a composition to Plant leaves, plant bark, plant fruits, plants Flowers, plant seeds, plant roots, plant pruning, plant grafts, plant healing tissues; soil or growth medium surrounding the plant; soil or growth medium prior to seeding the plant seeds in soil or growth medium; or in soil or growth medium A soil or growth medium prior to planting a plant, plant pruning, plant graft or plant healing tissue, the composition comprising the following: A. faecalis RTI301 deposited under ATCC PTA-121165 or having all of its identification a biologically pure culture of a mutant of a characteristic that is suitable for beneficial to plant growth and/or to confer protection to a susceptible plant to avoid pathogenic infection; and microbial, biological or chemical insecticides, fungicides, kills One or a combination of nematodes, bactericides, herbicides, plant extracts, plant growth regulators or fertilizers is in an amount suitable to be beneficial for plant growth and/or to confer protection against pathogenic infections.
在一個實施例中,提供一種用於達成有益於植物生長或對易感病植物賦予保護以避免病原性感染中之一或兩者的方法,該方法包括:將第一組合物與第二組合物之組合輸送至植物葉、植物莖皮、植物果實、植物花、植物種子、植物根部、植物剪枝、植物移植物、植物癒合組織;植物周圍土壤或生長介質;在土壤或生長介質中播種植物種子之前的土壤或生長介質;或在土壤或生長介質中種植植物、植物剪枝、植物移植物或植物癒合組織之前的土壤或生長介質,該第一組合物包含以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301或其具有其所有鑑別特徵之突變體的生物純培養物,呈適合於有益於植物生長及/或對易感病植物賦予保護以避免病原性感染之量;且該第二組合物包含微生物、生物或化學殺蟲劑、殺真菌劑、殺線蟲劑、殺菌劑、除草劑、植物提取物、植物生長調節劑或肥料之一或組合,呈適合於有益於植物生長及/或對易感病植物賦予保護以避免病原性感染之量。在一個實施例中,第一及第二組合物可輸送至植物葉。 In one embodiment, a method for achieving one or both of beneficial to plant growth or protection of a susceptible plant to avoid pathogenic infection is provided, the method comprising: combining the first composition with the second The combination of substances is delivered to plant leaves, plant stems, plant fruits, plant flowers, plant seeds, plant roots, plant pruning, plant transplants, plant healing tissues; soil or growth medium around the plant; seeded in soil or growth medium Soil or growth medium prior to plant seeds; or soil or growth medium prior to planting plants, plant pruning, plant transplants or plant healing tissues in soil or growth medium, the first composition comprising ATCC PTA-121165 A biologically pure culture of the deposited Bacillus amyloliquefaciens RTI301 or a mutant thereof having all of its identifying characteristics, in an amount suitable for beneficial to plant growth and/or protection of susceptible plants to avoid pathogenic infection; The second composition comprises a microbial, biological or chemical insecticide, fungicide, nematicide, bactericide, herbicide, plant extract Plant growth regulators or fertilizers or one combination, was adapted to benefit plant growth and / or to impart protection to the susceptible plants in order to avoid an amount of pathogenic infections. In one embodiment, the first and second compositions can be delivered to the foliage of the plant.
第一組合物可進一步包括載劑、界面活性劑、分散劑或酵母提取物之一或組合。酵母提取物可以在約0.01%至0.2% w/w範圍內的有 益於植物生長之施用率輸送。 The first composition may further comprise one or a combination of a carrier, a surfactant, a dispersant, or a yeast extract. Yeast extract can be in the range of about 0.01% to 0.2% w/w Conducive to the application rate of plant growth.
第二組合物之殺真菌劑可包括來自白羽扇豆之提取物。第二組合物之殺真菌劑可包括BLAD多肽。BLAD多肽可為來自甜羽扇豆(白羽扇豆)之天然存在之種子儲存蛋白的片段,其藉由對真菌細胞壁造成損害且破壞內細胞膜而作用於易感真菌病原體。第二組合物之殺真菌劑可包括約20% BLAD多肽。 The fungicide of the second composition may comprise an extract from white lupin. The fungicide of the second composition can include a BLAD polypeptide. The BLAD polypeptide may be a fragment of a naturally occurring seed storage protein from sweet lupin (white lupin) that acts on a susceptible fungal pathogen by causing damage to the fungal cell wall and disrupting the inner cell membrane. The fungicide of the second composition can include about 20% BLAD polypeptide.
在用於輸送RTI301與微生物、生物或化學殺蟲劑、殺真菌劑、殺線蟲劑、殺菌劑、除草劑、植物提取物、植物生長調節劑或肥料組合的本發明之組合物及方法中,植物生長益處及/或所賦予之保護可藉由幼苗活力提高、根發育改善、植物生長改善、植物健康提高、產量增加、外觀改善、對植物病原體之抗性提高、病原性感染減少或其組合展現。 In the compositions and methods of the present invention for delivering RTI 301 in combination with a microbial, biological or chemical insecticide, fungicide, nematicide, bactericide, herbicide, plant extract, plant growth regulator or fertilizer, Plant growth benefits and/or protection afforded by increased seedling vigor, improved root development, improved plant growth, improved plant health, increased yield, improved appearance, increased resistance to plant pathogens, reduced pathogenic infection, or combinations thereof Show.
在一個實施例中,該方法可進一步包括向以下各者施用液體肥料:植物周圍土壤或生長介質;在土壤或生長介質中播種植物種子之前的土壤或生長介質;或在土壤或生長介質中種植植物、植物剪枝、植物移植物或植物癒合組織之前的土壤或生長介質。 In one embodiment, the method may further comprise applying a liquid fertilizer to: soil or growth medium surrounding the plant; soil or growth medium prior to seeding the plant seed in the soil or growth medium; or planting in soil or growth medium Soil or growth medium prior to plant, plant pruning, plant graft or plant healing tissue.
在用於輸送RTI301與微生物、生物或化學殺蟲劑、殺真菌劑、殺線蟲劑、殺菌劑、除草劑、植物提取物、植物生長調節劑或肥料組合之方法中,組合物可呈液體、油性分散液、粉劑、乾燥可潤濕粉末、可撒佈顆粒或乾燥可潤濕顆粒形式。解澱粉芽孢桿菌RTI301可呈孢子或營養細胞形式。解澱粉芽孢桿菌RTI301可以約1.0×1010CFU/ha至約1.0×1014CFU/ha之有益於植物生長之施用率輸送。酵母提取物可以在約0.01%至0.2% w/w範圍內的有益於植物生長之施用率輸送。 In a method for transporting RTI 301 in combination with a microbial, biological or chemical insecticide, fungicide, nematicide, bactericide, herbicide, plant extract, plant growth regulator or fertilizer, the composition may be in the form of a liquid, Oily dispersions, powders, dry wettable powders, spreadable granules or dry wettable granules. Bacillus amyloliquefaciens RTI301 can be in the form of spores or vegetative cells. Bacillus amyloliquefaciens RTI301 be about 1.0 × 10 10 CFU / ha to about 1.0 × 10 14 CFU / benefit ha application rate of delivery of plant growth. The yeast extract can be delivered at a rate suitable for plant growth in the range of about 0.01% to 0.2% w/w.
在輸送RTI301與微生物、生物或化學殺蟲劑、殺真菌劑、殺線蟲劑、殺菌劑、除草劑、植物提取物、植物生長調節劑或肥料之本發明之組合物及方法中,殺蟲劑可包含畢芬寧。在一或多個實施例中, 殺線蟲劑可包含硫線磷(cadusafos)。在一或多個實施例中,殺蟲劑可包含畢芬寧及可尼丁(clothianidin)。在一或多個實施例中,殺蟲劑可包含畢芬寧且組合物可調配為液體。在一或多個實施例中,殺蟲劑可包含畢芬寧及可尼丁。在一或多個實施例中,殺蟲劑可包含畢芬寧及可尼丁且組合物可調配為液體。在一或多個實施例中,殺蟲劑可包含畢芬寧或ξ-賽滅寧。在一或多個實施例中,組合物可調配為液體且殺蟲劑可包含畢芬寧或ξ-賽滅寧。 In the compositions and methods of the present invention for delivering RTI 301 with microbial, biological or chemical insecticides, fungicides, nematicides, bactericides, herbicides, plant extracts, plant growth regulators or fertilizers, insecticides It can contain Bifenin. In one or more embodiments, The nematicide may comprise cadusafos. In one or more embodiments, the pesticide may comprise bifenin and clothianidin. In one or more embodiments, the pesticide can comprise diphennin and the composition can be formulated as a liquid. In one or more embodiments, the pesticide can comprise diphennin and cotinine. In one or more embodiments, the pesticide can comprise diphennin and cotinine and the composition can be formulated as a liquid. In one or more embodiments, the pesticide may comprise diphennin or acetonin. In one or more embodiments, the composition can be formulated as a liquid and the pesticide can comprise diphennin or acetonin.
殺蟲劑可為畢芬寧,且組合物調配物可進一步包含水合鋁-鎂矽酸鹽及選自由以下組成之群的至少一種分散劑:蔗糖酯、木質素磺酸鹽、烷基多醣苷、萘磺酸甲醛縮合物及磷酸酯。畢芬寧殺蟲劑可以範圍為0.1g/ml至0.2g/ml之濃度存在。畢芬寧殺蟲劑可以約0.1715g/ml之濃度存在。畢芬寧殺蟲劑之施用率可在每公頃約0.1公克畢芬寧(g ai/ha)至約1000g ai/ha範圍內,更佳在約1g ai/ha至約100g ai/ha範圍內。 The insecticide may be bifenin, and the composition formulation may further comprise hydrated aluminum-magnesium citrate and at least one dispersant selected from the group consisting of sucrose esters, lignosulfonates, alkyl polyglycosides, naphthalenes. Sulfonic acid formaldehyde condensate and phosphate ester. Bifenin insecticides can be present in concentrations ranging from 0.1 g/ml to 0.2 g/ml. The bifenin insecticide can be present at a concentration of about 0.1715 g/ml. The application rate of the Bifenin insecticide may range from about 0.1 gram per gram of bifenine (g ai/ha) to about 1000 g ai/ha, more preferably from about 1 g ai/ha to about 100 g ai/ha.
在一實施例中,畢芬寧組合物可包含:畢芬寧;水合鋁-鎂矽酸鹽;以及至少一種選自以下之分散劑:蔗糖酯、木質素磺酸鹽、烷基多醣苷、萘磺酸甲醛縮合物及磷酸酯。 In one embodiment, the Phenfenin composition may comprise: phenfenamicin; hydrated aluminum-magnesium citrate; and at least one dispersant selected from the group consisting of sucrose esters, lignosulfonates, alkyl polyglycosides, naphthalenesulfonic acid formaldehyde Condensate and phosphate.
畢芬寧可較佳以按組合物中所有組分之總重量計1.0重量%至35重量%,更尤其15重量%至25重量%之濃度存在。畢芬寧殺蟲劑組合物可以適合於與肥料混合為液體之方式調配。畢芬寧殺蟲劑組合物可以在0.1g/ml至0.2g/ml範圍內之濃度存在於液體調配物。畢芬寧殺蟲劑可以約0.1715g/ml之濃度存在於液體調配物。術語「可以適合於與肥料混合為液體之方式調配」及「呈與液體肥料相容之調配物」在本文中整個說明書中及申請專利範圍中可互換使用且意欲意謂調配物能夠溶解或分散或乳化於水溶液中以允許與肥料混合用於在液體調配物中輸送至植物。 Bifenin may preferably be present at a concentration of from 1.0% to 35% by weight, more particularly from 15% to 25% by weight, based on the total weight of all components in the composition. The Bifenin insecticide composition can be formulated to be mixed with a fertilizer to form a liquid. The Phenfenin insecticidal composition can be present in the liquid formulation at a concentration ranging from 0.1 g/ml to 0.2 g/ml. The bifenin insecticide can be present in the liquid formulation at a concentration of about 0.1715 g/ml. The terms "may be suitable for mixing with fertilizers as a liquid" and "formulations compatible with liquid fertilizers" are used interchangeably throughout the specification and patent application and are intended to mean that the formulation is capable of dissolving or dispersing. Emulsified in an aqueous solution to allow mixing with the fertilizer for delivery to the plant in a liquid formulation.
分散劑可較佳以按組合物中所有組分之總重量計約0.02重量%至約20重量%之總濃度存在。 The dispersing agent may preferably be present in a total concentration of from about 0.02% by weight to about 20% by weight based on the total weight of all components of the composition.
在一些實施例中,水合鋁-鎂矽酸鹽可選自由蒙脫石及綠坡縷石組成之群。 In some embodiments, the hydrated aluminum-magnesium silicate may be selected from the group consisting of montmorillonite and attapulgite.
在一些實施例中,磷酸酯可選自壬基酚磷酸酯及十三烷醇乙氧基化磷酸酯鉀鹽。 In some embodiments, the phosphate ester can be selected from the group consisting of nonylphenol phosphate and tridecyl alcohol ethoxylated phosphate potassium salt.
其他實施例可進一步包括抗凍劑、消泡劑及殺生物劑中之至少一者。 Other embodiments may further include at least one of an antifreeze, an antifoaming agent, and a biocide.
在一個實施例中,提供一種有益於植物生長之組合物,該組合物包含:以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301或其具有所有其鑑別特徵之突變體的生物純培養物;以及殺蟲劑。殺蟲劑可為擬除蟲菊酯(pyrethroid)、畢芬寧、七氟菊酯(tefluthrin)、ξ-賽滅寧、有機磷酸酯、氯氧磷(chlorethoxyfos)、陶斯松(chlorpyrifos)、丁基嘧啶磷(tebupirimfos)、賽扶寧(cyfluthrin)、非潑羅(fiproles)、費普尼(fipronil)、菸鹼類(nicotinoids)或可尼丁之一或組合。殺蟲劑可包括畢芬寧。組合物可呈與液體肥料相容之調配物。包括畢芬寧之組合物可進一步包括水合鋁-鎂矽酸鹽及至少一種分散劑。畢芬寧殺蟲劑可以在0.1g/ml至0.2g/ml範圍內之濃度存在。畢芬寧殺蟲劑可以約0.1715g/ml之濃度存在。 In one embodiment, a plant-promoting composition is provided, the composition comprising: Bacillus amyloliquefaciens RTI301 deposited with ATCC PTA-121165 or a biologically pure culture thereof having mutants of all of its identifying characteristics ; and pesticides. Insecticides may be pyrethroid, bifennin, tefluthrin, guanidine, organophosphate, chlorethoxyfos, chlorpyrifos, butyl pyrimidine One or a combination of (tebupirimfos), cyfluthrin, fiproles, fipronil, nicotinoids, or cotinine. The insecticide can include diphennin. The composition may be in a formulation compatible with liquid fertilizers. The composition comprising bifennin may further comprise hydrated aluminum-magnesium citrate and at least one dispersant. The bifenin insecticide can be present in a concentration ranging from 0.1 g/ml to 0.2 g/ml. The bifenin insecticide can be present at a concentration of about 0.1715 g/ml.
另外,在一或多個實施例中,本發明之組合物及方法之適合殺蟲劑、除草劑、殺真菌劑及殺線蟲劑可包括以下:殺蟲劑:A0)各種殺蟲劑,包括農用殺蟲劑(agrigata)、磷化鋁、鈍綏蟎、蚜小蜂、蚜繭蜂、食蚜蜂、青蒿素、苜蓿銀紋夜蛾NPV、三唑錫(azocyclotin)、枯草芽孢桿菌、蘇雲金芽孢桿菌屬亞莎華亞種(Bacillus thuringiensis-spp.aizawai)、蘇雲金芽孢桿菌屬庫斯塔克亞種(Bacillus thuringiensis spp.kurstaki)、蘇雲金芽孢桿菌、白僵菌 (Beauveria)、球孢白僵菌(Beauveria bassiana)、高效氟氯氰菊酯(betacyfluthrin)、生物製劑、殺蟲雙(bisultap)、溴氟菊酯(brofluthrinate)、溴硫磷-e(bromophos-e)、溴蟎酯(bromopropylate)、Bt-玉米-GM、Bt-大豆-GM、辣椒鹼(capsaicin)、培丹(cartap)、南蛇藤提取物、氯蟲苯甲醯胺(chlorantraniliprole)、滅幼脲(chlorbenzuron)、氯氧磷(chlorethoxyfos)、克福隆(chlorfluazuron)、陶斯松-e、蛇床子素、冰晶石、殺螟腈(cyanophos)、氰強尼普羅(cyantraniliprole)、賽洛寧(cyhalothrin)、錫蟎丹(cyhexatin)、賽滅寧、離額繭蜂、DCIP、二氯丙烯、三氯殺蟎醇(dicofol)、潛蠅、潛蠅+離額繭蜂、混滅威(dimethacarb)、二硫醚、乙酸十二烷基酯、因滅汀(emamectin)、麗蚜小蜂、EPN、漿角蚜小蜂、二溴化乙烯、桉油醇、脂肪酸、脂肪酸/鹽、芬殺蟎、仲丁威(BPMC)、芬普蟎、溴氟菊酯、氟蟎嗪、複滅蟎、安果、呋線威、γ-賽洛寧、大蒜汁、顆粒體病毒、異色瓢蟲、棉鈴蟲NPV、不活化細菌、吲哚-3-基丁酸、碘甲烷、鐵、水胺硫磷、異丙胺磷、異丙胺磷-m、異丙威、異拌磷、高嶺土、靈丹、瀏陽黴素、苦參鹼、地安磷、聚乙醛、綠僵菌、達馬松、速滅威(MTMC)、礦物油、滅蟻靈、間異硫氰酸鹽、殺蟲單、疣孢漆斑菌、二溴磷、芙新姬小蜂、菸鹼、菸鹼殺蟲劑、油、油酸、氧樂果、小花蝽、氧化苦參鹼、擬青黴菌、石蠟油、巴拉松-e(parathion-e)、巴氏桿菌、石油、信息素、磷酸、光桿狀菌、巴賽松(phoxim)、小植綏蟎、亞特松-e(pirimiphos-e)、植物油、小菜蛾GV、多角體病毒、多酚提取物、油酸鉀、布飛松(profenofos)、補骨內酯、普硫松(prothiofos)、吡唑硫磷、除蟲菊酯、噠嗪硫磷、嘧蟎醚、吡丙醚、皂樹提取物、滅蟎猛、油菜油、魚藤酮、皂素、皂劑(saponozit)、鈉化合物、氟矽酸鈉、澱粉、斯氏線蟲、鏈黴菌、氟蟲胺、硫、丁基嘧啶磷、七氟菊酯、雙硫磷、四氯殺蟎碸、久效威、甲基乙拌磷、轉基因 (例如Cry3Bb1)、唑蚜威、木黴菌、赤眼蜂、三福隆、輪枝菌、藜蘆鹼、異構殺蟲劑(例如κ-畢芬寧、κ-七氟菊酯)、介離子殺蟲劑、雙醯胺類殺蟲劑、吡嗪氟醯胺(pyraziflumid);A1)胺基甲酸酯類,包括得滅克(aldicarb)、棉靈威(alanycarb)、免扶克(benfuracarb)、加保利(carbaryl)、加保扶(carbofuran)、丁基加保扶(carbosulfan)、滅賜克(methiocarb)、納乃得(methomyl)、歐殺滅(oxamyl)、比加普(pirimicarb)、安丹(propoxur)及硫敵克(thiodicarb);A2)有機磷酸酯類,包括歐殺松(acephate)、穀速松-乙基(azinphos-ethyl)、穀速松-甲基(azinphos-methyl)、克芬松(chlorfenvinphos)、陶斯松(chlorpyrifos)、陶斯松-甲基(chlorpyrifos-methyl)、內吸磷-S-甲基(demeton-S-methyl)、大利松(diazinon)、二氯松(dichlorvos)/DDVP、雙特松(dicrotophos)、大滅松(dimethoate)、二硫松(disulfoton)、愛殺松(ethion)、撲滅松(fenitrothion)、芬殺松(fenthion)、加福松(isoxathion)、馬拉松(malathion)、達馬松(methamidaphos)、滅大松(methidathion)、美文松(mevinphos)、亞素靈(monocrotophos)、氧樂果(oxymethoate)、甲基滅多松(oxydemeton-methyl)、巴拉松(parathion)、甲基巴拉松(parathion-methyl)、賽達松(phenthoate)、福瑞松(phorate)、裕必松(phosalone)、益滅松(phosmet)、福賜米松(phosphamidon)、甲基亞特松(pirimiphos-methyl)、拜裕松(quinalphos)、託福松(terbufos)、樂本松(tetrachlorvinphos)、三落松(triazophos)及三氯松(trichlorfon);A3)環戊二烯有機氯化合物類,諸如安殺番(endosulfan);A4)非潑羅類,包括乙蟲清(ethiprole)、費普尼、氟蟲腈(pyrafluprole)及派瑞樂(pyriprole);A5)新菸鹼類似物類,包括啶蟲脒(acetamiprid)、可尼丁、呋蟲胺(dinotefuran)、吡蟲啉(imidacloprid)、烯啶蟲胺(nitenpyram)、噻蟲啉(thiacloprid)及噻蟲嗪(thiamethoxam);A6)賜諾殺類,諸如賜諾殺及斯平托蘭 (spinetoram);A7)來自汀類之氯離子通道活化劑,包括阿巴汀(abamectin)、苯甲酸因滅汀、伊維汀、林皮汀及密滅汀;A8)保幼激素模擬物,諸如烯蟲乙酯、烯蟲炔酯、美賜平(methoprene)、芬諾克(fenoxycarb)及百利普芬(pyriproxyfen);A9)選擇性同翅目餵養阻斷劑,諸如派滅淨(pymetrozine)、氟啶蟲醯胺(flonicamid)及哌氟喹腙(pyrifluquinazon);A10)蟎生長抑制劑,諸如克芬蟎、合賽多及依殺蟎;A11)粒線體ATP合成酶抑制劑,諸如汰芬諾克、芬布錫及毆蟎多;氧化磷酸化去偶合劑,諸如克凡派(chlorfenapyr);A12)菸鹼乙醯膽鹼受體通道阻斷劑,諸如殺蟲磺(bensultap)、鹽酸培丹、硫賜安(thiocyclam)及殺蟲雙鈉;A13)來自苯甲醯脲類之甲殼素生物合成類型0抑制劑,包括雙三氟蟲脲、二福隆、氟芬隆、六伏隆、祿芬隆、諾伐隆及得福隆;A14)甲殼素生物合成類型1抑制劑,諸如布芬淨;A15)蛻皮瓦解劑,諸如賽滅淨;A16)蛻皮素受體促效劑,諸如滅芬諾、得芬諾、合芬隆及環蟲醯肼;A17)章魚胺受體促效劑,諸如三亞蟎;A18)粒線體複合物電子輸送抑制劑比達本(pyridaben)、得芬瑞(tebufenpyrad)、脫芬瑞(tolfenpyrad)、氟芬內林、腈吡蟎酯、丁氟蟎酯、愛美松、亞醌蟎或嘧蟎酯;A19)電壓依賴性鈉通道阻斷劑,諸如因得克(indoxacarb)及氰氟蟲胺;A20)脂質合成抑制劑,諸如賜派芬、螺甲蟎酯及螺蟲乙酯;A21)來自二醯胺類之利阿諾定受體調節劑,包括氟蟲雙醯胺、鄰苯二甲醯胺化合物(R)-3-氯-N1-{2-甲基-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]苯基}-N2-(1-甲基-2-甲基磺醯基乙基)鄰苯二甲醯胺及(S)-3-氯-N1-{2-甲基-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]苯基}-N2-(1-甲基-2-甲基磺醯基乙基)鄰苯二甲醯胺、氯蟲醯胺(chloranthraniliprole)及氰強尼普羅;A22)未知或不確定作用模式之化合物,諸如印楝素、安米氟美(amidoflumet)、畢芬載(bifenazate)、氟噻蟲碸、協力精、啶蟲丙醚、氟啶蟲胺腈;或A23)來自擬除蟲菊酯類 之鈉通道調節劑,包括阿納寧、丙烯除蟲菊酯、畢芬寧、賽扶寧、λ-賽洛寧、賽滅寧、α-賽滅寧、β-賽滅寧、ξ-賽滅寧、第滅寧、益化利、依芬寧、芬普寧、芬化利、護賽寧、τ-福化利、百滅寧、矽護芬及泰滅寧。 Additionally, in one or more embodiments, suitable insecticides, herbicides, fungicides, and nematicides of the compositions and methods of the present invention can include the following: insecticides: A0) various insecticides, including Agricultural insecticide (agrigata), aluminum phosphide, blunt cockroach, cockroach bee, cockroach bee, eater bee, artemisinin, N. glabrata NPV, azocyclotin, Bacillus subtilis, Bacillus thuringiensis species Asha China and Asia (Bacillus thuringiensis-spp.aizawai), Bacillus thuringiensis库斯塔克亚species (Bacillus thuringiensis spp.kurstaki), Bacillus thuringiensis, Beauveria (BEAUVERIA), Beauveria Beauveria bassiana , betacyfluthrin, biologics, bisultap, brofluthrinate, bromophos-e, bromopropylate, Bt-corn-GM, Bt-soybean-GM, capsaicin, cartap, southern snake vine extract, chlorantraniliprole, chlorbenzuron, chlorophosphonate (chlorethoxyfos), chlorfluazuron, taosson-e Osthole, cryolite, cyanophos, cyantraniliprole, cyhalothrin, cyhexatin, cytosine, geranium, DCIP, dichloropropene , dicofol, scorpion, scorpion fly + scorpion bee, dimethacarb, disulfide, dodecyl acetate, emamectin, striata, EPN, pulp Hornbill bees, dibromoethylene, eucalyptol, fatty acids, fatty acids/salts, fentanyl, zhongdingwei (BPMC), fenfluramine, brommethrin, fluoxazine, chlorpyrifos, ango , furosemide, γ-cylonine, garlic juice, granulosis virus, heterochromatic ladybug, cotton bollworm NPV, inactivated bacteria, indole-3-butyric acid, methyl iodide, iron, hirudin, different Amphetamine, isopropylamine-m, isoprocarb, isophosphorus, kaolin, lingdan, liuyangmycin, matrine, diammine, polyacetal, Metarhizium, damascus, acesulfame MTMC), mineral oil, mirex, isothiocyanate, insecticide, Fusarium oxysporum, dibromophosphorus, Fuxinji wasp, nicotine, nicotine insecticide, oil, oleic acid Omethoate Small calyx, oxymatrine, Paecilomyces, paraffin oil, parathion-e, pasteurella, petroleum, pheromone, phosphoric acid, light bacillus, phoxim, small plant绥螨, ultimisol-e (pirimiphos-e), vegetable oil, Plutella xylostella GV, polyhedrosis virus, polyphenol extract, potassium oleate, profenofos, psorale, prothiofos , pyrazophos, pyrethrin, pyridaphenthione, pyrimidine, pyriproxyfen, soap tree extract, chlorpyrifos, canola oil, rotenone, saponin, saponozit, sodium compound, Sodium fluoroantimonate, starch, nematode, Streptomyces, sulfluramid, sulfur, butyl pyrimidine, tefluthrin, dithiphos, tetrachloromethane, chlorpyrifos, methyl ethion Transgenic (eg Cry3Bb1), zodiazepam, Trichoderma, Trichogramma, Sanfulong, Verticillium, Veratrine, Isomerized Insecticides (eg κ-biphennin, κ-hetamethrin), mesophore Insecticides, biguanide insecticides, pyrazilflumid; A1) urethanes, including aldicarb, alanycarb, benfurac Arb), carbaryl, carbofuran, carbosulfan, metiocarb, methodyl, oxamyl, bicap Pirimicarb), propoxur and thiodicarb; A2) organophosphates, including acephate, azinphos-ethyl, tamarind-methyl Azinphos-methyl), chlorfenvinphos, chlorpyrifos, chlorpyrifos-methyl, demeton-S-methyl, diazinon, two Dichlorvos/DDVP, dicrotophos, dimethoate, disulfoton, ethion, fenitrothion, fenthion, plus Isoxathion, malathion, methamidaphos, methidathion, mevinphos, monocrotophos, oxymethoate, oxydemeton- Methyl), parathion, parathion-methyl, phenthoate, phorate, phosalon e), phosmet, phosphamidon, pirimiphos-methyl, quinalphos, terfufos, tetrachlorvinphos, three falling Triazophos and trichlorfon; A3) cyclopentadiene organochlorine compounds, such as endosulfan; A4) non-poor, including ethiprole, fepni, Pyrafluprole and pyriprole; A5) neonicotinoid analogues, including acetamiprid, cotinine, dinotefuran, imidacloprid, acetamiprid Nitenpyram, thiacloprid and thiamethoxam; A6) spinosad, such as spinosad and spinetoram; A7) chloride channel activator from statins , including abaftin (abamectin), benzoic acid, statin, rividine, citidine and methiophene; A8) juvenile hormone mimics, such as methionine, enediyl ester, methine Methoprene), fenoxycarb and pyriproxyfen; A9) selective homopteran feeding blockers, such as pymetrozine, Flonicamid and pyrifluquinazon; A10) sputum growth inhibitors, such as ketopurine, dexamethasone and acetonide; A11) mitochondrial ATP synthase inhibitors, such as Nock, fenbuxil and hydrazine; oxidative phosphorylation decoupling agents, such as chlorfenapyr; A12) nicotinic acetylcholine receptor channel blockers, such as benzultap, hydrochloric acid Pedan, thiocyclam and insecticidal disodium; A13) Chitin biosynthesis type 0 inhibitors from benzamidine, including ditrifluorobacillus, diflubenzuron, fluorofenon, six volts Long, Lucendon, Norvaron and Defolon; A14) Chitin biosynthesis type 1 inhibitors, such as buffingin; A15) quercerin, such as racemic cleansing; A16) quercetin receptor agonist , such as fentanyl, defenofol, phenymidine and cyclazone; A17) octopamine receptor agonist, such as triterpenoids; A18) mitochondrial complex electron transport inhibitor darridaben , tebufenpyrad, tolfenpyrad, flufenine, nitrile pyridin, butaflurane, amemusone, azine or pyrimidin A19) voltage-dependent sodium channel blockers, such as indoxacarb and cyprofenil; A20) lipid synthesis inhibitors, such as chlorfenapyr, spironolactone, and spirotetramat; A21) from A linoredine receptor modulator of guanamines, including flubendiamide, phthalimin compound (R)-3-chloro-N1-{2-methyl-4-[1,2, 2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalic acid and (S) -3-chloro-N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}-N2-(1-methyl- 2-methylsulfonylethyl) phthalimide, chloranthraniliprole, and cyanarylpron; A22) Compounds of unknown or indeterminate mode of action, such as azadirachtin, amphetamine (amidoflumet), bifenazate, fluthiazide, synergistic sperm, acetamiprid, fluramide; or A23) sodium channel regulators from pyrethroids, including ananin, Pyrethroid, Bifenin, Saifu Ning, λ-Xelonine, Sai Ningning, α-赛灭宁, β-赛灭宁, ξ-赛灭宁, 灭宁宁, Yihuali, Yifen Ning, Fenpning, Fenhua Li, Husaining, τ-Fuhuali, Baishenning, Qifufen and Taininging.
殺真菌劑:B0)苯并烯氟菌唑、抗霜黴菌、辛唑嘧菌胺、吲唑磺菌胺、銅鹽(例如氫氧化銅、氯氧化銅、硫酸銅、過氧硫酸銅)、白可列(boscalid)、硫氟醯胺(thiflumazide)、氟替尼(flutianil)、呋霜靈(furalaxyl)、腐絕(thiabendazole)、麥鏽靈(benodanil)、滅普寧(mepronil)、艾索非他米(isofetamid)、甲呋醯胺(fenfuram)、必殺吩(bixafen)、氟唑菌醯胺(fluxapyroxad)、噴福芬(penflufen)、氟唑環菌胺(sedaxane)、丁香菌酯(coumoxystrobin)、烯肟菌酯(enoxastrobin)、氟菌蟎酯(flufenoxystrobin)、唑菌酯(pyraoxystrobin)、唑胺菌酯(pyrametostrobin)、三環吡菌威(triclopyricarb)、烯肟菌胺(fenaminstrobin)、苯氧菌胺(metominostrobin)、吡菌苯威(pyribencarb)、敵蟎普(meptyldinocap)、三苯醋錫(fentin acetate)、氯化三苯錫(fentin chloride)、氫氧化三苯錫(fentin hydroxide)、土黴素(oxytetracycline)、克氯得(chlozolinate)、地茂散(chloroneb)、四氯硝基苯(tecnazene)、依得利(etridiazole)、霜黴威(iodocarb)、硫菌威(prothiocarb)、枯草芽孢桿菌合成、解澱粉芽孢桿菌(例如菌株QST 713、FZB24、MBI600、D747)、來自互生葉白千層(Melaleuca alternifolia)之提取物、來自白羽扇豆(Lupinus albus doce)之提取物、BLAD多肽、啶菌噁唑(pyrisoxazole)、噁咪唑(oxpoconazole)、乙環唑(etaconazole)、胺苯吡菌酮(fenpyrazamine)、萘替芬(naftifine)、特比萘芬(terbinafine)、維利微素(validamycin)、丁吡嗎啉(pyrimorph)、威利芬那雷特(valifenalate)、熱必斯(fthalide)、撲殺熱(probenazole)、異噻菌胺(isotianil)、昆布糖(laminarin)、來自大虎杖之提取物、亞磷酸 及鹽、葉枯酞(teclofthalam)、咪唑嗪(triazoxide)、甲氧苯唳菌(pyriofenone)、有機油、碳酸氫鉀、四氯異苯腈、唑呋草(fluoroimide);B1)唑類,包括比多農、糠菌唑、環克座、待克利、達克利、恩康唑、依普座、氟喹唑、芬克座、護矽得、護汰芬、菲克利、亞胺唑、種菌唑、滅特座、邁克尼、平克座、普克利、丙硫菌唑、矽氟唑、三泰芬、三泰隆、得克利、四克利、滅菌唑、咪醯胺、披扶座、依滅列、賽福座、賽座滅、免賴得、貝芬替、腐絕、麥穗靈、噻唑菌胺、依得利及殺紋寧、氧環唑、達克利-M、噁咪唑、巴克素、烯效唑、1-(4-氯-苯基)-2-([1,2,4]三唑-1-基)-環庚醇及硫酸依滅列;B2)嗜毬果傘素,包括亞托敏、醚菌胺、烯肟菌酯、氟嘧菌酯、克收欣(kresoxim-methyl)、苯氧菌胺、肟醚菌胺、啶氧菌酯、百克敏、三氟敏、烯肟菌酯、(2-氯-5-[1-(3-甲基苄氧亞胺基)乙基]苄基)胺基甲酸甲酯、(2-氯-5-[1-(6-甲基吡啶-2-基甲氧亞胺基)乙基]苄基)胺基甲酸甲酯及2-(鄰-(2,5-二甲基苯氧亞甲基)-苯基)-3-甲氧基丙烯酸甲酯、2-(2-(6-(3-氯-2-甲基-苯氧基)-5-氟-嘧啶-4-基氧基)-苯基)-2-甲氧亞胺基-N-甲基-乙醯胺及3-甲氧基-2-(2-(N-(4-甲氧基-苯基)-環丙烷伸亞胺醯基硫基甲基)-苯基)-丙烯酸甲酯;B3)羧醯胺,包括萎鏽靈、本達樂(benalaxyl)、本達樂-M、環醯菌胺、福多寧(flutolanil)、福拉比(furametpyr)、滅普寧(mepronil)、滅達樂(metalaxyl)、右滅達樂(mefenoxam)、呋醯胺、歐殺斯(oxadixyl)、嘉保信(oxycarboxin)、吡噻菌胺、吡唑萘菌胺、賽氟滅(thifluzamide)、汰敵寧(tiadinil)、3,4-二氯-N-(2-氰基苯基)異噻唑-5-甲醯胺、達滅芬(dimethomorph)、氟嗎啉、氟醯菌胺、氟吡菌胺(吡考苯紮(picobenzamid))、座賽胺、加普胺、二氯西莫、雙炔醯菌胺、N-(2-(4-[3-(4-氯苯基)丙-2-炔氧基]-3-甲氧苯基)乙基)-2-甲磺醯基-胺基-3-甲基丁醯胺、N-(2-(4-[3-(4-氯-苯基)丙-2-炔氧基]-3-甲氧基-苯基)乙基)-2-乙磺醯胺基-3-甲基丁醯胺、3- (4-氯苯基)-3-(2-異丙氧羰基-胺基-3-甲基-丁醯胺基)丙酸甲酯、N-(4'-溴聯苯-2-基)-4-二氟甲基-甲基噻唑-δ-甲醯胺、N-(4'-三氟甲基-聯苯-2-基)-4-二氟甲基-2-甲基噻唑-5-甲醯胺、N-(4'-氯-3'-氟聯苯-2-基)-4-二氟甲基-2-甲基-噻唑-5-甲醯胺、N-(3\4'-二氯-4-氟聯苯-2-基)-3-二氟-甲基-1-甲基-吡唑-4-甲醯胺、N-(3',4'-二氯-5-氟聯苯-2-基)-3-二氟甲基-1-甲基吡唑-4-甲醯胺、N-(2-氰基-苯基)-3,4-二氯異噻唑-5-甲醯胺、2-胺基-4-甲基-噻唑-5-甲醯苯胺、2-氯-N-(1,1,3-三甲基-茚滿-4-基)-菸鹼醯胺、N-(2-(1,3-二甲基丁基)-苯基)-1,3-二甲基-5-氟-1H-吡唑-4-甲醯胺、N-(4'-氯-3',5-二氟-聯苯-2-基)-3-二氟甲基-1-甲基-1H-吡唑-4-甲醯胺、N-(4'-氯-3',5-二氟-聯苯-2-基)-3-三氟甲基-1-甲基-1H-吡唑-4-甲醯胺、N-(3',4'-二氯-5-氟-聯苯-2-基)-3-三氟甲基-1-甲基-1H-吡唑-4-甲醯胺、N-(3',5-二氟-4'-甲基-聯苯-2-基)-3-二氟甲基-1-甲基-1H-吡唑-4-甲醯胺、N-(3',5-二氟-4'-甲基-聯苯-2-基)-3-三氟甲基-1-甲基-1H-吡唑-4-甲醯胺、N-(順-2-雙環丙基-2-基-苯基)-3-二氟甲基-1-甲基-1H-吡唑-4-甲醯胺、N-(反-2-雙環丙基-2-基-苯基)-3-二氟-甲基-1-甲基-1H-吡唑-4-甲醯胺、氟吡菌醯胺、N-(3-乙基-3,5-5-三甲基-環己基)-3-甲醯胺基-2-羥基-苯甲醯胺、土黴素、矽硫芬、N-(6-甲氧基-吡啶-3-基)環丙烷甲醯胺、2-碘-N-苯基-苯甲醯胺、N-(2-雙環-丙基-2-基-苯基)-3-二氟甲基-1-甲基吡唑-4-基甲醯胺、N-(3',4',5'-三氟聯苯-2-基)-1,3-二甲基吡唑-4-基甲醯胺、N-(3',4',5'-三氟聯苯-2-基)-1,3-二甲基-5-氟吡唑-4-基-甲醯胺、N-(3',4',5'-三氟聯苯-2-基)-5-氯-1,3-二甲基-吡唑-4-基甲醯胺、N-(3',4',5'-三氟聯苯-2-基)-3-氟甲基-1-甲基吡唑-4-基甲醯胺、N-(3',4',5'-三氟聯苯-2-基)-3-(氯氟甲基)-1-甲基吡唑-4-基甲醯胺、N-(3',4',5'-三氟聯苯-2-基)-3-二氟甲基-1-甲基吡唑-4-基甲醯胺、N-(3',4',5'-三氟聯苯-2-基)-3-二氟甲基-5-氟-1-甲基吡唑-4-基甲醯胺、N-(3',4',5'-三氟聯苯-2-基)-5-氯-3-二氟甲基-1-甲基吡唑-4-基甲 醯胺、N-(3',4',5'-三氟聯苯-2-基)-3-(氯二氟甲基)-1-甲基吡唑-4-基甲醯胺、N-(3',4',5'-三氟聯苯-2-基)-1-甲基-3-三氟甲基吡唑-4-基甲醯胺、N-(3',4',5'-三氟聯苯-2-基)-5-氟-1-甲基-3-三氟甲基吡唑-4-基甲醯胺、N-(3',4',5'-三氟聯苯-2-基)-5-氯-1-甲基-3-三氟甲基吡唑-4-基甲醯胺、N-(2',4',5'-三氟聯苯-2-基)-1,3-二甲基吡唑-4-基甲醯胺、N-(2',4',5'-三氟聯苯-2-基)-1,3-二甲基-5-氟吡唑-4-基甲醯胺、N-(2',4',5'-三氟聯苯-2-基)-5-氯-1,3-二甲基吡唑-4-基甲醯胺、N-(2',4',5'-三氟聯苯-2-基)-3-氟甲基-1-甲基吡唑-4-基甲醯胺、N-(2',4',5'-三氟聯苯-2-基)-3-(氯氟甲基)-1-甲基吡唑-4-基甲醯胺、N-(2',4',5'-三氟聯苯-2-基)-3-二氟甲基-1-甲基吡唑-4-基甲醯胺、N-(2',4',5'-三氟聯苯-2-基)-3-二氟甲基-5-氟-1-甲基吡唑-4-基甲醯胺、N-(2',4',5'-三氟聯苯-2-基)-5-氯-3-二氟甲基-1-甲基吡唑-4-基甲醯胺、N-(2',4',5'-三氟聯苯-2-基)-3-(氯二氟甲基)-1-甲基吡唑-4-基甲醯胺、N-(2',4',5'-三氟聯苯-2-基)-1-甲基-3-三氟甲基吡唑-4-基甲醯胺、N-(2',4',5'-三氟聯苯-2-基)-5-氟-1-甲基-3-三氟甲基吡唑-4-基甲醯胺、N-(2',4',5'-三氟聯苯-2-基)-5-氯-1-甲基-3-三氟甲基吡唑-4-基甲醯胺、N-(3',4'-二氯-3-氟聯苯-2-基)-1-甲基-3-三氟甲基-1H-吡唑-4-甲醯胺、N-(3',4'-二氯-3-氟聯苯-2-基)-1-甲基-3-二氟甲基-1H-吡唑-4-甲醯胺、N-(3',4'-二氟-3-氟聯苯-2-基)-1-甲基-3-三氟甲基-1H-吡唑-4-甲醯胺、N-(3',4'-二氟-3-氟聯苯-2-基)-1-甲基-S-二氟甲基-1H-吡唑-4-甲醯胺、N-(3'-氯-4'-氟-3-氟聯苯-2-基)-1-甲基-3-二氟甲基-1H-吡唑-4-甲醯胺、N-(3',4'-二氯-4-氟聯苯-2-基)-1-甲基-3-三氟甲基-1H-吡唑-4-甲醯胺、N-(3',4'-二氟-4-氟聯苯-2-基)-1-甲基-S-三氟甲基-1H-吡唑-4-甲醯胺、N-(3',4'-二氯-4-氟聯苯-2-基)-1-甲基-3-二氟甲基-1H-吡唑-4-甲醯胺、N-(3',4'-二氟-4-氟聯苯-2-基)-1-甲基-3-二氟甲基-1H-吡唑-4-甲醯胺、N-(3'-氯-4'-氟-4-氟聯苯-2-基)-1-甲基-S-二氟甲基-1H-吡唑-4-甲醯胺、N-(3',4'-二氯-5-氟聯苯-2-基)- 1-甲基-3-三氟甲基-1H-吡唑-4-甲醯胺、N-(3',4'-二氟-5-氟聯苯-2-基)-1-甲基-3-三氟甲基-1H-吡唑-4-甲醯胺、N-(3',4'-二氯-5-氟聯苯-2-基)-1-甲基-S-二氟甲基-1H-吡唑-甲醯胺、N-(3',4'-二氟-5-氟聯苯-2-基)-1-甲基-3-二氟甲基-1H-吡唑-4-甲醯胺、N-(3',4'-二氯-5-氟聯苯-2-基)-1,3-二甲基-1H-吡唑-4-甲醯胺、N-(3'-氯-4'-氟-5-氟聯苯-2-基)-1-甲基-3-二氟甲基-1H-吡唑-4-甲醯胺、N-(4'-氟-4-氟聯苯-2-基)-1-甲基-3-三氟甲基-1H-吡唑-4-甲醯胺、N-(4'-氟-5-氟聯苯-2-基)-1-甲基-3-三氟甲基-1H-吡唑-4-甲醯胺、N-(4'-氯-5-氟聯苯-2-基)-1-甲基-3-三氟甲基-1H-吡唑-4-甲醯胺、N-(4'-甲基-5-氟聯苯-2-基)-1-甲基-3-三氟甲基-1H-吡唑-4-甲醯胺、N-(4'-氟-5-氟聯苯-2-基)-1,3-二甲基-1H-吡唑-4-甲醯胺、N-(4'-氯-5-氟聯苯-2-基)-1,3-二甲基-1H-吡唑-4-甲醯胺、N-(4'-甲基-5-氟聯苯-2-基)-1,3-二甲基-1H-吡唑-4-甲醯胺、N-(4'-氟-6-氟聯苯-2-基)-1-甲基-3-三氟甲基-1H-吡唑-4-甲醯胺、N-(4'-氯-6-氟聯苯-2-基)-1-甲基-3-三氟甲基-1H-吡唑-4-甲醯胺、N-[2-(1,1,2,3,3,3-六氟丙氧基)-苯基]-3-二氟甲基-1-甲基-1H-吡唑-4-甲醯胺、N-[4'-(三氟甲硫基)-聯苯-2-基]-3-二氟甲基-1-甲基-1 H-吡唑-4-甲醯胺及N-[4'-(三氟甲硫基)-聯苯-2-基]-1-甲基-3-三氟甲基-1-甲基-1H-吡唑-4-甲醯胺;B4)雜環化合物,包括扶吉胺、比芬諾(pyrifenox)、布瑞莫(bupirimate)、嘧菌環胺、芬瑞莫(fenarimol)、富米綜(ferimzone)、嘧菌胺、尼瑞莫(nuarimol)、派美尼(pyrimethanil)、賽福寧(triforine)、拌種咯、護汰寧、阿迪嗎啉(aldimorph)、嗎菌靈、芬普福、三得芬、苯鏽啶、依普同、撲滅寧、免克寧、凡殺同、咪唑菌酮、辛噻酮、撲殺熱、5-氯-7-(4-甲基-哌啶-1-基)-6-(2,4,6-三氟苯基)-[1,2,4]三唑并[1,5-a]嘧啶、敵菌靈、達滅淨、百快隆、丙氧喹啉、三賽唑、2-丁氧基-6-碘-3-丙基烯-4-酮、酸化苯并噻二唑-S-甲酯、四氯丹、蓋普丹(captan)、邁隆、福爾培(folpet)、氰菌胺、快諾芬(quinoxyfen)、N,N- 二甲基-3-(3-溴-6-氟-2-甲基吲哚-1-磺醯基)-[1,2,4]三唑-1-磺醯胺、5-乙基-6-辛基-[1,2,4]三唑并[1,5-a]嘧啶-2,7-二胺、2,3,5,6-四氯-4-甲磺醯基-吡啶、3,4,5-三氯-吡啶-2,6-二甲腈、N-(1-(5-溴-3-氯-吡啶-2-基)-乙基)-2,4-二氯-菸鹼醯胺、N-((5-溴-3-氯吡啶-2-基)-甲基)-2,4-二氯-菸鹼醯胺、二氟林、氯啶、嗎菌靈乙酸酯、唑呋草、殺稻瘟菌素-S、蟎離丹、咪菌威、野燕枯、野燕枯-甲基硫酸鹽、歐索林酸及粉病靈;B5)胺基甲酸酯,包括鋅錳乃浦、錳乃浦、威百畝、磺菌威、免得爛、福美鐵、甲基鋅乃浦、得恩地、鋅乃浦、益穗、乙黴威、纈黴威、苯噻菌胺、霜黴威、霜黴威鹽酸鹽、N-(1-(1-(4-氰基苯基)-乙磺醯基)丁-2-基)胺基甲酸4-氟苯酯、3-(4-氯-苯基)-3-(2-異丙氧基羰胺基-3-甲基-丁醯基胺基)丙酸甲酯;或B6)其他殺真菌劑,包括胍、多寧、多寧游離鹼、克熱淨、雙胍鹽;抗生素:春日黴素、土黴素及其鹽、鏈黴素、保粒黴素、維利黴素A;硝基苯基衍生物:百蟎克、白粉克、大脫蟎;含硫雜環基化合物:腈硫醌、稻瘟靈;有機金屬化合物:薯瘟錫鹽;有機磷化合物:護粒松、丙基喜樂松、福賽得(fosetyl)、福賽得-鋁、亞磷酸及其鹽、白粉松、甲基脫克松;有機氯化合物:益發靈、氟硫滅、六氯苯、苯酞、賓克隆、五氯硝基苯、多保淨、甲基多保淨、甲基益發靈;其他:環氟菌胺、克絕、二甲嘧酚、依瑞莫、呋霜靈、滅芬農及螺環菌胺、雙胍辛乙酸鹽、克熱淨乙酸鹽、克熱淨-參(烷苯磺酸鹽)、春日黴素鹽酸鹽水合物、二氯酚、五氯苯酚及其鹽、N-(4-氯-2-硝基-苯基)-N-乙基-4-甲基-苯磺醯胺、氯硝胺、異丙基滅鏽胺、四氯硝基苯、聯苯、溴硝丙二醇、二苯胺、米多黴素、啉銅、調環酸鈣、N-(環丙基甲氧基亞胺基-(6-二氟甲氧基-2,3-二氟-苯基)-甲基)-2-苯基乙醯胺、N'-(4-(4-氯-3-三氟甲基-苯氧基)-2,5-二甲基-苯基)-N-乙基-N-甲基甲脒、N'-(4-(4-氟-3-三氟甲基-苯氧基)-2,5-二甲基-苯基)-N-乙基-N-甲基甲脒、N'-(2-甲基-5-三氟甲基- 4-(3-三甲基矽烷基-丙氧基)-苯基)-N-乙基-N-甲基甲脒及N'-(5-二氟甲基-2-甲基-4-(3-三甲基矽烷基-丙氧基)-苯基)-N-乙基-N-甲基甲脒。 Fungicide: B0) Benzoene fluconazole, downy mildew, fluzinamide, carbazolam, copper salt (such as copper hydroxide, copper oxychloride, copper sulfate, copper peroxosulfate), Boscalid, thiflumazide, flutianil, furalaxyl, thiabendazole, benodanil, mepronil, Aesop Isofetamid, fenfuram, bixafen, fluxapyroxad, penflufen, sedaxane, syringolide (isofetamid) Coumoxystrobin), enoxastrobin, flufenoxystrobin, pyraoxystrobin, pyramatetostrobin, triclopyricarb, fenaminstrobin , metominostrobin, pyribencarb, meptyldinocap, fentin acetate, fentin chloride, triphenyltin hydroxide (fentin) Hydroxide), oxytetracycline, chlozolinate, chloroneb, tetrachloronitrobenzene (tecnaze) Ne), etridiazole, iodocarb, prothiocarb, Bacillus subtilis synthesis, Bacillus amyloliquefaciens (eg strain QST 713, FZB24, MBI600, D747), from alternate leaf white Extract of Melaleuca alternifolia , extract from white lupinus ( Lupinus albus doce ), BLAD polypeptide, pyrisoxazole, oxpoconazole, etaconazole, albendazole Fenpyrazamine, naftifine, terbinafine, validamycin, pyrimorph, valifenalate, philistine (fthalide), probenazole, isotianil, laminarin, extract from Polygonum cuspidatum, phosphorous acid and salt, teclofthalam, triazoxide, nail Pyrofenone, organic oil, potassium bicarbonate, tetrachloroisophthalonitrile, fluoroimide; B1) azoles, including more than peas, carbendazole, cyclazone, holly, dar Klee, Enconazole, Epto, Fluoroquinazole, Fenke, Guardian, and Protection , Fickley, imidazole, inocastazole, chlorpyrifos, micney, pingke, pugliine, prothioconazole, flurazol, tripafin, three tailong, dexclily, tikili, sterilized azole, Imiamine, pedicure, idylindole, safty, squadron, smectite, befenbut, rot, wheat ear, ethaboxam, edulis and chlorpyrifos , Dakli-M, Imidazole, Barkerol, Uniconazole, 1-(4-Chloro-phenyl)-2-([1,2,4]triazol-1-yl)-cycloheptanol and sulfuric acid B2) opiate, including atorenosin, noxylamine, enestrobin, fluoxastrobin, kresoxim-methyl, phenoxybenzamine, oxime, Pyridoxine, hexagram, trifluoro-sensitive, enestrobin, methyl 2-(2-chloro-5-[1-(3-methylbenzyloxyimino)ethyl]benzyl)carbamate, Methyl 2-chloro-5-[1-(6-methylpyridin-2-ylmethoxyimino)ethyl]benzyl)carbamate and 2-(o-(2,5-dimethyl) Methyl phenoxymethylene)-phenyl)-3-methoxy acrylate, 2-(2-(6-(3-chloro-2-methyl-phenoxy)-5-fluoro-pyrimidine- 4-yloxy)-phenyl)-2-methoxyimino-N-methyl-acetamide and 3-methoxy-2- (2-(N-(4-methoxy-phenyl)-cyclopropane)-imidylthiomethyl)-phenyl)-methyl acrylate; B3) Carboxamide, including wilting, present Benalaxyl, Bendula-M, cycloheximide, flutanil, furametpyr, mepronil, metalaxyl, mefenoxam ), furosemide, oxadixyl, oxycarboxin, penthiopyre, pyrazolamide, thifluzamide, tiadinil, 3,4-dichloro -N-(2-cyanophenyl)isothiazol-5-formamide, dimethomorph, flumorph, flufenamide, fluoprazamide (picobenzamid), Amine, gupamine, diclosan, dipropionamide, N-(2-(4-[3-(4-chlorophenyl)prop-2-ynyloxy)-3-methoxy Phenyl)ethyl)-2-methanesulfonyl-amino-3-methylbutanamine, N-(2-(4-[3-(4-chloro-phenyl)prop-2-ynyloxy) 3-yloxy-phenyl)ethyl)-2-ethanesulfonylamino-3-methylbutanamine, 3-(4-chlorophenyl)-3-(2-isopropoxy Carbonyl-amino-3-methyl-butylammonium)propionic acid methyl ester, N-(4'-bromobiphenyl-2-yl)-4-difluoromethyl-methylthiazole-δ-formamidine amine N-(4'-trifluoromethyl-biphenyl-2-yl)-4-difluoromethyl-2-methylthiazole-5-formamide, N-(4'-chloro-3'-fluoro Biphenyl-2-yl)-4-difluoromethyl-2-methyl-thiazole-5-carboxamide, N-(3\4'-dichloro-4-fluorobiphenyl-2-yl)- 3-Difluoro-methyl-1-methyl-pyrazole-4-carboxamide, N-(3',4'-dichloro-5-fluorobiphenyl-2-yl)-3-difluoromethyl 1-methylpyrazole-4-carboxamide, N-(2-cyano-phenyl)-3,4-dichloroisothiazol-5-carboxamide, 2-amino-4-methyl Base-thiazole-5-methylanilide, 2-chloro-N-(1,1,3-trimethyl-indan-4-yl)-nicotinium amide, N-(2-(1,3- Dimethylbutyl)-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamide, N-(4'-chloro-3',5-difluoro- Biphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-(4'-chloro-3',5-difluoro-biphenyl- 2-yl)-3-trifluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-(3',4'-dichloro-5-fluoro-biphenyl-2-yl )-3-trifluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-(3',5-difluoro-4'-methyl-biphenyl-2-yl)- 3-Difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-(3',5-difluoro-4'-methyl-biphenyl-2-yl)-3- Trifluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-(cis-2-bicyclopropyl-2-yl-benzene )-3-Difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-(trans-2-dicyclopropyl-2-yl-phenyl)-3-difluoro-A -1-methyl-1H-pyrazole-4-carboxamide, flupirtine, N-(3-ethyl-3,5-5-trimethyl-cyclohexyl)-3-carboxamidine Amino-2-hydroxy-benzamide, oxytetracycline, thiophanate, N-(6-methoxy-pyridin-3-yl)cyclopropanecarbamide, 2-iodo-N-phenyl- Benzylamine, N-(2-bicyclo-propyl-2-yl-phenyl)-3-difluoromethyl-1-methylpyrazol-4-ylcarboxamide, N-(3', 4',5'-Trifluorobiphenyl-2-yl)-1,3-dimethylpyrazole-4-ylcarboxamide, N-(3',4',5'-trifluorobiphenyl- 2-yl)-1,3-dimethyl-5-fluoropyrazole-4-yl-carbenamide, N-(3',4',5'-trifluorobiphenyl-2-yl)-5 -Chloro-1,3-dimethyl-pyrazol-4-ylcarboxamide, N-(3',4',5'-trifluorobiphenyl-2-yl)-3-fluoromethyl-1 -methylpyrazol-4-ylformamide, N-(3',4',5'-trifluorobiphenyl-2-yl)-3-(chlorofluoromethyl)-1-methylpyrazole 4-ylformamide, N-(3',4',5'-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methylpyrazole-4-ylcarboxamide , N-(3',4',5'-trifluorobiphenyl-2-yl)-3-difluoromethyl-5-fluoro-1-methylpyrazole-4-ylcarboxamide, N- (3',4',5'-trifluorobiphenyl-2-yl)-5-chloro-3- Fluoromethyl-1-methylpyrazole-4-ylcarboxamide, N-(3',4',5'-trifluorobiphenyl-2-yl)-3-(chlorodifluoromethyl)- 1-methylpyrazol-4-ylcarboxamide, N-(3',4',5'-trifluorobiphenyl-2-yl)-1-methyl-3-trifluoromethylpyrazole- 4-ylformamide, N-(3',4',5'-trifluorobiphenyl-2-yl)-5-fluoro-1-methyl-3-trifluoromethylpyrazol-4-yl Formamide, N-(3',4',5'-trifluorobiphenyl-2-yl)-5-chloro-1-methyl-3-trifluoromethylpyrazole-4-ylcarboxamide , N-(2',4',5'-trifluorobiphenyl-2-yl)-1,3-dimethylpyrazol-4-ylcarboxamide, N-(2',4',5 '-Trifluorobiphenyl-2-yl)-1,3-dimethyl-5-fluoropyrazole-4-ylcarboxamide, N-(2',4',5'-trifluorobiphenyl- 2-yl)-5-chloro-1,3-dimethylpyrazole-4-ylcarboxamide, N-(2',4',5'-trifluorobiphenyl-2-yl)-3- Fluoromethyl-1-methylpyrazole-4-ylcarboxamide, N-(2',4',5'-trifluorobiphenyl-2-yl)-3-(chlorofluoromethyl)-1 -methylpyrazol-4-ylcarboxamide, N-(2',4',5'-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methylpyrazole-4 -carbamamine, N-(2',4',5'-trifluorobiphenyl-2-yl)-3-difluoromethyl-5-fluoro-1-methylpyrazole-4-yl Indoleamine, N-(2',4',5'-trifluorobiphenyl-2-yl)-5-chloro-3-difluoromethyl-1-methylpyrazole-4-ylcarboxamide N-(2',4',5'-trifluorobiphenyl-2-yl)-3-(chlorodifluoromethyl)-1-methylpyrazol-4-ylcarboxamide, N-(2 ',4',5'-Trifluorobiphenyl-2-yl)-1-methyl-3-trifluoromethylpyrazole-4-ylcarboxamide, N-(2',4',5' -Trifluorobiphenyl-2-yl)-5-fluoro-1-methyl-3-trifluoromethylpyrazole-4-ylcarboxamide, N-(2',4',5'-trifluoro Biphenyl-2-yl)-5-chloro-1-methyl-3-trifluoromethylpyrazole-4-ylcarboxamide, N-(3',4'-dichloro-3-fluorobiphenyl -2-yl)-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide, N-(3',4'-dichloro-3-fluorobiphenyl-2-yl )-1-methyl-3-difluoromethyl-1H-pyrazole-4-carboxamide, N-(3',4'-difluoro-3-fluorobiphenyl-2-yl)-1- Methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide, N-(3',4'-difluoro-3-fluorobiphenyl-2-yl)-1-methyl-S -difluoromethyl-1H-pyrazole-4-carboxamide, N-(3'-chloro-4'-fluoro-3-fluorobiphenyl-2-yl)-1-methyl-3-difluoro Methyl-1H-pyrazole-4-carboxamide, N-(3',4'-dichloro-4-fluorobiphenyl-2-yl)-1-methyl-3-trifluoromethyl-1H -pyrazole-4-carbamide, N-(3',4'-difluoro-4-fluorobiphenyl-2-yl)-1-methyl-S-trifluoromethyl-1H-pyrazole- 4-Protonamine, N-(3',4'-dichloro-4-fluorobiphenyl-2-yl)-1-methyl-3-difluoromethyl-1H-pyrazole-4-carboxamidine Amine, N -(3',4'-difluoro-4-fluorobiphenyl-2-yl)-1-methyl-3-difluoromethyl-1H-pyrazole-4-carboxamide, N-(3'-Chloro-4'-fluoro-4-fluorobiphenyl-2-yl)-1-methyl-S-difluoromethyl-1H-pyrazole-4-carboxamide,N-(3',4' -Dichloro-5-fluorobiphenyl-2-yl)-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide, N-(3',4'-difluoro- 5-fluorobiphenyl-2-yl)-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide, N-(3',4'-dichloro-5-fluoro Benz-2-yl)-1-methyl-S-difluoromethyl-1H-pyrazole-formamide, N-(3',4'-difluoro-5-fluorobiphenyl-2-yl) -1-methyl-3-difluoromethyl-1H-pyrazole-4-carboxamide, N-(3',4'-dichloro-5-fluorobiphenyl-2-yl)-1,3 -Dimethyl-1H-pyrazole-4-carboxamide, N-(3'-chloro-4'-fluoro-5-fluorobiphenyl-2-yl)-1-methyl-3-difluoromethyl -1H-pyrazole-4-carboxamide, N-(4'-fluoro-4-fluorobiphenyl-2-yl)-1-methyl-3-trifluoromethyl-1H-pyrazole-4 -Procarbamide, N-(4'-fluoro-5-fluorobiphenyl-2-yl)-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide, N-( 4'-Chloro-5-fluorobiphenyl-2-yl)-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide, N-(4'-methyl-5- Fluorbiphenyl-2-yl)-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide, N-(4'-fluoro-5-fluorobiphenyl-2-yl) -1,3- Methyl-1H-pyrazole-4-carboxamide, N-(4'-chloro-5-fluorobiphenyl-2-yl)-1,3-dimethyl-1H-pyrazole-4-carboxamidine Amine, N-(4'-methyl-5-fluorobiphenyl-2-yl)-1,3-dimethyl-1H-pyrazole-4-carboxamide, N-(4'-fluoro-6 -fluorobiphenyl-2-yl)-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide, N-(4'-chloro-6-fluorobiphenyl-2-yl )-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide, N-[2-(1,1,2,3,3,3-hexafluoropropoxy)- Phenyl]-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-[4'-(trifluoromethylthio)-biphenyl-2-yl]-3 -Difluoromethyl-1-methyl-1 H-pyrazole-4-carboxamide and N-[4'-(trifluoromethylthio)-biphenyl-2-yl]-1-methyl- 3-trifluoromethyl-1-methyl-1H-pyrazole-4-carboxamide; B4) heterocyclic compounds including chlorinamine, pyrifenox, bupirimate, azoxystrobin Cyclic amine, fenarimol, ferimzone, azoxystrobin, nuarimol, pyrimethanil, triforine, seed dressing, protection, Aldimorph, carbendazim, fenfluramine, darfusin, fenpropidin, ipproxil, chlorhexidine, chlorhexidine, chlorhexidine, imidacloprid, octyl ketone, Pyrogen, 5-chloro-7-(4-methyl-piperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1 , 5-a] pyrimidine, carbendazim, chlorhexidine, baiweilong, propoxyquinoline, trioxazole, 2-butoxy-6-iodo-3-propyl Ace-4-one, acidified benzothiadiazole-S-methyl ester, tetrachlorodan, captan, melon, folfet, cyanamide, quinoxyfen, N , N-dimethyl-3-(3-bromo-6-fluoro-2-methylindole-1-sulfonyl)-[1,2,4]triazole-1-sulfonamide, 5- Ethyl-6-octyl-[1,2,4]triazolo[1,5-a]pyrimidine-2,7-diamine, 2,3,5,6-tetrachloro-4-methylsulfonate Base-pyridine, 3,4,5-trichloro-pyridine-2,6-dicarbonitrile, N-(1-(5-bromo-3-chloro-pyridin-2-yl)-ethyl)-2, 4-Dichloro-nicotine decylamine, N-((5-bromo-3-chloropyridin-2-yl)-methyl)-2,4-dichloro-nicotinium decylamine, difluoroline, chloridine , carbendazim acetate, oxazolin, blasticidin-S, saponin, imiprozil, wild swallow, wild swallow-methyl sulfate, oxolinic acid and powdery disease; B5) urethanes, including zinc-manganese, manganese-niobium, Weibaimu, sulfavir, elixirs, fumei, methyl zinc, Pu'er, zinc, Pu, Yisui, and B. Granules, carbendazim, phenothiamine, propamocarb, chlorfenapyr hydrochloride, N-(1-(1-(4-cyanophenyl)-ethanesulfonyl)butan-2-yl) 4-fluorophenyl carbamic acid, 3-(4-chloro-phenyl)-3-(2-isopropoxycarbonylamino) Methyl 3-methyl-butyl-decylamino)propionate; or B6) other fungicides, including guanidine, tannin, toxin free base, ke shui, biguanide; antibiotics: kasugamycin, oxytetracycline And its salt, streptomycin, granulin, vilimycin A; nitrophenyl derivatives: Baiqi grams, white powder grams, large aphid; sulfur-containing heterocyclic compounds: nitrile sulfonium, rice blast Ling; organometallic compounds: dip and tin salts; organophosphorus compounds: granules pine, propyl chelsson, fosetyl, foss-aluminum, phosphorous acid and its salts, white pine, methyl gram Pine; organochlorine compounds: Yifaling, fluorosulfuron, hexachlorobenzene, benzoquinone, berberine, pentachloronitrobenzene, chlorhexidine, methyl chlorhexidine, methyl valproate; others: cycloflufenamide , ketone, xylenol, irilimole, furosemide, fenfenin and spirocycline, bisindole acetate, gramacetal acetate, gram-net-paraben (alkylbenzene sulfonate), Kasugamycin hydrochloride hydrate, dichlorophenol, pentachlorophenol and its salt, N-(4-chloro-2-nitro-phenyl)-N-ethyl-4-methyl-benzenesulfonamide, Chloramine, isopropyl rustamine, tetrachloronitrate Benzene, biphenyl, bromide, diphenylamine, midodinomycin, copper porphyrin, calcium cyclate, N-(cyclopropylmethoxyimino-(6-difluoromethoxy-2,3) -difluoro-phenyl)-methyl)-2-phenylacetamide, N'-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethyl -phenyl)-N-ethyl-N-methylformamidine, N'-(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl )-N-ethyl-N-methylformamidine, N'-(2-methyl-5-trifluoromethyl-4-(3-trimethyldecyl-propoxy)-phenyl)- N-ethyl-N-methylformamidine and N'-(5-difluoromethyl-2-methyl-4-(3-trimethyldecyl-propoxy)-phenyl)-N- Ethyl-N-methylformamidine.
除草劑:C1)乙醯輔酶A羧化酶抑制劑(ACC),例如環己烯酮肟醚,諸如禾草滅、克草同、氯丙氧定、環殺草、西殺草、肟草酮、丁苯草酮、環苯草酮或吡喃草酮;苯氧基苯氧丙酸酯,諸如炔草酯、氰氟草酯、禾草靈、噁唑禾草靈、精噁唑禾草靈、噻唑禾草靈、吡氟禾草靈、精吡氟禾草靈、吡氟氯禾靈、氟吡甲禾靈、精氟吡甲禾靈、異噁草醚、喔草酯、喹禾靈、精喹禾靈或喹禾糠酯;或芳胺基丙酸,諸如麥草氟甲酯或麥草氟異丙酯;C2)乙醯乳酸合成酶抑制劑(ALS),例如咪唑啉酮,諸如依滅草、滅草喹、甲基咪草酯(咪草酯)、甲氧咪草菸、甲基咪草菸或咪草菸;嘧啶基醚,諸如嘧硫酸、嘧硫鈉、雙草醚鈉、KIH-6127或嘧苯草肟(pyribenzoxym);磺醯胺,諸如雙氟磺草胺、唑嘧磺草胺或磺草唑胺;或磺醯脲,諸如醯嘧磺隆、四唑嘧磺隆、苄嘧磺隆、氯嘧磺隆、氯磺隆、醚磺隆、環磺隆、胺苯磺隆、乙氧嘧磺隆、嘧啶磺隆、氯吡嘧磺隆、唑吡嘧磺隆、甲磺隆、菸嘧磺隆、氟嘧磺隆、氟磺隆、吡嘧磺隆、碸嘧磺隆、甲嘧磺隆、噻吩磺隆、醚苯磺隆、苯磺隆、氟胺磺隆、三氟甲磺隆、磺醯磺隆、甲醯嘧磺隆或碘甲磺隆;C3)醯胺,例如草毒死(CDAA)、新燕靈、溴丁醯草胺、草克樂(chiorthiamid)、草乃敵、乙苯醯草(etobenzanid(benzchlomet))、噻唑草醯胺、調節膦(fosamin)或庚醯草胺;C4)生長素除草劑,例如吡啶甲酸,諸如畢克草或畢克爛;或2,4-D或草除靈;C5)生長素輸送抑制劑,例如萘草胺或二氟吡隆;C6)類胡蘿蔔素生物合成抑制劑,例如吡草酮、可滅蹤(clomazone/dimethazone)、吡氟草胺、氟咯草酮、氟啶草酮、吡唑特、苄草唑、異噁唑草酮、異噁氯草酮、甲基磺草酮、磺草酮(sulcotrione/chlormesulone)、克草酮(ketospiradox)、呋草酮、達草滅 或殺草強;C7)烯醇丙酮醯莽草酸-3-磷酸合成酶抑制劑(EPSPS),例如草甘膦或草硫膦;C8)麩醯胺酸合成酶抑制劑,例如畢拉草(bilanafos/bialaphos)或草銨膦;C9)脂質生物合成抑制劑,例如醯苯胺,諸如莎稗磷或苯噻草胺;氯代乙醯苯胺,諸如二甲噻草胺、S-二甲噻草胺、乙草胺、甲草胺、丁草胺、丁烯草胺、乙醯甲草胺、二甲草胺、吡草胺、異丙甲草胺、S-異丙甲草胺、丙草胺、撲草胺、廣草胺、猛殺草、甲氧噻草胺或二甲苯草胺;硫脲,諸如蘇達滅、草滅特、燕麥敵、哌草丹、EPTC、戊草丹、草達滅、克草猛、苄草丹、禾草丹(thiobencarb/benthiocarb)、野麥畏或滅草猛;或呋草黃或氟草磺胺;C10)有絲分裂抑制劑,例如胺基甲酸酯,諸如黃草靈、長殺草、氯苯胺靈、坪草丹、拿草特(pronamid/propyzamid)、苯胺靈或仲草丹;二硝基苯胺,諸如氟草胺、比達寧、敵樂胺、丁氟消草、氟消草、黃草消、胺硝草、胺基丙氟靈或氟樂靈;吡啶,諸如氟硫草定或噻草定;或抑草磷、敵草索(DCPA)或抑芽丹;C11)原卟啉原IX氧化酶抑制劑,例如二苯基醚,諸如氟鎖草醚、氟鎖草醚鈉、苯草醚、必芬諾(bifenox)、草枯醚(CNP)、氯氟草醚、消草醚、乙羧氟草醚、氟黃胺草醚、氟呋草醚、乳氟禾草靈、除草醚、硝氟草醚或氧氟吩;噁二唑,諸如丙炔噁草酮或惡草靈;環狀醯亞胺,諸如草芬定、佈芬草、唑草酮、吲哚酮草酯、氟烯草酸、丙炔氟草胺、氟米丙平、富普巴(flupropacil)、氟噻甲草酯、甲磺草胺或噻二唑胺;或吡唑,諸如ET-751.JV 485或氟氯草胺;C12)光合作用抑制劑,例如敵稗、噠草特或吡啶達醇;苯并噻二嗪酮,諸如本達隆(bentazone);二硝基苯酚,例如殺草全、地樂酚、地樂酯、特樂酚或DNOC;聯吡啶,諸如莎草快、苯敵快、敵草快或百草枯;脲,諸如氯溴隆、綠麥隆、枯莠隆、噁唑隆、敵草隆、噻二唑隆、非草隆、伏草隆、異丙隆、異惡隆、利穀隆、噻唑隆、滅草唑、吡喃隆、甲氧隆、綠穀隆、草不隆、 環草隆或得匍隆;苯酚,諸如溴苯腈或碘苯腈;氯草敏;三嗪,諸如莠滅淨、莠去津、氰草津、敵草淨(desmein)、戊草津(dimethamethryn)、六嗪酮、撲滅通、撲草淨、撲滅津、西瑪津、西草淨、甲氧去草淨、去草淨、特丁津或草達津;三嗪酮,諸如苯嗪草酮或賽克津;尿嘧啶,諸如除草定、環草定或特草定;或雙胺基甲酸酯,諸如甜菜安或甜菜寧;C13)增效劑,例如環氧乙烷,諸如滅草環;C14)CIS細胞壁合成抑制劑,例如異噁草胺或敵草腈;C15)各種其他除草劑,例如二氯丙酸,諸如茅草枯;二氫苯并呋喃,諸如乙呋草黃;苯乙酸,諸如伐草克(chlorfenac/fenac);或疊氮津、燕麥靈、地散磷、苯噻隆、氟磺胺草、特克草(buminafos)、特咪唑草、炔草隆、唑草胺、氯草靈、燕麥酯、枯草隆、環庚草醚、苄草隆、環莠隆、環草津、三環噻草胺、二苄基隆(dibenzyluron)、殺草淨、香草隆、草止津、草藻滅、乙嗪草酮、氟唑磺隆、氟苯草滅(fluorbentranil)、氟胺草唑、草特靈、異樂靈、卡草靈、氟磺醯草胺、滅草隆、滅落脫、敵草胺、磺樂靈、噁美酮(oxaciclomefone)、棉胺寧、哌草磷、環丙腈津、環丙氟靈、稗草畏、密草通、草克死(CDEC)、芽根靈、三嗪氟草胺、三唑羧醯胺(triazofenamid)或三甲隆;或其環境上相容的鹽。 Herbicide: C1) Acetyl-CoA carboxylase inhibitor (ACC), such as cyclohexenone oxime ether, such as grass, ketone, chlorpropoxy, cyclohexane, chlorpyrifos, valerian Ketone, butyl ketone, benzophenone or pyridone; phenoxyphenoxypropionate, such as clodinafop, cyhalofop, oxacillin, oxazolyl, oxazol Cao Ling, thiazol-grass, flurazepam, flupirtine, flupirtine, flupirtine, flupirtine, clomazone, valerate, quin Orphan, quizalofop-p-ethyl or quinoxalate; or arylaminopropionic acid, such as wheat fluoromethyl ester or wheat straw fluoroisopropyl ester; C2) acetamidine lactate synthase inhibitor (ALS), such as imidazolinone, Such as acesulfame, imazaquin, imidate (imidate), imazamox, methyl imazethapyr or imazethapyr; pyrimidinyl ether, such as pyruvic acid, sodium thiosulfate, double grass Ether sodium, KIH-6127 or pyribenzoxym; sulfonamide, such as diflufenacil, flufensulfuron or sulfazinamide; or sulfonylurea, such as sulfometuron, tetrazole Sulfoxsulfuron, bensulfuron-methyl, chlorsulfuron-methyl, chlorsulfuron Ethersulfuron, cyclosulfuron, ethametsulfuron, ethoxysulfuron, pyrimidine, chlorpyrifos, oxazolidine, metsulfuron, nicosulfuron, flusulfuron, fluoride Sulfonamide, pyrazosulfuron, sulfometuron, sulfometuron, thifensulfuron, ether benzosulfuron, bensulfuron, flufensulfuron, trifluoromethanesulfuron, sulfonium sulfonate, formazan Sulfon or iodosulfuron; C3) guanamine, such as chlorpyrifos (CDAA), neoyanling, brombutachlor, chiorthiamid, grass, and ethidium (etobenzanid (benzchlomet) )), thiazolinamide, phosphine (fosamin or heptylamine; C4) auxin herbicide, such as picolinic acid, such as chlorpyrifos or gramin; or 2,4-D or herbicide; C5) auxin transport inhibitors, such as naproxil or diflupiron; C6) carotenoid biosynthesis inhibitors, such as piracetone, clomazone/dimethazone, diflufenic acid, fluroxypyr Ketone, fluroxypyr, pyrazol, benzoxazole, isoxaflutole, isoxafluzate, mesotrione, sulcotrione/chlormesulone, ketospiradox, fur Grass ketone Or killing grass; C7) enol acetone oxalic acid-3-phosphate synthase inhibitor (EPSPS), such as glyphosate or phosphinothricin; C8) glutamate synthetase inhibitor, such as bilberry ( Bilanafos/bialaphos) or glufosinate; C9) lipid biosynthesis inhibitors, such as indoline, such as samarium or mefenacet; chloroacetanilide, such as methotrexate, S-methicillin Amine, acetochlor, alachlor, butachlor, butachlor, acetochlor, dimethylamine, metazachlor, metolachlor, S-metolachlor, propylidene Amine, acetochlor, acetochlor, chlorpyrifos, methoxymethoxamine or xanthin; thiourea, such as sulbactam, chlorhexidine, oatmeal, piperidan, EPTC, pentosan, Grass chlorhexidine, chlorpyrifos, benzobendan, thiobencarb/benthiocarb, wild wheat or chlorpyrifos; or furosemide or flufensulfate; C10) mitotic inhibitors, such as urethane , such as Huangcao Ling, long-killing grass, chlorpheniramine, pingcao Dan, pronamid/propyzamid, aniline or ketone; dinitroaniline, such as fluramide, daramine, dexamethasine, Fluoride, flufenazone, huangcaoxiao, pendimethalin, alanine or trifluralin; pyridine, such as flurazepam or thiacildine; or oxacillin, diquat (DCPA) or Calyxate; C11) protoporphyrinogen IX oxidase inhibitor, such as diphenyl ether, such as acifluorfen, acifluorfen sodium, dipivoxil, bifenox, chlorhexidine (CNP) ), flufenacet, herbicide ether, flufenacetate, flufenazone, flufenacetate, flufenacil, herbicide ether, nitrofurazone or oxyfluorophene; oxadiazole, Such as propyne oxalofenone or oxacillin; cyclic quinone imine, such as oxafluridine, buffing grass, oxafluridone, oxadiazon, flumethacic acid, propargyl flufenate, flumicil , flupropacil, flumethoate, mesoxalam or thiadiazole; or pyrazole, such as ET-751.JV 485 or flufenacet; C12) photosynthesis inhibitors, such as enemies Anthraquinone, valerate or pyridinol; benzothiadiazinone, such as bentazone; dinitrophenol, such as chlorfenapyr, dinose, dilofen, tetral or DNOC; Pyridine, such as sedge fast, benzene fast, enemy grass fast or Herbaceous; urea, such as chlorbromide, chloromeron, acetonide, oxazolone, diuron, thiadiazol, oxadiazepine, oxaflurazine, isoproturon, isoxron, ligulon , thiazolyl, chlorpyrifos, pyrrolidine, methoxylated, green valley, grass, Cycloheximide or decapone; phenol, such as bromoxynil or iodobenzonitrile; chloramphenicol; triazines such as chlorpyrifos, atrazine, cyanazine, desmein, dimethamethryn , hexazinone, chlorpyrifos, chlorpyrifos, chlorpyrifos, simazine, cisplatin, methoxy oxacillin, chlorpyrifos, terbutin or chlorpyrifos; triazinone, such as oxazinone Or selezine; uracil, such as herbicidal, cyclohexidine or terpene; or bis-carbamate, such as beet or beetin; C13) synergist, such as ethylene oxide, such as herbicide Ring; C14) CIS cell wall synthesis inhibitors, such as isoxachlor or dichlorfen; C15) various other herbicides, such as dichloropropionic acid, such as thatch; dihydrobenzofuran, such as ethigen yellow; benzene Acetic acid, such as chlorfenac/fenac; or azidazine, oatmeal, disperse phosphorus, benzothiazide, flufenazone, buminafos, terazosole, cloacazone, oxazinamide , chlorsulfurin, oatmeal ester, haysulfuron, cycloheptyl ether, benzalkon, guanylon, oxadiazepine, tricyclic thiamatine, dibenzyluron, kill Net, vanilla, grass, chlorpyrifos, oxazinone, flufensulfuron, fluorbentranil, fluoxazole, chlorfluralin, lycopene, carbendazim, fluorosulfonate Valeramine, chlorpyrifos, chlorpyrifos, dichlorfen, chloramphenicol, oxaciclomefone, ketamine, piperacite, cyprodinil, ciprofloxacin, valerian, dense Caotong, gram death (CDEC), bud root, triazine fenacetamide, triazofenamid or trimethyl ketone; or an environmentally compatible salt thereof.
殺線蟲劑或生物殺線蟲劑:免賴得、地蟲威、涕滅碸威、威線肟、二胺磷、芬滅松、硫線磷、除線磷、普伏松、豐索磷、噻唑磷、速殺硫磷、異醯胺松(isamidofof)、依殺松、磷蟲威、硫磷嗪、菸鹼硫磷、甲基減蚜磷、乙醯蟲腈、苯氯噻、氯化苦、邁隆、氟噻蟲碸、1,3-二氯丙烯(二氯丙烯)、二硫二甲烷、威百畝鈉、威百畝鉀、威百畝鹽(所有MITC產生劑)、溴化甲烷、生物土壤改良劑(例如芥菜籽、芥菜籽提取物)、土壤蒸汽薰蒸、異硫氰酸烯丙酯(AITC)、硫酸二甲酯、糠醛(醛)。 Nematicides or bio-nematicides: free of lysine, chlorpyrifos, annihilation, sputum, diamine, fensin, sulphur, phosphorus, pusson, phosphos, Thiazophos, acesulfame, isamimidofof, chlorfenapyr, chlorpyrifos, nicotinic thiophosphorus, methyl phosphazone, acetaminophen, phenylchlorothiophene, chlorination Bitter, Mellon, fluthiazem, 1,3-dichloropropene (dichloropropene), dithiodimethane, Weibaimu sodium, Weibaimu potassium, Weibaimu salt (all MITC generators), bromine Methane, biological soil improver (such as mustard seed, mustard seed extract), soil steam fumigation, allyl isothiocyanate (AITC), dimethyl sulfate, furfural (aldehyde).
本發明之適合植物生長調節因子包括以下各物:植物生長調節因子:D1)抗生長素,諸如降固醇酸、2,3,5-三碘苯甲酸;D2)生長素,諸如4-CPA、2,4-D、2,4-DB、2,4-DEP、2,4-滴丙酸(dichlorprop)、涕丙酸、IAA、IBA、萘乙醯胺、α-萘乙酸、1-萘酚、萘氧基乙酸、環烷酸鉀、環烷酸鈉、2,4,5-T;D3)細胞分裂素,諸如2iP、苄基腺嘌呤、4-羥基苯乙醇、活動素、玉米素;D4)脫葉劑,諸如氰胺化鈣、噻節因、草多索、益收生長素、脫葉亞磷、甲氧隆、五氯苯酚、噻苯隆、脫葉磷;D5)乙烯抑制劑,諸如艾維激素(aviglycine)、1-甲基環丙烯;D6)乙烯釋放劑,諸如ACC、乙烯矽、益收生長素、乙二肟;D7)殺配子劑,諸如噠嗪酮酸鉀、抑芽丹;D8)赤黴素,諸如赤黴素、赤黴酸;D9)生長抑制劑,諸如脫落酸、嘧啶醇、比達寧(butralin)、加保利、三丁氯苄膦、氯苯胺靈、敵草克、氟節胺、增糖胺、殺木膦、草甘二膦、苯嘧丙醇、茉莉酸、抑芽丹、壯棉素、哌壯素、茉莉酮、苯胺靈、調節安(tiaojiean)、2,3,5-三碘苯甲酸;D10)形態素,諸如氯氟酸、氯甲丹、二氯甲丹、抑草丁;D11)生長延緩劑,諸如克美素(chlormequat)、丁醯肼、調嘧醇、氟磺醯草胺、巴克素、四環唑、烯效唑;D12)生長刺激劑,諸如油菜素內酯、油菜素內酯-乙基、DCPTA、氯吡脲、惡黴靈、補骨內酯、三十烷醇;D13)類別不明之植物生長調節劑,諸如菊乙胺酯、氟磺胺草、特克草、香芹酮、氯化膽鹼、苯氰丁醯胺、苯噠嗪酸、氰胺、環丙酸醯胺、環己醯亞胺、環丙磺醯胺、丙醯芸苔素內酯、吲熟酯、乙烯、呋苯硫脲、乙二醇縮糖醛、增產肟、氯乙亞磺酸(holosulf)、依納素、砷酸鉛、滅速克、調環酸、比達農(pydanon)、殺雄啉、抑芽唑、抗倒酯。 Suitable plant growth regulators of the invention include the following: plant growth regulator: D1) anti-auxin, such as treasic acid, 2,3,5-triiodobenzoic acid; D2) auxin, such as 4-CPA , 2,4-D, 2,4-DB, 2,4-DEP, 2,4-dipropionic acid, dipropionic acid, IAA, IBA, naphthylamine, α-naphthylacetic acid, 1- Naphthol, naphthyloxyacetic acid, potassium naphthenate, sodium naphthenate, 2,4,5-T; D3) cytokinins, such as 2iP, benzyl adenine, 4-hydroxyphenylethanol, activin, corn D4) defoliant, such as calcium cyanamide, thiazide, sedum, auxin, defoliated phosphorus, methoxylated, pentachlorophenol, thiabendazole, defoliated phosphorus; D5) ethylene inhibition Agents, such as aviglycine, 1-methylcyclopropene; D6) ethylene release agents, such as ACC, vinyl hydrazine, auxin, acetonide; D7) gametocides, such as potassium oxazinone , sulphate; D8) gibberellin, such as gibberellic acid, gibberellic acid; D9) growth inhibitors, such as abscisic acid, pyrimidine alcohol, butralin, plus poly, tributyl chlorophosphonazo, chlorine Aniline, diquat, fluorohexamine, glycosaminoglycan Killing phosphine, glyphosate, pyripramine, jasmonic acid, sulphate, strong cotton, piperazine, jasmonone, aniline, tiaojiean, 2,3,5-triiodobenzene Formic acid; D10) morphines, such as chlorofluoric acid, chloromethyl sulphate, dichloromethyl sulphate, sulphate; D11) growth retardants, such as chlormequat, butyl hydrazine, chlorfluazurol, flufenacetamide , bucksin, tetracyclazole, uniconazole; D12) growth stimulators, such as brassinolide, brassinolide-ethyl, DCPTA, chlorpyrifos, carbendazim, psorale, triacontane Alcohol; D13) Plant growth regulators of unknown class, such as methamine, sulfamethoxazole, tek grass, carvone, choline chloride, benzalkonium, benzoxazinic acid, cyanamide, ring Indole propionate, cycloheximide, ciprofloxacin, propican lactone, benzoic acid ester, ethylene, furose thiourea, ethylene glycol acetal, sputum, chloroethane sulfonate Acid (holosulf), enaxin, lead arsenate, chlorhexidine, cyclohexanoic acid, pydanon, chlordamine, oxazole, anti-pivoxil.
肥料可為液體肥料。術語「液體肥料」係指呈含有不同比率之氮、磷及鉀(例如(但不限於)10%氮、34%磷及0%鉀)及微量養分的流體或液體形式之肥料,通常稱為高磷且促進快速及強有力根生長之基 肥。 The fertilizer can be a liquid fertilizer. The term "liquid fertilizer" means a fluid or liquid form of fertilizer containing nitrogen, phosphorus and potassium in various ratios (such as, but not limited to, 10% nitrogen, 34% phosphorus and 0% potassium) and micronutrients, commonly referred to as High phosphorus and promotes rapid and strong root growth fat.
本發明之化學調配物可呈任何適當習知形式,例如乳液濃縮物(EC)、懸浮液濃縮物(SC)、懸乳乳液(SE)、膠囊懸浮液(CS)、水可分散顆粒(WG)、可乳化顆粒(EG)、油包水乳液(EO)、水包油乳液(EW)、微乳液(ME)、油性分散液(OD)、油狀可混溶可流動劑(OF)、油狀可混溶液體(OL)、可溶濃縮物(SL)、超低體積懸浮液(SU)、超低體積液體(UL)、可分散濃縮物(DC)、可濕潤粉末(WP)或與農業上可接受之佐劑組合之任何技術上可行調配物。 The chemical formulations of the present invention may be in any suitable conventional form, such as emulsion concentrates (EC), suspension concentrates (SC), suspoemulsion emulsions (SE), capsule suspensions (CS), water dispersible granules (WG). ), emulsifiable particles (EG), water-in-oil emulsion (EO), oil-in-water emulsion (EW), microemulsion (ME), oily dispersion (OD), oily miscible flowable agent (OF), Oily miscible solution (OL), soluble concentrate (SL), ultra low volume suspension (SU), ultra low volume liquid (UL), dispersible concentrate (DC), wettable powder (WP) or Any technically feasible formulation in combination with an agriculturally acceptable adjuvant.
在本發明之另一實施例中,提供用組合物塗佈之植物種子,該組合物包括以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301或其具有所有其鑑別特徵之突變體的生物純培養物的孢子,以適合於有益於植物生長及/或對易感病植物賦予保護以避免病原性感染之量存在。植物生長益處及/或所賦予之保護可藉由幼苗活力提高、根發育改善、植物生長改善、植物健康提高、產量增加、外觀改善、對植物病原體之抗性提高、病原性感染減少或其組合展現。 In another embodiment of the present invention, there is provided a plant seed coated with a composition comprising Bacillus amyloliquefaciens RTI301 deposited under ATCC PTA-121165 or a mutant thereof having all of its identifying characteristics Spores of pure cultures are present in an amount suitable to be beneficial for plant growth and/or to confer protection to susceptible plants to avoid pathogenic infections. Plant growth benefits and/or protection afforded by increased seedling vigor, improved root development, improved plant growth, improved plant health, increased yield, improved appearance, increased resistance to plant pathogens, reduced pathogenic infection, or combinations thereof Show.
塗佈在植物種子上之組合物可包括每顆種子約1.0×102CFU至每顆種子約1.0×109CFU之量的解澱粉芽孢桿菌孢子。 The composition coated on the plant seed may comprise from about 1.0 x 10 2 CFU per seed to about 1.0 x 109 CFU per seed.
植物種子可包括(但不限於)單子葉植物、雙子葉植物、穀物、玉米、甜玉米、爆玉米、玉米種、青貯玉米、飼料玉米、稻穀、小麥、大麥、高粱、甘藍型蔬菜、椰菜、甘藍菜、花椰菜、芽甘藍、散葉甘蘭、羽衣甘藍、芥菜、球莖甘藍、鱗莖類蔬菜、洋蔥、大蒜、蔥、果蔬菜、胡椒、番茄、茄子、地面櫻桃、樹蕃茄、秋葵、葡萄、香草/香料、瓜類蔬菜、黃瓜、哈密瓜、甜瓜、香甘瓜、番南瓜、西瓜、南瓜、茄子、綠葉蔬菜、萵苣、芹菜、菠菜、香芹、菊苣、豆科植物/蔬菜(多汁且乾燥之豆子及豌豆)、豆子、四季豆、食莢菜豆、殼豆、大豆、乾豆、回回豆、利馬豆、豌豆、鷹嘴豆、豌豆瓣、扁豆、油料 種子作物、芥花、蓖麻、棉花、亞麻、花生、油菜籽、紅花、芝麻、向日葵、大豆、根/塊莖及球莖蔬菜、胡蘿蔔、馬鈴薯、甘薯、甜菜、薑、辣根、蘿蔔、人參、蕪菁、甘蔗、甜菜、草或草皮草之種子。 Plant seeds may include, but are not limited to, monocots, dicots, grains, corn, sweet corn, popcorn, corn, silage corn, feed corn, rice, wheat, barley, sorghum, kale, broccoli , kale, broccoli, Brussels sprouts, broccoli, kale, mustard, broccoli, bulbous vegetables, onions, garlic, onions, fruit vegetables, pepper, tomato, eggplant, ground cherry, tree tomatoes, okra, grapes, Vanilla/spice, melon, cucumber, cantaloupe, melon, cantaloupe, squash, watermelon, pumpkin, eggplant, green leafy vegetables, lettuce, celery, spinach, parsley, chicory, legumes/vegetables (succulent and Dried beans and peas), beans, green beans, pod beans, shell beans, soybeans, dried beans, peas, lima beans, peas, chickpeas, peas, lentils, oil Seed crops, mustard, ramie, cotton, flax, peanuts, rapeseed, safflower, sesame, sunflower, soybean, root/tuber and bulbous vegetables, carrots, potatoes, sweet potatoes, beets, ginger, horseradish, radish, ginseng, Seeds of turnip, sugar cane, sugar beet, grass or turf grass.
在一或多個實施例中,植物種子可包括乾豆、玉米、小麥、大豆、菜籽、稻穀、黃瓜、胡椒、番茄、番南瓜、棉花、草及草皮草之種子。 In one or more embodiments, the plant seeds can include seeds of dried beans, corn, wheat, soybeans, rapeseed, rice, cucumber, pepper, tomato, squash, cotton, grass, and turfgrass.
藉由經塗佈之植物種子處理之病原性感染可由植物病原體引起,該等植物病原體包括例如(但不限於)植物真菌病原體、植物細菌病原體、葡萄孢屬、灰葡萄孢菌、蔥鱗葡萄孢菌、歐文菌屬、胡蘿蔔軟腐歐文菌、解澱粉歐文菌、鐮刀菌屬、大刀鐮刀菌、禾穀鐮刀菌、尖孢鐮刀菌、古巴尖孢鐮刀菌、番茄尖孢鐮刀菌、棒形鐮刀菌、黃單孢菌屬、地毯草黃單孢菌、油菜黃單孢菌胡蘿蔔致病變種、桃李黃單孢菌、核桃黃單孢菌、水稻黃單孢菌水稻變種、假單孢菌屬、丁香假單孢菌番茄致病變種、疫黴菌屬、致病疫黴菌、寄生疫黴菌、大豆疫黴菌、辣椒疫黴菌、樟疫黴菌、草莓疫黴菌、疫黴菌屬、櫟樹猝死病菌、棕櫚疫黴菌、菸草疫黴菌、絲核菌屬、立枯絲核菌、玉蜀黍絲核菌、稻枯斑絲核菌、褐色絲核菌、禾穀絲核菌、紫紋羽絲核菌、草莓絲核菌、枝生絲核菌、覆盆子絲核菌、豆狀絲核菌、菜豆殼球孢菌、稻瘟菌、腐黴屬、終極腐黴菌、瓜果腐黴菌、畸雌腐黴菌、簇囊腐黴菌、水生腐黴菌、森林腐黴菌、黑粉菌屬、裸黑粉菌、玉蜀黍黑粉菌、甘蔗鞭黑粉菌、麥角菌屬、麥角菌、腥黑粉菌屬、小麥腥黑粉菌、光滑腥黑粉菌、稻粒黑粉菌、小麥矮腥黑粉菌、莖點黴屬、大豆生莖點黴、多變莖點黴、甘藍莖點黴、禾旋孢腔菌、禾頂囊殼、炭疽菌屬或其組合。 Pathogenic infections treated by coated plant seeds may be caused by plant pathogens including, for example, but not limited to, plant fungal pathogens, plant bacterial pathogens, Botrytis, Botrytis cinerea, Botrytis cinerea Bacteria, Owens, Carrot soft rot, Owen bacteria, Fusarium oxysporum, Fusarium, Fusarium oxysporum, Fusarium graminearum, Fusarium oxysporum, Fusarium oxysporum, Fusarium oxysporum, Fusarium oxysporum , Xanthomonas, Rhizoctonia solani, Xanthomonas camphora, carcinogenic lesions, P. oleracea, P. oleracea, P. xylori, rice varieties, Pseudomonas, Pseudomonas syringae tomato pathogen, Phytophthora, Phytophthora infestans, Phytophthora parasitica, Phytophthora sojae, Phytophthora capsici, Phytophthora capsici, Phytophthora strawberry, Phytophthora, eucalyptus, palm plague Mold, Phytophthora nicotiana, Rhizoctonia, Rhizoctonia solani, Rhizoctonia solani, Rhizoctonia solani, Rhizoctonia solani, Rhizoctonia solani, Rhizoctonia solani, Strawberry silk nucleus Bacteria Phytophthora, Rhizoctonia solani, Rhizoctonia solani, Coccidioides, Magnaporthe oryzae, Pythium, Pythium, Pythium, Pythium, Pythium, Pythium , forest Pythium, black powder fungus, naked black powder fungus, maize black powder fungus, sugar cane whip black powder fungus, ergot fungus, ergot fungus, black fungus genus, wheat black powder fungus, smooth black Powder fungus, rice black powder fungus, wheat dwarf smut, stalk genus, soybean stalk, mildew, sphaerophyll, sphaerophyll, Helminthosporium, sclerotium, anthrax Genus or a combination thereof.
塗佈至植物種子上之組合物可進一步包括微生物、生物或化學 殺蟲劑、殺真菌劑、殺線蟲劑、殺菌劑或植物生長調節劑之一或組合,其以適合於有益於植物生長及/或對易感病植物賦予保護以避免病原性感染之量存在。殺蟲劑可包括畢芬寧。殺線蟲劑可包括硫線磷。殺蟲劑可包括畢芬寧及噻蟲胺。 The composition applied to the plant seeds may further comprise microorganisms, organisms or chemistry One or a combination of an insecticide, fungicide, nematicide, bactericide or plant growth regulator present in an amount suitable to be beneficial for plant growth and/or to confer protection to susceptible plants to avoid pathogenic infections. . The insecticide can include diphennin. Nematicides may include sulphur phosphorus. Insecticides may include bifenin and clothianidin.
在本發明之另一實施例中,提供一種用於達成有益於植物生長或對易感病植物賦予保護以避免病原性感染中之一或兩者的方法,該方法包括:將植物種子種植在適合生長介質中或使植物之營養剪枝/組織在適合生長介質中再生,其中種子已用一種組合物塗佈或營養剪枝/組織已經該組合物接種,該組合物包含以ATCC PTA-121165寄存之解澱粉芽孢桿菌RTI301或其具有其所有鑑別特徵之突變體的生物純培養物,其中有益於植物自種子或營養剪枝/組織之生長及/或賦予保護以避免病原性感染。植物生長益處及/或所賦予之保護可藉由幼苗活力提高、根發育改善、植物生長改善、植物健康提高、產量增加、外觀改善、對植物病原體之抗性提高、病原性感染減少或其組合展現。 In another embodiment of the present invention, there is provided a method for achieving one or both of beneficial to plant growth or to confer protection to susceptible plants to avoid pathogenic infections, the method comprising: planting plant seeds in Suitable for growing in a medium or for regenerating a plant's nutrient pruning/tissue in a suitable growth medium, wherein the seed has been coated with a composition or nutrient pruning/tissue has been inoculated with the composition comprising ATCC PTA-121165 A biologically pure culture of the deposited B. amyloliquefaciens RTI 301 or a mutant thereof having all of its identifying characteristics, wherein the growth of the plant from the seed or nutrient pruning/tissue is beneficial and/or protection is provided to avoid pathogenic infection. Plant growth benefits and/or protection afforded by increased seedling vigor, improved root development, improved plant growth, improved plant health, increased yield, improved appearance, increased resistance to plant pathogens, reduced pathogenic infection, or combinations thereof Show.
在一個實施例中,該方法可進一步包括向以下各者施用液體肥料:植物周圍土壤或生長介質;在土壤或生長介質中播種植物種子之前的土壤或生長介質;或在土壤或生長介質中種植植物、植物剪枝、植物移植物或植物癒合組織之前的土壤或生長介質。 In one embodiment, the method may further comprise applying a liquid fertilizer to: soil or growth medium surrounding the plant; soil or growth medium prior to seeding the plant seed in the soil or growth medium; or planting in soil or growth medium Soil or growth medium prior to plant, plant pruning, plant graft or plant healing tissue.
在一個實施例中,提供一種藉由對易感病植物賦予保護以避免或減少病原性感染有益於植物生長,同時使針對處理之抗性積聚減至最少之方法。該方法包括將第一組合物及第二組合物以分開施用及改變時間間隔輸送至易感病植物,其中第一及第二組合物各者以適合於對植物賦予保護以避免或減少病原性感染之量輸送。第一組合物包括以ATCC第PTA-121165號寄存之解澱粉芽抱桿菌RTI301或其具有其所有鑑別特徵之突變體的生物純培養物。第二組合物包括一或多種具有 殺真菌或殺菌特性之化學活性劑。在該方法中,第一及第二組合物以改變時間間隔輸送至植物葉、植物莖皮、植物果實、植物花、植物種子、植物根部、植物剪枝、植物移植物、植物癒合組織或植物周圍土壤或生長介質之一或組合。在該方法中,賦予保護以避免及/或減少病原性感染所需之化學活性劑的總量減少且針對處理之抗性積聚減至最少。植物生長益處及/或所賦予之保護可藉由幼苗活力提高、根發育改善、植物生長改善、植物健康提高、產量增加、外觀改善、對植物病原體之抗性提高、病原性感染減少或其組合展現。 In one embodiment, a method of protecting plant growth by avoiding or reducing pathogenic infections while imparting protection to susceptible plants while minimizing the accumulation of resistance to treatment is provided. The method comprises delivering the first composition and the second composition to a susceptible plant at separate application and varying time intervals, wherein each of the first and second compositions is adapted to confer protection to the plant to avoid or reduce pathogenicity The amount of infection is delivered. The first composition comprises a biologically pure culture of Bacillus amyloliquefaciens RTI301 deposited with ATCC PTA-121165 or a mutant having all of its identifying characteristics. The second composition includes one or more A chemical active agent that kills fungi or bactericidal properties. In this method, the first and second compositions are delivered to plant leaves, plant stems, plant fruits, plant flowers, plant seeds, plant roots, plant pruning, plant transplants, plant healing tissues or plants at varying time intervals. One or a combination of surrounding soil or growth medium. In this method, the total amount of chemical active agent required to impart protection to avoid and/or reduce pathogenic infection is reduced and the accumulation of resistance to treatment is minimized. Plant growth benefits and/or protection afforded by increased seedling vigor, improved root development, improved plant growth, improved plant health, increased yield, improved appearance, increased resistance to plant pathogens, reduced pathogenic infection, or combinations thereof Show.
第一組合物可進一步包括載劑、界面活性劑、分散劑或酵母提取物之一或組合。酵母提取物可以在約0.01%至0.2% w/w範圍內的有益於植物生長之施用率輸送。 The first composition may further comprise one or a combination of a carrier, a surfactant, a dispersant, or a yeast extract. The yeast extract can be delivered at a rate suitable for plant growth in the range of about 0.01% to 0.2% w/w.
在藉由對易感病植物賦予保護以避免或減少病原性感染有益於植物生長同時將針對處理之抗性積聚減至最少的方法中,改變時間間隔可在相隔1天至10天範圍內且可相隔5至7天。第一次施用之時間安排可視特定作物而定且可在種植時、作物萌芽後幾週、開花時、出現疾病時或在預期疾病出現前的範圍內。第一及第二組合物各者可輸送至植物葉、植物果實或植物花。適合於對植物賦予保護以避免或減少病原性感染的輸送量可為約1.0×1010CFU/ha至約1.0×1014CFU/ha解澱粉芽孢桿菌RTI301。適合於對植物賦予保護以避免或減少病原性感染的輸送量可為約1.0×1010CFU/ha至約1.0×1014CFU/ha解澱粉芽孢桿菌RTI301及約0.01%至0.2% w/w酵母提取物。 In a method of protecting a susceptible plant to avoid or reduce pathogenic infections that are beneficial to plant growth while minimizing the accumulation of resistance to treatment, the time interval of change can be in the range of 1 day to 10 days apart and It can be 5 to 7 days apart. The timing of the first application may depend on the particular crop and may be within the range of planting, weeks after germination of the crop, flowering, disease, or pre-exposure. Each of the first and second compositions can be delivered to a plant leaf, plant fruit or plant flower. Suitable for plants to confer protection to avoid or reduce the amount of pathogenic infections delivery may be about 1.0 × 10 10 CFU / ha to about 1.0 × 10 14 CFU ha Solution / Bacillus amyloliquefaciens RTI301. Delivery rates suitable for conferring protection to plants to avoid or reduce pathogenic infections may range from about 1.0 x 10 10 CFU/ha to about 1.0 x 10 14 CFU/ha B. amyloliquefaciens RTI 301 and about 0.01% to 0.2% w/w. Yeast extract.
一或多種以分開施用及改變時間間隔輸送至易感病植物之化學活性劑可包括例如(但不限於)以下之一或組合:甲氧基丙烯酸酯(strobilurine)、三唑、護汰芬(flutriafol)、得克利、丙硫菌唑(prothiaconazole)、氟環唑(expoxyconazole)、氟吡菌醯胺、四氯異苯腈、甲基托布津、氫氧化銅殺真菌劑、基於EDBC之殺真菌劑、鋅錳 乃浦(mancozeb)、琥珀酸去氫酶(succinase dehydrogenase,SDHI)殺真菌劑、必殺吩、依普同(iprodione)、達滅芬或威利芬那雷特。 One or more chemically active agents delivered to the susceptible plant at separate administrations and varying time intervals may include, for example, but not limited to, one or a combination of the following: strobilurine, triazole, dimethoate ( Flutriafol), dextran, prothiaconazole, expoxyconazole, fluopyram, tetrachloroisophthalonitrile, methyl thiophanate, copper hydroxide fungicide, EDBC-based fungicide Agent, zinc manganese Mancozeb, succinase dehydrogenase (SDHI) fungicide, chlorpyrifos, iprodione, dafoxdine or velifenate.
一或多種以分開施用及改變時間間隔輸送至易感病植物之化學活性劑可包括氟吡菌醯胺加上得克利且包含RTI301之第一組合物之輸送可替換四氯異苯腈殺真菌劑之輸送。植物可為葫蘆且病原性感染可由白粉病引起。 One or more chemically active agents delivered to the susceptible plant at separate administrations and varying time intervals may include flupirtine plus dekli and a first composition comprising RTI 301 for delivery of a replaceable tetrachloroisophthalonitrile fungicide Delivery of the agent. The plant can be a gourd and the pathogenic infection can be caused by powdery mildew.
一或多種以分開施用及改變時間間隔輸送至易感病植物之化學活性劑可包括甲基托布津殺真菌劑且包含RTI301之第一組合物之輸送可替換丙硫菌唑殺真菌劑之輸送。 One or more chemically active agents delivered to the susceptible plant at separate application and varying time intervals may comprise a methyl thiophanate fungicide and the delivery of the first composition comprising RTI 301 may be substituted for the delivery of the prothioconazole fungicide .
一或多種以分開施用及改變時間間隔輸送至易感病植物之化學活性劑可包括氫氧化銅殺真菌劑且包含RTI301之第一組合物之輸送可替換四氯異苯腈殺真菌劑之輸送。 One or more chemically active agents delivered to the susceptible plant at separate application and varying time intervals may comprise a copper hydroxide fungicide and the delivery of the replaceable tetrachloroisophthalonitrile fungicide comprising the first composition of RTI301 .
在一個實施例中,提供一種產品,其包含:包含以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301或其具有其所有鑑別特徵之突變體的生物純培養物的第一組合物;包含微生物、生物或化學殺蟲劑、殺真菌劑、殺線蟲劑、殺菌劑、除草劑、植物提取物、植物生長調節劑或肥料之一或組合的第二組合物,其中該第一及第二組合物分開包裝且其中各組合物為適合於達成有益於植物生長及/或對易感病植物賦予保護以避免病原性感染中的一或兩者之量;以及用於將適合於有益於植物生長之量的第一與第二組合物之組合輸送至以下之說明書:植物葉、植物莖皮、植物果實、植物花、植物種子、植物根部、植物剪枝、植物移植物、植物癒合組織;植物周圍土壤或生長介質;在土壤或生長介質中播種植物種子之前的土壤或生長介質;或在土壤或生長介質中種植植物、植物剪枝、植物移植物或植物癒合組織之前的土壤或生長介質。 In one embodiment, a product is provided comprising: a first composition comprising a biologically pure culture of Bacillus amyloliquefaci RTI301 deposited with ATCC PTA-121165 or a mutant having all of its identifying characteristics; a second composition of one or a combination of a microbial, biological or chemical insecticide, fungicide, nematicide, bactericide, herbicide, plant extract, plant growth regulator or fertilizer, wherein the first and second The compositions are packaged separately and wherein each composition is in an amount suitable to achieve one or both of beneficial to plant growth and/or to confer protection to susceptible plants to avoid pathogenic infection; and for use in a plant that would be suitable for benefiting The combined amount of the first and second compositions is delivered to the following instructions: plant leaves, plant bark, plant fruits, plant flowers, plant seeds, plant roots, plant pruning, plant grafts, plant healing tissues; Soil or growth medium around the plant; soil or growth medium before planting the seed in the soil or growth medium; or planting the plant in soil or growth medium, Was pruning the plant or plant healing of graft tissue prior to soil or growth medium.
該產品中殺蟲劑可為擬除蟲菊酯、畢芬寧、七氟菊酯、ξ-賽滅 寧、有機磷酸酯、氯氧磷、陶斯松、丁基嘧啶磷、賽扶寧、非潑羅、費普尼、菸鹼類或可尼丁之一或組合。 The insecticide in this product can be pyrethroid, bifennin, tefluthrin, ξ-赛 One or a combination of Ning, organophosphate, oxyphosphonate, taosson, butyl pyrimidine, cyprofen, non-Piro, fepnini, nicotine or cotinine.
該產品中第一組合物可進一步包括載劑、界面活性劑、分散劑或酵母提取物之一或組合。 The first composition in the product may further comprise one or a combination of a carrier, a surfactant, a dispersant or a yeast extract.
在該產品中,第一及第二組合物可呈液體、粉劑、可撒佈顆粒、乾燥可潤濕粉末或乾燥可潤濕顆粒形式。在一個實施例中,第一組合物呈液體形式,且解澱粉芽孢桿菌RTI301可以約1.0×108CFU/ml至約1.0×1012CFU/ml之濃度存在。在一個實施例中,第一組合物呈粉劑、乾燥可潤濕粉末、可撒佈顆粒或乾燥可潤濕顆粒形式,且解澱粉芽孢桿菌RTI301可以約1.0×108CFU/g至約1.0×1012CFU/g之濃度存在。在一個實施例中,第一組合物呈油性分散液形式且解澱粉芽孢桿菌RTI301以約1.0×108CFU/ml至約1.0×1012CFU/ml之濃度存在。 In this product, the first and second compositions may be in the form of a liquid, a powder, a spreadable granule, a dry wettable powder or a dry wettable granule. In one embodiment, the first composition is in liquid form and the B. amyloliquefaciens RTI301 can be present at a concentration of from about 1.0 x 10 8 CFU/ml to about 1.0 x 10 12 CFU/ml. In one embodiment, the first composition is in the form of a powder, a dry wettable powder, a spreadable granule or a dry wettable granule, and the B. amyloliquefaciens RTI 301 can be from about 1.0 x 10 8 CFU/g to about 1.0 x. A concentration of 10 12 CFU/g is present. In one embodiment, the first composition is in the form of an oily dispersion and B. amyloliquefaciens RTI301 is present at a concentration of from about 1.0 x 10 8 CFU/ml to about 1.0 x 10 12 CFU/ml.
在本發明之一個實施例中,提供一種組合物,該組合物包括以下中之至少一者:分離之豐原素-MA化合物、分離之豐原素MB化合物、分離之豐原素MC化合物、分離之去羥基豐原素MA化合物、分離之去羥基豐原素MB化合物、分離之去羥基豐原素MC化合物、分離之豐原素H化合物、分離之去羥基豐原素H化合物、分離之豐原素I化合物及分離之去羥基豐原素I化合物,呈適合於達成有益於植物生長或對易感病植物賦予保護以避免病原性感染中一或兩者之量,該等豐原素及去羥基豐原素化合物具有下式:
其中R為OH,n在8至20範圍內,FA為直鏈、異或反異,且:對於豐原素MA,X1為Ala,X2為Thr,且X3為Met;對於豐原素MB,X1為Val,X2為Thr,且X3為Met;對於豐原素MC,X1為Aba,X2為Thr,且X3為Met;對於豐原素H,X1為Val,X2為Thr,且X3為Hcy;且對於豐原素I,X1為Ile,X2為Thr,且X3為Ile;以及其中R為H,n在8至20範圍內,FA為直鏈、異或反異,且:對於去羥基豐原素MA,X1為Ala,X2為Thr,且X3為Met;對於去羥基豐原素MB,X1為Val,X2為Thr,且X3為Met;對於去羥基豐原素MC,X1為Aba,X2為Thr,且X3為Met;對於去羥基豐原素H,X1為Val,X2為Thr,且X3為Hcy;且對於去羥基豐原素I,X1為Ile,X2為Thr,且X3為Ile。 Wherein R is OH, n is in the range of 8 to 20, FA is linear, XOR or di-isomeric, and: for abundance MA, X 1 is Ala, X 2 is Thr, and X 3 is Met; for abundance MB X 1 is Val, X 2 is Thr, and X 3 is Met; for abundance MC, X 1 is Aba, X 2 is Thr, and X 3 is Met; for abundance H, X 1 is Val, X 2 Is Thr and X 3 is Hcy; and for alanogen I, X 1 is Ile, X 2 is Thr, and X 3 is Ile; and wherein R is H, n is in the range of 8 to 20, and FA is linear, XOR or singular, and: for dehydroxylectin MA, X 1 is Ala, X 2 is Thr, and X 3 is Met; for dehydroxyl-rich MB, X 1 is Val, X 2 is Thr, and X 3 Is Met; for dehydroxylectin MC, X 1 is Aba, X 2 is Thr, and X 3 is Met; for dehydroxylectin H, X 1 is Val, X 2 is Thr, and X 3 is Hcy; For dehydroxylectin I, X 1 is Ile, X 2 is Thr, and X 3 is Ile.
在另一實施例中,該組合物進一步包含表XIII中所列之其他分離之豐原素樣及去羥基豐原素樣化合物之一或組合,呈適合於賦予有益於植物生長或保護易感病植物以避免病原性感染中的一或兩者之量。 In another embodiment, the composition further comprises one or a combination of other isolated abundance-like and dehydroxy-norformin-like compounds listed in Table XIII, suitable for imparting benefits to plants for growth or protection of susceptible plants To avoid the amount of one or both of the pathogenic infections.
植物生長益處及/或所賦予之保護可藉由幼苗活力提高、根發育改善、植物生長改善、植物健康提高、產量增加、外觀改善、對植物病原體之抗性提高、病原性感染減少或其組合展現。 Plant growth benefits and/or protection afforded by increased seedling vigor, improved root development, improved plant growth, improved plant health, increased yield, improved appearance, increased resistance to plant pathogens, reduced pathogenic infection, or combinations thereof Show.
豐原素-MA、豐原素-MB、豐原素-MC、豐原素-H及豐原素-I化合物及去羥基豐原素-MA、去羥基豐原素-MB、去羥基豐原素-MC、去羥基豐原素-H及去羥基豐原素-I化合物以及其他豐原素樣及去羥基豐原素樣化合物之一或組合可藉由在熟習此項技術者熟知之適合條件,諸如本文中實例中描述之彼等條件下首先培養RTI301解澱粉芽孢桿菌菌株或產生豐原素-MA、豐原素-MB、豐原素-MC、豐原素-H及豐原素-I化合物及去羥基豐原素-MA、去羥基豐原素-MB、去羥基豐原素-MC、去羥基豐原素-H及去羥基豐原素-I化合物之另一解澱粉芽孢桿菌菌株,包括(但不限於)在869或M2培養基中培養菌株3至6天來 分離。隨後可使用熟習此項技術者熟知之方法進一步分離存在於解澱粉芽孢桿菌培養物上清液中之豐原素樣及去羥基豐原素樣環狀脂肽。舉例而言,解澱粉芽孢桿菌培養物上清液可如本文在實例16所述酸化至pH 2,或用CaCl2(Ajesh,K等人,2013,「Purification and characterization of antifungal lipopeptide from a soil isolated strain of Bacillus cereus.」,Worldwide research efforts in the fighting against microbial pathogens:from basic research to technological developments.A.Mendez-Vilas(編輯).第227-231頁)或NH4SO4(Kim,SH等人,2000,Biotechnol Appl Biochem.31(Pt 3):249-253)處理,此與或不與有機萃取步驟(Kim,PI等人,2004,J Appl Microbiol.97(5):942-949),諸如各種相分離形式,包括(但不限於)直接液體分配、膜超過濾及泡沫分級分離(Baker,SC等人,2010,Adv Exp Med Biol.672:281-288)組合。 Fengyuansu-MA, Fengyuansu-MB, Fengyuansu-MC, Fengyuansu-H and Fengyuansu-I compounds and hydroxy-hydroxytoxin-MA, hydroxy-hydroxytoxin-MB, hydroxy-hydroxytoxin-MC, dehydroxy-fuyuan One or a combination of a pro-H and a dehydroxyl-richin-I compound, as well as other abundance-like and dehydroxy-norformin-like compounds, may be by suitable conditions well known to those skilled in the art, such as those described in the examples herein. Under the conditions, firstly culture RTI301 strain of Bacillus amyloliquefaciens or produce abundance-MA, amylin-MB, amylin-MC, amyloin-H and amylin-I compound, and dehydroxyl-producin-MA, dehydroxy-hydroxytoxin- Another strain of Bacillus amyloliquefaciens of MB, dehydroxyhydroxytoxin-MC, dehydroxylungin-H and dehydroxylungin-I compounds, including but not limited to cultured strains in 869 or M2 medium for 3 to 6 days To separate. The adiponectin-like and dehydroxyl-rich-like cyclic lipopeptides present in the supernatant of B. amyloliquefaciens culture can then be further isolated using methods well known to those skilled in the art. For example, the B. amyloliquefaciens culture supernatant can be acidified to pH 2 as described herein in Example 16, or with CaCl 2 (Ajesh, K et al., 2013, "Purification and characterization of antifungal lipopeptide from a soil isolated Strain of Bacillus cereus.", Worldwide research efforts in the fighting against microbial pathogens: from basic research to technological developments. A. Mendez-Vilas (eds.) pp. 227-231) or NH 4 SO 4 (Kim, SH et al. , 2000, Biotechnol Appl Biochem . 31 (Pt 3): 249-253), with or without organic extraction steps (Kim, PI et al, 2004, J Appl Microbiol. 97(5): 942-949), Combinations such as various phase separation formats include, but are not limited to, direct liquid dispensing, membrane ultrafiltration, and foam fractionation (Baker, SC et al, 2010, Adv Exp Med Biol. 672:281-288).
在一個實施例中,豐原素-MA、豐原素-MB、豐原素-MC、豐原素-H及豐原素-I化合物及去羥基豐原素-MA、去羥基豐原素-MB、去羥基豐原素-MC、去羥基豐原素-H及去羥基豐原素-I化合物以及表XIII中列出之其他豐原素樣及去羥基豐原素樣化合物之一或組合可自可產生此等化合物之解澱粉芽孢桿菌菌株之生物純培養物分離。 In one embodiment, amylin-MA, amylin-MB, amylin-MC, amylin-H, and a protoxin-I compound and a dehydroxyl-producin-MA, a dehydroxyl-producin-MB, a dehydroxy-hydroxytoxin -MC, dehydroxyhydroxytoxin-H and dehydroxylungin-I compounds, and one or a combination of other abundance-like and dehydroxy-norformin-like compounds listed in Table XIII can produce self-producing starch spores of such compounds The biologically pure culture of the Bacillus strain is isolated.
在一個實施例中,豐原素-MA、豐原素-MB、豐原素-MC、豐原素-H及豐原素-I化合物及去羥基豐原素-MA、去羥基豐原素-MB、去羥基豐原素-MC、去羥基豐原素-H及去羥基豐原素-I化合物以及表XIII中所列之其他豐原素樣及去羥基豐原素樣化合物之一或組合可自以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301之生物純培養物分離。 In one embodiment, amylin-MA, amylin-MB, amylin-MC, amylin-H, and a protoxin-I compound and a dehydroxyl-producin-MA, a dehydroxyl-producin-MB, a dehydroxy-hydroxytoxin -MC, dehydroxylectin-H and dehydroxylectin-I compounds, and one or a combination of other abundance-like and dehydroxy-norformin-like compounds listed in Table XIII can be deposited with ATCC PTA-121165 The biologically pure culture of Bacillus amyloliquefaciens RTI301 was isolated.
在一個實施例中,提供解澱粉芽孢桿菌菌株之生物純培養物的提取物,該提取物包括豐原素-MA、豐原素-MB、豐原素-MC、豐原 素-H及豐原素-I化合物及去羥基豐原素-MA、去羥基豐原素-MB、去羥基豐原素-MC、去羥基豐原素-H及去羥基豐原素-I化合物及表XIII中列出之其他豐原素樣及去羥基豐原素樣化合物之一或組合。 In one embodiment, an extract of a biologically pure culture of a B. amyloliquefaciens strain is provided, the extract comprising amylin-MA, amylin-MB, abundance-MC, Fengyuan 素-H and abundance-I compounds and hydroxy-hydroxytoxin-MA, hydroxy-hydroxytoxin-MB, hydroxy-hydroxytoxin-MC, hydroxy-hydroxytoxin-H and hydroxy-hydroxytoxin-I compounds and Table XIII One or a combination of other abundances and dehydroxy-flavone-like compounds.
在一個實施例中,提供以ATCC第PTA-121165號寄存之解澱粉芽孢桿菌RTI301之生物純培養物的提取物,該提取物包括豐原素-MA、豐原素-MB、豐原素-MC、豐原素-H及豐原素-I化合物及去羥基豐原素-MA、去羥基豐原素-MB、去羥基豐原素-MC、去羥基豐原素-H及去羥基豐原素-I化合物及表XIII中列出之其他豐原素樣及去羥基豐原素樣化合物之一或組合。 In one embodiment, an extract of a biologically pure culture of Bacillus amyloliquefaciens RTI301 deposited under ATCC PTA-121165 is provided, the extract comprising amylin-MA, amylin-MB, abundance-MC, Fengyuan素-H and abundance-I compounds and hydroxy-hydroxytoxin-MA, hydroxy-hydroxytoxin-MB, hydroxy-hydroxytoxin-MC, hydroxy-hydroxytoxin-H and hydroxy-hydroxytoxin-I compounds and Table XIII One or a combination of other abundances and dehydroxy-flavone-like compounds.
包括豐原素-MA、豐原素-MB、豐原素-MC、豐原素-H及豐原素-I化合物及去羥基豐原素-MA、去羥基豐原素-MB、去羥基豐原素-MC、去羥基豐原素-H及去羥基豐原素-I化合物及視情況其他分離之豐原素樣及去羥基豐原素樣化合物之一或組合中的至少一者之組合物可進一步包括微生物、生物或化學殺蟲劑、殺真菌劑、殺線蟲劑、殺菌劑、除草劑、植物提取物、植物生長調節劑或肥料之一或組合,以適合於有益於植物生長及/或對易感病植物賦予保護以避免病原性感染之量存在。 Including abundance-MA, amylin-MB, abundance-MC, abundance-H and abundance-I compounds and dehydroxy-hydroxytoxin-MA, dehydroxy-prolamin-MB, dehydroxy-hydroxytoxin-MC, dehydroxyl The composition of at least one of the abundance-H and the dehydroxyl-richin-I compound and optionally one or a combination of other isolated abundance-like and dehydroxy-norformin-like compounds may further comprise microbial, biological or chemical insecticidal One or a combination of agents, fungicides, nematicides, bactericides, herbicides, plant extracts, plant growth regulators or fertilizers, suitable for beneficial to plant growth and/or protection of susceptible plants to avoid The amount of pathogenic infection exists.
殺真菌劑可包括來自白羽扇豆之提取物。殺真菌劑可包括BLAD多肽。BLAD多肽可為來自甜羽扇豆(白羽扇豆)之天然存在之種子儲存蛋白的片段,其藉由對真菌細胞壁造成損害且破壞內細胞膜而作用於易感真菌病原體。殺真菌劑可包括約20% BLAD多肽。 The fungicide may include an extract from white lupin. The fungicide can include a BLAD polypeptide. The BLAD polypeptide may be a fragment of a naturally occurring seed storage protein from sweet lupin (white lupin) that acts on a susceptible fungal pathogen by causing damage to the fungal cell wall and disrupting the inner cell membrane. The fungicide may comprise about 20% BLAD polypeptide.
包括豐原素-MA、豐原素-MB、豐原素-MC、豐原素-H及豐原素-I化合物及去羥基豐原素-MA、去羥基豐原素-MB、去羥基豐原素-MC、去羥基豐原素-H及去羥基豐原素-I化合物中之至少一者的組合物可呈液體、油性分散液、粉劑、可撒佈顆粒或乾燥可潤濕顆粒形式。 Including abundance-MA, amylin-MB, abundance-MC, abundance-H and abundance-I compounds and dehydroxy-hydroxytoxin-MA, dehydroxy-prolamin-MB, dehydroxy-hydroxytoxin-MC, dehydroxyl The composition of at least one of the abundance-H and the dehydroxyl-prohalin-I compound may be in the form of a liquid, an oily dispersion, a powder, a dispersible granule or a dry wettable granule.
在一個實施例中,提供一種有益於植物生長及/或賦予保護以避免植物病原性感染之方法,其包括將有效量之包含分離之豐原素-MA、豐原素-MB、豐原素-MC、豐原素-H及豐原素-I化合物及去羥基豐原素-MA、去羥基豐原素-MB、去羥基豐原素-MC、去羥基豐原素-H及去羥基豐原素-I化合物以及其他分離之豐原素樣及去羥基豐原素樣化合物之一或組合的提取物或組合物施用於植物或果實或植物根部或根周圍之土壤,以有益於植物生長及/或賦予保護以避免植物病原性感染。植物生長益處及/或所賦予之保護可藉由幼苗活力提高、根發育改善、植物生長改善、植物健康提高、產量增加、外觀改善、對植物病原體之抗性提高、病原性感染減少或其組合展現。 In one embodiment, a method is provided for benefiting plant growth and/or conferring protection against phytopathogenic infections, comprising: comprising an effective amount comprising isolated proemin-MA, amylin-MB, amylin-MC, Fengyuansu-H and adiponectin-I compounds and dehydroxyl-precipitin-MA, hydroxy-hydroxytoxin-MB, hydroxy-hydroxytoxin-MC, hydroxy-hydroxytoxin-H and dehydroxy-hydroxy-proto-I compounds and other separations An extract or composition of one or a combination of aureus-like and dehydroxy-norformin-like compounds is applied to the soil surrounding the roots or roots of the plant or fruit or plant to benefit plant growth and/or to confer protection against phytopathogenic infections. . Plant growth benefits and/or protection afforded by increased seedling vigor, improved root development, improved plant growth, improved plant health, increased yield, improved appearance, increased resistance to plant pathogens, reduced pathogenic infection, or combinations thereof Show.
在施用有效量之包含分離之豐原素-MA、豐原素-MB、豐原素-MC、豐原素-H及豐原素-I化合物及去羥基豐原素-MA、去羥基豐原素-MB、去羥基豐原素-MC、去羥基豐原素-H及去羥基豐原素-I化合物及其他分離之豐原素樣或去羥基豐原素樣化合物之一或組合的提取物或組合物之方法中,植物可包括例如單子葉植物、雙子葉植物、穀物、玉米、甜玉米、爆玉米、種子玉米、青貯玉米、飼料玉米、稻穀、小麥、大麥、高粱、蘆筍、漿果、藍莓、黑莓、樹莓、羅甘莓、越橘、蔓越橘、醋栗、接骨木、黑醋栗、蔓越莓、越莓、甘藍型蔬菜、椰菜、甘藍菜、花椰菜、芽甘藍、散葉甘藍、羽衣甘藍、芥菜、球莖甘藍、瓜類蔬菜、黃瓜、哈密瓜、甜瓜、香甘瓜、番南瓜、西瓜、南瓜、茄子、鱗莖類蔬菜、洋蔥、大蒜、蔥、柑橘、橙子、葡萄柚、檸檬、紅橘、橘柚、柚子、果蔬菜、胡椒、番茄、地面櫻桃、樹蕃茄、秋葵、葡萄、香草/香料、葉類蔬菜、萵苣、芹菜、菠菜、香芹、菊苣、豆科植物/蔬菜(多汁且乾燥之豆子及豌豆)、豆子、四季豆、食莢菜豆、殼豆、大豆、乾豆、回回豆、利馬豆、豌豆、鷹嘴豆、豌豆瓣、扁豆、油料種子作物、芥花、蓖麻、椰子、棉花、亞 麻、油棕櫚、橄欖、花生、油菜籽、紅花、芝麻、向日葵、大豆、梨果、蘋果、海棠果、梨、榅桲、夏花山楂、根/塊莖及球莖蔬菜、胡蘿蔔、馬鈴薯、甘薯、木薯、甜菜、薑、辣根、蘿蔔、人參、蕪菁、核果、杏子、櫻桃、油桃、桃子、李子、梅子、草莓、堅果、杏仁、開心果、山核桃、核桃、榛子、板栗、腰果、山毛櫸堅果、胡桃、夏威夷果、獼猴桃、香蕉、(藍)龍舌蘭、草、草皮草、觀賞植物、一品紅、硬木剪枝、栗樹、橡樹、楓樹、甘蔗或甜菜。 In the effective amount, the isolated abundance of protoxin-MA, abundance-MB, abundance-MC, abundance-H and amylin-I compound and dehydroxyl-proto- s-MA, hydroxy-hydroxytoxin-MB, dehydroxyl In the method of extracting or extracting a prostaglandin-MC, a dehydroxyl-prohalin-H and a dehydroxyl-prohalin-I compound and one of the other isolated abundance-like or dehydroxy-norformin-like compounds, the plant may comprise For example, monocots, dicots, grains, corn, sweet corn, popcorn, seed corn, silage corn, feed corn, rice, wheat, barley, sorghum, asparagus, berries, blueberries, blackberries, raspberries, roganberries , cranberry, cranberry, gooseberry, elderberry, black currant, cranberry, raspberry, kale, broccoli, kale, broccoli, Brussels sprouts, broccoli, kale, mustard, bulb Cabbage, melon, cucumber, cantaloupe, melon, cantaloupe, squash, watermelon, pumpkin, eggplant, bulbous vegetables, onions, garlic, onions, citrus, oranges, grapefruit, lemon, red orange, orange grapefruit, Grapefruit, fruits and vegetables , pepper, tomato, ground cherry, tree tomato, okra, grape, vanilla/spice, leafy vegetables, lettuce, celery, spinach, parsley, chicory, legumes/vegetables (succulent and dry beans and peas) , beans, green beans, pod beans, shell beans, soybeans, dried beans, back beans, lima beans, peas, chickpeas, pea petals, lentils, oilseed crops, canola, nettle, coconut, cotton, Asian Hemp, oil palm, olive, peanut, rapeseed, safflower, sesame, sunflower, soybean, pear fruit, apple, jellyfish, pear, alfalfa, summer flower hawthorn, root/tuber and bulbous vegetables, carrot, potato, sweet potato, Cassava, beet, ginger, horseradish, radish, ginseng, turnip, stone fruit, apricot, cherry, nectarine, peach, plum, plum, strawberry, nut, almond, pistachio, pecan, walnut, hazelnut, chestnut, cashew, Beech nuts, walnuts, macadamia nuts, kiwi, bananas, (blue) agave, grass, turf grass, ornamental plants, poinsettia, hardwood pruning, chestnut, oak, maple, sugar cane or beet.
在施用有效量之包含分離之豐原素-MA、豐原素-MB、豐原素-MC、豐原素-H及豐原素-I化合物及去羥基豐原素-MA、去羥基豐原素-MB、去羥基豐原素-MC、去羥基豐原素-H及去羥基豐原素-I化合物及其他分離之豐原素樣或去羥基豐原素樣化合物之一或組合的提取物或組合物之方法中,病原性感染可由植物病原體引起,該等植物病原體包括例如植物真菌病原體、植物細菌病原體、鏽菌、葡萄孢屬、灰葡萄孢菌、蔥鱗葡萄孢菌、歐文菌屬、胡蘿蔔軟腐歐文菌、解澱粉歐文菌、狄克氏菌屬、達旦狄克氏菌、黑脛病菌、土壤桿菌屬、根癌土壤桿菌、黃單孢菌屬、地毯草黃單孢菌、油菜黃單孢菌胡蘿蔔致病變種、桃李黃單孢菌、核桃黃單抱菌、水稻黃單孢菌水稻變種、焦枯菌屬、葉緣焦枯菌、卡地菌屬、韌皮部桿菌、鐮刀菌屬、大刀鐮刀菌、禾穀鐮刀菌、尖孢鐮刀菌、古巴尖孢鐮刀菌、番茄尖孢鐮刀菌、棒形鐮刀菌、核盤菌屬、向日葵核盤菌、小核盤菌、同果核盤菌、尾孢菌屬、鉤絲殼屬、葡萄白粉病菌(白粉病)、叉絲單囊殼屬(白粉病)、白叉絲單囊殼、克蘭德叉絲單囊殼、擬莖點菌屬、葡萄擬莖點黴病菌、交鏈孢菌屬、細極鏈格抱菌、蔥鏈格抱菌、交鏈格孢菌、立枯交鏈孢菌、鏈格孢菌、假單胞菌屬、丁香假單胞菌番茄變種、疫黴菌屬、致病疫黴菌、寄生疫黴菌、大豆疫黴菌、辣椒疫黴菌、樟疫黴菌、草莓疫黴菌、疫黴菌屬、櫟樹猝死病菌、棕櫚疫黴菌、菸草疫黴 菌、層鏽菌屬、豆薯層鏽菌、山馬蝗層鏽菌、曲黴菌屬、黃麴黴、黑麯黴、單孢鏽菌屬、菜豆銹病菌、枝孢菌屬、多主枝孢黴、根黴菌屬、少根根黴菌、青黴菌屬、絲核菌屬、立枯絲核菌、玉蜀黍絲核菌、稻枯斑絲核菌、褐色絲核菌、禾穀絲核菌、紫紋羽絲核菌、草莓絲核菌、枝生絲核菌、覆盆子絲核菌、豆狀絲核菌、菜豆殼球孢菌、稻瘟菌、球腔菌屬、禾生球腔菌、斐濟球腔菌(黑色香蕉葉斑病)、蘋果斑點球腔菌、檸檬球腔菌、稻瘟菌屬、稻瘟病菌、鏈核盤菌屬、桃褐腐病菌、藍莓僵果病病原菌、核果鏈核盤菌、炭疽菌屬、膠孢炭疽菌、辣椒炭疽菌、石斛炭疽菌、間座殼屬、柑桔間座殼菌、棒孢菌屬、多主棒孢菌、膠鏽菌屬、植物受檜膠鏽菌、裂盾菌屬、仁果裂盾菌、黏殼孢菌屬、梨果黏殼孢菌、葡萄座腔菌屬、葡萄潰瘍病病菌、明孢盤菌屬、威爾遜孢殼菌屬、嗜果威爾遜孢殼菌、單囊殼菌屬、斑點單囊殼菌、薔薇單囊殼菌、白粉菌屬、殼多孢菌屬、穎枯殼針孢、腐黴屬、終極腐黴菌、瓜果腐黴菌、畸雌腐黴菌、簇囊腐黴菌、水生腐黴菌、森林腐黴菌、黑星菌屬、蘋果黑星病菌、輪枝孢菌屬、黑粉菌屬、裸黑粉菌、玉蜀黍黑粉菌、甘蔗鞭黑粉菌、麥角菌屬、麥角菌、腥黑粉菌屬、小麥腥黑粉菌、光滑腥黑粉菌、稻粒黑粉菌、小麥矮腥黑粉菌、莖點黴屬、大豆生莖點黴、多變莖點黴、甘藍莖點黴、禾旋孢腔菌、禾頂囊殼、炭疽菌屬、雲紋病菌屬、大麥雲紋病菌、離蠕孢屬、長蠕孢屬、大麥長蠕孢、玉蜀黍長蠕孢、索萊長蠕孢及小麥褐斑長蠕孢或其組合。 In the effective amount, the isolated abundance of protoxin-MA, abundance-MB, abundance-MC, abundance-H and amylin-I compound and dehydroxyl-proto- s-MA, hydroxy-hydroxytoxin-MB, dehydroxyl Pathogenic infection in a method of extracting or extracting a protosulin-MC, a dehydroxyl-prohalin-H and a dehydroxyl-proto-I compound and other isolated abundance-like or dehydroxy-norformin-like compounds May be caused by plant pathogens including, for example, plant fungal pathogens, plant bacterial pathogens, rust fungi, Botrytis, Botrytis cinerea, Botrytis cinerea, Owenium, Carrot soft rot, Erwinia , Dick's genus, D. dandelion, black smut, Agrobacterium, Agrobacterium tumefaciens, Xanthomonas, P. sphaeroides, Xanthomonas campestris, carrot-induced disease, peach and plum Xanthomonas, Monochamus humilis, Rice Variety of Xanthomonas oryzae, Saccharomyces, Saccharomyces cerevisiae, Carterella, phloem, Fusarium, Fusarium oxysporum, Fusarium graminearum Fusarium, Fusarium oxysporum, Fusarium oxysporum, Fusarium oxysporum, Sclerotinia, S. sclerotiorum, Sclerotinia sclerotiorum, Sclerotinia sclerotiorum, Cercospora, H. genus, Grape white powder Pathogens (powder disease), sclerotium sclerotium (powder disease), white stalk single sac, clams, single sac, stalk, sphaeroides, Phytophthora Genus, fine-stranded chain bacteria, onion chain bacteria, Alternaria alternata, Alternaria alternata, Alternaria, Pseudomonas, Pseudomonas syringae, tomato Phytophthora Phytophthora infestans, Phytophthora infestans, Phytophthora sojae, Phytophthora sojae, Phytophthora capsici, Phytophthora capsici, Phytophthora infestans, Phytophthora, eucalyptus, Phytophthora palmatum, Phytophthora nicotiana Phytophthora, Puccinia genus, Phakopsora pachyrhizi, P. sylvestris, Aspergillus, Scutellaria, Aspergillus niger, Puccinia rot, Bean rust, Cladosporium, Multi-spore Mildew, Rhizopus, Rhizopus, Penicillium, Rhizoctonia, Rhizoctonia solani, Rhizoctonia solani, Rhizoctonia solani, Rhizoctonia solani, Rhizoctonia cerealum, Violet Rhizoctonia solani, Rhizoctonia solani, Rhizoctonia solani, Rhizoctonia sclerophylla, Rhizoctonia solani, Coccidioides, Magnaporthe oryzae, Glomus, Trichoderma, Fiji ball Cavity (black banana leaf spot), apple spotted bacterium, lemon bacterium, rice blast, rice blast, chain genus, brown rot, blueberry fruit pathogen, stone fruit chain Phytophthora, anthrax, anthrax, anthrax, anthracnose, anthrax, genus, citrus, genus, genus, genus, genus, rust, plant Phytophthora rust, Shield genus, Phytophthora, Helminthosporium, Phytophthora, Phytophthora, Grape canker, Clostridium, Phytophthora, Phytophthora velutipes, Phytophthora, Phytophthora, Phytophthora capsici, Polygonum genus, Polyporus genus, Phytophthora, Pythium Genus, ultimate Pythium, Pythium, Pythium, Pythium, Pythium, Pythium, Pseudomonas, Escherichia coli, Verticillium, Sphaerotheca, Naked black powder fungus, maize black powder fungus, sugarcane whip black powder fungus, ergot fungus, ergot fungus, sphaerotheca fuliginea, wheat black powder fungus, smooth black powder fungus, rice black powder fungus, wheat Dwarf sphaeroides, Pleurotus ostreatus, soybean stems, variegated shoots, cabbage stems, Helminthosporium, sclerotium, anthracnose, genus, genus, barley Phytophthora, genus Helminthosporium, Helminthosporium, Helminthosporium longum, Helminthosporium fulvus, Helminthosporium serrata and Helminthosporium hirsutum or a combination thereof.
包括以下實例以為一般技術者實施本發明揭示之標的物之代表性實施例提供指導。鑒於本發明及此項技術中之一般技術水準,一般技術者可瞭解,以下實例意欲僅為例示性的且可在不背離當前所揭示標的物之範疇的情況下採用許多變化、修改及改變。 The following examples are included to provide guidance for the general practitioner to implement representative embodiments of the subject matter disclosed herein. In view of the present invention and the general technical level of the present invention, it is to be understood by those skilled in the art that the following examples are intended to be illustrative only and that many variations, modifications and changes may be employed without departing from the scope of the presently disclosed subject matter.
將本文中稱為RTI301之植物相關菌株自生長在紐約長島之溫亞德的葡萄藤根圍土壤分離。將RTI301菌株之16S rRNA及rpoB基因定序,且隨後使用BLAST與NCBI及RDP資料庫中之其他已知細菌菌株進行比較。確定RTI301(SEQ ID NO:1)之16S RNA部分序列與解澱粉芽孢桿菌菌株NS6(KF177175)、解澱粉芽孢桿菌菌株FZB42(NR_075005)及枯草芽孢桿菌亞種枯草菌株DSM 10(NR_027552)之16S rRNA基因序列一致。亦確定RTI301(SEQ ID NO:2)之rpoB基因序列與解澱粉芽孢桿菌植物亞種TrigoCor1448(CP007244)(99%序列一致性;3個鹼基對差異)、解澱粉芽孢桿菌植物亞種AS43.3(CP003838)(99%序列一致性;7個鹼基對差異)、解澱粉芽孢桿菌CC178(CP006845)(99%序列一致性;8個鹼基對差異)及解澱粉芽孢桿菌FZB42(CP000560)(99%序列一致性;8個鹼基對差異)中相同基因具有序列相似性。RTI301菌株經鑑別為解澱粉芽孢桿菌。在DNA層面上rpoB基因之序列差異表明RTI301為解澱粉芽孢桿菌之新菌株。解澱粉芽孢桿菌RTI301於2014年4月17日依據國際承認用於專利程序的微生物寄存布達佩斯條約之條款寄存於美國菌種保藏中心(ATCC)(Manassas,Virginia,USA)且具有專利寄存編號PTA-121165。 Plant-associated strains referred to herein as RTI301 were isolated from vine roots soil grown in Wynyard, Long Island, New York. The 16S rRNA and rpoB genes of the RTI301 strain were sequenced and subsequently compared to other known bacterial strains in the NCBI and RDP databases using BLAST. To determine the 16S RNA partial sequence of RTI301 (SEQ ID NO: 1) and the 16S rRNA of B. amyloliquefaciens strain NS6 (KF177175), B. amyloliquefaciens strain FZB42 (NR_075005) and Bacillus subtilis subsp. subtilis strain DSM 10 (NR_027552) The gene sequence is identical. The rpoB gene sequence of RTI301 (SEQ ID NO: 2) was also determined with B. amyloliques plant subspecies TrigoCor1448 (CP007244) (99% sequence identity; 3 base pair difference), B. amyloliquefaciens plant subspecies AS43. 3 (CP003838) (99% sequence identity; 7 base pair differences), B. amyloliquefaciens CC178 (CP006845) (99% sequence identity; 8 base pair differences) and B. amyloliquefaciens FZB42 (CP000560) The same genes in the (99% sequence identity; 8 base pair differences) have sequence similarity. The RTI301 strain was identified as B. amyloliquefaciens. The sequence difference of the rpoB gene at the DNA level indicates that RTI301 is a new strain of B. amyloliquefaciens. Bacillus amyloliquefaciens RTI301 was deposited with the American Type Culture Collection (ATCC) (Manassas, Virginia, USA) on April 17, 2014 under the terms of the Budapest Treaty on the International Recognition of Microorganisms for the Purposes of Patent Procedures and has the patent registration number PTA- 121165.
解澱粉芽孢桿菌RTI301菌株之基因組的進一步序列分析揭露此菌株具有在其他緊密相關解澱粉芽孢桿菌菌株中無同源物的與羊毛硫抗生素生物合成相關之基因。此展示在圖1中,其展示圍繞及包括在解澱粉芽孢桿菌RTI301中發現之羊毛硫抗生素生物合成操縱子之基因 組結構的示意圖。圖1中,頂部箭頭組表示RTI301菌株之蛋白質編碼區,其中指示相對轉錄方向。為進行比較,兩種解澱粉芽孢桿菌參考菌株FZB42及TrigoCor1448的對應區域展示在RTI301菌株下面。RTI301菌株中羊毛硫抗生素合成操縱子中之基因最初使用RAST鑑別且其身分接著使用BLASTp精確化。與兩種參考菌株相比由RTI301菌株之基因編碼的蛋白質之胺基酸一致性程度由代表性箭頭之陰影程度以及箭頭內指示之一致性百分比兩者指示。自圖1可觀測到來自3種不同菌株之基因中羊毛硫抗生素合成操縱子周圍之區域中存在高度序列一致性,僅僅羊毛硫抗生素合成操縱子內序列一致性程度低(亦即羊毛硫抗生素合成操縱子內少於40%但周圍區域中大於99%)。針對NCBI之非冗餘(nr)核苷酸資料庫進行對此簇之BLASTn分析,且分析展示與解澱粉芽孢桿菌菌株之5'及3'側接區域具有高度同源性(類似於圖1中高度相似性%)。然而,羊毛硫肽生物合成簇為RTI301獨特的,且未觀測到與NCBI nr資料庫中任何先前測序之DNA具有顯著同源性。因此,此羊毛硫抗生素合成操縱子為解澱粉芽孢桿菌菌株RTI301之獨特特徵。 Further sequence analysis of the genome of B. amyloliquefaciens RTI 301 strain revealed that this strain has genes associated with lantibiotic biosynthesis in other closely related B. amyloliquefaciens strains without homologs. This display is shown in Figure 1 and shows the genes surrounding the lantibiotic biosynthesis operon found in B. amyloliquesii RTI301 Schematic diagram of the group structure. In Figure 1, the top arrow group indicates the protein coding region of the RTI301 strain, indicating relative transcriptional orientation. For comparison, the corresponding regions of the two B. amyloliquefaciens reference strains FZB42 and TrigoCor1448 are shown below the RTI301 strain. The genes in the lantibiotic synthesis operon in the RTI 301 strain were initially identified using RAST and their identity was then refined using BLASTp. The degree of amino acid identity of the protein encoded by the gene of the RTI 301 strain compared to the two reference strains is indicated by both the shaded degree of the representative arrow and the percent identity indicated within the arrow. It can be observed from Figure 1 that there is a high degree of sequence identity in the region around the lantibiotic synthesis operon in genes from three different strains, and only the degree of sequence identity in the lantibiotic synthesis operon is low (ie, lantibiotic synthesis) Less than 40% in the operon but greater than 99% in the surrounding area). BLASTn analysis of this cluster was performed against NCBI's non-redundant (nr) nucleotide library, and the analysis showed high homology to the 5' and 3' flanking regions of B. amyloliquefaciens strains (similar to Figure 1). Medium height similarity %). However, the lanthiopeptide biosynthetic cluster was unique to RTI301 and no significant homology to any previously sequenced DNA in the NCBI nr library was observed. Therefore, this lantibiotic synthesis operon is a unique feature of B. amyloliquefaciens strain RTI301.
確定施用細菌分離株對小麥之早期植物生長及活力的作用。實驗藉由在室溫下在通氣下在黑暗中在約2×107CFU/ml細菌之懸浮液中接種表面滅菌之發芽小麥種子2天來進行(亦在無細菌下進行對照)。隨後,接種及對照種子種植在填充有沙之6"盆中。每盆種植10顆種子且每次處理種植1盆,且根據需要交替澆水與經改質之霍格蘭氏溶液(Hoagland's solution)。盆在實驗室窗台中大約21℃下提供天然光/暗週期下培育13天,此時回收植物且量測參數。乾重測定為每9株植物之總重量,結果用解澱粉芽孢桿菌RTI301菌株接種之植物的總平均植 物乾重等於36.1mg,相比而言,未接種對照物之重量等於33.38mg,乾重比未接種對照增加8.1%。生長13天後所提取之植物之照片展示於圖2中。圖2A展示用RTI301接種之植物且圖2B展示對照植物。 The effect of application of bacterial isolates on early plant growth and vigor of wheat was determined. The experiment was carried out by inoculating surface-sterilized germinated wheat seeds in a suspension of about 2 x 10 7 CFU/ml bacteria in the dark at room temperature for 2 days (also in the absence of bacteria). Subsequently, the inoculated and control seeds were planted in 6" pots filled with sand. 10 seeds were planted per pot and 1 pot was planted per treatment, and alternately watered and modified Hoagland's solution as needed. The pots were incubated for 13 days under a natural light/dark cycle at approximately 21 ° C in a laboratory window sill, at which time the plants were recovered and the parameters were measured. The dry weight was determined as the total weight of each 9 plants, and the results were determined by Bacillus amyloliquefaciens. The total average plant dry weight of the plants inoculated with the RTI 301 strain was equal to 36.1 mg, compared to the weight of the uninoculated control equal to 33.38 mg and the dry weight increased by 8.1% compared to the uninoculated control. Photographs of the plants extracted after 13 days of growth Shown in Figure 2. Figure 2A shows plants inoculated with RTI301 and Figure 2B shows control plants.
另外,進行另一實驗,展示解澱粉芽孢桿菌RTI301菌株對小麥中早期生長之有益作用。藉由在10+8CFU/ml細菌之懸浮液中在室溫下在震盪下接種表面滅菌之發芽小麥種子2天來進行實驗。隨後,接種種子種植在1加侖填充有用石灰處理至pH 6.5之PROMIX BX之盆中。對於各處理,將9盆撒佈12顆種子,該等種子以2.5cm深度種植。盆在溫室中在22℃下在14/10hr光與暗循環下培育,且按需要一週澆水兩次。生長28天後植物之照片展示於圖3中。圖3A展示用RTI301接種之植物且圖3B展示對照植物。 In addition, another experiment was conducted to demonstrate the beneficial effects of the B. amyloliquefaciens RTI301 strain on early growth in wheat. The experiments were carried out by inoculating surface-sterilized germinated wheat seeds under shaking for 10 days at room temperature in a suspension of 10 +8 CFU/ml bacteria. Subsequently, the inoculated seeds were planted in a 1 gallon filled pot of PROMIX BX treated with lime to pH 6.5. For each treatment, 12 seeds were sprinkled with 9 pots, and the seeds were planted at a depth of 2.5 cm. The pots were incubated in a greenhouse at 22 ° C under 14/10 hr light and dark cycles and watered twice as needed. A photograph of the plants after 28 days of growth is shown in Figure 3. Figure 3A shows plants inoculated with RTI301 and Figure 3B shows control plants.
在盤分析中量測RTI301分離株對抗主要植物病原體之拮抗能力。藉由在869瓊脂培養盤上以4cm距離使細菌分離株及病原性真菌並排生長進行評估對抗植物真菌病原體之拮抗作用的盤分析。在室溫下培育培養盤,且長達兩週定期檢查生長行為,諸如生長抑制、地位佔用或無效果。在針對對抗細菌病原體之拮抗特性篩選之情況下,病原體首先在869瓊脂培養盤上擴散為菌苔。隨後,將各分離株之培養物之20μl等分試樣點樣於培養盤上。在室溫下培育培養盤,且長達兩週定期檢查已施用RTI301之位置周圍的菌苔中之抑制區。下表I展示拮抗活性之概述。RTI301菌株展示對抗廣泛範圍之植物病原性微生物的拮抗特性。 The antagonistic ability of the RTI301 isolate against major plant pathogens was measured in disk assays. Disc analysis against antagonism of plant fungal pathogens was evaluated by growing bacterial isolates and pathogenic fungi side by side on a 869 agar plate at 4 cm distance. The plates were incubated at room temperature and examined for growth behavior for up to two weeks, such as growth inhibition, status occupancy or no effect. In the case of screening for antagonistic properties against bacterial pathogens, the pathogen first spreads to the lawn on the 869 agar plate. Subsequently, a 20 μl aliquot of the culture of each isolate was spotted on a culture plate. The plate was incubated at room temperature and the zone of inhibition in the lawn around the site where RTI301 had been applied was periodically checked for up to two weeks. Table I below shows an overview of antagonistic activity. The RTI 301 strain exhibits antagonistic properties against a wide range of phytopathogenic microorganisms.
+++活性極強,++活性強,+活性,+-活性弱,-未觀測到活性 +++ very strong activity, strong ++ activity, + activity, weak activity -- no activity observed
除對植物生長之積極作用及拮抗特性之外,亦量測解澱粉芽孢桿菌RTI301菌株之各種表現性狀,且資料展示於下表II中。根據表II下方文字中所描述之程序進行分析。 In addition to the positive effects on plant growth and antagonistic properties, various performance traits of Bacillus amyloliquefaciens RTI301 strains were also measured and the data are shown in Table II below. Analyze according to the procedure described in the text below Table II.
+++極強,++強,+有些,+-弱,-未觀測到 +++ is very strong, ++ strong, + some, +-weak, - not observed
酸及乙偶姻測試. 將20μl含菌元培養物之869培養基轉移至1ml甲基紅-Voges Proskauer培養基(Sigma Aldrich 39484)。培養物在30℃、200rpm下培育2天。轉移0.5ml培養物,且添加50μl 0.2g/l甲基紅。紅色指示產酸。其餘0.5ml培養物與0.3ml 5% α-萘酚(Sigma Aldrich N1000),隨後0.1ml 40% KOH混合。培育30分鐘後解譯樣品。紅色顯影指示乙偶姻產生。對於酸及乙偶姻測試,未接種培養基用作陰性對照(Sokol等人,1979,Journal of Clinical Microbiology.9:538-540)。 Acid and acetoin test. 20 μl of 869 medium containing bacterial culture was transferred to 1 ml of methyl red-Voges Proskauer medium (Sigma Aldrich 39484). The culture was incubated at 30 ° C, 200 rpm for 2 days. 0.5 ml of the culture was transferred, and 50 μl of 0.2 g/l methyl red was added. Red indicates acid production. The remaining 0.5 ml of the culture was mixed with 0.3 ml of 5% alpha-naphthol (Sigma Aldrich N1000) followed by 0.1 ml of 40% KOH. Samples were interpreted after 30 minutes of incubation. Red development indicates the occurrence of acetoin. For the acid and acetoin tests, the uninoculated medium was used as a negative control (Sokol et al., 1979, Journal of Clinical Microbiology. 9: 538-540).
吲哚-3-乙酸 . 將20μl含菌元培養物之豐富869培養基轉移至補充有0.5g/l色胺酸之1ml 1/10 869培養基(Sigma Aldrich T0254)。在暗處在30℃、200RPM下培育培養物4-5天。使樣品離心,且使0.1ml上清液與0.2ml薩爾科夫斯基氏試劑(Salkowski's Reagent)(35%過氯酸,10mM FeCl3)混合。在暗處培育30分鐘後,產生粉紅色之樣品記錄為對IAA合成呈陽性。IAA稀釋液(Sigma Aldrich I5148)用作陽性比較;未接種培養基用作陰性對照(Taghavi等人,2009,Applied and Environmental Microbiology 75:748-757)。 Indole-3-acetic acid . 20 μl of the rich 869 medium containing the bacterial culture was transferred to 1 ml of 1/10 869 medium (Sigma Aldrich T0254) supplemented with 0.5 g/l of tryptophan. Cultures were incubated for 4-5 days at 30 ° C, 200 RPM in the dark. The sample was centrifuged and 0.1 ml of the supernatant was mixed with 0.2 ml of Salkowski's Reagent (35% perchloric acid, 10 mM FeCl3). After incubation for 30 minutes in the dark, the pink-producing sample was recorded as positive for IAA synthesis. IAA dilution (Sigma Aldrich I5148) was used as a positive comparison; uninoculated medium was used as a negative control (Taghavi et al, 2009, Applied and Environmental Microbiology 75: 748-757).
磷酸鹽溶解測試 . 將細菌接種於皮科夫斯卡婭(PVK)瓊脂培養基上,該培養基由每公升10g葡萄糖、5g三磷酸鈣、0.2g氯化鉀、0.5g硫酸銨、0.2g氯化鈉、0.1g硫酸鎂七水合物、0.5g酵母提取物、2mg硫酸錳、2mg硫酸鐵及15g瓊脂組成,pH為7,高壓滅菌。清除區指示磷酸鹽溶解細菌(Sharma等人,2011,Journal of Microbiology and Biotechnology Research 1:90-95)。 Phosphate Dissolution Test . Bacteria were inoculated on Picokovskaya (PVK) agar medium consisting of 10 g of glucose per liter, 5 g of calcium triphosphate, 0.2 g of potassium chloride, 0.5 g of ammonium sulfate, 0.2 g of chlorination. Sodium, 0.1 g of magnesium sulfate heptahydrate, 0.5 g of yeast extract, 2 mg of manganese sulfate, 2 mg of iron sulfate and 15 g of agar, pH 7, and autoclaved. The clearance zone indicates phosphate lytic bacteria (Sharma et al, 2011, Journal of Microbiology and Biotechnology Research 1: 90-95).
殼質酶活性 . 將10%濕重膠狀殼質添加至經改質之PVK瓊脂培養基(每公升10g葡萄糖、0.2g氯化鉀、0.5g硫酸銨、0.2g氯化鈉、0.1 g硫酸鎂七水合物、0.5g酵母提取物、2mg硫酸錳、2mg硫酸鐵及15g瓊脂,pH為7,高壓滅菌)中。細菌塗鋪在此等殼質盤上;清除區指示殼質酶活性(N.K.S.Murthy及Bleakley.,2012.「Simplified Method of Preparing Colloidal Chitin Used for Screening of Chitinase Producing Microorganisms」.The Internet Journal of Microbiology.10(2))。 Chitinase activity . Add 10% wet weight gelatinous shell to the modified PVK agar medium (10g glucose, 0.2g potassium chloride, 0.5g ammonium sulfate, 0.2g sodium chloride, 0.1g magnesium sulfate per liter) Heptahydrate, 0.5 g yeast extract, 2 mg manganese sulfate, 2 mg iron sulfate and 15 g agar, pH 7, autoclaved). Bacteria are plated on these hull disks; the clearance zone indicates chitinase activity (NKSMurthy and Bleakley., 2012. "Simplified Method of Preparing Colloidal Chitin Used for Screening of Chitinase Producing Microorganisms". The Internet Journal of Microbiology .10 ( 2)).
蛋白酶活性 . 細菌塗鋪在補充有10%牛奶之869瓊脂培養基上。清除區指示分解蛋白質之能力,表明蛋白酶活性(Sokol等人,1979,Journal of Clinical Microbiology.9:538-540)。 Protease activity . Bacteria were spread on 869 agar medium supplemented with 10% milk. The clearance zone indicates the ability to decompose proteins, indicating protease activity (Sokol et al., 1979, Journal of Clinical Microbiology. 9: 538-540).
在溫室中對大豆進行研究以確定解澱粉芽孢桿菌RTI301菌株預防及/或減輕植物病原體豆銹病(菜豆銹病菌)及植物病原體灰葡萄孢菌之作用的能力。 Soybeans were studied in a greenhouse to determine the ability of the B. amyloliquefaciens RTI301 strain to prevent and/or alleviate the effects of the plant pathogen bean rust (Nicky rust fungus) and the plant pathogen Botrytis cinerea.
在第一組實驗中,針對葉面施用以控制植物病原體菜豆銹病菌及灰葡萄孢菌,測試解澱粉芽孢桿菌RTI301菌株之不同調配物。實驗設計及調配物如下: In the first set of experiments, different formulations of Bacillus amyloliquefaciens RTI301 strain were tested for foliar application to control the plant pathogen Phytophthora rust and Botrytis cinerea. The experimental design and formulation are as follows:
調配物: Formulation :
廢醱酵液(SFB)中解澱粉芽孢桿菌RTI301孢子,於水中稀釋約100倍且以1×108cfu/ml之施用率施用於葉。 The spores of Bacillus amyloliquefaciens RTI301 in waste broth (SFB) were diluted about 100 times in water and applied to the leaves at an application rate of 1 x 10 8 cfu/ml.
廢醱酵液(SFB)中解澱粉芽孢桿菌RTI301孢子,於水中稀釋約100倍且添加酵母提取物且以1×108cfu/ml之施用率及約0.2%酵母提取物施用於葉。 The spores of Bacillus amyloliquefaciens RTI301 in waste broth (SFB) were diluted about 100-fold in water and yeast extract was added and applied to the leaves at an application rate of 1 x 10 8 cfu/ml and about 0.2% yeast extract.
SERENADE OPTIMUM(BAYER CROP SCIENCE,INC)產品以1×108cfu/ml枯草桿菌菌株QST713孢子之施用率施用。 The SERENADE OPTIMUM (BAYER CROP SCIENCE, INC) product was applied at a rate of application of 1 x 10 8 cfu/ml of B. subtilis strain QST713 spores.
HORIZON(HORIZON AG-PRODUCTS)產品以50g a.i./ha之施用 率(得克利)施用。 HORIZON (HORIZON AG-PRODUCTS) product is applied at 50g a.i./ha Rate (Dickley) applied.
BRAVO WEATHER STIK(SYNGENTA CROP PROTECTION,INC)產品以500g a.i./ha之施用率施用(四氯異苯腈)。 The BRAVO WEATHER STIK (SYNGENTA CROP PROTECTION, INC) product was applied at an application rate of 500 g a.i./ha (tetrachloroisophthalonitrile).
TACTIC(LOVELAND PRODUCTS,INC)產品以0.1875% v/v之濃度包括於所有上列調配物中。 TACTIC (LOVELAND PRODUCTS, INC) products are included in all of the above formulations at a concentration of 0.1875% v/v.
處理施用方法: Treatment application method :
軌道噴霧器(track sprayer)用於用各種上列處理接種21日齡常見豆類植物(具有兩個三葉),該噴霧器具有單一頂部噴嘴(TeeJet SS8001E平扇形),壓力=276kPa(40psi)。噴嘴高度為超過豆類植物葉子36cm(14")。施用體積為200L/ha且實驗中重複數目等於六次。處理植物單次接種以及對照植物未接收任何處理。 A track sprayer was used to inoculate 21 day old common legumes (with two trifolials) with various top treatments with a single top nozzle (TeeJet SS8001E flat fan) and pressure = 276 kPa (40 psi). The nozzle height was 36 cm (14") above the leaves of the legumes. The application volume was 200 L/ha and the number of replicates in the experiment was equal to six times. The single treatment of the treated plants and the control plants did not receive any treatment.
感染率: Infection rate :
處理施用一天後,測試植物以200k分生孢子/毫升之接種率感染豆銹病(菜豆銹病菌)。 One day after the treatment, the test plants were infected with bean rust (Nicky rust) at a vaccination rate of 200 k conidia/ml.
感染豆銹病(菜豆銹病菌)九天後,評估以下各者之疾病控制%:單獨用水稀釋100倍之廢醱酵液中RTI301孢子(「RTI301+1% SFB」)、用水稀釋100倍之廢醱酵液中RTI301孢子加上酵母提取物(「RTI301+1% SFB+酵母提取物」)、根據上述施用率之BRAVO WEATHER STIK、HORIZON及SERENADE OPTIMUM。未經處理之對照(僅水)產生28%疾病。 Nine days after infection with bean rust (Nicky rust), the disease control % of each of the following was evaluated: RTI301 spores ("RTI301+1% SFB") in 100% of the waste broth diluted with water, diluted 100 times with water. In the yeast solution, RTI301 spore plus yeast extract ("RTI301+1% SFB+ yeast extract"), BRAVO WEATHER STIK, HORIZON and SERENADE OPTIMUM according to the above application rates. An untreated control (water only) produced 28% of the disease.
實驗結果展示於表III中。結果表明對於RTI301菌株,添加酵母提取物使得與未添加酵母提取物下施用之RTI301菌株相比疾病控制增加約40%。當以相同施用率(亦即1×108cfu/ml)施用時,RTI301+1% SFB+酵母提取物展現之疾病控制量類似於針對SERENADE OPTIMUM所觀測之結果,即使RTI301調配物中SFB之量相對較低,為1%,且SFB可預期含有具有抗真菌活性之分泌化合物。 The experimental results are shown in Table III. The results indicate that for the RTI301 strain, the addition of the yeast extract resulted in an increase in disease control of about 40% compared to the RTI301 strain administered without the addition of the yeast extract. When administered at the same application rate (i.e., 1 x 10 8 cfu/ml), the RTI301 + 1% SFB + yeast extract exhibited a disease control amount similar to that observed for SERENADE OPTIMUM, even though the amount of SFB in the RTI301 formulation Relatively low, it is 1%, and SFB is expected to contain secretory compounds with antifungal activity.
使用上列相同調配物及實驗設計在胡椒植物中進行之實驗觀測到類似結果,該實驗量測RTI301展現之對病原體灰葡萄孢菌所引起之胡椒葡萄孢疫病的疾病控制量(資料未展示)。 A similar result was observed using the same formulation and experimental design listed above in pepper plants, which measured the disease control of bacillus blight spores caused by the pathogen Botrytis cinerea (data not shown) .
以下實驗描述RTI301對由植物病原體菜豆銹病菌所引起之豆銹病的疾病控制。實驗設計及調配物如下: The following experiment describes the disease control of RTI301 against bean rust caused by the phytopathogen Phytophthora rust. The experimental design and formulation are as follows:
調配物: Formulation :
解澱粉芽孢桿菌RTI301孢子在廢醱酵液(SFB)中,於水中稀釋約100倍且添加酵母提取物且以1×108cfu/ml之施用率及約0.2%酵母提取物施用於葉。 The B. amyloliquefaciens RTI301 spores were diluted about 100-fold in water in spent broth (SFB) and yeast extract was added and applied to the leaves at an application rate of 1 x 10 8 cfu/ml and about 0.2% yeast extract.
SERENADE OPTIMUM(BAYER CROP SCIENCE,INC)產品以1×108cfu/ml及4×108cfu/ml之施用率施用。 The SERENADE OPTIMUM (BAYER CROP SCIENCE, INC) product was applied at an application rate of 1 x 10 8 cfu/ml and 4 x 10 8 cfu/ml.
TACTIC(LOVELAND PRODUCTS,INC)以0.1875% v/v之濃度施用至所有調配物。 TACTIC (LOVELAND PRODUCTS, INC) was applied to all formulations at a concentration of 0.1875% v/v.
HORIZON(HORIZON AG-PRODUCTS)以50g a.i./ha之施用率(得克利)施用。 HORIZON (HORIZON AG-PRODUCTS) was applied at an application rate of 50 g a.i./ha (Dickley).
四氯異苯腈以500g a.i./ha之施用率施用。 Tetrachloroisophthalonitrile was applied at an application rate of 500 g a.i./ha.
處理施用方法: Treatment application method :
軌道噴霧器用於用各種上列處理接種21日齡豆類植物(具有兩個三葉),該噴霧器具有單一頂部噴嘴(TeeJet SS8001E平扇形),壓力=276kPa(40psi)。噴嘴高度為超過大豆植物葉子36cm(14")。施用體積為200L/ha且實驗中重複數目等於六次。處理植物單次接種以及對照植物未接收任何處理。 A track sprayer was used to inoculate 21 day old legumes (with two trifolials) with various top treatments with a single top nozzle (TeeJet SS8001E flat fan) and pressure = 276 kPa (40 psi). The nozzle height was 36 cm (14") above the leaves of the soybean plant. The application volume was 200 L/ha and the number of replicates in the experiment was equal to six times. The single treatment of the treated plants and the control plants did not receive any treatment.
感染率:Infection rate:
處理施用一天後,測試植物以200k分生孢子/毫升之接種率感染豆銹病(菜豆銹病菌)。感染豆銹病(菜豆銹病菌)十天後,評估以下各者之疾病控制%:廢醱酵液(SFB)中RTI301孢子(以1×108cfu/ml施用)、SERENADE OPTIMUM(以1×108cfu/ml施用)、SERENADE OPTIMUM(以4×108cfu/ml施用)、得克利(以50g a.i./ha施用)及四氯異苯腈(以50g a.i./ha施用)。亦包括作為對照之TACTIC(以0.1875%施用)施用於所有調配物。檢查對照產生23%疾病。實驗結果展示在以下表IV及圖4中。 One day after the treatment, the test plants were infected with bean rust (Nicky rust) at a vaccination rate of 200 k conidia/ml. Ten days after infection with soybean rust (Rh. solani), the disease control % of each of the following were evaluated: RTI301 spores (administered at 1 × 10 8 cfu/ml) and SERENADE OPTIMUM (1 × 10) in waste broth (SFB) 8 cfu/ml application), SERENADE OPTIMUM (administered at 4 x 10 8 cfu/ml), Dekli (administered at 50 g ai/ha) and tetrachloroisophthalonitrile (administered at 50 g ai/ha). TACTIC (administered at 0.1875%) was also included as a control for all formulations. The check control produced 23% of the disease. The experimental results are shown in Table IV below and Figure 4.
在另一類似實驗中,在溫室中對豆類植物進行研究以確定在變化病原體接種率下解澱粉芽孢桿菌RTI301菌株預防及/或減輕植物病原體豆銹病(菜豆銹病菌)作用之能力。所用調配物及處理方法與針對 先前實驗所述相同。 In another similar experiment, soybean plants were studied in a greenhouse to determine the ability of the B. amyloliquefaciens RTI301 strain to prevent and/or alleviate the effects of plant pathogen bean rust (Nicky rust fungus) under varying pathogen inoculation rates. Formulations and treatment methods used The same was stated in previous experiments.
感染率:Infection rate:
處理施用後一天,測試植物以50k至300k分生孢子/毫升範圍內之接種率感染豆銹病(菜豆銹病菌)。在感染豆銹病(菜豆銹病菌)十天之後,評估以下各者之疾病控制%:廢醱酵液(SFB)中RTI301孢子(以1×108cfu/ml施用)及SERENADE OPTIMUM(以1×108cfu/ml及4×108cfu/ml施用)及HORIZON(得克利;以50g a.i./ha施用)。亦包括作為對照之TACTIC(以0.1875%施用)施用於所有調配物。檢查對照中之疾病%為50k=6%,100k=6%,150k=15%,200k=15%,且300k=7%。實驗結果展示在以下表V及圖5中。 One day after the treatment, the test plants were infected with soybean rust (Nicky rust) at an inoculation rate ranging from 50 k to 300 k conidia/ml. Ten days after infection with soybean rust (Nicky rust), the disease control % of each of the following: RTI301 spores (administered at 1 × 10 8 cfu/ml) and SERENADE OPTIMUM (with 1 ×) in waste broth (SFB) were evaluated. 10 8 cfu/ml and 4×10 8 cfu/ml application) and HORIZON (dickley; administered at 50 g ai/ha). TACTIC (administered at 0.1875%) was also included as a control for all formulations. The % of the disease in the control was 50k=6%, 100k=6%, 150k=15%, 200k=15%, and 300k=7%. The experimental results are shown in Table V below and Figure 5.
研究在黃瓜田間試驗中進行以確定解澱粉芽孢桿菌RTI301菌株預防及/或減輕植物病原體葫蘆疾病白粉病作用的能力。 The study was conducted in a cucumber field trial to determine the ability of B. amyloliquefaciens RTI301 to prevent and/or alleviate the powdery mildew effect of the plant pathogen cucurbit disease.
整體上,各產品進行6次施用,其中施用之間的時間間隔為5至7 天。第一次施用之時間安排視特定作物而定且在種植時、作物萌芽後幾週、開花時、出現疾病時或預期疾病即將出現前的範圍內。 Overall, each product was applied 6 times with a time interval between 5 and 7 between applications. day. The timing of the first application depends on the particular crop and is within the range of the crop, the weeks after the crop is germinated, the flowering, the disease, or the expected disease.
調配物:Formulation:
SERENADE OPTIMUM(BAYER CROP SCIENCE,INC)以1400g/ha,對應於1.8×10+13CFU/ha之施用率施用。 SERENADE OPTIMUM (BAYER CROP SCIENCE, INC ) to 1400g / ha, corresponding to 1.8 × 10 +13 CFU / ha, of administration.
解澱粉芽孢桿菌RTI301孢子在廢醱酵液(SFB)中且添加酵母提取物,且施用於葉之施用率對應於與基於1400g/ha施用率及約0.01%至0.2%之酵母提取物,針對SERENADE OPTIMUM所推薦相同之菌落形成單位/公頃(CFU/ha)。 The Bacillus amyloliquefaciens RTI301 spore is in the waste mash (SFB) and the yeast extract is added, and the application rate to the leaves corresponds to the yeast extract based on the application rate of about 1400 g/ha and about 0.01% to 0.2%, The same colony forming units/ha (CFU/ha) are recommended by SERENADE OPTIMUM.
TACTIC(LOVELAND PRODUCTS,INC)以0.1875%v/v之濃度施用且包括在所有處理中。 TACTIC (LOVELAND PRODUCTS, INC) was applied at a concentration of 0.1875% v/v and was included in all treatments.
LUNA EXPERIENCE(BAYER CROP SCIENCE,INC)以500g a.i./ha之施用率施用(氟吡菌醯胺加上得克利殺真菌劑)。 LUNA EXPERIENCE (BAYER CROP SCIENCE, INC) was applied at an application rate of 500 g a.i./ha (fluopyram and dextrobacter fungicide).
BRAVO WEATHER STIK(SYNGENTA CROP PROTECTION,INC)以2240g a.i./ha之施用率施用(四氯異苯腈)。 BRAVO WEATHER STIK (SYNGENTA CROP PROTECTION, INC) was applied at an application rate of 2240 g a.i./ha (tetrachloroisophthalonitrile).
實驗設計如下:未經處理之對照、RTI301+TACTIC、SERENADE OPTIMUM+TACTIC及BRAVO WEATHER STIK+LUNA EXPERIENCE+TACTIC。 The experimental design is as follows: untreated control, RTI301+TACTIC, SERENADE OPTIMUM+TACTIC, and BRAVO WEATHER STIK+LUNA EXPERIENCE+TACTIC.
處理施用方法:Treatment application method:
如上所述進行六次施用。施用噴霧器設定為輸送30加侖/英畝。個別小塊土地使用具有平扇形噴嘴(8004類型)之CO2背包式噴霧器以4mph之地速噴灑且各噴嘴相隔18吋。 Six applications were performed as described above. The sprayer was set to deliver 30 gallons per acre. Individual plots were sprayed at a ground speed of 4 mph using a CO 2 backpack sprayer with a flat fan nozzle (type 8004) and each nozzle was 18 inches apart.
疾病評分:針對各處理,評估植物之5片葉子之疾病嚴重程度平均%。評估來自各處理之四個小塊土地的作物反應及白粉病之疾病控制。在各施用之後,即將下一次施用前,將試驗評級。白粉病來自天然感染。 Disease score: For each treatment, the average degree of disease severity of the 5 leaves of the plants was evaluated. Evaluation of crop response and disease control of powdery mildew from four plots of each treatment. After each application, the test will be rated just prior to the next application. Powdery mildew comes from natural infections.
實驗結果展示在以下表VI中且表明與SERENADE OPTIMUM相比,當以相同施用率施用時,作為單獨生物殺真菌劑,黃瓜中白粉病之控制類似。 The results of the experiment are shown in Table VI below and indicate that the control of powdery mildew in cucumber is similar when applied at the same application rate as a separate biofungicide compared to SERENADE OPTIMUM.
在番茄田間試驗中進行研究以確定解澱粉芽孢桿菌RTI301菌株預防及/或減輕植物病原體番茄細菌性斑病(黃單孢菌屬)作用的能力。 Studies were conducted in a tomato field trial to determine the ability of B. amyloliquefaciens RTI301 to prevent and/or alleviate the effects of the plant pathogen tomato bacterial spot disease (Homomonospora).
對作物總共進行4次施用,其中施用之間的時間間隔為5至7天。在將生物活性成分與化學活性成分之施用組合的方案4之情況下,第一次及第三次施用用生物活性成分進行,而第二次及第四次施用用化學活性成分進行。 A total of 4 applications were applied to the crop with a time interval between administrations of 5 to 7 days. In the case of Scheme 4 in which the bioactive component is combined with the administration of the chemically active ingredient, the first and third administrations are carried out with the biologically active ingredient, and the second and fourth administrations are carried out with the chemically active ingredient.
調配物:Formulation:
SERENADE OPTIMUM以1400g/ha之施用率,對應於1.8×10+13CFU/ha施用。 SERENADE OPTIMUM an application rate of 1400g / ha of, corresponding to 1.8 × 10 +13 CFU / ha administration.
解澱粉芽孢桿菌RTI301孢子在廢醱酵液(SFB)中且添加酵母提取物,且施用於葉之施用率對應於與基於1400g/ha施用率及約0.01%至0.2%酵母提取物,針對SERENADE OPTIMUM所推薦相同之菌落形成單位/公頃。 Bacillus amyloliquefaciens RTI301 spores are in waste mash (SFB) and yeast extract is added, and the application rate to the leaves corresponds to an application rate based on 1400 g/ha and about 0.01% to 0.2% yeast extract for SERENADE The same colony forming units/ha are recommended by OPTIMUM.
TACTIC(LOVELAND PRODUCTS,INC)以0.1875%v/v之濃度施 用。 TACTIC (LOVELAND PRODUCTS, INC) is applied at a concentration of 0.1875% v/v use.
KOCIDE 3000(DUPONT USA)以1850g a.i./ha之施用率(氫氧化銅殺真菌劑)施用。 KOCIDE 3000 (DUPONT USA) was applied at an application rate of 1850 g a.i./ha (copper hydroxide fungicide).
BRAVO WEATHER STIK(SYNGENTA CROP PROTECTION,INC)以2240g a.i./ha之施用率施用(四氯異苯腈)。 BRAVO WEATHER STIK (SYNGENTA CROP PROTECTION, INC) was applied at an application rate of 2240 g a.i./ha (tetrachloroisophthalonitrile).
實驗設計如下:未經處理之對照、RTI301+TACTIC、SERENADE OPTIMUM+TACTIC、SERENADE OPTIMUM+KOCIDE 3000+TACTIC及BRAVO WEATHER STIK+KOCIDE 3000+TACTIC。 The experimental design is as follows: untreated control, RTI301+TACTIC, SERENADE OPTIMUM+TACTIC, SERENADE OPTIMUM+KOCIDE 3000+TACTIC and BRAVO WEATHER STIK+KOCIDE 3000+TACTIC.
處理施用方法:Treatment application method:
將四次分開處理施用輸送至作物,其中各施用之間的時間間隔為5至7。施用噴霧器設定為輸送40加侖/英畝。個別小塊土地使用具有錐形噴嘴之CO2背包式噴霧器以3mph之地速噴灑且各噴嘴相隔12吋。輸送化學品之載劑為混合在2.5公升瓶中之水。 Four separate treatment applications were delivered to the crop with a time interval between 5 and 7 for each application. The sprayer was set to deliver 40 gallons per acre. Individual plots were sprayed at 3 mph using a CO 2 backpack sprayer with a conical nozzle and each nozzle was 12 相 apart. The carrier that transports the chemical is water mixed in a 2.5 liter bottle.
疾病嚴重程度藉由評估樹冠來量測。疾病嚴重程度平均%在各處理之植物中間評估。疾病控制百分比基於考慮患病、未經處理之對照植物為100%。資料展示於以下表VII中。處理包括:未經處理之對照、RTI301+TACTIC、SERENADE OPTIMUM+TACTIC、SERENADE OPTIMUM+KOCIDE 3000+TACTIC及BRAVO WEATHER STIK+KOCIDE 3000+TACTIC。 The severity of the disease was measured by assessing the canopy. The average % of disease severity was assessed in the middle of each treated plant. The percentage of disease control was based on 100% of diseased, untreated control plants. The data is shown in Table VII below. Treatments include: untreated control, RTI301+TACTIC, SERENADE OPTIMUM+TACTIC, SERENADE OPTIMUM+KOCIDE 3000+TACTIC, and BRAVO WEATHER STIK+KOCIDE 3000+TACTIC.
實驗結果展示在以下表VII中。用RTI301+TACTIC、SERENADE OPTIMUM+TACTIC及BRAVO WEATHER STIK+KOCIDE 3000+TACTIC處理同等良好地控制蕃茄中番茄細菌性斑病(黃單孢菌屬)。 The experimental results are shown in Table VII below. The RTI301+TACTIC, SERENADE OPTIMUM+TACTIC and BRAVO WEATHER STIK+KOCIDE 3000+TACTIC treatments were used to control tomato bacterial spot disease (Homomonospora) in tomatoes equally well.
表VII. 與SERENADE OPTIMUM及其他化學活性劑相比,解澱粉芽孢桿菌RTI301對蕃茄中番茄細菌性斑病(黃單孢菌屬)之控制結果
在喬治亞州(Georgia)之小麥、大豆、玉米、黃瓜及番茄田間試驗中進行研究以確定解澱粉芽孢桿菌RTI301菌株預防及/或減輕黃單抱菌屬引起之植物病原體小麥赤黴病、大豆銹病、玉米銹病、黃瓜白粉病及番茄細菌性斑病之作用的能力。 Studies in wheat, soybean, corn, cucumber, and tomato field trials in Georgia to determine that B. amyloliquefaciens RTI301 strain prevents and/or alleviates plant pathogens caused by Pseudomonas aeruginosa, wheat scab, soybean rust , the ability of corn rust, cucumber powdery mildew and tomato bacterial spot disease.
針對RTI301及SERENADE OPTIMUM各者,SERENADE OPTIMUM使用1400g/ha之施用率,且RTI301使用對應於基於1400g/ha施用率,針對SERENADE OPTIMUM所推薦相同之菌落形成單位/公頃的施用率,進行施用。 For each of RTI 301 and SERENADE OPTIMUM, SERENADE OPTIMUM used an application rate of 1400 g/ha, and RTI 301 was applied using an application rate corresponding to the same colony forming unit/ha for SERENADE OPTIMUM based on an application rate of 1400 g/ha.
一或多次處理施用輸送至作物,其中施用之間的時間間隔為5至7天。施用次數及第一次施用之時間安排視特定作物而定且在種植時、作物萌芽後幾週、開始開花時、出現疾病時或預期疾病即將出現時的範圍內。施用噴霧器設定為輸送20-30加侖/英畝(1891/ha)。個別小塊土地使用具有雙平扇形噴嘴之CO2背包式噴霧器(8003型或8004型)以3-4mph之地速噴灑。 One or more treatments are administered to the crop with a time interval between administrations of 5 to 7 days. The number of applications and the timing of the first application are dependent on the particular crop and are within the range of the time of planting, weeks after the germination of the crop, the onset of flowering, the onset of disease, or the onset of the expected disease. The application sprayer was set to deliver 20-30 gallons per acre (1891/ha). Individual plots were sprayed at 3-4 mph using a CO 2 backpack sprayer (Model 8003 or 8004) with double flat fan nozzles.
對於小麥赤黴病,在作物開始開花時對植物進行單一處理施用。處理三天後,植物用赤黴病病原體玉米赤黴(亦稱為禾穀鐮刀菌)人工感染。藉由確定受赤黴病影響(小穗變白)之小麥頭部百分比來量測疾病嚴重程度。疾病嚴重程度之控制百分比係基於考慮未經處理之對照植物中疾病嚴重程度%為100%。資料展示於以下表VIII中。 For wheat scab, the plants are applied in a single treatment when the crop begins to flower. After three days of treatment, the plants were artificially infected with the pathogen of the scab, Zea mays (also known as Fusarium graminearum). Disease severity was measured by determining the percentage of wheat head affected by scab (white spikes). The percent control of disease severity is based on considering that the % disease severity in untreated control plants is 100%. The data is shown in Table VIII below.
對於大豆銹病,對植物進行6次處理施用。初始施用在生長R1階 段輸送。此試驗具有天然感染。疾病嚴重程度藉由評估莖幹及樹冠量測。特定言之,每個小塊土地六個2呎區段評估為子樣品且嚴重程度藉由自整個樹冠評估展示銹病症狀之葉百分比來確定。疾病嚴重程度之控制百分比係基於考慮未經處理之對照植物中疾病嚴重程度%為100%。資料展示於以下表VIII中。 For soybean rust, the plants were applied 6 times. Initial application in growth R1 Segment delivery. This test has a natural infection. The severity of the disease was measured by assessing the stem and canopy. In particular, six 2呎 segments per plot were evaluated as subsamples and the severity was determined by assessing the percentage of leaves showing rust symptoms from the entire canopy. The percent control of disease severity is based on considering that the % disease severity in untreated control plants is 100%. The data is shown in Table VIII below.
對於玉米銹病,對植物進行6次處理施用。此試驗具有天然感染。疾病嚴重程度藉由評估樹冠量測。每個小塊土地六個2呎區段評估為子樣品且嚴重程度藉由自整個樹冠評估展示銹病症狀之葉百分比來確定。疾病嚴重程度評分為每1m列之命中數目。評估來自各處理之四個小塊土地的作物反應及玉米銹病之疾病控制。疾病嚴重程度之控制百分比係基於考慮未經處理之對照植物中疾病嚴重程度%為100%。資料展示於以下表VIII中。 For corn rust, plants were treated 6 times. This test has a natural infection. The severity of the disease was measured by assessing the canopy. Six 2 呎 sections of each plot were evaluated as subsamples and the severity was determined by assessing the percentage of leaves showing rust symptoms from the entire canopy. The severity of the disease was scored as the number of hits per 1 m column. The crop response from the four plots of each treatment and the disease control of corn rust were assessed. The percent control of disease severity is based on considering that the % disease severity in untreated control plants is 100%. The data is shown in Table VIII below.
對於黃瓜白粉病,在作物萌芽約3週之後對植物進行6次處理施用。疾病嚴重程度平均%在各處理之植物5片葉子中評估。評估來自各處理之四個小塊土地的作物反應及白粉病之疾病控制。在各施用之後,快要下一次施用前,將試驗評級。白粉病來自天然感染。疾病嚴重程度之控制百分比係基於考慮未經處理之對照植物中疾病嚴重程度%為100%。資料展示於以下表VIII中。 For cucumber powdery mildew, the plants were applied 6 times after the crop was germinated for about 3 weeks. The mean % disease severity was assessed in 5 leaves of each treated plant. Evaluation of crop response and disease control of powdery mildew from four plots of each treatment. After each application, the test was rated just prior to the next application. Powdery mildew comes from natural infections. The percent control of disease severity is based on considering that the % disease severity in untreated control plants is 100%. The data is shown in Table VIII below.
對於番茄細菌性斑病,對植物進行6次處理施用。藉由在樹冠進行觀察且評估受影響葉之百分比來量測疾病嚴重程度。疾病嚴重程度之控制百分比係基於考慮未經處理之對照植物中疾病嚴重程度%為100%。資料展示於以下表VIII中。 For tomato bacterial spot disease, the plants were applied 6 times. Disease severity was measured by observing in the canopy and assessing the percentage of affected leaves. The percent control of disease severity is based on considering that the % disease severity in untreated control plants is 100%. The data is shown in Table VIII below.
表VIII. 與SERENADE OPTIMUM相比,解澱粉芽孢桿菌RTI301對小麥赤黴病、大豆銹病、玉米銹病、黃瓜白粉病及番茄細菌性斑病之疾病控制的結果
* 疾病嚴重程度之控制百分比係基於考慮未經處理之對照植物中疾病嚴重程度%為100%。 * The percentage control of disease severity is based on considering that the % disease severity in untreated control plants is 100%.
+PMD:白粉病 + PMD: Powdery mildew
如藉由未經處理之對照%所量測,RTI301比SERENADE OPTIMUM更好地控制小麥赤黴病及大豆銹病。在控制黃瓜白粉病、玉米銹病及番茄細菌性斑病上,如藉由未經處理之對照%所量測,RTI301與SERENADE OPTIMUM相當。在處理施用方案中,未指出RTI301具有陰性作物反應。 RTI301 better controls wheat scab and soybean rust than SERENADE OPTIMUM, as measured by untreated control %. RTI301 is comparable to SERENADE OPTIMUM in controlling cucumber powdery mildew, corn rust, and tomato bacterial spot, as measured by untreated control %. In the treatment administration protocol, RTI301 was not indicated to have a negative crop response.
在大豆中進行實驗以確定解澱粉芽孢桿菌RTI301菌株預防及/或減輕大豆中猝死症候群疾病之作用的能力。如下所述,使用RTI301孢子進行實驗。對於實驗,菌株在14L醱酵槽中在2XSG中形成孢子。收集孢子,洗滌且在H2O中濃縮,濃度為1.0×1010CFU/mL。 Experiments were conducted in soybean to determine the ability of B. amyloliquefaciens RTI301 strain to prevent and/or alleviate the effects of sudden death syndrome in soybean. Experiments were performed using RTI301 spores as described below. For the experiment, the strain formed spores in 2XSG in a 14L fermentation tank. Spores were collected, washed with H 2 O and concentrated in a concentration of 1.0 × 10 10 CFU / mL.
大豆中實驗設定如下:1)種子未經處理;2)種子經CRUISERMAXX(殺蟲劑加上殺真菌劑,含有噻蟲嗪(thiamethoxam)、護汰寧加上滅達樂-M;SYNGENTA CROP PROTECTION,INC)與甲基托布津殺真菌劑(其為典型大豆種子處理)組合處理(CRUISERMAXX與甲基托布津組合稱為「化學對照」);以 及3)種子經化學對照處理加上每顆種子接種5.0×10+5cfu菌株RTI301。 The experimental settings in soybean were as follows: 1) the seed was untreated; 2) the seed was passed through CRUISERMAXX (insecticide plus fungicide, containing thiamethoxam, shi ning plus statin-M; SYNGENTA CROP PROTECTION , INC) combined with methyl thiophanate fungicide (which is typical soybean seed treatment) (combined with CRUISERMAXX and methyl thiophanate as "chemical control"); and 3) seed treated with chemical control plus each seed 5.0 x 10 + 5 cfu strain RTI301 was inoculated.
在愛荷華州艾姆斯市接種棒形鐮刀菌(大豆猝死症候群之致病因子)之土壤上進行田間試驗。棒形鐮刀菌在濕潤高壓處理顆粒種子上生長。在顆粒種子經菌絲生長覆蓋之後,種子經空氣乾燥且隨後長大。所製備之地面接種體與大豆種子一起以指定施用率種植以確保更高及更均勻之感染率。雖然症狀本身不明顯,但此疾病在該季早期感染,直至在該季後期。119天後,確定大豆猝死症候群之疾病發病率、疾病嚴重程度及疾病指數。另外,確定各處理之大豆產量。 Field trials were conducted on soils inoculated with Fusarium oxysporum (a causative agent of soy dying syndrome) in Ames, Iowa. Fusarium oxysporum grows on wet high pressure treated granule seeds. After the granule seeds are covered by mycelial growth, the seeds are air dried and then grown. The prepared ground inoculum was planted with soybean seeds at a specified application rate to ensure a higher and more uniform infection rate. Although the symptoms themselves are not obvious, the disease is infected early in the season until the end of the season. After 119 days, the disease incidence, disease severity and disease index of the Sudden Death Syndrome were determined. In addition, the soybean yield of each treatment was determined.
表IX中之結果展示大豆種子用解澱粉芽孢桿菌RTI301接種對疾病控制具有積極作用,如藉由各種參數所量測;且與經單獨化學對照處理之種子相比,對大豆整個產量具有積極作用;且使得與單獨化學對照相比,大豆產量增加7.8%(55.2至59.5蒲式耳/英畝)。 The results in Table IX show that soybean seed vaccination with B. amyloliquefaciens RTI301 has a positive effect on disease control, as measured by various parameters; and has a positive effect on the overall yield of soybean compared to seeds treated with chemical control alone. And resulted in a 7.8% increase in soybean yield (55.2 to 59.5 bushels per acre) compared to the separate chemical controls.
在土壤接種棒形鐮刀菌(大豆猝死症候群之致病因子)之條件下種植119天後測定大豆之疾病發病率、疾病嚴重程度、疾病指數及產量。 Soybean disease incidence, disease severity, disease index, and yield were determined after 119 days of planting under conditions of soil inoculation with Fusarium oxysporum (a causative agent of soybean sudden death syndrome).
研究在番茄田間試驗中進行以確定解澱粉芽孢桿菌RTI301菌株預防及/或減輕植物病原體褐灰黴(灰葡萄孢菌)作用的能力。 The study was conducted in a tomato field trial to determine the ability of the B. amyloliquefaciens RTI301 strain to prevent and/or alleviate the effects of the plant pathogen, Botrytis cinerea (B. cinerea).
對作物進行總共4次施用,其中施用之間的時間間隔為7天。 A total of 4 applications were applied to the crop with a time interval between administrations of 7 days.
調配物:Formulation:
SERENADE MAX以4000g/ha之施用率,對應於2.0×10+14CFU/ha之枯草芽孢桿菌菌株QST713施用。 SERENADE MAX was applied at an application rate of 4000 g/ha corresponding to 2.0 x 10 + 14 CFU/ha of Bacillus subtilis strain QST713.
解澱粉芽孢桿菌RTI301孢子在廢醱酵液(SFB)中且添加酵母提取物,且施用率為約0.01%至0.2%酵母提取物下2.0×10+13CFU/ha。 Spores of Bacillus amyloliquefaciens RTI301 the spent fermentation broth Po (SFB) and the yeast extract, and the application rate is from about 0.01 to 0.2% yeast extract was under 2.0 × 10 +13 CFU / ha.
用SWITCH(嘧菌環胺375g/kg加上護汰寧250g/kg;SYNGENTA CROP PROTECTION,INC)以0.8kg/ha之施用率進行作物之頭兩次施用,接著以1.8kg/ha之施用率兩次施用SIGNUM(白可列267g/kg加上百克敏67g/kg;BAYER CROP SCIENCE,INC)。此在本文中稱為「FARMER方案」。 The first two applications of the crop were carried out with SWITCH (cytosine 375 g/kg plus shining 250 g/kg; SYNGENTA CROP PROTECTION, INC) at an application rate of 0.8 kg/ha, followed by an application rate of 1.8 kg/ha. SIGNIUM was administered twice (white 267 g/kg plus 100 g/67 g/kg; BAYER CROP SCIENCE, INC). This is referred to herein as the "FARMER program."
SILWET L77(HELENA CHEMICAL)為一種非離子型有機聚矽氧界面活性劑,以每100公升噴霧溶液0.15公升之施用率用於所有處理中,除了SERENADE MAX。 SILWET L77 (HELENA CHEMICAL) is a nonionic organopolyfluorene surfactant used in all treatments at an application rate of 0.15 liters per 100 liters of spray solution, except for SERENADE MAX.
實驗設計如下:未經處理之對照(UTC)、FARMER方案+SILWET L77、RTI301+SILWET L77及SERENADE MAX。 The experimental design was as follows: untreated control (UTC), FARMER protocol + SILWET L77, RTI301 + SILWET L77 and SERENADE MAX.
處理施用方法:Treatment application method:
進行兩次獨立田間試驗,各具有4個複本,且兩次試驗結果組合且作為平均值結果呈現。將四次分開處理施用輸送至作物,其中各施用之間的時間間隔為7天。在開始處理前三天,所有小塊土地,包括未經處理之對照,均經SWITCH處理以遏制初始疾病發展。施用噴霧器設定為輸送53加侖/英畝。個別小塊土地使用具有錐形噴嘴之CO2背包式噴霧器以1.7mph(0.8m/s或2.9km/h)之地速噴灑且各噴嘴相隔2吋(5.5cm)。 Two independent field trials were performed, each with 4 replicates, and the two trial results were combined and presented as average results. Four separate treatment applications were delivered to the crop with a time interval between each application of 7 days. Three days before the start of treatment, all small plots, including untreated controls, were treated with SWITCH to contain the initial disease progression. The sprayer was set to deliver 53 gallons per acre. Individual plots were sprayed at 1.7 mph (0.8 m/s or 2.9 km/h) using a CO 2 backpack sprayer with conical nozzles and each nozzle was 2 吋 (5.5 cm) apart.
將所有蕃茄收穫,計數,稱重,且分成可銷售或患病以確定產量。疾病發病率(受褐灰黴影響之果實%)藉由在5個分開日期收穫時評 估各處理之果實來量測,且表示為「疾病壓力曲線下面積」(AUDPC)。疾病發病率及累積產量資料展示於以下表X中。UTC中疾病發病率隨時間之變化展示在以下圖(圖6)中,且展示疾病壓力在兩次試驗過程期間增加,以極高疾病壓力結束,亦即兩次試驗各者感染之果實%分別為51.5%及44.5%。 All tomatoes were harvested, counted, weighed, and divided into marketable or diseased to determine yield. Incidence of disease (% of fruit affected by brown mold) by grading on 5 separate dates Estimate the fruit of each treatment and measure it as "area under the disease stress curve" (AUDPC). Disease incidence and cumulative yield data are shown in Table X below. The change in disease incidence over time in UTC is shown in the following figure (Figure 6), and shows that disease stress increases during the two trials, ending with extremely high disease stress, ie, the % of each infected fruit in each of the two trials It is 51.5% and 44.5%.
結果展示觀測到解澱粉芽孢桿菌RTI301及基於化學活性劑之FARMER方案對蕃茄上褐灰黴(灰葡萄孢菌)控制最佳,且勝過使用具有濃度比RTI301高10倍之枯草芽孢桿菌菌株QST713的SERENADE MAX之處理。 The results showed that it was observed that B. amyloliquefaciens RTI301 and FARMER based on chemical active agents had the best control of B. cinerea (Botrytis cinerea), and it was better than using Bacillus subtilis strain QST713 which was 10 times higher than RTI301. Processing of SERENADE MAX.
在草莓田間試驗中進行研究以確定解澱粉芽抱桿菌RTI301菌株預防及/或減輕植物病原體褐灰黴(灰葡萄孢菌)作用的能力。 A study was conducted in a strawberry field trial to determine the ability of B. amyloliquefaciens RTI301 to prevent and/or alleviate the effects of the plant pathogen, Botrytis cinerea (B. cinerea).
對作物總共進行4次施用,其中施用之間的時間間隔為7天。 A total of 4 applications were applied to the crop with a time interval between administrations of 7 days.
調配物: Formulation :
SERENADE MAX以4000g/ha之施用率,對應於2.0×10+14CFU/ha之枯草芽孢桿菌菌株QST713施用。 SERENADE MAX was applied at an application rate of 4000 g/ha corresponding to 2.0 x 10 + 14 CFU/ha of Bacillus subtilis strain QST713.
解澱粉芽孢桿菌RTI301孢子在廢醱酵液(SFB)中且添加酵母提取物且施用率為約0.01%至0.2%酵母提取物下2.0×10+13CFU/ha。另外, 一種非離子型有機聚矽氧界面活性劑SILWET L77(HELENA CHEMICAL)以每100公升噴霧溶液0.15公升之施用率添加。 Spores of Bacillus amyloliquefaciens RTI301 the spent fermentation broth Po (SFB) and the yeast extract and the application rate is from about .01 to 0.2% yeast extract was under 2.0 × 10 +13 CFU / ha. Further, a nonionic organopolyfluorene surfactant SILWET L77 (HELENA CHEMICAL) was added at an application rate of 0.15 liter per 100 liters of the spray solution.
用SWITCH(嘧菌環胺375g/kg加上護汰寧250g/kg;SYNGENTA CROP PROTECTION,INC)以0.8kg/ha之施用率進行作物之頭兩次施用,接著以1.8kg/ha之施用率兩次施用SIGNUM(白可列267g/kg加上百克敏67g/kg;BAYER CROP SCIENCE,INC)。此在本文中稱為「FARMER方案」。 The first two applications of the crop were carried out with SWITCH (cytosine 375 g/kg plus shining 250 g/kg; SYNGENTA CROP PROTECTION, INC) at an application rate of 0.8 kg/ha, followed by an application rate of 1.8 kg/ha. SIGNIUM was administered twice (white 267 g/kg plus 100 g/67 g/kg; BAYER CROP SCIENCE, INC). This is referred to herein as the "FARMER program."
實驗設計如下:未經處理之對照(UTC)、FARMER方案、RTI301+SILWET L77及SERENADE MAX。 The experimental design is as follows: untreated control (UTC), FARMER protocol, RTI301+SILWET L77 and SERENADE MAX.
處理施用方法: Treatment application method :
進行四個獨立田間試驗,各具有4個複本,且試驗結果組合且作為平均值結果呈現。將四次分開處理施用輸送至作物,其中各施用之間的時間間隔為7天。在開始處理前之三天,所有小塊土地,包括未經處理之對照,均經SWITCH處理以遏制初始疾病發展。施用噴霧器設定為輸送53至107加侖/英畝,視施用時作物密度而定。個別小塊土地使用具有錐形噴嘴之CO2背包式噴霧器以0.56mph(0.25m/s或0.9km/h)之地速噴灑且各噴嘴相隔2吋(5.5cm)。 Four independent field trials were performed, each with 4 replicates, and the test results were combined and presented as average results. Four separate treatment applications were delivered to the crop with a time interval between each application of 7 days. Three days before the start of treatment, all small plots, including untreated controls, were treated with SWITCH to contain the initial disease progression. The application sprayer is set to deliver between 53 and 107 gallons per acre depending on the crop density at the time of application. Individual plots were sprayed at a ground speed of 0.56 mph (0.25 m/s or 0.9 km/h) using a CO 2 backpack sprayer with a conical nozzle and each nozzle was 2 吋 (5.5 cm) apart.
將所有草莓收穫,計數,稱重,且分成可銷售或患病以確定產量。疾病發病率(受褐灰黴影響之果實%)藉由在6個分開日期收穫時評估各處理之果實來量測,且表示為「疾病壓力曲線下面積」(AUDPC)。相對於未經處理之對照的疾病發病率及產量增加%展示於以下表XI中。UTC之疾病發病率隨時間之變化展示在以下圖(圖7),且展示在試驗期間進展之疾病壓力到達感染果實20%至45%之最高疾病壓力。 All strawberries were harvested, counted, weighed, and divided into marketable or diseased to determine yield. The incidence of disease (% of fruit affected by B. cinerea) was measured by assessing the fruits of each treatment at the time of harvest on 6 separate dates, and was expressed as "area under the disease pressure curve" (AUDPC). The % increase in disease incidence and yield relative to the untreated control is shown in Table XI below. The change in UTC disease incidence over time is shown in the following figure (Figure 7) and shows that the disease pressure progressing during the trial reaches the highest disease stress of 20% to 45% of the infected fruit.
以下表XI中之結果展示對所有三個處理,解澱粉芽孢桿菌RTI301、SERENADE MAX及FARMER方案,均觀測到草莓上褐灰黴 (灰葡萄孢菌)比未經處理之對照改善之控制,其中用RTI301處理之產量增加數值上略微更高。 The results in Table XI below show that for all three treatments, B. amyloliquefaciens RTI301, SERENADE MAX and FARMER protocols, all observed on the strawberry (G. cinerea) was better controlled than the untreated control, where the yield increase with RTI301 treatment was slightly higher.
進行實驗以研究在用解澱粉芽孢桿菌RTI301菌株處理植物種子後對玉米中植物生長及發育之作用。 Experiments were conducted to investigate the effects on plant growth and development in maize after treatment of plant seeds with B. amyloliquefaciens RTI301 strain.
特定言之,玉米中實驗設定如下:1)種子未經處理;2)種子經MAXIM(廣譜種子處理殺真菌劑護汰寧作為其活性成分,每顆種子0.0625mg;SYNGENTA CROP PROTECTION,INC)、APRON XL(活性成分滅達樂-M,每顆種子0.0625mg;SYNGENTA CROP PROTECTION,INC)及PONCHO(可尼丁殺蟲劑,每顆種子0.25mg;BAYER CROPSCIENCE,INC)之組合(其為典型玉米種子處理,MAXIM、APRON XL及PONCHO之組合稱為「化學對照」)處理;以及3)種子經化學對照處理加上接種每顆種子5.0×10+5cfu菌株RTI301。在位於伊利諾伊州肖尼敦(Shawneetown,Illinois)之田間位置進行三個試驗,每個試驗每個處理5個複本。3個試驗之條件為天然疾病壓力或土壤接種禾穀鐮刀菌或絲核菌之一。禾穀鐮刀菌及絲核菌分開生長在濕潤高壓處理之顆粒種子上且接著空氣乾燥。用於所選試驗中之乾燥接種體與種子以指定施用率混合,以在種子開始生長時提供感染。 Specifically, the experimental settings in corn are as follows: 1) the seeds are not treated; 2) the seeds are subjected to MAXIM (broad-spectrum seed treatment fungicides as the active ingredient, 0.0625 mg per seed; SYNGENTA CROP PROTECTION, INC) , combination of APRON XL (active ingredient, halal-M, 0.0625 mg per seed; SYNGENTA CROP PROTECTION, INC) and PONCHO (canidin insecticide, 0.25 mg per seed; BAYER CROPSCIENCE, INC) A typical corn seed treatment, a combination of MAXIM, APRON XL, and PONCHO is referred to as a "chemical control"treatment; and 3) a seed is chemically treated plus a seed of 5.0 x 10 + 5 cfu strain RTI301 per seed. Three trials were conducted at the field location in Shawneetown, Ill., with 5 replicates per treatment. The conditions of the three trials were natural disease stress or soil inoculation with one of Fusarium graminearum or Rhizoctonia. Fusarium graminearum and Rhizoctonia solani are separately grown on wet high pressure treated granule seeds and then air dried. The dried inoculum used in the selected assay is mixed with the seed at a specified application rate to provide infection as the seed begins to grow.
田間試驗之平均玉米產量結果(蒲式耳/英畝)呈現在以下表XII中。表XII中之結果展示與經單獨化學對照處理之種子相比,在所有3個條件下接種化學對照加上解澱粉芽抱桿菌RTI301對玉米整個平均產量具有作用。統計學相關性(呈字母)基於P=0.1。值得注意地,與單獨化學對照相比,對於接種絲核菌之試驗,觀測到RTI301加上化學對照下40.1蒲式耳/英畝之極大產量益處。另外,記錄人工接種禾穀鐮刀菌之試驗及天然疾病壓力分別3.3蒲式耳/英畝及8.4蒲式耳/英畝之產量增加。概言之,用化學對照加上RTI301處理使所有3個試驗中產量增加,且使得玉米植物接種絲核菌之試驗的產量極大增加。 The average corn yield results for the field trials (bushel/acre) are presented in Table XII below. The results in Table XII show that inoculation of the chemical control plus B. amyloliquefaciens RTI301 had an effect on the overall yield of corn compared to the seeds treated with the chemical control alone. Statistical relevance (in letters) is based on P = 0.1. Notably, a significant yield benefit of RTI301 plus 40.1 bushels per acre under the chemical control was observed for the test for inoculation of Rhizoctonia compared to the chemical control alone. In addition, the test for the artificial inoculation of Fusarium graminearum and the natural disease stress increased by 3.3 bushels per acre and 8.4 bushels per acre, respectively. In summary, treatment with the chemical control plus RTI 301 resulted in an increase in yield in all three trials and a significant increase in the yield of the maize plant inoculated with Rhizoctonia.
用活體外盤分析進行研究以確定解澱粉芽孢桿菌RTI301菌株增強FRACTURE(CONSUMO EM VERDE(CEV),BIOTECNOLOGIA DAS PLANTAS S.A.,PORTUGAL)控制真菌植物病原體之效能的拮抗能力。FRACTURE為基於植物提取物之調配物,其含有20% BLAD多肽作為活性成分。BLAD多肽為甜羽扇豆(白羽扇豆)中之天然存在之種子儲存蛋白的片段,其藉由對真菌細胞壁造成損害且破壞內細胞膜而作用於易感真菌病原體。 Studies were performed using in vitro disc assay to determine the antagonistic ability of B. amyloliquefaciens RTI301 to enhance FRACTURE (CONSUMO EM VERDE (CEV), BIOTECNOLOGIA DAS PLANTAS S.A., PORTUGAL) to control the efficacy of fungal plant pathogens. FRACTURE is a plant extract based formulation containing 20% BLAD polypeptide as the active ingredient. The BLAD polypeptide is a fragment of a naturally occurring seed storage protein in sweet lupin (white lupin) that acts on a susceptible fungal pathogen by causing damage to the fungal cell wall and disrupting the inner cell membrane.
藉由在869瓊脂培養盤上或在869+1% FRACTURE瓊脂盤上使細 菌分離株及病原性真菌並排生長進行評估對抗植物真菌病原體之拮抗作用的盤分析。在各盤之相對側上,將20μl含有1×108CFU/ml或1×109CFU/ml之RTI301孢子溶液以離盤中心4cm之距離點樣。隨後,將20μl真菌孢子溶液或接種真菌菌絲體之瓊脂塞置於盤中心中。盤在25℃下培育7天,且定期檢查生長行為,諸如生長抑制、生態棲位佔據或無作用。 Disk assays against antagonism of plant fungal pathogens were evaluated by growing bacterial isolates and pathogenic fungi side by side on 869 agar plates or on 869 + 1% FRACTURE agar plates. On the opposite side of each disk, 20 μl of RTI301 spore solution containing 1 × 10 8 CFU/ml or 1 × 10 9 CFU/ml was spotted at a distance of 4 cm from the center of the disk. Subsequently, 20 μl of the fungal spore solution or the agar plug inoculated with the fungal mycelium was placed in the center of the disk. The plates were incubated at 25 ° C for 7 days and the growth behavior was checked regularly, such as growth inhibition, ecological habitat occupancy or no effect.
解澱粉芽孢桿菌RTI301與FRACTURE組合提供之對抗禾穀鐮刀菌及古巴尖孢鐮刀菌的拮抗活性之結果展示在圖8A-8F(禾穀鐮刀菌)及圖9A-9F(古巴尖孢鐮刀菌)。 The results of the antagonistic activity against Fusarium graminearum and Fusarium oxysporum provided by the combination of Bacillus amyloliquefaciens RTI301 and FRACTURE are shown in Figures 8A-8F (Fusarium graminearum) and Figures 9A-9F (Fusarium oxysporum) .
圖8A-8F為展示解澱粉芽孢桿菌RTI301在FRACTURE存在及不存在下控制禾穀鐮刀菌之盤分析的影像。A)869瓊脂盤上禾穀鐮刀菌之生長;B)在20μl分別含有1×108CFU/ml(左)或1×109CFU/ml(右)之RTI301孢子溶液存在下869瓊脂盤上禾穀鐮刀菌之生長;C)869瓊脂盤上20μl分別含有1×108CFU/ml(左)或1×109CFU/ml(右)之解澱粉芽孢桿菌RTI301孢子溶液之生長;D)869+1% FRACTURE瓊脂盤上禾穀鐮刀菌之生長;E)在20μl分別含有1×108CFU/ml(左)或1×109CFU/ml(右)之RTI301孢子溶液存在下869+1% FRACTURE瓊脂盤上禾穀鐮刀菌之生長;F)869+1% FRACTURE瓊脂盤上20μl分別含有1×108CFU/ml(左)或1×109CFU/ml(右)之解澱粉芽孢桿菌RTI301孢子溶液之生長。 Figures 8A-8F are images showing the analysis of B. amyloliquefaciens RTI 301 to control Fusarium graminearum in the presence and absence of FRACTURE. A) Growth of Fusarium graminearum on 869 agar plate; B) 869 agar plate in the presence of 20 μl of RTI301 spore solution containing 1×10 8 CFU/ml (left) or 1×10 9 CFU/ml (right) Growth of Fusarium graminearum; C) 20 μl of 869 agar plate containing 1×10 8 CFU/ml (left) or 1×10 9 CFU/ml (right) growth of Bacillus amyloliquefaciens RTI301 spore solution; D) Growth of Fusarium graminearum on 869+1% FRACTURE agar plate; E) 869+ in the presence of 20 μl of RTI301 spore solution containing 1×10 8 CFU/ml (left) or 1×10 9 CFU/ml (right) Growth of Fusarium graminearum on 1% FRACTURE agar plate; F) 20 μl on 869+1% FRACTURE agar plate containing 1×10 8 CFU/ml (left) or 1×10 9 CFU/ml (right) starch Growth of the spore solution of Bacillus RTI301.
圖9A-9F為展示解澱粉芽孢桿菌RTI301在FRACTURE存在及不存在下控制古巴尖孢鐮刀菌之盤分析的影像。A)869瓊脂盤上古巴尖孢鐮刀菌之生長;B)在20μl分別含有1×108CFU/ml(左)或1×109CFU/ml(右)之RTI301孢子溶液存在下869瓊脂盤上古巴尖孢鐮刀菌之生長;C)869瓊脂盤上20μl分別含有1×108CFU/ml(左)或1×109CFU/ml(右)之解澱粉芽孢桿菌RTI301孢子溶液之生長;D)869+1% FRACTURE瓊 脂盤上古巴尖孢鐮刀菌之生長;E)在20μl分別含有1×108CFU/ml(左)或1×109CFU/ml(右)之RTI301孢子溶液存在下869+1% FRACTURE瓊脂盤上古巴尖孢鐮刀菌之生長;F)869+1% FRACTURE瓊脂盤上20μl分別含有1×108CFU/ml(左)或1×109CFU/ml(右)之解澱粉芽孢桿菌RTI301孢子溶液之生長。 Figures 9A-9F are images showing the analysis of Bacillus cerevisiae RTI301 controlling Fusarium oxysporum in the presence and absence of FRACTURE. A) Growth of Fusarium oxysporum on the 869 agar plate; B) 869 agar plate in the presence of 20 μl of RTI301 spore solution containing 1 × 10 8 CFU/ml (left) or 1 × 10 9 CFU/ml (right) Growth of Fusarium oxysporum on C; 869; 20 μl of a solution on the 869 agar plate containing 1×10 8 CFU/ml (left) or 1×10 9 CFU/ml (right) of Bacillus amyloliquefaciens RTI301 spore solution; D) 869+1% FRACTURE agar plate on the growth of Fusarium oxysporum; E) in 20μl containing 1 × 10 8 CFU / ml (left) or 1 × 10 9 CFU / ml (right) of the RTI301 spore solution Growth of Fusarium oxysporum on the 869+1% FRACTURE agar plate; F) 869+1% FRACTURE agar plate containing 20μl of 1×10 8 CFU/ml (left) or 1×10 9 CFU/ml (right) The growth of the spore solution of Bacillus amyloliquefaciens RTI301.
結果展示869瓊脂培養基中1% FRACTURE之存在不抑制解澱粉芽孢桿菌RTI301之生長。RI301抑制之缺乏與對其他解澱粉芽孢桿菌菌株所觀測形成對比,其中1% FRACTURE之存在抑制菌株生長。此外,雖然添加1% FRACTURE至869培養基減少禾穀鐮刀菌及古巴尖孢鐮刀菌之生長,但未實現真菌生長之全部抑制。然而,解澱粉芽孢桿菌RTI301之存在累加抑制禾穀鐮刀菌與古巴尖孢鐮刀菌之真菌生長。因此,解澱粉芽孢桿菌RTI301可用於增強FRACTURE效能。關於黃麴黴之控制亦觀測到類似結果(資料未展示)。 Results The presence of 1% FRACTURE in 869 agar medium did not inhibit the growth of B. amyloliquefaciens RTI301. The lack of inhibition of RI301 was contrasted with that observed for other strains of B. amyloliquefaciens, where the presence of 1% FRACTURE inhibited strain growth. In addition, although the addition of 1% FRACTURE to 869 medium reduced the growth of Fusarium graminearum and Fusarium oxysporum, no complete inhibition of fungal growth was achieved. However, the presence of B. amyloliquefaciens RTI301 cumulatively inhibits fungal growth of Fusarium graminearum and Fusarium oxysporum. Therefore, B. amyloliquefaciens RTI301 can be used to enhance FRACTURE potency. Similar results were observed for the control of Astragalus membranaceus (data not shown).
先前已報導五種類別豐原素型代謝物及去羥基豐原素型代謝物藉由包括解澱粉芽孢桿菌之微生物物種產生(參見例如Li,Xing-Yu等人,2013,J.Microbiol.Biotechnol.23(3),313-321;Pecci Y等人,2010,Mass Spectrom.,45(7):772-77)。此等代謝物環狀脂肽為亦含有脂肪酸基之環狀肽分子。五種類別豐原素及去羥基豐原素型代謝物稱為A、B、C、D及S。五種類別各者之此等代謝物之主鏈結構以及特定胺基酸序列展示在圖10中。 It has previously been reported that five classes of abundane-type metabolites and dehydroxy-hydroxytoxin-type metabolites are produced by microbial species including Bacillus amyloliquefaciens (see, for example, Li, Xing-Yu et al., 2013, J. Microbiol . Biotechnol. 23 (3), 313-321; Pecci Y et al, 2010 , Mass Spectrom ., 45(7): 772-77). These metabolite cyclic lipopeptides are cyclic peptide molecules which also contain fatty acid groups. The five classes of abundance and dehydroxyl-producing metabolites are called A, B, C, D and S. The backbone structure of these metabolites and the specific amino acid sequence for each of the five classes are shown in Figure 10.
藉由解澱粉芽孢桿菌RTI301產生之豐原素型及去羥基豐原素型代謝物使用UHPLC-TOF MS分析。在M2培養基中30℃下生長6天之後藉由RTI301菌株產生之豐原素型代謝物之分子量與針對豐原素型及去羥基豐原素型代謝物所預期之理論分子量相比。另外,為確定藉由 RTI301菌株產生之各種豐原素型代謝物之胺基酸組成,對先前經由UHPLC-TOF MS鑑別之豐原素型代謝物各者使用LC-MS-MS進行肽測序。以此方式,確定解澱粉芽孢桿菌RTI301產生豐原素A、豐原素B及豐原素C以及去羥基豐原素A、去羥基豐原素B及去羥基豐原素C。意外地,除此等已知之化合物之外,確定RTI301菌株亦產生先前未鑑別之此等化合物衍生物。 The abundance of the amylobacterin and the dehydroxyl-precipitate metabolite produced by B. amyloliquesii RTI301 were analyzed using UHPLC-TOF MS. The molecular weight of the abundane-type metabolite produced by the RTI 301 strain after growth for 6 days at 30 ° C in M 2 medium was compared to the theoretical molecular weight expected for the abundance of the abundance and the dehydroxy-hydroxytoxin-type metabolite. In addition, to determine The amino acid composition of various abundane-type metabolites produced by the RTI 301 strain was subjected to peptide sequencing using LC-MS-MS for each of the abundane-type metabolites previously identified by UHPLC-TOF MS. In this manner, it was determined that B. amyloliquefaciens RTI301 produced abundance of A, abundance of B, and abundance of C, and a dehydroxyl-producin A, a dehydroxyl-producin B, and a dehydroxy-hydroxytoxin C. Surprisingly, in addition to these known compounds, it was determined that the RTI 301 strain also produced previously unidentified compound derivatives.
舉例而言,確定解澱粉芽孢桿菌RTI301菌株產生豐原素樣及去羥基豐原素樣化合物,其中環狀肽鏈之位置8(圖10中稱為X3)之L-異白胺酸經L-甲硫胺酸置換。新類別豐原素及去羥基豐原素在本文中稱為MA、MB及MC,係指A類、B類及C類衍生物,其中圖10中X3處之L-異白胺酸經L-甲硫胺酸置換。新鑑別之分子以粗體展示於圖10及以下表XIII中。 For example, it is determined that the B. amyloliquefaciens RTI301 strain produces a protosanoid-like and dehydroxy-norformin-like compound in which the L-isoleucine acid at position 8 (referred to as X 3 in FIG. 10) of the cyclic peptide chain is L- Methionine replacement. The new classes of protosan and dehydroxylectin are referred to herein as MA, MB and MC, and refer to class A, B and C derivatives, wherein L-isoleucine at X 3 in Figure 10 is L- Methionine replacement. The newly identified molecules are shown in bold in Figure 10 and in Table XIII below.
進一步確定RTI301菌株產生其他類別之先前未鑑別豐原素及去羥基豐原素。在此類別中,豐原素B及去羥基豐原素B之L-異白胺酸(圖10中之位置X3)經L-高半胱胺酸(Hcy)置換。此等先前未鑑別之豐原素及去羥基豐原素代謝物在本文中稱作豐原素H及去羥基豐原素H且展示在圖6及表XIII中。 It was further determined that the RTI301 strain produced other classes of previously unidentified abundance and dehydroxylectin. In this category, fengycin B and activin B to the hydroxyl BBCA L- isoleucine (position of FIG. 10 X 3) via L- homocysteine (of Hcy) replacement. These previously unidentified abundane and dehydroxylectin metabolites are referred to herein as proemin H and dehydroxylectin H and are shown in Figure 6 and Table XIII.
進一步確定RTI301菌株產生其他類別先前未鑑別之豐原素及去羥基豐原素代謝物。在此類別中,環狀肽主鏈結構之位置4(圖10中之位置X1)的胺基酸經L-異白胺酸置換。此等先前未鑑別之代謝物本文中稱為豐原素I及去羥基豐原素I且展示在圖10及表XIII中。 It was further determined that the RTI301 strain produced other classes of previously unidentified abundance and dehydroxylectin metabolites. In this category, the position of the main chain structure of the cyclic peptide 4 (FIG. 10 in the position X 1) is replaced by the amino acid L- isoleucine. These previously unidentified metabolites are referred to herein as aureoline I and dehydroxylectin I and are shown in Figure 10 and Table XIII.
下表XIII中提供先前報導之豐原素型及去羥基豐原素型脂肽及新鑑別之代謝物的胺基酸序列的概述。 An overview of the amino acid sequences of the previously reported proepine-type and dehydroxy-hydroxy-protopin-type lipopeptides and newly identified metabolites is provided in Table XIII below.
表XIII. 解澱粉芽孢桿菌RTI301中豐原素型脂肽之UHPLC-TOF MS鑑別的概述
來自解澱粉芽孢桿菌菌株RTI301之拮抗脂肽自RTI301廢醱酵液分離且展示其保留其活性。 The antagonist lipopeptide from B. amyloliquefaciens strain RTI301 was isolated from the RTI301 waste mash and was shown to retain its activity.
在此實驗中,根據Smyth,TJP等人,2010,「Isolation and Analysis of Lipopeptides and High Molecular Weight Biosurfactants.」:Handbook of Hydrocarbon and Lipid Microbiology,K.N.Timmis(編輯).第3687-3704頁中描述之程序,解澱粉芽孢桿菌RTI301培養物上清液酸化至pH 2。藉由UHPLC-TOF MS分析脂肽之回收,且測試其針對灰葡萄孢菌及禾穀鐮刀菌之拮抗活性。 In this experiment, the procedure described in Smyth, TJP et al., 2010, "Isolation and Analysis of Lipopeptides and High Molecular Weight Biosurfactants.": Handbook of Hydrocarbon and Lipid Microbiology, KNTimmis (eds.), pp. 3687-3704. The B. amyloliquefaciens RTI301 culture supernatant was acidified to pH 2. The recovery of lipopeptides was analyzed by UHPLC-TOF MS and tested for antagonistic activity against Botrytis cinerea and Fusarium graminearum.
RTI301在M2孢子形成培養基中在30℃下培養六天,且廢醱酵液(301-SFB)在18,514g下離心20分鐘以移除孢子。上清液隨後藉由添加濃HCl酸化至pH 2.0,且在4℃下沈澱隔夜。隨後樣品在18,514g下離心20分鐘以獲得固體粗脂肽。球粒凍乾隔夜,溶解於原始體積之M2培養基中,且藉由LCMS分析。提取伊枯草菌素(C14、C15、C16)、表面活性素(C12、C13、C14、C15、C16、C17)及豐原素(A、B、C、D、S)之質量,整合且計算總和,以比較來自各樣品之脂肽的相對豐度。圖11為展示在酸沈澱之後自RTI301廢醱酵液(SFB)回收之脂肽的百分比之圖。術語「301-AP-球粒」及「301-AP-上清液」分別指在離心之SFB進行酸沈澱之後獲得的再懸浮球粒及上清液。圖11中之圖的結果展示脂肽總量之80%藉由酸沈澱回收。對於伊枯草菌素,沈澱35%,而經由酸沈澱方法,59%伊枯草菌素未回收。表面活性素及豐原素使用酸沈澱100%回收。 RTI301 was cultured in M2 sporulation medium at 30 ° C for six days, and spent broth (301-SFB) was centrifuged at 18,514 g for 20 minutes to remove spores. The supernatant was then acidified to pH 2.0 by the addition of concentrated HCl and precipitated overnight at 4 °C. The sample was then centrifuged at 18,514 g for 20 minutes to obtain a solid crude lipopeptide. The pellets were lyophilized overnight, dissolved in the original volume of M2 medium and analyzed by LCMS. Extract the quality of italin (C14, C15, C16), surfactant (C12, C13, C14, C15, C16, C17) and agrosperm (A, B, C, D, S), integrate and calculate the sum To compare the relative abundance of lipopeptides from each sample. Figure 11 is a graph showing the percentage of lipopeptides recovered from RTI301 spent broth (SFB) after acid precipitation. The terms "301-AP-spherule" and "301-AP-supernatant" refer to resuspended pellets and supernatant obtained after acid precipitation of SFB in centrifugation, respectively. The results in the graph of Figure 11 show that 80% of the total amount of lipopeptide is recovered by acid precipitation. For the imipenin, 35% was precipitated, and by the acid precipitation method, 59% of the avermectin was not recovered. Surfactant and abundance are 100% recovered using acid precipitation.
為證實LCMS結果與拮抗活性相關,用藉由LCMS分析之相同樣品進行生物分析。對於該生物分析,20μl灰葡萄孢菌或禾穀鐮刀菌接種體在培養盤中間點樣,其中301-AP-球粒樣品在10μl、20μl及40μl等分試樣中點樣。對於灰葡萄孢菌及禾穀鐮刀菌盤,分別在30℃下培育5天或7天之後,檢查抗真菌活性。結果展示酸沈澱之樣品(301- AP-球粒)與起始廢醱酵液具有類似程度之針對灰葡萄孢菌與禾穀鐮刀菌之拮抗活性。生物分析結果與LCMS資料良好相關。 To confirm that the LCMS results correlate with the antagonistic activity, bioassays were performed using the same samples analyzed by LCMS. For this bioassay, 20 [mu]l of Botrytis cinerea or Fusarium graminearum inoculum was spotted in the middle of the plates, with 301-AP-spherule samples spotted in 10 [mu]l, 20 [mu]l and 40 [mu]l aliquots. For the Botrytis cinerea and Fusarium graminearum disks, the antifungal activity was examined after incubation at 30 ° C for 5 or 7 days, respectively. Results show samples of acid precipitation (301- AP-spherulites have similar degrees of antagonistic activity against Botrytis cinerea and Fusarium graminearum in the same degree as the starting waste mash. Bioanalytical results are well correlated with LCMS data.
本文中引用之所有公開案、專利申請案、專利及其他參考文獻均以全文引用的方式併入本文中。 All publications, patent applications, patents, and other references cited herein are hereby incorporated by reference in their entirety.
雖然以上標的物已以說明及實例方式出於清楚瞭解之目的相當詳細地描述,但熟習此項技術者應瞭解某些改變及修改可在申請專利範圍之範疇內進行。 Although the above-described subject matter has been described in considerable detail for the purpose of illustration and example, it will be understood by those skilled in the art that certain changes and modifications can be made within the scope of the claimed invention.
1. 食品工業發展研究所生物資源保存及研究中心;105年04月26日;BCRC 910728 1. Center for Biological Resource Conservation and Research, Institute of Food Industry Development; April 26, 105; BCRC 910728
1. 美國:American Type Culture Collection(ATCC);2014年04月17日;PTA-121165 1. United States: American Type Culture Collection (ATCC); April 17, 2014; PTA-121165
<110> 美商富曼西公司 <110> American Fumanxi Company
<120> 有益於植物生長及治療植物疾病之解澱粉芽孢桿菌RTI301組合物及使用方法 <120> Bacillus amyloliquefaciens RTI301 composition and method for using the same for plant growth and treatment of plant diseases
<130> 61083-PCT <130> 61083-PCT
<160> 2 <160> 2
<170> PatentIn version 3.5 <170> PatentIn version 3.5
<210> 1 <210> 1
<211> 1554 <211> 1554
<212> DNA <212> DNA
<213> 解澱粉芽孢桿菌 <213> Bacillus amyloliquefaciens
<400> 1 <400> 1
<210> 2 <210> 2
<211> 3246 <211> 3246
<212> DNA <212> DNA
<213> 解澱粉芽孢桿菌 <213> Bacillus amyloliquefaciens
<400> 2 <400> 2
Claims (95)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW105115448A TW201740812A (en) | 2016-05-18 | 2016-05-18 | Bacillus amyloliquefaciens RTI301 compositions and methods of use for benefiting plant growth and treating plant disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW105115448A TW201740812A (en) | 2016-05-18 | 2016-05-18 | Bacillus amyloliquefaciens RTI301 compositions and methods of use for benefiting plant growth and treating plant disease |
Publications (1)
Publication Number | Publication Date |
---|---|
TW201740812A true TW201740812A (en) | 2017-12-01 |
Family
ID=61229994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW105115448A TW201740812A (en) | 2016-05-18 | 2016-05-18 | Bacillus amyloliquefaciens RTI301 compositions and methods of use for benefiting plant growth and treating plant disease |
Country Status (1)
Country | Link |
---|---|
TW (1) | TW201740812A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112029693A (en) * | 2020-09-30 | 2020-12-04 | 河南省农业科学院植物保护研究所 | Bacillus amyloliquefaciens with growth promoting effect and capable of preventing and treating sesame stem blight and fusarium wilt and application thereof |
TWI726335B (en) * | 2019-06-17 | 2021-05-01 | 國立臺灣大學 | Composition for improving the ability of plants to resistance diseases |
CN115074278A (en) * | 2022-06-24 | 2022-09-20 | 浙江大学 | Biocontrol strain sx27 and application thereof in prevention and treatment of rice grain smut |
-
2016
- 2016-05-18 TW TW105115448A patent/TW201740812A/en unknown
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI726335B (en) * | 2019-06-17 | 2021-05-01 | 國立臺灣大學 | Composition for improving the ability of plants to resistance diseases |
CN112029693A (en) * | 2020-09-30 | 2020-12-04 | 河南省农业科学院植物保护研究所 | Bacillus amyloliquefaciens with growth promoting effect and capable of preventing and treating sesame stem blight and fusarium wilt and application thereof |
CN112029693B (en) * | 2020-09-30 | 2022-06-07 | 河南省农业科学院植物保护研究所 | Bacillus amyloliquefaciens with growth promoting effect and capable of preventing and treating sesame stem blight and fusarium wilt and application thereof |
CN115074278A (en) * | 2022-06-24 | 2022-09-20 | 浙江大学 | Biocontrol strain sx27 and application thereof in prevention and treatment of rice grain smut |
CN115074278B (en) * | 2022-06-24 | 2023-06-13 | 浙江大学 | Biocontrol strain sx27 and application thereof in preventing and controlling rice grain smut |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW201639462A (en) | Bacillus amyloliquefaciens RTI301 compositions and methods of use for benefiting plant growth and treating plant disease | |
KR102465155B1 (en) | Bacillus thuringiensis RTI545 composition and method of use for plant growth benefit and plant pest control | |
JP6758296B2 (en) | Microbial compositions that benefit plant growth and treat plant diseases | |
CN113271780B (en) | Bacillus amyloliquefaciens FCC1256 composition and method for controlling plant pathogens | |
TW201639461A (en) | Bacillus amyloliquefaciens RTI472 compositions and methods of use for benefiting plant growth and treating plant disease | |
TW201637570A (en) | Bacillus licheniformis RTI184 compositions and methods of use for benefiting plant growth | |
US20180020676A1 (en) | Bacillus velezensis rti301 compositions and methods of use for benefiting plant growth and treating plant disease | |
JP2018502111A5 (en) | Bacillus amyloliquefaciens (BACILLUS AMYLOLIQUEFACIENS) RTI 301 composition | |
US20160183532A1 (en) | Microbial compositions for use in combination with soil insecticides for benefiting plant growth | |
TW201639460A (en) | Composition and method using insecticide and Bacillus strain D747 | |
TW201740812A (en) | Bacillus amyloliquefaciens RTI301 compositions and methods of use for benefiting plant growth and treating plant disease | |
TWI737609B (en) | Microbial compositions and methods of use for benefiting plant growth and treating plant disease | |
TW201740808A (en) | Bacillus amyloliquefaciens RTI472 compositions and methods of use for benefiting plant growth and treating plant disease | |
TW201709823A (en) | Bacillus licheniformis RTI184 compositions and methods of use for benefiting plant growth | |
KR102791435B1 (en) | Bacillus amyloliquefaciens FCC1256 composition and method for controlling plant pathogens |